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Abstract 
Angelicoin A (I), angelicoin B (II), cristatic acid (III) and grifolic acid (IV) (Figure 
A1) are members of the resorcylate family of natural products which contain a common 6-
alkyl-2,4-dihydroxy benzoic acid core (β-resorcylate unit). 
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Figure A1 
The total syntheses of angelicoin A (I) and angelicoin B (II) from 2,2,6-trimethyl-4H-
1,3-dioxin-4-one V are reported using late stage aromatisation reactions via diketo-
dioxinones as advanced intermediates. In the case of angelicoin A (I), biomimetic 
aromatisation was coupled with a highly regioselective palladium(0)-catalysed 
decarboxylative prenyl migration as the key step (Scheme A1).
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Scheme A1 
The palladium(0)-catalysed decarboxylative, prenylation and aromatisation sequence 
furnished both linear VII and branched adducts VI. Extensive optimisation of conditions to 
improve the ratio of linear to branched adducts involved the screening of palladium catalysts, 
ligands, solvents, reactions times, temperature and organic and inorganic bases.
(a)(c) 
The regioselectivity of this novel palladium(0)-catalysed decarboxylative prenyl 
migration was determined unambiguously through X-ray crystallographic studies.
(a)(c) 
Furthermore, an intermolecular mechanism is proposed after thorough mechanistic studies 
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including cross over and variable concentration experiments, base studies, and 
regioselectivity investigations. 
Two synthetic approaches towards the total synthesis of cristatic acid methyl ester are 
reported. The first approach investigated a one-pot reaction to install the furan moiety VIII 
(Scheme A2), via a Nef reaction, deprotection, decarboxylation and furan formation. 
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Scheme A2 
The second approach attempted to perform a one-pot Pd(0)-decarboxylative 
allylation, TMSE deprotection and aromatisation to provide the core of cristatic acid IX 
(Scheme A3). 
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Scheme A3 
Finally, studies towards the total synthesis of grifolic acid (IV) are reported utilising 
the palladium(0)-catalysed decarboxylative allyl migration and aromatisation sequence. 
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Abbreviations 
 delta; change in; heat to reflux 
 chemical shift 
(–) rotates a plane of light clockwise 
(+) rotates a plane of light anti-clockwise 
° C degrees Celsius 
Å Angstrӧm; bond lengths (X-ray Crystallography) 
AAA asymmetric allylic alkylation 
Anal. analytical 
app.  apparent 
aq. aqueous 
Ar aromatic 
ATP adenosine triphosphate 
B base 
BINAP 2,2'-bis(diphenylphosphino)-1,1'-binaphthyl 
Bn benzyl 
Bpy 2,2’-bipyridine 
br. broad 
Bt benzotriazole 
calc. calculated 
CAN ceric ammonium nitrate 
cat. catalytic 
CDI 1,1'-carbonyldiimidazole 
CDK cyclin-dependent kinase 
CI chemical ionisation 
cm
-1
 reciprocal centimetre 
COD 1,5-cyclooctadiene 
conc. concentration 
COSY correlation spectroscopy 
Cp cyclopentadienyl 
d doublet 
d6 deuterated 
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DDQ 2,3-dichloro-5,6-dicyano-1,4-benzoquinone 
DEPT distortionless enhancement by polarization transfer 
DIAD diisopropyl azodicarboxylate 
DIBAL-H diisobutylaluminium hydride 
DIOP 2,3-O-isopropylidene-2,3-dihydroxy-1,4 
bis(diphenylphosphino)butane 
DIPEA N,N-diisopropylethylamine 
DMAP 4-dimethylaminopyridine 
DME dimethoxyethane 
DMF dimethylformamide 
DMI 1,3-dimethyl-2-imidazolidinone 
DMPU 1,3-dimethyl-3,4,5,6-tetrahydro-2(1H)-pyrimidinone 
DMSO dimethyl sulphoxide 
dppf 1,1'-bis(diphenylphosphino)ferrocene 
DTBP di-tert-butyl peroxide 
DUPHOS 1,2-bis[(2R,5R)-2,5-diisopropylphospholano]benzene 
E entgegen (on opposite sides) 
EI electron impact 
equiv. equivalent 
ESI electrospray ionisation 
et al. et alii (and others) 
EWG electron withdrawing group 
FTIR Fourier transform infrared spectroscopy 
g gram 
GC gas chromatography 
GPR G- protein coupled receptor 
GSK3 glycogen synthase kinase 3 
h hour 
HBTU O-benzotriazole-N,N,N',N'-tetramethyl-uronium-hexafluoro-
phosphate 
HMBC heteronuclear multiple bond correlation 
HMPA hexamethylphosphoramide 
HRMS high resolution mass spectroscopy 
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HSP90 Heat Shock Protein 90 
HSQC heteronuclear single quantum correlation 
HWE Horner Wadsworth Emmons 
Hz hertz 
IR infrared 
J coupling constant (in NMR) 
L litre 
LDA lithium diisoproplyamine 
LiHMDS lithium bis(trimethylsilyl)amide 
m  milli; multiplet (NMR spectroscopy); metre; medium (IR 
spectroscopy); meta 
M molarity; Mega 
m.p. melting point 
MAP mitogen-activated protein 
M-CoA malonyl coenzyme A 
m-CPBA meta-chloroperoxybenzoic acid  
Mes mesitylene 
min minute 
mol mole 
MOM methoxy methyl ether 
MOP 2-(diphenylphosphino)-2′-methoxy-1,1′-binaphthyl 
MS mass spectroscopy; molecular sieves 
MsCl methanesulphonyl chloride 
n nano 
NIS N-iodosuccinimide 
NMR nuclear magnetic resonance 
NOESY Nuclear Overhauser Effect Spectroscopy 
Nu nucleophile 
Pd2(dba)3 tris(dibenzylideneacetone)dipalladium(0) 
PG protecting group 
pH measure of the activity of the (solvated) hydrogen ion 
PHOX phosphinooxazolines 
pKa acid dissociation constant at logarithmic scale 
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PMB p-methoxybenzyl ether 
ppm parst per million 
Pr prenyl 
py pyridine 
QUINAP 1-(2-diphenylphosphino-1-naphthyl)isoquinoline 
R rectus (clockwise rotation in descending order of priority) 
RALs resorcylic acid lactones 
RBR Ramburg Bäcklund Reaction 
RCM ring closing metathesis 
Re Re face (leading to (R) stereocentre) 
Red-Al sodium bis(2-methoxyethoxy)aluminium hydride 
Rf retention factor 
Rochelle’s salt potassium sodium tartrate 
RSM residual starting material 
rt room temperature 
s second; single (NMR spectroscopy); strong (IR spectroscopy) 
S sinister (anticlockwise rotation in descending order of priority) 
SEM 2-(trimethylsilyl)ethoxymethyl ether 
sh. sharp 
Si Si face (leading to (S) stereocentre) 
soln. solution 
t triplet; time; tert 
TBAF tetra-n-butylammonium fluoride 
TBDPS tert-butyldiphenylsilyl ether 
TBS tert-butyldimethylsilyl ether 
TES triethylsilyl ether 
TFA trifluoroacetic acid 
THF tetrahydrofuran 
TIPS triisopropylsilyl ether 
TLC thin layer chromatography 
TMEDA tetramethylethylenediamine 
TMS trimethylsilyl ether 
TMSE 2-(trimethylsilyl)ethyl ether 
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TsOH p-toluenesulfonic acid 
UV ultraviolet 
vmax strong and selected absorbances (in IR) 
w weak 
wt. % weight percentage 
Z Zusammen (on the same side) 
α alpha 
β beta 
γ gamma 
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1 Introduction 
1.1 Resorcylic Acid Lactones (RALs) 
Resorcylic Acid Lactones (RALs) are polyketide natural products which contain a common 
β-resorcylate unit 1[1] (Figure 1). RALs have been known for decades since the isolation of 
radicicol (2) in 1953,
[2]
 followed by zearalenone (3) in 1962.
[3][4] 
 
OR1
O
R2HO
OH
O
Cl
HO
OH O
O
O
O
OOH
HO O
radicicol (2)
zearalenone (3)
 -resorylate unit 1
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O
O
OH
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aigialomycin D (4)
HO
OH O
OH
O
cristatic acid (5)
O
OH
HO
O
angelicoin A (6)
O
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MeO
O
angelicoin B (7)
OH
OH
O
MeO
amorfrutin A (8)
O
O
MeO
HO
O
mycophenolic acid (9)
OH
Macrocycl ic RALs Ter penoidal RALs
used in Chinese medicine to treat typhoid and dysentery .
ant ibacterial, haemoly tic proper ties, cy totoxic
ant imicrobial, anti-inf lammatory
antimalar ial, CDK inhibitor
HSP90 inhibitor
estrogen agonist immunosuppressant
 
Figure 1: Resorcylic Acid Lactones (RALs) 
RALs can vary widely in their structure, for example radicicol (2),
[2] 
zearaleone (3)
[3][4] 
and 
aigialomycin D (4)
[5] 
contain the β-resorcylate unit 1, fused to a macrocyclic ring.[1] While 
cristatic acid (5),
[6][7] 
angelicoin A (6),
[8][9] 
angelicoin B (7),
[8][9] 
amorfruitin A (8)
[10] 
and 
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mycophenolic acid (9)
[11] 
contain the β-resorcylate unit 1 attached to terpenoid-like moieties. 
The resorcylate family of natural products have served as synthetic testing grounds for novel 
and elegant methodologies from academic groups for over the past 50 years (see Section 1.4 
below).
[12]
 Additionally, the pharmaceutical industry
[13][14]
 (see Section 1.3 below for more 
information regarding mycophenolic acid (9)) have shown a great interest in the resorcylate 
family of natural products due to their wide array of biological properties (Figure 1).
[15][16][17]
 
 
1.2 Biological Properties of RALs 
The RAL family of natural products portray a high diversity of biological properties. 
Radicicol (2) isolated from Humicola fuscoatrais
[2]
 is a potent and selective inhibitor of Heat 
Shock Protein 90 (HSP90).
[18] 
HSP90 is upregulated in cancer cells and radicicol (2) is a 
competitive ligand for the ATP binding site.
[17] 
Some RALs such as radicicol (2) also inhibit 
MAP kinases (MAP kinases regulate a cell’s response to its environment).[16]  
Aigialomycin D (4), isolated in 2002 from mangrove fungus Aigialus parvus BCC 5311
[5]
 has 
moderate antimalarial activity (low μM) but is also cytotoxic at similar concentrations.[5][16] 
Additionally, it shows moderate kinase inhibition (low μM) of CDK1, CDK5 and 
GSK3.
[19][20] 
Zearaleone (3) isolated from Fusarium graminearum
[3][4]
 has estrogen agonistic 
properties and the macrocyle is able to adopt a conformation which mimics one of a 
steroid.
[14][16]  
 
Angelicoin A (6) and angelicoin B (7) were isolated from the roots of the herb 
Pleurospermum angelicoides, found in the Himalayan mountains, in 2006 by Baba et al.
[9] 
The roots are used locally in Chinese medicine to treat typhoid and dsyentry.
[8] 
Amorfrutin A 
(8) was isolated in 1981 by Mitscher et al., from the ethanolic extracts of the shrub Amorpha 
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fruticosa originating in North America, China and Korea.
[10] 
Amorfrutin A (8) exhibits 
narrow spectrum antimicrobial activity against Gram-positive and acid-fast 
microorganisms.
[10]  
Cristatic acid (5) was isolated in 1981 by Steglich et al. from the mushroom Albatrellus 
cristatus.
[6] 
It has been shown to have antibiotic activity against gram-positive bacteria, 
Haemolytic function and to have an inhibitory effect on the Ehrlich carcinoma.
[7][21] 
 
1.3 Mycophenolic Acid (9)  
Mycophenolic acid (9) (Figure 1) was originally discovered in 1893 by Bartolomeo Gosio 
and utilised as an antibiotic treatment against Bacillus anthracis.
[22] 
Subsequently, it has been 
shown to possess many valuable biological properties such as antiviral,
[23] 
antifungal,
[24] 
antibacterial,
[25] 
antitumour
[26]
 and antipsoriasis.
[27] 
It is famously regarded as an 
immunosuppressant in kidney, heart and liver transplants and is currently marketed under two 
brands CellCept™ (Mycophenolate Mofitil) by Roche and Myfortic™ (Mycophenolate 
Sodium) by Novartis.
[13] 
 
CellCept™ and Myfortic™ work by inhibiting IMPDH (Inosine Monophosphate 
Dehydrogenase) in purine biosynthesis which is necessary for the growth of T and B cells. 
Suppressing these cells reduces the risk of organ rejection following a transplant. However, 
suppression also weakens the body’s ability to defend against infection.[13] Myfortic™ and 
CellCept™ can also be used in the treatment of autoimmune diseases, such as systemic lupus 
erythematosus and pemphigus vulgaris.
[28] 
Mycophenolic acid (9) exemplifies how valuable 
some resorcylate natural products can be within the pharmaceutical industry. 
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1.4 Total Syntheses of RALs 
1.4.1 Danishefsky’s Approach to Cylcoproparadicicol (10)  
Danishefsky et al. published the total synthesis of cycloproparadiciol (10) in 2004, utilising a 
Diels-Alder reaction to put in place the resorcylate core 11.
[29] 
The Diels-Alder reaction took 
place between cyclic diene 12 and ynolide 13 (Scheme 2).  
The synthesis of ynolide 13 is shown below in Scheme 1. Ring Closing Metathesis (RCM) 
was unsuccessful under standard conditions, presumably due to the presence of the acetylene 
(owing to its linear form thus preventing cyclisation).
[29][30] 
Danishefsky et al. employed 
dicobalt to act as a protecting group for the alkyne 14 enabling the correct geometry to 
facilitate cyclisation. Complexion of dicobalt afforded complex 15, RCM followed by 
decomplexation then furnished macrocycle 13 in 50% yield over 2 steps. The next step in the 
synthesis involved the Diels-Alder reaction between ynolide 13 and cyclic diene 12 (Scheme 
2). 
OO
H
H
OTBS
14 15
Co2(CO)8,
toluene
100%
O O
H
H
OTBS
(OC)3Co
Co
(CO)3
N N
Mes Mes
Ru
Ph
PCy3
Cl
Cl
CH2Cl2, rt
O O
H
H
OTBS
(OC)3Co
Co
(CO)3
CAN, DTBP, Me2CO
-10 oC, 50% over 2 steps
O O
H
H
OTBS
13  
Scheme 1: Synthetic Route to Ynolide 13
[29]
 
Heating ynolide 13 and cyclic diene 12 facilitated a Diels-Alder reaction; this was followed 
by selective desilyation of the TMS groups by silica gel chromatography, providing 
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resorcylate 11 in an excellent 78% yield. The final steps in the total synthesis are illustrated 
below in Scheme 3.  
O O
H
H
OTBS
13
OTMS
TMSO
12
O O
HO
OH
OTBS
H
H
11
160 oC, neat;
then silica gel, 78%
 
Scheme 2: Diels-Alder Reaction of Ynolide 13 with Cyclic Diene 12
[29]
 
It was necessary to protect the two phenolic groups as acetates 16 in order to enable oxidation 
of the secondary alcohol to a ketone. Thus, following phenolic protection, silylether 16 was 
deprotected permitting oxidiation of the secondary alcohol to a ketone. The acetates were 
then deprotected, chlorination followed furnishing cycloproparadicicol (10) in a 70% 
yield.
[29] 
This synthesis exhibits two excellent methodologies which enabled gram quantities 
of cycloproparadicicol (10) to be produced for biological testing.
[29] 
Ac2O, DMAP, DMF
87%
O O
HO
OH
OTBS
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O O
AcO
OAc
OTBS
H
H
16
1. HF/py, THF
2. Dess-Martin periodinane,
CH2Cl2, 0
oC to rt, 80% over 2 steps
3. 5% NaHCO3, MeOH, 92%
O O
HO
OH
O
H
H SO2Cl2, CH2Cl2, 0
oC
O O
HO
OH
O
H
H
70%
Cl
O O
HO
OH
O
H
H
27%
Cl
cycloproparadicicol (10)
11
 
Scheme 3: Final Steps in the Synthesis of Cycloproparadiciol (10)
[29]
 
The synthetic route exemplifies the excellent targets that RALs can be to academic groups. 
This is shown again in the total synthesis of aigiaolmycin D (4) by Harvery et al. (Section 
1.4.2).
[31]
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1.4.2 Harvey’s Approach to Aigialomycin D (4) 
Harvey et al. published the total synthesis of aigialomycin D (4) in 2008.
[31] 
Two of the key 
steps in the total synthesis, RCM and a Ramburg-Bäcklund reaction (RBR) are shown below 
in Scheme 4.  
Esterification between alcohol 17 and carboxylic acid 18 was accomplished utilising 
Mitsunobu conditions and provided ester 19 in a 94% yield. Oxidation of the sulphur moiety 
afforded sulphone 20 and RCM furnished macrocycle 21 in an 86% yield. A RBR was then 
performed which enabled the formation of olefin 22. Finally, deprotection afforded 
aigialomycin D (4).
[31] 
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Scheme 4: Synthesis of Aigiaolmycin D (4)
[31] 
 
1 Introduction   
32 
 
1.5 Traditional Methods for the Formation of RALs 
Sections 1.1 to 1.4 have discussed why RALs are excellent synthetic targets. However, most 
RAL syntheses begin with a preformed aromatic unit, such as resorcylic acid (23) or 
orseillinic acid (24) (Figure 2). The remainder of the RAL is then usually constructed onto 
this unit.  
OH
O
HO
OH
OH
O
HO
OH
orsellinic acid (24)resorcylic acid (23)  
Figure 2: Resorcylic Acid (23) and Orselinic Acid (24)  
This is exemplified in the total synthesis of radicicol (2) by Danishefsky et al.
[32] 
which began 
with the units shown in Scheme 5. Unit 25, is derived from orseillinic acid (24) through 
protection of the two phenolic groups and a radical chlorination of the aromatic methyl. 
O
Cl
HO
OH O
O
O
O OH
Cl
OR
RO
HO
O
H
H
S
S
Li
Macrolactonisation
RCM
Alky lation
R= Protecting Group
(2) 25
 
Scheme 5: Retrosynthetic Analysis of Radicicol (2)
[32]
 
Beginning a total synthesis with orseillinic (24) or resorcylic acid (23) is a good method, 
however, often requires the use of protecting groups which can prove difficult to remove at 
the end of the synthesis. This is evident in Danishefsky’s total synthesis of 
cycloproparadicicol (Section 1.4.1) whereby the addition and removal of protecting groups 
added an extra two steps to the total synthesis.
[29] 
For these reasons, Barrett et al. have 
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employed a biomimetic approach for the synthesis of RALs inspired by the biosynthesis of 
polyketides. 
1.6 The Biosynthesis of Polyketides 
The biosynthesis hypothesis was first postulated in the early 20
th
 century by Collie.
[33] 
Collie’s ideas were later revived and formulated by Birch in the 1960’s into the polyketide 
hypothesis, which is still accepted today.
[34] 
The biosynthesis of a polyketide chain involves a 
number of decarboxylative Claisen thioester condensation reactions involving malonyl 
coenzyme A. Further reactions and reductive chemistries furnish the RAL 26 (Scheme 
6).
[16][35][36] 
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Scheme 6: Biosynthesis of a Polyketide and Aromatisation to an RAL 
The biosynthetic pathway is catalysed by polyketide synthases which are large multidomain 
enzymes found in a variety of fungal strains.
[16] 
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1.7 Cyclisation of Polyketides 
Inspired by the biosynthesis of polyketides Barrett et al. studied the work of Harris & 
Harris
[37]
 for a synthetic method to cyclise polyketides. Harris et al. demonstrated that simple 
polyketide metabolites could undergo cyclisations under different pHs in order to generate 
different aromatic heterocycles (Scheme 7).
[37]  
Harris et al. showed that triketoacid 27 can undergo an aldol reaction over a pH range of 4 to 
strongly basic. Intermediate 28 can be seen under basic conditions but aromatises quickly to 
form resorcyclic acid 29. Treatment of triketoacid 27 with HF under anhydrous conditions 
provided 4-pyrone 32 and under acetic anhydride, triketoacid 27 formed enol lactone 31 
(Scheme 7).
[37] 
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Scheme 7: Cyclisation of Polyketides
[37]
 
Barrett et al. were interested in the transformation of tiketoacid 27 into resorcylic acid 29. 
The reaction conditions were studied further and optimised, discovering that careful pH 
control was essential for efficient aromatisation.
[38]
 However, it was apparent that triketoacids 
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27 were not especially stable under ambient conditions and thus would be difficult to utilise 
and carry through in a total synthesis. Barrett et al. therefore searched for a method to 
‘protect’ the polyketide chain and were enthused by the work of Hyatt et al.[39] 
 
1.8 Dioxinone in Total Synthesis 
In 1984, Hyatt et al. demonstrated that under elevated temperatures dioxinone 33 performs a 
retro Diels-Alder reaction to generate a highly electrophilic ketene 34 which can then be 
trapped by a range of nucleophiles such as alcohols and amines to provide the corresponding 
β-keto esters or β-keto amides (Scheme 8).[39]  
O O
O
 O
C
O
NuH
Nu
O O
33 34  
Scheme 8: Opening of Dioxinone 33 
Dioxinone 33 has been exploited in a number of total syntheses
[40]
 demonstrating its practical 
use. For example Paquette et al. utilised dioxinone 33 in the total synthesis of (+)-
ikarugamycin in 1989.
[41] 
Addition of the phosphorous dioxinone 36 provided vinyl 
dioxinone 37. Upon heating, 37 underwent a retro Diels-Alder reaction forming a ketene 
enabling macrocyclisation to furnish macrocyle 38 (Scheme 9).
[41] 
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Scheme 9: Dioxinone 36 in the Total Synthesis of (+)-Ikarugamycin
[41]
 
In essence dioxinone 33 can be envisaged as a protected keto-ester which facilitates 
polyketide chains to be utilised and carried through in a total synthesis. Utilising the work of 
Birch et al.,
[34] 
Harris et al.
[37] 
and Hyatt et al.
[39] 
the Barrett group were able to devise a 
biomimetic retrosynthesis for the construction of resorcylate natural products.  
 
1.9 Retrosynthesis for the Construction of Resorcylate Natural Products 
Barrett et al. established that the resorcylate core 39 could be available from aromatisation of 
triketo-ester 10 which could in turn be obtained from heating triketo-ketene 41 in the 
presence of an alcohol. Finally, triketo-ketene 41 could be afforded from diketo-dioxinone 42 
by thermolysis (Scheme 10). Following studies within the Barrett group and reaction 
optimisation, two main routes for the synthesis of the resorcylate core were established 
(Section 1.10).  
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Scheme 10: Retrosynthesis for the Construction of Resorcylate Natural Products 
 
1.10 Synthesis of the Resorcylate Core 39 
The two routes for the synthesis of the resorcylate core 39 are shown in Scheme 11. Route A 
involves thermolysis of diketo-dioxinone 42 to generate ketene 41 which is then trapped with 
alcohol 43 to afford triketo-ester 40. Cyclisation under basic conditions furnishes ester 44, 
acidic mediated dehydration then affords the resorcylate core 39.
[42][43] 
Standard conditions 
utilised within the Barrett group for this transformation (Route A) begin by heating diketo-
dioxinone 42 in toluene with the respective alcohol 43. Alternatively, this first step can take 
place in a sealed tube with the addition of 4 Å molecular sieves. Following consumption of 
diketo-dioxinone 42, the reaction mixture is concentrated by rotary evaporation and 
redissolved in an alcoholic solvent such as MeOH or i-PrOH. An inorganic base is then added 
to the solution such as CsOAc, Cs2CO3 or K2CO3 to facilitate the cylcisation. Finally, TFA, 
acetic acid or HCl is added into the reaction mixture to enable dehydration to take place, 
furnishing the resorcylate core 39.
[42][43]
 
Route B proceeds by treating diketo-dioxinone 42 with base in order to facilitate cyclisation, 
dehydration then occurs utilising an acidic work-up, generating an isopropylidene protected 
resorcylate 45 which can be further substituted to afford the resorcylate natural product.
[43] 
Standard conditions utilised in the Barrett group for Route B include stirring diketo-
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dioxinone 42 in CH2Cl2 with Et3N or alternatively in MeOH with Cs2CO3. An acidic workup 
then takes place in order to provide resorcylate 45.
[43]
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Scheme 11: Two Synthetic Routes for the Formation of the Resorcylate Core 
The Barrett approach for the formation of the resorcylate core has been named the ‘Late-
Stage Aromatisation Strategy.’ 
 
1.11 Application of the Late-Stage Aromatisation Strategy  
The Barrett group have demonstrated the large applicability of the late-stage aromatisation 
strategy in the total synthesis of resorcylate natural products.
[44] 
One recent example was in 
the total synthesis of cruentaren A (46) by Marianne Fouché (Scheme 12).
[45]
 
The synthesis begins with heating diketo-dioxinone 47 to facilitate ketene formation and then 
trapping with the alcohol 48. Cyclisation under basic conditions and acid mediated 
dehydration afforded resorcylate 49. Methylation of phenol 49 was achieved in 82% yield 
and this allowed alkyne metathesis furnishing alkyne 50 in an excellent 75% yield. PMB 
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deprotection afforded an alcohol which underwent azide formation via a Mitsunobu reaction. 
Subsequent Staudinger reduction efficiently gave amine 51. Amide bond formation between 
amine 51 and carboxylic acid 52 was achieved using HBTU as the coupling reagent. Mono-
cleaveage of the methyl group followed by silylether deprotections afforded resorcylate 53. 
The final step in the total synthesis involved a Lindlar reduction of the alkyne to give 
cruentaren A (46).
[45] 
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Scheme 12: Synthesis of Cruentaren A (46)
[45] 
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1.12 Discovery of the Decarboxylative Allyl MigrationI 
Recently Barrett et al. reported the total synthesis of aigialomycin D (4).
[46] 
The approach 
featured a key Pd(0)-catalysed deallylation and decarboxylation of allyl ester 54, employing 
morpholine as a nucleophilic palladium π-allyl cation scavenger, to provide the ketene 
precursor. Subsequent ketene trapping, aromatisation, RCM and deprotection gave 
aigialomycin D (4) in a 15% overall yield (Scheme 13). 
OH
HO
O
O
OH
OH
aigialomycin D (4)
OH
HO
O
O
O
O
O O
O
O O
O
O
OO
1. Grubbs-Hoveyda II
2. 1 M HCl, MeOH-H2O
1. Pd (0), morpholine
3. Cs2CO3, MeOH
4. AcOH
2. PhMe, 
HO
78% over 2 steps
44% over 4 steps
54
 
Scheme 13: Final Steps in the Synthesis of Aigialomycin D (4) 
During these studies Barrett et al. observed that reaction of allyl ester 54 with Pd(PPh3)4 in 
the absence of mopholine resulted in a modified Carroll rearrangement affording diketo-
dioxinone 55. Subsequent ketene trapping with alcohol 56 gave triketoester. Aldol cyclisation 
using caesium acetate followed by acid mediated aromatisation provided resorcylate 57 in 
42% yield over 3 steps. The regiochemistry of arene 57 was confirmed by nOe analysis in the 
1
H NMR spectrum (Scheme 14).
[47]
 
                                                          
I
 Section 1.12 has been published: Anderson, K.; Calo, F.; Pfaffeneder, T.; White, A. J. P.; 
Barrett, A. G. B. Org. Lett. 2011, 13, 5748-5750. 
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Scheme 14: Discovery of the Decarboxylative Allyl Migration 
Having discovered this unusual transformation it is now exploited due to the known allylated 
resorcylate natural products such as cristatic acid (5), amorfrutin A (8), mycophenolic acid 
(9) and angelicoin A (6) (Figure 3). 
HO
OH O
OH
O
cristatic acid (5)
O
OH
HO
O
angelicoin A (6)
OH
OH
O
MeO
amorfrutin A (8)
O
O
MeO
HO
O
mycophenolic acid (9)
OH
 
Figure 3: Allylated Resorcylate Natural Products 
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1.13 Decarboxylation and Allylation: The Carroll Rearrangement 
The Carroll rearrangement was discovered in the 1940’s and proceeds via a [3,3]-sigmatropic 
rearrangement followed by decarboxylation to provide γ,β-unsaturated carbonyl compounds 
58 from allylic esters of β-ketocarboxylic acids 59 (Scheme 15).[48][49] The reaction requires 
high temperatures, strongly basic conditions and its success can depend on the electronic 
properties and size of the substrate.
[50]
 
R
O
O
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R
O OH
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O
enolisation
R
O
O
OH
58
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Scheme 15: The Carroll Rearrangement 
In the 1980’s Tsuji et al. and Tsuda et al. both independently discovered that the Carroll 
rearrangement could be catalysed by Pd (Scheme 16). This enabled the reaction to be carried 
out under neutral and mild conditions (typically at temperatures between 0 and 25 °C).
[51] 
Scheme 16 illustrates the mechanism for the Tsuji-Trost reaction. First, the π-allyl-palladium 
complex 60 is formed by oxidative addition, followed by decarboxylation. Subsequent 
intermolecular allylation gives the allylated ketone 59.
[52][53][54]
 
R
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Scheme 16: Tsuji-Trost Reaction 
Additionally, Tsuji demonstrated that allyl cyanoacetate 61, derivatives of dialkyl-malonates 
62 and nitro ester 63 can undergo decarboxylation-allylation to give allyl α-allyl carboxylate 
64, α-allyl nitrile 65 and α-alkylnitro alkane 66 respectively (Scheme 17), presenting the 
versatility of this transformation.
[52]
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AllylO2C CO2Allyl
62
Pd(OAc)2, PPh3
DMF, 120 C, 65%
CN
Pd(OAc)2, PPh3
dioxane, 100 C, 65%
CN CN
65, 76%
21%
O2N Pd(OAc)2, PPh3
THF, -50 C, 59%
63
AllylO2C
64
CO2Allyl
61
CO2Allyl O2N
66  
Scheme 17: Versatility of the Tsuji-Trost Reaction
[52]
 
More recently Trost et al. and Tunge et al. have demonstrated that this pathway can be 
advanced onto more complicated systems.
[55][56][57] 
 
1.14 Asymmetric Tsuji-Trost Reaction 
Until recently an asymmetric catalytic transformation for the Claisen rearrangement had not 
been developed, with the majority of attempts focusing on Lewis acid activation.
[58] 
In 2004, 
Tunge et al. reported high levels of asymmetric induction through the utilisation of 
nucleophilic catalysts and chiral ligands.
[59] 
The group investigated the use of Pd2(dba)3 and 
Trost’s ligand 69,[60] which provided high levels of enantioselectivity for cyclic and methyl-
substituted allyl compounds (Table 1). (The enantioselectivity of this reaction will be 
discussed in Section 1.16).  
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Table 1: Asymmetric Palladium-Catalysed Rearrangements of R
1
COCH2CO2R
2[61]
 
O
O
O
R2R1
Pd2(dba)3 (5 mol%)
Trost's ligand 69 (10 mol%)
benzene, 25 C
O
R1 R2  
Entry R
1 
R
2
 Time/ h ee
a 
Yield/ %
b 
1 Me 
 
15 86 82 
2 Me 
 
15 86 85 
3 Me 
 
24 94 75 
a 
Measured at 25 °C. 
b
 Isolated yield after column chromatography. 
 
1.15 Regio- and Enantioselective Tsuji-Trost Reaction  
In 2004, Trost et al. published studies on a regio- and enantioselective decarboxylative allylic 
alkylation of ketones through allyl enol carbonates. Table 2 below illustrates some of the 
optimisation studies for alkylation at the tertiary carbon.
[61] 
The results demonstrated 
excellent regio- and enantioselectivity in the creation of quaternary sterogenic centres. 
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Table 2: Selected Optimisation Studies
[61]
 
O O
O
Pd2(dba)3CHCl3 (2.5 mol%)
Ligand (5.5 mol%)a
Solvent, 23 C, 4 to 24 h
O O
+
R-67 68  
Entry Ligand Solvent ee
b
 Yield of R-67/ %
c
 Yield of 68/ %
c
 
1 69 DME 66 81 8 
2 71  DME 76 87 2 
3 69 Toluene 31 73 0 
4 70 Toluene 61 73 2 
5 71 Toluene 60 85 1 
a
All reactions were performed on a 0.3 mmol scale at 0.1 M. 
b
The ee values (in percent) were determined by chiral GC. 
c
The yields (in percent) were determined by quantitative GC analysis using decane as internal 
reference.  
 
HNNH
OO
PPh2 Ph2P
(R,R)-69
Ph Ph
HNNH
OO
PPh2 Ph2P
(R,R)-70
HNNH
OO
PPh2 Ph2P
(S,S)-71  
Scheme 18: Chiral Ligands used in Optimisation Studies
[61]
 
Trost et al. indicated that metal catalysed allylic alkylations are slow and consequently lead 
to enolate equilibrium which in turn can result in a competition between polyalkylation, loss 
of regioselectivity and alkylation of the original enolate. Nonetheless, Trost et al. were able 
to control the enolate equilibrium and induce regioselectivity by maintaining neutral 
conditions and having a low concentration of the enolate at any given time.
[61]  
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1.16 Counterion Effect in Asymmetric Allylic Alkylation 
In 2002, Trost et al. published work on the counterion effect in a Pd-catalysed asymmetric 
allylic alkylation (AAA) (Table 3).
[62] 
Table 3 demonstrates the importance in the choice of 
base for the alkylation of an enolate in terms of enantioselectivity. This can be explained by 
the cartoons in Scheme 19 below (Scheme 19 can also be utilised to explain the asymmetric 
Tsuji-Trost reaction discussed in Section 1.14 as well as the decarboxylative AAA, due to the 
nucleophile being comparable). 
Table 3: Counterion Effect in Palladium-Catalysed AAA of 1-Methyl-2-Tetralone
[62]
 
O O
(R)-(+)-72
2.5 mol% [(3-C3H5)]PdCl]2, 5.0 mol% Ligand
1.1 equiv. base, allyl acetate, DME , 0 C
 
Entry Base Ligand Yield of 72/ % ee 
1 LDA (S,S)-69 90% –33% 
2 Cs2CO3 (S,S)-69 91% +45% 
3 Cs2CO3 (S,S)-73 93% +90% 
 
HNNH
OO
PPh2 Ph2P
(R,R)-73  
Figure 4: Ligand 73
[62]
 
When non-coordinating Cs2CO3 is the base in the reaction and with (S,S)-73 as the ligand, the 
enolate substrate approaches the Si face under the ‘flap’ of the ligand to avoid unfavourable 
steric interactions that would occur at the Re face (giving the (+)-enantiomer, Entry 3, Table 
3). However, with the co-ordination of LDA the enolate enters from the Re face to avoid 
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disfavoured interactions between the ligand and the i-propyl groups on LDA (giving the (–)-
enantiomer, Entry 1, Table 3).
[62][63] 
Thus enantioselectivity can be explained in this manner 
depending on the substrate and ligand being used in the transformation.
[64]
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Scheme 19: Cartoon Models for the Alkylation of a Charge Separated Palladium Enolate
[63]
 
 
1.17 Enantioselective Ligand Studies 
In 2004, Stoltz et al. carried out studies towards the enantioselective decarboxylation 
allylation reaction (Table 4) paying particular attention to the ligands used in the 
transformation.
[65] 
These studies showed that in the allylation step the phosphinooxazoline 
(PHOX) ligands were very good at producing enantioselectivity (Entries 7-10, Table 4).
[65]  
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Table 4: Results from Stoltz’s Enantioselective Ligand Screening[65] 
O O
O
Pd2(dba)3 (5 mol%)
Ligand (12.5 mol %)
THF, 25 C
O
+ CO2
S-67  
Entry Ligand Time/ h Yield of S-67/ % ee/ % 
1 (R,R)-Trost ligand 69 5 92 64 
2 (R)-BINAP 74 5 76 2 
3 (R,R)-Me-DUPHOS 75 5 66 0 
4 (R,R)-DIOP 76 2 59 2 
5 (R)-MOP 77 3 47 13 
6 (R)-QUINAP 78 2 97 61 
7 (R)-Ph-PHOX 79 2 95 65 
8 (S)-Bn-PHOX 80 5 94 63 
9 (R)-I-Pr-PHOX 81 2 95 83 
10 (S)-t-Bu-PHOX 82 2 96 88 
P
P
(R,R)-Me-DUPHOS 75
O
O
P
P
(R,R)-DIOP 76
O
P
Ph
Ph
N
P
Ph
Ph
N
O
Ph
PPh2
(R)-Ph-PHOX 79
N
O
PPh2
Ph
(S)-Bn-PHOX 80
N
O
PPh2
(S)-I-Pr-PHOX 81
N
O
PPh2
(S)-t-Bu-PHOX 82
(R)-MOP 77
(R)-QUINAP 78
P
P
(R)-BINAP 74
Ph
Ph
Ph
Ph
 
Figure 5: Ligands from Table 4
[65]
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1.18 Mechanistic Studies 
In 2004, Tunge et al.
[59] 
performed mechanistic studies to establish the order of 
decarboxylation and allylation. Through utilisation of a quaternary α-carbon 83, α-
deprotonation would not be possible therefore the only plausible mechanism would involve 
decarboxylation followed by allylation (Scheme 20). Ketoester 83 underwent Pd-catalysed 
decarboxylation allylation at a similar rate to other substrates (see Table 1 above) proving 
that decarboxylation precedes allylation.
[59]
 
O
O
O O
BnEt
Pd(PPh3)4 (10 mol %)
Et Bn
83
benzene, 25 C
18 h  
Scheme 20: Substrate and Reaction Conditions Utilised for Tunge’s Mechanistic Study[59] 
In 2009, Stoltz et al. conducted a mechanistic study into the asymmetry of the palladium 
catalysed enantioselective decarboxylative allylation reactions of ketone enolates. X-ray 
crystal structures were obtained for the intermediates in the catalytic cycle providing 
evidence for the enantioselective allylic alkylation mechanism (Scheme 21).
[66]
 
Substrate 84 undergoes coordination to ester 85 to give complex 86 followed by oxidative 
addition to give carboxylate 87, (the resting state of the catalytic cycle). The next step is 
decarboxylation (the turnover limiting step of the catalytic cycle) affording enolate 88. 
Finally, rapid C-C bond formation gives reductive elimination to form (S)-67 and substrate 84 
which can continue the catalytic cycle by complexation with another ester 85.
[66]  
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Scheme 21: Proposed Mechanism for the Enantioselective Allylic Alkylation
[66] 
 
1.19 Decarboxylation, Allylation and Migration 
In 2011, Tunge et al. published work on a migratory decarboxylative coupling of coumarins. 
Scheme 22 illustrates optimised conditions for allyl ester 89.
[67]
 
O
O
O
O
89
3 mol% [Pd2(dba)3]
6 mol% Xantphos 129
toluene, 70 C, 12h
90%
O O
 
Scheme 22: Migratory Decarboxylative Allylation
[67]
 
Allylation usually occurs regiospecifically at the site bearing the carboxylate. Therefore when 
Tunge et al. discovered allylation with migration, mechanistic studies were conducted. 
Interestingly, it was found that allylation occurred followed by decarboxylation, which 
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explained why the migration was occurring. This mechanism was deduced because 
carboxylic acid 90 was isolated in the reaction mixture after 2 h. The acid 90 could then be 
decarboxylated successfully by treatment with Pd(0) (Scheme 23).
[67] 
 
O
O
O
O
3 mol% [Pd2(dba)3]
6 mol% Xantphos 129 O O
90
COOH
O O
3 mol% [Pd2(dba)3]
6 mol% Xantphos 129,
toluene, 70 C, 24 h
H
92%
 
Scheme 23: Isolation of Carboxylic Acid 90 and Subsequent Decarboxylation
[67]
 
 
1.20 Total Synthesis of Spirotryprostatin B via Diastereoselective 
Prenylation 
In 2007, Trost et al. synthesised Spirotryprostatin B (91) with a related migratory 
decarboxylation-allylation (Scheme 24).
[68] 
Trost et al. were able to perform a 
diastereoselective decarboxylative prenylation utilising Pd(0) and a phosphinooxazoline 
(PHOX) ligand. This work demonstrates the usefulness of the Tsuji-Trost reaction and its use 
in natural product synthesis. The synthesis also demonstrated that PHOX ligands could be 
utilised for prenyl groups, previously this ligand type had been limited to allyl or 2-
substituted allyl groups.
[68] 
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Scheme 24: Synthesis of Spirotryprostatin B (91)
[68]  
 
1.21 Application of the Decarboxylative Allylation and Migration Sequence 
The aim of this research was to apply the Pd(0)-decarboxylative allylation migration (see 
Section 1.10) and the late-stage aromatisation strategy (see Section 1.12) to the total 
synthesis of resorcylate natural products. Figure 6 illustrates five resorcylate natural products 
that will be discussed and studied further throughout this thesis. 
HO
OH O
OH
O
cristatic Acid (5)
O
OH
HO
O
angelicoin A (6)
O
OH
MeO
O
angelicoin B (7)
OH
OH
O
MeO
amorfrutin A (8)
used in Chinese medicine to treat typhoid and dysentery .
ant ibacterial, haemoly tic proper ties, cy totoxicantimicrobial, ant i-inf lammatory
OH
OH
O
HO
grifolic Acid (92)
agonist  
Figure 6: Resorcylate Natural Products 
The isolation and biological properties of amorfrutin A (8),
[10] 
cristatic acid (5),
[6][7] 
angelicoin 
A (6)
[8][9] 
and angelicoin B (7)
[8][9] 
were discussed in Section 1.1 above. Grifolic acid (92) was 
isolated in 1981 by Steglich et al. from the mushroom Albatrellus cristatus.
[6][69] 
Grifolic acid 
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(92) has shown GPR120 agonistic activity. The GPR120 is a G-protein-coupled receptor 
found within the intestinal tract and thought to play an important role in insulin release.
[70]
 
 
1.22 General Retrosynthetic Strategy 
Scheme 25 below illustrates a general retrosynthetic strategy for the construction of 
angelicoin A (6), amorfrutin A (8), grifolic acid (92) and cristatic acid (5) (Figure 6). It was 
envisaged that resorcylate 93 could be obtained from aromatisation of triketo-acid 94 (R
1
=H). 
Trapping of ketene 95 with the respective alcohol could afford triketo-acid 94. Ketene 95 
could be obtained by heating diketo-dioxinone 96 under elevated temperatures to facilitate a 
retro Diels-Alder reaction. Finally, diketo-dioxinone 96 could be obtained following a 
decarboxylative allyl migration beginning with diketo-ester-dioxinone 97.  
R2
OR1R3
R4 OH
HO
O
Aromatisation
O O
O
O
R2
O
R4R3
Pd(0)-Decarboxylative
Allyl Migration
O O
O
O O
O
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C
O O
R2
O
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O
O O
R2
O
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O
R1OH
Heat
R2
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97  
Scheme 25: Retrosynthetic Strategy 
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1.23 Alternative Strategies for the Incorporation of an Allyl Moiety onto 
the Resorcylate Core 
The retrosynthetic strategy (Scheme 25) would enable the formation of a substituted aromatic 
resoryclate to be completed in a four step one-pot synthesis under mild conditions. Standard 
conditions for the introduction of allylic moieties onto aromatic rings utilises high 
temperatures and strong bases. For example, in 1995, Anderson et al. published the total 
synthesis of mycophenolic acid (9). They utilised high temperatures to execute a [2,3]-
sigmatropic rearrangement to add an allyl moiety on to the aromatic unit (Scheme 26).
[71]
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MeO
OMe
O
K2CO3, Me2CO
, 7.2 h
Br
O
MeO
OMe
O
210 C, 3 h
99% over 2 steps
OH
MeO
OMe
O
 
Scheme 26: Addition of Allyl moiety in the synthesis of Mycophenol Acid (9)
[71]  
In 2009, Yoshida et al. published the total synthesis of radulainin E.
[72] 
Yoshida et al. utilised 
Fürstner’s procedure for the regioselective C-allylation. However, as Scheme 27 illustrates 
the procedure was not very reliable as two isomers 98 and 99 were obtained, nonetheless it 
was possible to transform 99 into 98 by heating in o-dichlorobenzene. The procedure for the 
incorporation of the allyl moiety also employed high temperatures and strong bases.
[72]
 
OH
Ag2CO3, toluene
140 C, 24 h
Br
HO
O
OEt
OH
98 15%
HO
O
OEt +
OH
99 60%
O
O
OEt
o-dichlorobenzene
quant itative  
Scheme 27: C-Allylation in the Total Synthesis of Radulanin D
[72]
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1.24 Research Project Aims 
The aim of this research project was to demonstrate a Pd(0)-catalysed regioselective 
decarboxylative, allylation and aromatisation sequence utilising mild conditions for the 
synthesis of resorcylate natural products. The resorcylate natural products studied include 
angelicoin B (7), angelicoin A (6), cristatic acid (5), amorfrutin A (8) and grifolic acid (92) 
(Figure 6). Additionally, optimisation and mechanistic studies were conducted into the Pd(0)-
catalysed regioselective decarboxylative-allylation and aromatisation sequence and X-ray 
crystallography was utilised to verify unambiguously the novel regioselectivity.
2 The Total Synthesis of Angelicoin B (7) and Angelicoin A (6)
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2 The Total Synthesis of Angelicoin B (7) and 
Angelicoin A (6)
II
 
2.1 Previous Studies for the Construction of Angelicoin B (7) 
Angelicoin B (7)
[8][9]
 (Figure 7) was chosen as a synthetic target to demonstrate the 
biomimetic late-stage aromatisation strategy (see Section 1.10 of the Introduction).
[42][43]
 
O
OH
MeO
O
angelicoin B (7)  
Figure 7: Angelicoin B (7) 
Previous studies, within the Barrett group, for the construction of angelicoin B (7) are 
illustrated below in Scheme 28.
[73] 
The first step in the synthesis utilised a similar method 
first described by Tararov et al. in 2006.
[74] Thermolysis of Meldrum’s acid and trapping of 
the resulting ketene with allyl alcohol provided carboxylic acid 100 in a 30% yield. Acid 100 
was then treated with oxalyl chloride and catalytic DMF in order to afford acid chloride 101. 
Simultaneously, dioxinone 33 was treated with LiHMDS for 2.5 h and then acid chloride 101 
was added in order to facilitate a Claisen condensation and provide ketoester-dioxinone 102 
in a 20% yield. Addition of MgCl2 and pyridine followed by acid chloride 103 furnished 
diketo-ester dioxinone 104. Treatment of diketoester-dioxinone 104 with Pd(PPh3)4 and 
morpholine followed by late stage aromatisation conditions
[42][43]
 provided resorcylate 105 in 
39% yield over 4 steps. Deprotection of the silylether 105 followed by acid mediated 
                                                          
II
 Parts of Chapter 2 have been published and therefore have similarity to Anderson, K.; Calo, 
F.; Pfaffeneder, T.; White, A. J. P.; Barrett, A. G. B. Org. Lett. 2011, 13, 5748-5750 and 
Cordes, J.; Calo, F.; Anderson, K.; Pfaffeneder, T.; Laclef, S.; White, A. J. P.; Barrett, A. G. 
M. J. Org. Chem., 2012, 77, 652–657. 
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lactonisation afforded lactone 106 which was then selectively methylated in order to provide 
angelicoin B (7) in an overall 5.5% yield and 9 linear steps from dioxinone.  
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Cl
O
O
O
100 (1.0 equiv.) 101
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1. Pd(PPh3)4 (10 mol%),
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2. MeOH (excess), PhMe,  1 h
3. i -PrOH, CH2Cl2, (3:5)
CsOAc (3.0 equiv.), 3 h, rt
4. AcOH (excess), 18 h
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1. H2SiF6 (4.0 equiv.), MeCN, rt, 2 h
2. p-TsOH (cat.), THF, , 2 h
100% over 2 steps
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+
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MeI (1.6 equiv.), Me2CO
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Scheme 28: Synthetic Route for the Synthesis of Angelicoin B (7)  
There were a number of key steps that needed attention in the synthesis (Scheme 28): yield 
optimisation was essential for the thermolysis of allyl alcohol with Meldrum’s acid; the 
Claisen condensation of acid chloride 101 onto dioxinone 33 and the decarboxylation, 
deallylation and aromatisation steps. 
 
2.2 Yield Optimisation Studies 
Thermolysis of allyl alcohol and Meldrum’s acid had previously been carried out at 80 °C for 
8 h giving a yield of 30% (Scheme 28). It was thought that the low yield could be because the 
reaction had not gone to completion. Thus, it was decided to increase the temperature to 100 
°C and heat for 18 h, pleasingly this increased the yield to 70% (Scheme 32). 
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The Claisen condensation reaction between dioxinone 33 and acid chloride 101 had formerly 
provided ketoester-dioxinone 102 in a 20% yield (Scheme 28). This low yield could have 
been due to two effects. Firstly, dioxinone 33 had been stirred in LiHMDS for 2.5 h prior to 
the addition of acid chloride 101, presumably, this was too long and decomposition of 
dioxinone 33 or THF was occurring. Accordingly, it was ensured that an excess of HMDS 
was added to THF prior to addition of n-BuLi and that dioxinone 33 was stirred for 1 h in 
LiHMDS preceding the addition of acid chloride 101 (Scheme 29).
[75][76][77] 
It was hypothesised that the second cause for the low yield of keto-ester-dioxinone 102 was 
due to the reaction temperature following the addition of acid chloride 101. The reaction had 
been allowed to warm from –78 °C to 0 °C over 2 h (following the addition of acid chloride 
101). Generally, the addition of an enolate with an acid chloride should occur very quickly at 
–78 °C.[78] Hence the reaction was monitored at –78 °C and quenched when complete. 
Completion of the reaction took 2 h at –78 °C, providing keto-ester-dioxinone 102 in 65% 
yield (Scheme 29).
 
O O
O
O
O
O
102
O O
O
1. LiHMDS (3.0 equiv.), THF,
-78 C to rt, 30 min
Cl
O
O
O
101 (1.0 equiv.)
33 (3.0 equiv.)
-78 C, 2 h, 65%  
Scheme 29: Formation of Ketoester-Dioxinone 102 
The next step was to optimise the Pd(0)-decarboxylative deallylation and aromatisation 
sequence. Formerly, the aromatisation had been carried out utilising standard aromatisation 
conditions providing methyl ester 105 in 39% yield over 4 steps (Scheme 28). However, it 
was predicted that isoproplyidene protected resorcylate 107 could be formed by stirring 
diketo-dioxinone 108 with morpholine for 18 h (Scheme 30). This is because it has been 
shown within the Barrett group that diketo-dioxinones can be aromatised, utilising bases such 
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as triethylamine, into the corresponding isopropylidene protected resorcylates (see Section 
1.10 of the Introduction).
[43] 
Therefore the Pd(0)-decarboxylative deallyation reaction was 
repeated with an excess of morpholine providing isopropylidene protected resorcylate 107 in 
a pleasing 80% yield (Scheme 30). 
O
O
HO
O
O O
O
O O
OO
OSii-Pr3
OSii-Pr3
107
104 (1.0 equiv.)
Pd(PPh3)4 (10 mol%)
morpholine (3.3 equiv.)
THF, 0 °C to rt,
18 h, 80%
O O
O
O O OSii-Pr3
108
 
Scheme 30: Pd(0)-Decarboxylative Deallylation and Aromatisation 
Deprotection of the silylether 107 was achieved by treatment with H2SiF6 and lactonisation 
was facilitated under acidic conditions affording lactone 106 in an 82% yield over 2 steps. 
Finally, it was necessary to validate the final yield for the selective methylation of phenol 
106. Selective methylation was undertaken furnishing angelicoin B (7) in a 79% yield 
(Scheme 31).  
O
O
HO
O
O
OH
HO
O
OSii-Pr3
107 (1.0 equiv.)
106 (1.0 equiv.)
1. H2SiF6 (0.6 equiv.),
MeCN, 25 °C, 2 h
2. p-TsOH.H2O (cat.), THF,
, 2 h, 82% over 2 steps
K2CO3 (1.0 equiv.),
MeI (1.6 equiv.),
Me2CO, , 1 h,
79%
O
OH
MeO
O
angelicoin B (7)
 
Scheme 31: Final Steps in the Synthesis of Angelicoin B (7) 
The selective methylation was an interesting step because two phenol moieties were present 
on the aromatic ring 106. pKa values of phenols with EWGs in the ortho and para positions 
are normally comparable,
[79] 
but in this case the indicated proton (Figure 8) was energetically 
stabilised by Hydrogen bonding and thereby the pKa should have increased, making it less 
available for methylation.
[80] 
In addition, the para phenol had increased accessibility for 
methylation compared with the ortho phenol. Nevertheless, the reaction had to be monitored 
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closely because, if left for too long, methylation occurred on both phenol functionalities 
(Figure 8).  
O
O
HO
O
H
H-Bonding
106  
Figure 8: H-Bonding in Lactone 106 
 
2.3 Total Synthesis of Angelicoin B (7) 
Scheme 32 below illustrates the final synthetic route to angelicoin B (7), which was 
completed in an overall yield of 29% over 6 linear steps starting from dioxinone 33. 
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0 °C to rt, 18 h, 80%
1. H2SiF6 (0.6 equiv.), MeCN,
2 h, 25 °C
2. p-TsOH.H2O (cat.), THF, ,
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K2CO3 (1.0 equiv.),
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OH
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Scheme 32: Enhanced Synthesis of Angelicoin B (7) 
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2.4 Retrosynthetic Analysis of Angelicoin A (6) 
Having successfully completed the total synthesis of angelicoin B (7) utilising the late-stage 
aromatisation strategy, it was decided to conduct studies towards the total synthesis of 
angelicoin A (6) utilising the Pd(0)-decarboxylative allylation and aromatisation sequence. It 
was envisaged that angelicoin A (6) could be prepared from the aromatic precursor 109 
through deprotection of the alcohol followed by lactonisation. Late stage aromatisation could 
be used to obtain the resorcylate 109. It was thought that a Pd(0)-decarboxylative prenylation 
could be facilitated to give diketone-dioxinone 110 starting from diketo-ester-dioxinone 111 
(Scheme 33). 
O
OOH
HO
OMe
OOH
HO
OSii-Pr3
O O O
O
(6)
109
110
Deprotection
Aromatisation
Trapping
Ketene Formation
Pd(0)-Decarboxylative
Prenylation
O OSii -Pr3 O O O
O
111
O OSii -Pr3
OO
Lactonisation
 
Scheme 33: Retrosynthetic Analysis of Angelicoin A (6) 
 
2.5 Previous Studies Towards the Total Synthesis of Angelicoin A (6) 
Studies towards the total synthesis of angelicoin A (6) had formerly been carried out within 
the Barrett group (Scheme 34).
[73] Formation of diketo-prenylester-dioxinone 111 was carried 
out in a similar manner to the synthesis of diketo-allylester-dioxinone 104 described in 
section 2.2 above. Diketoester-dioxinone 111 was then treated with Pd(PPh3)4 in the absence 
of morpholine in order to facilitate a Pd(0)-decarboxylative prenylation. Standard 
aromatisation conditions
[43]
 were then undertaken providing resorcylate 109 in a 12% yield 
2 The Total Synthesis of Angelicoin B (7) and Angelicoin A (6)
   
63 
 
over 4 steps. The final steps were attempted however, unfortunately lactonisation under 
acidic conditions led to the formation of tricycle 112 due to cyclisation between the phenol 
and the protonated prenyl moiety (Scheme 35).  
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1. LiHMDS (3.0 equiv.), THF,
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to 0 C, 3 h, 24%
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O
O
O
1. MgCl2 (1.5 equiv.), py (2.7 equiv.),
CH2Cl2, 0 C, 20 min
(COCl)2 (1.0 equiv.),
CH2Cl2
DMF (cat.),
0 C to rt, 2 h
48%
+
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OSii -Pr3
OSii -Pr3
109 (1.0 equiv.)
111 (1.0 equiv.)
1. Pd(PPh3)4 (10 mol%),
THF, 0 °C, 20 min; rt, 20 min
2. MeOH (excess), PhMe, , 1 h
3. i-PrOH, CH2Cl2, (3:5),
CsOAc (3.0 equiv.), rt, 2 h
4. AcOH (excess), 4 h, rt
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1. H2SiF6 (4.0 equiv.), MeCN,
0 C, 20 min, , 45 min
2. p-TsOH.H2O (cat.), THF, , 2h,
52% over 2 steps
Cl
O OSii -Pr3
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O
O
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Scheme 34: Previous Studies Towards the Synthesis of Angelicoin A (6) 
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HO
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Scheme 35: Cyclisation under Acidic Conditions 
It was apparent that all the yields in the synthesis required optimisation, particularly the 
Pd(0)-decarboxylative prenylation. Furthermore, an alternative method was required for the 
lactonisation step. Accordingly, detailed studies towards the synthesis of angelicoin A (6) 
were conducted, focusing on each synthetic step. 
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2.6 Studies Towards the Synthesis of Keto-Dioxinone 113 
2.6.1 Synthesis of Acid 114 
The desired acid 114 was obtained utilising a similar method to that used by Tararov et al.
[74] 
Thermolysis of Meldrum’s acid and trapping of the resulting ketene with prenyl alcohol 
provided acid 114 in a 51% yield (Scheme 36 illustrates a proposed mechanism). 
OH
O
O
OH
O
114
O O
OO
H
O O
OHO
retro [4+2] HO
O
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O

O
O
OH
O
H
+H
-H
 
Scheme 36: Proposed Mechanism for the Formation of Acid 114 
In order to improve the yield of the reaction it was decided to increase the temperature to 140 
o
C, the boiling point of prenyl alcohol. However, the yield decreased to 30% presumably due 
to decomposition of the starting materials. The next strategy was to reduce the temperature to 
120 
o
C, use two equivalents of prenyl alcohol and improve the reaction workup. The usual 
workup commenced with the stirring of the reaction mixture in a saturated aqueous solution 
of NaHCO3 for 10 min. This was increased to 5 h to ensure that all the acid 114 had formed 
the corresponding Na salt and would not be lost in workup. These three alterations increased 
the yield of acid 114 to an excellent 94%. 
 
2.6.2 Synthesis of Ketoester-Dioxinone 113 
The next step of the synthesis was the formation of the acid chloride 115, which was obtained 
utilising oxalyl chloride and catalytic DMF (Scheme 34). Ketoester-dioxinone 113 was 
formed by treating dioxinone 33 with LiHMDS followed by the addition of acid chloride 115 
2 The Total Synthesis of Angelicoin B (7) and Angelicoin A (6)
   
65 
 
(Scheme 34). It was predicted that the mechanism progressed via a ketene intermediate which 
was then attacked by the lithium enolate of dioxinone to provide diketo-dioxinone 113 
(Scheme 37). 
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 Scheme 37: Proposed Mechanism for the Formation of Ketoester-Dioxinone 113 
The yield of this transformation was improved in the synthesis of angelicoin B (7) (see 
Section 2.2 above). These optimisation factors were applied to this reaction and the reaction 
yield increased to 45%. In order to improve the yield further, a concentration study was 
undertaken (Table 5).  
Table 5: Concentration Studies 
Entry Concentration/ M Yield/ %
a
 
1 0.046 65 
2 0.023 45 
a
Isolated yield after column chromatography. 
The results illustrated that the reaction yield was higher at a low concentration (Entry 1, 
Table 5). It was hypothesised that at low concentration the number of collisions between the 
molecules would decrease leading to fewer side reactions. The effect of concentration slowed 
overall rates of reactions, which lead to a higher yield for the energetically favoured 
reaction.
[81] 
Interestingly, no addition onto C-2 of dioxinone 33 (Scheme 37) was observed. 
To improve the yield further the benzotriazole leaving group was investigated. Formerly 
within the Barrett Group the benzotriazole leaving group has provided higher yields in this 
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transformation compared to the corresponding acid chloride.
[82] 
This is presumably because 
benzotriazole is a softer and more stable leaving group than the chloride (please see Section 
2.7.2 below for a detailed explanation).
[82][83] 
The benzotriazole amide 116 can be isolated, 
stored and characterised prior to treatment with dioxinone 33, whereas the acid chloride 115 
is formed in situ (therefore it is hard to assess when the reaction has gone to completion and 
if the acid chloride that has been formed is decomposing).  
Benzotriazole was pre-stirred with thionyl chloride for 1 h, acid 114 was then added and the 
mixture stirred for 24 h affording benzotriazole amide 116 in 81% yield. Benzotriazole amide 
116 was then added to the lithium enolate derived from dioxinone 33, furnishing ketoester-
dioxinone 113 in an excellent 93% yield (Scheme 38).  
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THF, -78 C, 30 min
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N
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O
O
O
116 (1.0 equiv.)
-78 C to rt, 18 h, 93%
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Scheme 38: Formation of Benzotriazole Amide and Subsequent Addition to Dioxinone 33 
 
2.7 Studies Towards the Synthesis of Diketo-Prenylester-Dioxinone 111 
2.7.1 Acid Chloride 117 
Steps for the formation of acid 118 were achieved following a similar procedure by Tschaen 
et al.
[85] 
Protection of alcohol 119 with TIPSOTf afforded silylether in 70% yield. A number 
of conditions were then investigated for the hydrolysis; stirring in LiOH/THF gave no 
conversion to the acid 118, thus the hydroxide source was changed to NaOH and the ester 
2 The Total Synthesis of Angelicoin B (7) and Angelicoin A (6)
   
67 
 
stirred for 18 h, giving only 30% conversion. However, stirring ester in NaOH/THF for 72 h 
gave full conversion to the acid 118. Conversion of the acid 118 to the acid chloride 117 was 
achieved using oxalyl chloride and catalytic DMF (Scheme 39).  
 
HO
O OSii -Pr3
MeO
O OH
Cl
O OSii-Pr3
(COCl)2 (1.0 equiv.),
CH2Cl2,
DMF (cat.), 0 C
to rt, 3 h
119 (1.0 equiv.) 118 (1.0 equiv.)
117
1. Pr3Sii-OTf (1.0 equiv.),
2,6-lutidine (1.6 equiv.),
CH2Cl2, 0 C to rt, 4 h, 70%
2. NaOH/THF, rt, 72 h,
quantitative  
Scheme 39: Steps in the Formation of Acid Chloride 117 
 
2.7.2 Diketo-Prenylester-Dioxinone 111 
The synthesis of diketo-prenylester-dioxinone 111 was based on a similar procedure reported 
previously in the Barrett group.
[82]
 Ketoester-dioxinone 113 was treated with MgCl2 and 
pyridine, with MgCl2 acting as a chelating agent enabling pyridine to deprotonate at the 
correct position (Scheme 40 shows the proposed mechanism).
[86][87] 
Subsequently, addition of 
acid chloride 117 furnished diketo-prenylester-dioxinone 111 in a modest 50% yield. 
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Scheme 40: Mechanism in the Formation of Diketo-Prenylester-Dioxinone 111
[86]
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A number of side products, including O-acylation were observed during this reaction by 
1
H 
NMR spectroscopy. Therefore, it was decided to investigate each step of the reaction in order 
to further improve the yield. Formation of the acid chloride 117 was monitored by IR 
spectroscopy to determine the optimal reaction time, which was found to be 1 h at 0 °C. The 
next strategy was to lower the acylation reaction temperature; accordingly the reaction was 
carried out at –78 °C giving a 43% yield of prenyl ester 111.  
 
Changing the leaving group in the Claisen condensation had dramatically increased the yield 
of ketoester-dioxinone 113 (Scheme 38). Consequently, three different leaving groups were 
studied in relation to this reaction; Weinreb amide 120, benzotriazole amide 121 and 
anhydride 122. These were chosen due to their differing levels of reactivity. The leaving 
groups provided soft electrophiles compared to hard acid chloride 117 and therefore 
decreased the possibility of O-acylation (Scheme 41).
[83][84][88] 
O O O
O
O
O
Hard Electrophile, attacked by O
Soft Electrophile, attacked by C  
Scheme 41: Diagram showing the Attack of C onto Soft Electrophiles and O onto Hard 
Electrophiles 
 
The synthesis of electrophiles 120-122 is shown in Scheme 42. Weinreb amide 120 was 
synthesised by acid chloride formation of acid 118 followed by treatment with the Weinreb 
amide hydrochloride salt. Benzotriazole amide 121 was obtained utilising the same procedure 
described earlier in Section 2.7.1 (Scheme 38). Finally, anhydride 122 was formed in situ 
through treatment with Et3N and pivaloyl chloride.  
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Scheme 42: Formation of Electrophiles 120-122 
With compounds 120-122 in hand, the addition reaction was investigated. The Weinreb 
amide 120 and benzotriazole 121 leaving groups returned starting material and the pivilate 
leaving group 122 gave decomposition of the starting materials. Finally, the reaction was 
repeated with the acid chloride 177 using two equivalents of MgCl2 (to ensure MgCl2 
chelation and so prevent O-acylation) which gave diketo-prenylester-dioxinone 111 in an 
excellent 81% yield (Scheme 43). 
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O O
O
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1. MgCl2 (2.0 equiv.), py (2.7 equiv.),
CH2Cl2, 0 C, 30 min
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Scheme 43: Synthesis of Diketo-Ester-Dioxinone 111 
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2.8 Pd(0)-Decarboxylative-Prenylation and Late Stage Aromatisation 
The next step to be investigated was the Pd(0)-decarboxylative prenylation and aromatisation 
sequence. Previous attempts within the Barrett group had been conducted affording 
resorcylate 109 in a 12% yield (Scheme 34).
[73] 
Therefore, it was decided to conduct 
methodical optimisation studies into this transformation with the aim of screening different 
bases, ligands, catalysts, solvents, temperatures and reaction times.  
OMe
OH
HO
OO O
O
O O
OO
OSii-Pr3
OSii-Pr3
109
111 (1.0 equiv.)
1. Pd(PPh3)4 (10 mol%),
THF, 0 °C, 20 min, rt, 20 min
2. MeOH (excess), PhMe, , 1 h
3. i -PrOH, CH2Cl2 (3:5),
CsOAc (3.0 equiv.), r.t., 2 h
4. AcOH (excess), 4 h, rt
12% over 4 steps
 
Scheme 44: Decarboxylative Prenylation and Aromatisation  
The first reaction that was carried out was to treat diketo-prenylester-dioxinone 111 with 
Pd(PPh3)4 (Scheme 45). The aim of this experiment was to observe the intermediates formed 
prior to performing the late-stage aromatisation conditions. Two products were obtained from 
this reaction, the branched product 123 in a 5% yield and the linear product 110 which 
aromatised within the reaction mixture to afford resorcylate 124 in an 18% yield. These 
results were extremely interesting and demonstrated a number of important points regarding 
this sequence. 
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Scheme 45: Reaction of Diketo-Prenylester-Dioxinone 111 with Pd(PPh3)4 
Formerly, it was thought that only one isomer, the linear product 110, was observed in this 
transformation (Scheme 44). But, these results demonstrated that a branched isomer 123 was 
also present (Scheme 45). The Tsuji-Trost Pd(0)-decarboxylative allylation typically affords 
the linear product over the branched product, due to the nucleophile attacking the least 
hindered end of the π-Pd(0)-allyl intermediate.[89] Therefore the ratio of linear 110 to 
branched 123 product from the reaction (Scheme 45) was in accordance with a typical Tsuji-
Trost Pd(0)-decarboxylative allylation. 
  
Interestingly, the linear product 110 aromatised within the reaction mixture without the 
requirement of an additional base or the late-stage aromatisation conditions. This result 
demonstrated that it was energetically more favourable for linear-diketo-dioxinone 110 to 
aromatise. Presumably, during the course of the Pd(0)-decarboxylative prenylation the 
presence of an enolate 126 and/or carboxylate 125 (Figure 9) would be available to act as a 
base and facilitate the aromatisation. Deprotonation of diketo-dioxinone 110 to form enolate 
127 would facilitate cyclisation and subsequent dehydration would furnish resorcylate 124 
(Scheme 46 below shows a proposed mechanism). 
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Figure 9: Proposed Aromatisation Bases 
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Scheme 46: Proposed Aromatisation Mechanism 
Finally, branched product 123 did not aromatise within the reaction mixture presumably due 
to sterics blocking cyclisation from occurring (Figure 10). 
O O O
O
O OSii-Pr3
Ster ic Bulk
Block ing
Aromat isat ion  
Figure 10: Steric Bulk Blocking Aromatisation 
Due to the low yield of resorcylate 124 and diketo-dioxinone 123 (Scheme 45) it was 
apparent that either the starting material 111, the linear isomer 110 (prior to aromatisation) 
and the branched isomer 123 were decomposing during the reaction. When morpholine was 
used in the reaction (see Section 2.2) the yield of resorcylate 107 increased to 80% because 
morpholine was facilitating both deallylation and aromatisation. This reaction demonstrated 
that when a base was present the aromatisation of diketo-dioxinone 108 increased. Utilising 
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this information it was decided to study the effect of a base in the Pd(0)-decarboxylative 
prenylation and aromatisation sequence. 
 
2.9 Studies Towards the Use of Tertiary Amine Bases  
Morpholine, a secondary amine, traps the π-allyl Pd complex enabling deallylation to 
occur.
[46][82] 
Accordingly, tertiary amines were explored because it was assumed they would 
facilitate aromatisation but not cause deallylation.
[43]
 
Unfortunately, overall the yield of resorcylate 124 and diketo-dioxinone 123 did not increase 
following this study (Table 6). However, interestingly the ratio of 123:124 did alter 
depending on the base and the reaction time. The first tertiary amine to be investigated was 4-
methylmorpholine (Table 6, Entry 1). The yield decreased for both 123 and 124 and the ratio 
of 123:124 changed to 1:1. This result indicated that the base was affecting the linear to 
branched ratio but not noticeably affecting the aromatisation step. Tunge et al.
[90] 
have shown 
that changing the base in a decarboxylative allylation can dramatically affect the linear to 
branched ratio of the products obtained. Presumably, this is because the base can alter the 
terminus of attack on the π-allyl Pd complex. (The use of a base in this transformation will be 
discussed further in the mechanistic studies Section 3.5). 
The next base to be screened was 4-ethylmorpholine (Table 6, Entry 2), the yield of 123 and 
124 increased to 20% but the ratio of 123:124 remained the same. It was thought that 4-
ethylmorpholine was affecting the reaction in a similar manner to 4-methylmorpholine. 
Guanidine (Table 6, Entry 3) provided 17% of RSM and decomposition of the remaining 
diketo-prenylester-dioxinone 111. Consequently, 4-ethylmorpholine was screened again with 
a longer reaction time (Table 6, Entry 4); however, after 2 h the same result was observed as 
after 30 min (Table 6, Entry 2). A shorter reaction time of 10 min (Table 6, Entry 5) was 
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attempted, which provided the same result as for 30 min (Table 6, Entry 2) and 2 h (Table 6, 
Entry 4). It was apparent that the reaction was complete after 10 min and that the tertiary 
amine base was not increasing the yield of either resorcylate 124 or diketo-dioxinone 123.  
Table 6: Results from the Tertiary Amine Base Studies 
OO
O
HO
OSii-Pr3
O O O
O
O OSii -Pr3
124
O O O
O
OO
O OSii -Pr3
111 (1.0 equiv.)
123
Pd(PPh3)4 (10 mol%),
THF, 0 °C to rt
+
 
Entry Time Tertiary Amine
b
 Yield
a
 123:124 
1 30 min 4-Methylmorpholine 123 5%, 124 5% 1:1 
2 30 min 4-Ethylmorpholine 123 10%, 124 10% 1:1 
3 30 min Guanidine RSM (17%) - 
4 2 h 4-Ethylmorpholine 123 10%, 124 10% 1:1 
5 10 min 4-Ethylmorpholine 123 11%, 124 10% 1:1 
a
Yield isolated after column chromatography. 
b
3.0 equivalents of tertiary amine. 
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2.10 Utilisation of an Inorganic Base 
It was known within the Barrett group that Cs2CO3 can be utilised to aid aromatisation in the 
late-stage aromatisation strategy.
[42][43][82] 
Tunge et al.
[90] 
have also demonstrated increased 
yields in the decarboxylative allylation reaction through the use of Cs2CO3. Additionally, 
Cs2CO3 has a high solubility in organic solvents compared with other inorganic bases.
[91] 
For 
these 3 reasons Cs2CO3 was chosen for this study.  
The results were very encouraging with entry 4 (Table 7) giving the highest yield of 
resorcylate 124 and diketo-dioxinone 123. It was interesting that a longer reaction time of 18 
h increased the yield of 123 and 124 (Table 7, Entry 2) compared with a reaction of 1 h 
(Table 7, Entry 1). This was different to the results shown in Table 6 whereby the reaction 
had gone to completion after 10 min with 4-ethylmorpholine (Table 6, Entry 5). Surprisingly, 
the ratio of linear 124 to branched 123 products was different with Cs2CO3 compared to 4-
ethylmorpholine. 
Pleasingly, the yield of resorcylate 124 was higher than diketo-dioxinone 123 because 
resorcylate 124 was required in the total synthesis of angelicoin A (6) (Section 47). It was 
significant that when the number of equivalents of Cs2CO3 was increased from 1 to 3 the 
yield of both resorcylate 124 and diketo-dioxinone 123 increased indicating that Cs2CO3 may 
be aiding both the decarboxylation, prenylation and aromatisation steps within the reaction. 
(The use of Cs2CO3 as a base is discussed in more detail in the mechanistic discussion 
Section 3.5).  
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Table 7: Studies Utilising Cs2CO3 
OO
O
HO
OSii-Pr3
O O O
O
O OSii -Pr3
124
O O O
O
OO
O OSii-Pr3
111 (1.0 equiv.)
123
Pd(PPh3)4 (10 mol%),
Cs2CO3,THF, 0 °C to rt
+
 
Entry Time/ h  Equiv. of Cs2CO3 Yield
a 
123:124 
1 1 1 123 8%, 124 35% 1:4 
2 18 1 123 10%, 124 41%
 
1:4 
3 18 3 123 9%, 124 48%
 
1:5 
4 18 Excess 123 8%, 124 49%
 
1:5 
a 
Isolated yield after column chromatography. 
 
2.11 Catalyst and Ligands Studies 
A number of Pd catalysts and ligands were screened in order to observe the effect on both the 
yield and linear 124 to branched 123 ratio. Some of the Pd sources commonly used by 
Murakami et al.,
[92] 
Stoltz et al.,
[93] 
Tunge et al.
[94] 
and Trost et al.
[95] 
for decarboxylative-
allylations are Pd2(dba)3 128 and Pd(PPh3)4. Additionally, a number of ligands widely utilised 
are rac-BINAP 74, Trost 69, Xantphos 129, PPh3 and dppf 130 (Figure 11).
[60][64][96]
 With this 
information to hand a number of small scale reactions were investigated (Table 8). 
It was apparent that Pd(II) sources, PdCl2 and Pd(OAc)2 (Table 8, Entries 7 & 8) failed to 
catalyse the reaction, whereas Pd(0) sources such as Pd(PPh3)4 and Pd2(dba)3 /Xantphos were 
effective catalysts.  It was interesting but not surprising that the type of catalyst and ligand 
had a significant effect on the linear to branched ratio. This is because the yield of a reaction 
and linear to branched ratio can vary dramatically depending upon the catalyst and ligands 
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being utilised for the transformation.
[89] 
The optimum conditions found were Pd(PPh3)4 at 10 
mol% giving resorcylate 124 in a 50% yield and diketo-dioxinone 123 in a 10% yield (Table 
8, Entry 2). 
Table 8: Catalyst and Ligand Studies 
111 (1.0 equiv.)
OO
O
HO
OSii -Pr3
O O O
O
O OSii-Pr3
124
O O O
O
OO
O OSii -Pr3
124
Cs2CO3 (3.0 equiv.),
THF,
0 °C to rt, 18 h
+
 
Entry Catalyst Ligand (20%) Yield
a
 123:124 
1 Pd(PPh3)4 (2.5 mol%) - 123 8%, 124 43%, 1:4 
2 Pd(PPh3)4 (10 mol%) - 123 10%, 124 50% 1:5 
3 Pd2(dba)3 (5 mol%) Xantphos 123 31%, 124 24% 3:2 
4 Pd2(dba)3 (5 mol%) rac-BINAP 123 2%, 124 10% 1:5 
5 Pd2(dba)3 (5 mol%) Trost 123 6%, 124 25% 1:4 
6 Pd2(dba)3 (5 mol%) dppf RSM - 
7 Pd(OAc)2 (10 mol%) PPh3 RSM - 
8 PdCl2 (10 mol%) PPh3 RSM - 
a
Isolated yield after column chromatography. 
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Figure 11: Ligands and Palladium Sources Utilised in Table 8 
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2.12 Temperature Studies  
Results from studies towards the temperature of the Pd(0)-decarboxylative prenylation and 
aromatisation sequence are illustrated in Table 9. The results from the temperature 
investigations demonstrated that the optimum temperature was to begin the reaction at 0 °C, 
allow it to warm to rt and stir for 18 h (Table 9, Entry 3). Interestingly, the starting material 
111 had been consumed after 1 h at 40 °C (Table 9, Entry 4) but the yield was lower than 
stirring for 18 h at rt (Table 9, Entry 3). This result indicated the sensitivity of the reaction to 
heat; the rate increased however, decomposition of diketo-dioxinones 123 and 110 and the 
starting material 111 also increased.  
Table 9: Temperature Studies  
OO
O
HO
OSii -Pr3
O O O
O
O OSii-Pr3
124
O O O
O
OO
O OSii-Pr3
111 (1.0 equiv.)
123
+
Pd(PPh3)4 (10 mol%),
Cs2CO3 (3.0 equiv.),
THF
 
Entry Temperature Time Yield
a
 123:124 
1 –78 °C 8 h RSM - 
2 0 °C 8 h 123 6%, 124 40%
b
 1:6 
3 0 °C to rt 18 h 123 10%, 124 52% 1:5 
4 40 °C 1 h 123 10%, 124 40%
c
 1:4 
a
Isolated yield after column chromatography. 
b
Consumption of the starting material 111 by TLC after 8 h. 
c
Consumption of the starting material 111 by TLC after 1 h. 
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2.13 Solvent Studies  
The final study was to look at the solvent effect on the Pd(0)-decarboxylative prenylation and 
aromatisation sequence. A number of solvents were screened, however, only THF was found 
to be effective (Table 10, Entry 5). 
Table 10: Solvent Studies 
111 (1.0 equiv.)
OO
O
HO
OSii-Pr3
O O O
O
O OSii -Pr3
124
O O O
O
OO
O OSii -Pr3
123
+
Pd(PPh3)4 (10 mol%),
Cs2CO3 (3.0 equiv.),
0 C to rt, 18 h
 
Entry Solvent Yield
a
 123:124 
1 DMF RSM - 
2 Et2O RSM - 
3 Toluene RSM - 
4 CH2Cl2 RSM - 
5 THF 123 11%, 124 51% 1:5 
a
Isolated yield after column chromatography. 
In conclusion, a thorough optimisation study has taken place whereby the best conditions 
were found to be Pd(PPh3)4 (10 mol%), Cs2CO3 (3 equivalents), 0 °C to rt over 18 h in THF, 
providing resorcylate 124 in a 50% yield and diketo-dioxinone 123 in a 10% yield. With 
these conditions to hand studies towards the total synthesis of angelicoin A (6) were 
continued. 
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2.14 Final Steps in the Synthesis of Angelicoin A (6) 
The final steps in the synthesis of angelicoin A (6) are shown in scheme 47. Deprotection of 
silylether 124 was accomplished utilising TBAF furnishing alcohol 128 in an excellent 97% 
yield. Finally, lactonisation was carried out under basic conditions (to avoid cyclisation of the 
phenol onto the protonated prenyl moiety which occurs under acidic conditions, see Section 
2.5) by heating alcohol 128 with KOH in EtOH affording angelicoin A (6) in a 90% yield.  
OO
O
HO
124 (1.0 equiv.)
OSi-iPr3
O O
O
HO
OH
KOH (excess),
EtOH,
60 C, 30 min,
90%
O
O
HO
OH
128 (1.0 equiv.)
angelicoin A (6)
TBAF (8.0 equiv.),
THF,
rt, 18 h, 97%
 
Scheme 47: Final Steps in the Synthesis of Angelicoin A (6) 
The synthesis of angelicoin A (6) was completed in 5 linear steps starting from dioxinone 33 
in an overall 33% yield.
 
 
2.15 Conclusions and Future Work  
The total synthesis of angelicoin B (7) has been completed in 6 linear starting steps from 
dioxinone 33 in an overall 29% yield. The synthesis exhibits the key Pd(0)-decarboxylative 
deallylation and aromatisation transformation which provided resorcylate 107 in an excellent 
80% yield starting from diketo-ester-dioxinone 104. In addition, the yield of the Claisen 
condensation between dioxinone 33 and acid chloride 101 was increased from 20% to a good 
65%. 
The total synthesis of angelicoin A (6) has been carried out in 5 linear steps starting from 
dixoinone 33 in an overall 33% yield. Thorough optimisation studies were conducted into the 
novel Pd(0)-decarboxylative prenylation and aromatisation sequence investigating the effects 
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of catalyst, ligand, solvent, temperature and base. These studies demonstrated that diketo-
ester-dioxinone 111 could be transformed into resorcylate 124 and diketo-dioxinone 123 in 
an excellent 60% yield and in a 5:1 ratio respectively. Optimised synthetic steps from these 
total syntheses are currently being utilised successfully within the Barrett group in the 
synthesis of other resorcylate natural products and other biologically active resorcylate 
analogues. 
In the future it would be interesting to continue studies towards the optimisation of the Pd(0)-
decarboxlyative allylation and aromatisation sequence. Tunge et al. have shown that 
Ruthenium, Iridium and Molybdenum can be efficient catalysts for this transformation.
[90] 
Hence, the reaction could be attempted with these metals utilising a variety of ligands and 
bases to see if the yield or the linear to branched ratio alters. 
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3 Verification and Mechanistic Studies Towards the 
Migratory Pd(0)-Decarboxylative Prenylation 
The last chapter describes the total synthesis of angelicoin A (6) utilising a migratory Pd(0)-
decarboxylative prenylation and aromatisation sequence. The next strategy was to prove that 
the Pd(0)-decarboxylative prenylation was truly migratory. It was postulated that an effective 
way to prove the migratory nature of this reaction was to obtain an X-ray crystal structure of 
the intermediates both before and after the decarboxylative prenylation had taken place. The 
aim was to prove that the prenylester functionality was indeed on C-3 of diketoester-
dioxinone 111 prior to treatment with Pd(PPh3)4 and that the prenyl moiety migrated to C-1 
after treatment with Pd(PPh3)4 (Scheme 48). 
3.1 X-ray Crystal Structure of Tricyle 130
III
  
Unfortunately, diketo-prenylester-dioxinone 111 was an oil at rt. It was thought that 
aromatisation and removal of the silylether would provide a crystal suitable for X-ray 
crystallography. Accordingly, diketo-prenylester 111 was aromatised by treatment with Et3N 
affording phenol 129 in a 40% yield. Deprotection of the silylether 130 was implemented 
utilising TBAF, interestingly lactonisation occurred within the reaction mixture furnishing 
tricycle 130 in a 63% yield. Gratifyingly, tricycle 130 was a crystalline solid suitable for X-
ray crystallography (Scheme 48).  
                                                          
III
 Section 3.1 has been published and therefore has similarity to Anderson, K.; Calo, F.; 
Pfaffeneder, T.; White, A. J. P.; Barrett, A. G. B. Org. Lett. 2011, 13, 5748-5750. 
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O O
1
2
3
O
O
OO
111 (1.0 equiv.)
OO
O
HO
Et3N (excess),
CH2Cl2,
rt, 24 h, 40%
OSii -Pr3
O O
OO
O
O
O
HO
130
O OSii-Pr3
129 (1.0 equiv.)
TBAF (4.4 equiv.),
THF,
rt, 48 h, 63%
 
Scheme 48: Steps in the Synthesis of Tricycle 130 
The X-ray crystal structure of tricycle 130 is shown below in Figure 12. The X-ray crystal 
structure verified the position of the prenylester functionality being on C-3 of diketo-
prenylester-dioxinone 111 prior to treatment with Pd(PPh3)4. 
 
Figure 12: X-ray Crystal Structure of Tricycle 130 
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3.2 X-ray Crystal Structure of Angelicioin A (6)
IV
 
The next step was to prove the position of the prenyl moiety after the Pd(0)-decarboxylative 
prenylation had taken place. Sections 2.8 - 2.13 discussed the optimisation studies towards 
the Pd(0)-decarboxylative prenylation and late stage aromatisation sequence. Two products 
were obtained from this reaction, the linear product 110 which aromatised within the reaction 
mixture to give resorcylate 124 and the branched product 123 (Scheme 45). The aim was to 
prove that the position of the prenyl moiety was on C-1 and not C-3 of resorcylate 124 
(Figure 13). Unfortunately, resorcylate 124 (Figure 13) was not a crystalline solid and not 
suitable for X-ray crystallography. However, Angelicoin A (6) (Figure 13) provided an 
excellent crystalline solid and an X-ray crystal structure was obtained (Figure 14). 
O
OOH
HO
1
2
3
HO
OSii -Pr3
angelicoin A (6)
124
OO
O
 
Figure 13: Resorcylate 124 and Angelicoin A (6) 
The X-ray crystal structure established that migration had occurred during the Pd(0)-
decarboxylative prenylation due to the position of the linear prenyl moiety being on C-1 of 
the aromatic ring (Figure 14). 
                                                          
IV
 Section 3.2 has been published and therefore has similarity to Anderson, K.; Calo, F.; 
Pfaffeneder, T.; White, A. J. P.; Barrett, A. G. B. Org. Lett. 2011, 13, 5748-5750. 
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Figure 14: X-ray Crystal Structure of Angelicoin A (6) 
 
3.3 Towards an X-ray Crystal Structure of Branched Resorcylate 
The next strategy was to obtain an X-ray crystal structure of the branched isomer 123 from 
the Pd(0)-decarboxylative prenylation reaction. Regrettably, diketo-dioxinone 123 was an oil 
at rt and thus investigations into its aromatisation were conducted (Table 11).  
Three standard methods utilised within the Barrett group for aromatisation of diketo-
dioxinones
[42][43] 
were attempted for diketo-dioxinone 123 (Table 11) (see Section 1.10 of the 
Introduction). All of these methods furnished residual starting material 123 (Table 11, Entries 
1 & 2) or decomposition of the starting material 123 (Table 11, Entry 3). It was thought that 
aromatisation was not occurring due to the bulky nature of the branched olefin preventing 
cyclisation (Figure 10).  
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Table 11: Studies Towards the Aromatisation of Diketo-dioxinone 123 
O O
O
O O OSii -Pr3
OO
O
HO
OSii-Pr3
123 131
Conditions
 
Entry Reaction Conditions Product 
1 Cs2CO3 (excess), MeOH, rt to , 18 h RSM 
2 Et3N(excess), CH2Cl2, rt to , 18 h RSM 
3 MeOH (excess), PhMe, , 1 h; 
Cs2CO3 (3.0 equiv.), MeOH, rt, 4h; 
AcOH (excess), rt, 3h 
Decomposition of the SM 
 
It was apparent that the low yield of diketo-dioxinone 123 following the Pd(0)-
decarboxylative prenylation was making it hard to bring material through in order to 
aromatise. Moreover, the separation of resorcylate 124 from diketo-dioxinone 123 was very 
difficult because the two products had similar Rf values (in a wide range of eluents). 
Therefore conditions were investigated that could provide a high yield of the branched 
product 123.  
As illustrated previously in Section 2.11 certain Pd catalysts and ligands can provide a higher 
percentage of branched product 123. Additionally, it has been shown by Tunge et al.
[90][94] 
and Lacour et al.
[97][98] 
that utilising Ruthenium in this transformation can promote formation 
of branched product. Table
 
12 below illustrates the Ruthenium catalysts, bases and ligands 
that were screened. Unfortunately, none of conditions screened (Table 12) yielded the desired 
products. Presumably, the structure of diketo-prenylester-dioxinone 111 was not suitable for 
Ruthenium catalysis. 
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Table 12: Ruthenium Conditions Investigated 
OO
O
HO
OSii -Pr3
O O
O
O O OSii -Pr3
124
123
Conditions
O O O
O
OO
111
O OSii-Pr3
+
 
Entry Catalyst (10 mol%) Ligand (20 
mol%) 
Solvent Temp. Time Outcome 
1 RuCp(MeCN)3.PF6 - CH2Cl2 0 
o
C to  18 h RSM 
2 RuCp(MeCN)3 - THF 0 
o
C to  18 h RSM 
3 RuClCp(PPh3)2 - THF 0 
o
C to  48 h RSM 
4 RuClCp(PPh3)2 Py THF 0 
o
C to  48 h RSM 
5 RuClCp(PPh3)2 Bpy THF 0 
o
C to  48 h RSM 
6 RuClCp(PPh3)2 TMEDA THF 0 
o
C to rt 18 h RSM 
7 Ru(methylallyl)2(COD) - THF 0 
o
C to  18 h RSM 
8 Ru(methylallyl)2(COD) Py THF 0 
o
C to  18 h RSM 
9 Ru(methylallyl)2(COD) Bpy THF 0 
o
C to  18 h RSM 
10 Ru(methylallyl)2(COD) TMEDA THF 0 
o
C to r.t. 18 h RSM 
11 [Cp*RuCl]4 - THF 0 
o
C to  18 h RSM 
12 [Cp*RuCl]4 Py THF 0 
o
C to  18 h RSM 
13 [Cp*RuCl]4 Bpy THF 0 
o
C to rt 18 h RSM 
14 [Cp*RuCl]4 TMEDA THF 0 
o
C to rt 18 h RSM 
15 [Cp*RuCl]4 Py CH2Cl2 0 
o
C to rt 18 h RSM 
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Consequently, the protecting group was changed from a silylether to a benzyl ether. It was 
postulated that following aromatisation, diketo-dioxinone 132 would not require deprotection 
because the two aromatic functionalities within the molecule would induce π-stacking 
providing a solid suitable for X-ray crystallography (Scheme 49).
[99]
 
O O O
O
OO
OO
O
HO
OBn
O O
O
O O OBn
O O
O
HO
O
O OBn +
132
133 134
Decarboxy lative
Preny lat ion
Aromatisation
135
Possible  interact ions
aiding the f ormat ion of a
crystal suitable for
X -ray crystallography
 
Scheme 49: Possible Synthetic Route Towards Resorcylate 135 
The synthetic route towards resorcylate 135 (Scheme 50) began with the benzyl protection of 
alcohol 136, giving benzyl ether 137 in a 76% yield. Saponification of methyl ester 137 to 
acid 138 took place using NaOH/ THF. Acid chloride 139 was then synthesised in situ 
utilising oxalyl chloride and catalytic DMF. Formation of diketo-ester-dioxinone 132 was 
achieved by treating ketoester-dioxinone 113 with MgCl2 and pyridine followed by the 
addition of acid chloride 139. When diketo-ester-dioxinone 132 was treated with Pd(PPh3)4, 
the Pd(0)-decarboxylative prenylation took place providing resorcylate 133 in a 35% yield. 
Unfortunately, branched-diketo-dioxinone 134 could only be seen in the crude 
1
H NMR and 
was not available in adequate yield to isolate by silica column chromatography.   
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MeO
O OBn
HO
O OBn
MeO
O OH
Cl
O OBn
O O
O
O O
O
1. MgCl2 (2.2 equiv.), py (2.7 equiv.),
CH2Cl2, 0 C, 30 min
136 (1.0 equiv.) 137 (1.0 equiv.) 138 (1.0 equiv.) 139
113 (1.0 equiv.)
OO
O
HO
BnO
O O
O
O O OBn
133 35% 134
TSA (cat.),
cyclohexane,
CH2Cl2, rt, 18 h, 76%
NaOH/ THF
rt, 72 h, 83%
(COCl)2 (3.0 equiv.),
CH2Cl2,
DMF (cat.), 0 C
to rt, 3 h
2. 139 (1.0 equiv.),
0 C, 30 min, 65%
O O O
O
OO
O OBn
132 (1.0 equiv.)
Pd(PPh3)4 (10 mol%),
Cs2CO3 (3.0 equiv.), THF,
0 C to rt, 18 h
Cl3C
NH2
O
(2.0 equiv.)
 
Scheme 50: Towards the Synthesis of Branched-Diketo-Dioxinone 134 
The next approach involved utilising a methyl group as the side chain in diketo-ester-
dioxinone. It was assumed that this side chain would enable the synthesis of a solid following 
aromatisation of the branched-diketo-dioxinone 141 suitable for X-ray crystallography. The 
synthesis of branched-diketo-dioxinone 141 and its subsequent aromatisation is illustrated in 
Scheme 51. 
Diketoester-dioxinone 140 was formed by prestirring ketoester-dioxinone 113 with MgCl2 
and pyridine followed by the addition of acetyl chloride. Treatment of diketoester-dioxinone 
140 with Pd(PPh3)4 facilitated the Pd(0)-decarboxylative prenylation and aromatisation 
providing linear resorcylate 142 in a 50% yield and branched-diketo-dioxinone 141 in a 10% 
yield (Scheme 51). 
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O O O
O
OO
O O
O
O O
O
1. MgCl2 (2.0 equiv.), py (2.7 equiv.),
CH2Cl2, 0 C, 30 min
2. acetyl chloride (1.4 equiv.),
0 C, 30 min, 86%
OO
O
HO
O O
O
O O
O O
O
HO
O
Conditions see
T able 13
113 (1.0 equiv.)
140 (1.0 equiv.)
Pd(PPh3)4 (10 mol%),
Cs2CO3 (3.0 equiv.),
THF, 0 C to rt, 18 h,
142 = 50%, 141 = 10%
+
141 (1.0 equiv.)
142
143  
Scheme 51: Synthesis of Branched-Diketo-Dioxinone 141 and its Subsequent Aromatisation 
The final step was to aromatise branched-diketo-dioxinone 141, a number of conditions were 
screened, and these are shown in Table 13 below. Regrettably, it was not possible to 
aromatise branched-diketo-dioxinone 141 under basic aromatisation conditions (Table 
13).
[42][43][82] 
Again, this was presumably due to the bulky nature of the branched prenyl group 
preventing aromatisation (Figure 10). 
Table 13: Conditions Screened for the Aromatisation of 141 
Entry Base Solvent Conditions Outcome 
1 Et3N (excess)   CH2Cl2 rt to , 72 h RSM 
2 Cs2CO3 (excess) MeOH rt to , 72 h RSM 
3 LDA (excess) THF –78 °C to , 48 h RSM 
It was decided to conduct the late stage aromatisation conditions; accordingly diketo-
dioxinone 141 was refluxed in toluene and MeOH (Scheme 52). The reaction was monitored 
by TLC and consumption of the starting material took 18 h (usually only 1 h of heating is 
required). Remarkably, the reaction led to the formation of branched-resorcylate 144 
(Scheme 52). 
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O O
O
O O
OH
HO
144
OMe
O
141 (1.0 equiv.)
MeOH (excess),
toluene,
, 18 h, 80%
 
Scheme 52: Formation of Branched-Resorcylate 144 
Aromatisation of diketo-dioxinones usually requires treatment with acid, base or pressure 
(sealed tube),
[42][43][82] 
making this result very intriguing. Scheme 53 below illustrates a 
proposed mechanism for this aromatisation. It was hypothesised that following formation of 
ketene 145 and subsequent trapping with MeOH to afford triketo-ester, the enol form of 
triketo-ester 146 would perform an intramolecular cyclisation under elevated temperatures to 
furnish cycle 147. Finally, dehydration and tautomerisation would afford resorcylate 143.  
O O O
MeO
O
OH
OH
147
O O
O
O O 
C
O O O
O
MeOH
H
145141
O OH O
MeO
O
145
H
O
OMe
OH
HO
144
O
OMe
1. +H+/-H+
2. tautomerise
HO
-H2O
 
Scheme 53: Proposed Aromatisation Mechanism at Elevated Temperatures 
Unfortunately branched-resorcylate 144 was a gum and thus not crystalline, nevertheless the 
new aromatisation conditions were noteworthy and are currently being studied further within 
the Barrett group.  
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3.4 Synthesis of Branched-Resorcylate 148
V
 
During studies towards total synthesis of amorfrutin A (8) it was found that refluxing 
branched-diketo-dioxinone 148 with Cs2CO3 in THF provided branched-resorcylate 149 in a 
68% yield (Scheme 54). 
O
O O O O
1
2
3
O
O
O
HO
148 (1.0 equiv.)
149
Cs2CO3 (2.0 equiv.),
THF, ,
5 h, 68%
 
Scheme 54: Synthesis of Branched-Resorcylate 149 
Pleasingly, branched-resorcylate 149 was a crystalline solid and an X-ray crystal structure 
was obtained (Figure 15). The X-ray structure confirmed the position of the branched prenyl 
moiety being on C-1 of the aromatic ring (Scheme 54), providing further evidence for the 
migration of the Pd(0)-decarboxylative prenylation and aromatisation sequence.  
 
Figure 15: X-ray Crystal Structure of Branched-Resorcylate 149 
 
                                                          
V
 Work in Section 3.4 has been carried out by Dr Sylvain Laclef. He is duly thanked for his 
contribution to this research. Additionally, this work has been published and therefore has 
similarity to Laclef, S.; Anderson, K.; White, A. J. P.; Barrett, A. G. M. Tetrahedron Letters 
2012, 53, 225–227.  
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3.5 Mechanistic Investigations 
The migration of the Pd(0)-decarboxylative prenylation had been proved unambiguously by 
X-ray crystallography studies. Hence, the next approach was to conduct mechanistic studies 
into this intriguing reaction. Initially it was considered that the mechanism could be taking 
place via a modified Carroll Rearrangement (Scheme 55)
[48] 
through formation of the π-allyl 
Pd complex 151 followed by decarboxylation to provide diketo-dioxinone 152. Subsequent 
intermolecular allylation would provide the allylated-diketodioxinone 150, which would 
readily undergo aromatisation.  
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Scheme 55: Observed Prenyl Migration and Postulated Reaction Mechanism via a Modified 
Carroll Rearrangement  
 
3.6 Substrate Investigations 
3.6.1 Allyl Group 
It was decided to investigate the Pd(0)-decarboxylative allylation and aromatisation sequence 
in relation to the allyl and crotyl moieties. The aim was to see if these groups would migrate 
and with the crotyl moiety to see if any branched isomer would be obtained. Diketo-
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allylester-dioxinone 153 was prepared by treatment of ketoester-dioxinone 102 with MgCl2 
and pyridine followed by the addition of acetyl chloride (Scheme 56).  
The Pd(0)-decarboxylative allylation of diketo-ester-dioxinone 153 provided allyl resorcylate 
154 and resorcylate 155 in a 1:1 ratio and overall 60% yield. This result demonstrated that the 
allylation was migratory, though, the yield of allyl-resorcylate 154 was lower than expected 
(possible reasons for this will be discussed in Section 3.9).  
O O O
O
O
OO
153 (1.0 equiv.)
HO
OO
O
HO
OO
O
154, 30% 155, 30%
+
Pd(PPh3)4 (10 mol%),
Cs2CO3 (3.0 equiv.)
THF, 0 C to rt, 18 h
O O O
O
102 (1.0 equiv.)
O
O
1. MgCl2 (2.0 equiv.), py (2.7 equiv.),
CH2Cl2, 0 C, 30 min
2. acetyl chloride (1.4 equiv.),
0 C, 30 min, 83%
 
Scheme 56: Synthesis of Diketo-Ester-Dioxinone 153 and Subsequent Treatment with Pd(PPh3)4 
3.6.2 Crotyl Group 
The synthesis of diketo-crotylester-dioxinone 156 (Scheme 57) was completed utilising the 
methods discussed previously in Section 2.6. Subsequent reaction of diketo-crotylester-
dioxinone 156 with Pd(PPh3)4 provided crotyl-resorcylate 157 in a 46% yield. This result 
provided additional evidence for the migratory nature of this sequence but interestingly, no 
branched product was observed in this transformation (Scheme 57). 
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1. MgCl2 (2.0 equiv.), py (2.7 equiv.),
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Scheme 57: Formation of Diketo-Crotylester-Dioxinone 156 and Reaction with Pd(PPh3)4 
 
3.7 Concentration Studies 
The next approach was to study the effects of reaction concentration on the course of the 
reaction to determine if any other products would be produced. The optimised conditions for 
the Pd(0)-decarboxylative-allylation-aromatisation sequence (0.2 M) gave the branched-
diketo-dioxinone 141 and linear resorcylate 142. Surprisingly, when the reaction 
concentration was decreased (0.014 M), two new products, the resorcylates 159 and 155 were 
formed and isolated in a 1:1 ratio and 83% overall yield (Scheme 58). Interestingly, at this 
lower concentration (0.014 M), only traces of diketodioxinone 141 and resorcylate 142 were 
isolated. Similarly, at the higher concentration (0.2 M), only traces of resorcylate 159 and 155 
were isolated (Scheme 58). The reaction was repeated on diketo-ester-dioxinone 132 to 
ensure reproducibility of this unusual result. Delightfully, the same result was obtained with 
diketo-ester-dioxinone 132 (Scheme 58). Scheme 58 illustrates the results from the 
concentration studies and highlights the intermediates (in square brackets) that were formed 
throughout the reaction.  
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Entry Conc. Diketo-Dioxinone Prenyl-
Resorcylate 
Prenylester-
Prenyl-
Resorcylate 
Resorcylate 
1 0.2 M 141= 10% 
134= 0% 
142= 50% 
161= 65% 
159= 2% 
163= 1% 
155= 3% 
165= 2% 
2 
 
 
0.014 M 
 
141= 0.5% 
134= 0% 
142= 3% 
133= 2% 
159= 42% 
163= 32% 
155= 41% 
165=33% 
Scheme 58: Concentration Studies towards Pd(0)-Decarboxylative Prenylation Sequence 
3 Verification and Mechanistic Studies Towards the Migratory Pd(0)-Decarboxylative 
Prenylation   
98 
 
It was postulated that intermolecular trapping of the π-prenyl-palladium(II) cation complex 
produced from oxidative insertion of a Pd(0) complex into the C-O bond of ester 140 by a 
second molecule of diketo-ester-dioxinone 140, afforded intermediate dioxinones 158 and 
160. Subsequent aromatisation resulted in the formation of the two resorcylates 159 and 155. 
These results are consistent with the operation of an intermolecular mechanism at low 
concentration in which diketoester 140 serves as both a π-prenyl donor and acceptor.  
Interestingly, at low concentration the branched-diketo-prenylester-dioxinone 167 was not 
observed (Figure 16). At a high concentration there are a high number of collisions between 
the enolate (nucleophile) and the π-prenyl-Palladium(II) cation complex (electrophile).[100] It 
was therefore postulated that when the concentration was decreased the number of collisions 
between the enolate and the π-prenyl-Palladium(II) cation complex would decrease and this 
was why the branched-diketo-prenylester-dioxinone 166 was not seen. 
OO
O
RHO
OO
O O OO
RO
O O
166 167  
Figure 16: Branched-Diketo-Prenylester-Dioxinone 166 and Branched-Prenylester-Resorcylate 
167 
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3.8 Cross-Over Experiment
VI
 
Encouraged by these findings, the next study sought to examine a cross-over experiment 
between unlabelled and deuterium labelled compounds. The study focused on the 
rearrangements of esters 168 and 169 at a concentration of 0.2 M (Scheme 59). Four 
resorcylates 170, 171, 172 and 173 were obtained from the cross over experiment with esters 
170 and 171 being isolated together in 70% yield and 1:1 ratio and esters 172 and 173 also 
isolated together in 70% yield and 1:1 ratio (yield is based on using 1.0 equivalent of 168 and 
1.0 equivalent of 169). These results are consistent with the prenyl moiety migration 
occurring via an intermolecular mechanism at a concentration of 0.2 M. 
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O
HO
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D D
OO
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HO
D D
O O
O
O O
OO
O O
O
O O
OO
D
D
OMe
Pd(PPh3)4 (10 mol%),
THF,
Cs2CO3 (3.0 equiv.),
0 °C to rt, 1 h
172 173
171
172 + 173 = 70% (1:1 ratio)
170 + 171 = 70% (1:1 ratio)
168
169
170
(1.0 equiv.)
(1.0 equiv.)
 
Scheme 59: Cross-Over Experiment between non-Deuterated Ester Diketodioxinone 168 and 
Deuterated Ester 169 
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 Work in Section 3.8 has been carried out by Dr Sylvain Laclef. He is duly thanked for his 
contribution to this work.  
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3.9 Proposed Mechanism 
In consistence with the results of these experiments, the following mechanism was proposed 
(Scheme 60). It was hypothesised that prenylester-diketodioxinone 140 can enter the catalytic 
manifold in one of two ways, either as a prenyl donor affording diketodioxinone 160 
(Pathway B) or as a prenyl acceptor giving the double prenyl dioxinone 158 (Pathway A). 
Diketodioxinone 160 can subsequently undergo prenylation to provide prenyl-diketo-
dioxinone 150. Finally, the double prenyl dioxinone 158 can undergo deprenylation and 
decarboxylation to provide prenyl-diketodioxinone 150, which can readily undergo 
aromatisation to provide resorcylate 142. Resorcylates 159 and 155 were isolated when the 
reaction was carried out at low concentration. Under these conditions the intramolecular 
cyclisation reaction to form resorcylate 155 and prenylated-resorcylate 159 proceeded faster 
than the intermolecular reactions to form prenyl-diketodioxinone 150. It was hypothesised 
that the intramolecular reaction proceeded faster than the intermolecular reaction due to the 
low concentration. At a low concentration an intramolecular reaction is more likely to 
proceed over an intermolecular one because both of the reactive components are tethered 
together, whereas with an intermolecular reaction the two reactive components are required 
to travel through the solvent in order to react.
[101]
 
 
3 Verification and Mechanistic Studies Towards the Migratory Pd(0)-Decarboxylative 
Prenylation   
101 
 
Pd (0)
Pd (II)
AllylationDeallylation
-CO2
Allylation Deallylation
-CO2
Pathway A
Pathway B
-H2O
-H2O
-H2O
O O OO
O
O O
140
O O OO
O
OO
O
HO
155
160
O O OO
O
150
OO
O
HO
142
O O OO
O
O O
OO
O
HO
OO
159
158
 
Scheme 60: Proposed Mechanism 
Section 3.6.1 above described the reaction of diketo-allylester-dioxinone 153 with Pd(PPh3)4 
which provided two products allyl-resorcylate 154 and resorcylate 155 in a 60% yield and 1:1 
ratio (Scheme 61). Presumably, resorcylate 155 was obtained in a 30% yield because 
aromatisation of diketo-dioxinone 160 was faster than allylation of diketo-dioxinone 160. 
O O O
O
O
OO
153 (1.0 equiv.)
HO
OO
O
HO
OO
O
154, 30% 155, 30%
+
Pd(PPh3)4 (10 mol%),
Cs2CO3 (3.0 equiv.),
THF, 0 C to rt, 18 h
 
Scheme 61: Reaction of Diketo-Allylester-Dioxinone 153 with Pd(PPh3)4 
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3.10 Base Studies 
The next plan was to formalise the role of Cs2CO3 in the mechanism to establish if it was 
catalysing the aromatisation step or the decarboxylation and allylation step, or both steps. To 
explore this question, ethyl ester 174 was allowed to react with allyl chloride as an 
electrophile in the presence of Pd(PPh3)4 in THF. Interestingly, no product was formed and 
starting material 174 was recovered confirming that a base is required for this transformation 
to take place (with an external allylation).  
As stated previously in Section 2.8 several intermediates are generated during the course of 
the reaction including an enolate 175 and/or a carboxylate 176 (Figure 17) that could be 
acting as a general base. To investigate the topic further ethyl ester 174 (synthesis is shown in 
Scheme 62) was allowed to react with allyl chloride and CsOAc at 0.2 M, which resulted in 
the formation of the hexasubstituted resorcylate 177 in an 82% yield (Scheme 62). Reaction 
using Cs2CO3 in place of CsOAc at 0.2 M resulted in the formation of the same, resorcylate 
177 in an 81% yield. The Barrett group have recently utilised this allylation reaction in the 
synthesis of diverse hexasubstituted benzene derivatives, whereby the acetate anion was 
generated in situ and acted as a base in the reaction.
[102]
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Scheme 62: Synthesis of Diketo-Ester-Dioxinone and Subsequent Reaction between Ethyl Ester 
174 and Allyl chloride 
These studies indicated that a general base is required for the transformation, which could be 
an enolate 175, and/or a carboxylate 176 (Figure 17). 
O O O
O
OO
O
carboxylate 175
O O O
O
O
enolate 176
 
Figure 17: Proposed Aromatisation Bases 
 
3.11 Regioselectivity Investigations
VII
 
The next strategy was to investigate the regioselectivity of the reaction and to understand why 
the allylation was migratory. In order to examine this it was decided to treat diketo-dioxinone 
179 with allyl acetate and ascertain the regioselectivity of allylation (Scheme 63). Keto-
dioxinone 178 was prepared via deprotonation of dioxinone 33 followed by the addition of 
acetyl chloride. Subsequent treatment of keto-dioxinone 178 with LDA followed by Et2Zn 
and addition of N-methoxy-N-methylbenzamide (182) furnished diketo-phenyl-dioxinone 179 
in a 76% yield.
[103] 
High regioselectivity in the allyl transfer step was observed providing 
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 Work in Section 3.11 was carried out in collaboration with Dr Sylvain Laclef. He is duly 
thanked for his collaboration and contributions to this work. 
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diketo-dioxinone 180 which then aromatised to give resorcylate 181 in an 82% yield (Scheme 
63). 
O
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Scheme 63: Preparation of Diketo-Dioxinone 179 and Subsequent Allylation and Aromatisation 
 
This experiment was consistent with the decarboxylation in Pathway B of the proposed 
mechanism (Scheme 60) where decarboxylation could be occurring before or after 
prenylation (allylation). It was therefore postulated that the regioselectivity was not driven by 
decarboxylation but could be due to the difference in pKa with prenylation (allylation) 
occurring at C-3 instead of C-5 due to the C-3 methylene having a lower pKa due to the 
adjacent dioxinone ring.
[104] 
The mechanistic studies that were conducted are consistent with 
an intermolecular reaction manifold. 
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3.12 Conclusions and Future Work 
3.12.1 Pd(0)-Decarboxylative Allylation and Aromatisation 
The migratory Pd(0)-decarboxylative prenylation and aromatisation sequence has been 
unambiguously verified through the use of X-ray crystallography. An X-ray crystal structure 
has been obtained proving the position of the ester functionality in diketo-ester-dioxinone 111 
prior to treatment with Pd(PPh3)4. X-ray crystal structures of both the linear resorcylate (6) 
and branched resorcylate 149 have been obtained confirming the position of the prenyl 
moiety on the aromatic ring and thus the migratory nature of the Pd(0)-decarboxylative 
prenylation and aromatisation sequence.  
Thorough mechanistic investigations including substrate studies, concentration studies, cross 
over experiments and base studies have been performed, leading to the proposal of an 
intermolecular mechanism for the migratory Pd(0)-decarboxylative prenylation. In the future 
it would be valuable to conduct further mechanistic studies towards Pd(0)-decarboxylative 
prenylation including in-situ NMR and react IR investigations. The aim of these two 
investigations would be to monitor the intermediates formed in the Pd(0)-decarboxylative 
prenylation that cannot be isolated. Prenylated-diketo-prenylester-dioxinone 158 and diketo-
dioxinone 160 are not isolated however, they should be seen utilising in-situ NMR and react 
IR and thus provide further evidence for the proposed mechanism (Scheme 64).  
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Scheme 64: Proposed Mechanism 
In addition, it would be advantageous to carry out the decarboxylative prenylation with 1 
equivalent of Pd(PPh3)4 at a low concentration (0.014 M) in order to observe the products that 
were produced. Theoretically with 1.0 equivalent of Pd(PPh3)4 pathway A of the proposed 
mechanism (Scheme 64) would be shut down. Therefore at a low concentration only 
resorcylate 155 should be obtained.  
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3.12.2 Aromatisation under Elevated Temperatures 
Section 3.3 demonstrated that aromatisation could occur at elevated temperatures without the 
requirement of a base, acid or pressure (sealed tube) (Scheme 65). This initial result could be 
studied further utilising a variety of alcohols such as ethanol or i-propanol. Moreover, 
different side chains could be investigated in place of the branched prenyl moiety. These 
results could be utilised by the Medicinal Section of the Barrett group towards the synthesis 
of different resorcylate analogues. Recently, the resorcinol scaffold has been shown to be an 
HSP90 inhibitor.
[105] 
Therefore new methodologies to generate analogues of the resorcinol 
scaffold will be invaluable for biological screening/testing. 
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Scheme 65: Aromatisation at Elevated Temperatures 
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4 Towards the Total Synthesis of Cristatic Acid 
Methyl Ester (183) 
Cristatic acid methyl ester 183 was chosen as a synthetic target to exhibit both the late-stage 
aromatisation strategy and the Pd(0)-decarboxylative allylation sequence. Cristatic acid (5) 
was isolated from the fruiting bodies of the higher mushroom Albatrellus cristatus by 
Steglich et  al. in 1981.
[6][7]  
Albatrelles cristatus exhibits a wide range of biological 
properties including antibiotic activity against gram-positive bacteria, a strong haemolytic 
function and has a considerable inhibitory effect against cells of the ascites form of the 
Ehrlich carcinoma.
[6][106] 
 
HO
OH O
OMe
O
183  
Figure 18: Cristatic Acid Methyl Ester 183 
The only two previous preparative approaches towards the total synthesis of cristatic acid (5) 
were published by Fürstner et al. in 2000
[106] 
and Joullié et al. in 1988.
[107]
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4.1 Approach of Joullié et al.
[107]  
Joullié et al. published studies towards the total synthesis of cristatic acid (5) in 1988. The 
group focused on three main sections of the molecule: the resorcylate core 184, the 2,4-
disubstitued furan 185 and the intervening terpenoid chain 186 (Scheme 66).
[107]  
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Scheme 66: Retrosynthetic Analysis
 
Interestingly, the resorcylate core was prepared using a modified procedure developed by 
Barrett et al.
[38] 
Allyl bromide was attached to the resorcylate core via an alkylation of the 
potassium phenolate 184. The 2,4-disubstitued furan 185 was prepared from furfural
[108]
 and 
attached onto the terpenoid chain via an alkylation to give aldehyde 187. The synthesis was 
finished by formation of the olefin and deprotection of one of the MOM groups to afford 
MOM protected cristatic acid 188. Unfortunately the total synthesis was not completed due to 
problems deprotecting the MOM groups. A number of conditions were screened; however, 
only one MOM group was finally removed in 25% yield.
[107] 
This illustrates that careful 
choice of protecting groups is crucial early in a synthesis (Scheme 67). 
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Scheme 67: Joullié’s Approach to Cristatic Acid (5)[107] 
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4.2 Fürstner’s Approach[106] 
The key disconnections in Fürstner’s approach to cristatic acid methyl ester 183 involved an 
oxidative cleavage to put in place the furan moiety, a Wittig reaction to install the olefin and 
a number of alkylations to build the essential benzylic and alkyl bonds (Scheme 68).
[106]  
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Scheme 68: Retrosynthetic Analysis
 
The synthesis began through alkylation of sodium phenolate with allyl bromide followed by 
phenolic SEM protections providing prenyl resorcylate 189. Allylic oxidation and subsequent 
conversion to the bromide furnished bromide-prenyl-resorcylate 190. Displacement with 
phenyl sulphonyl 191 then took place followed by a reduction with sodium amalgam to 
afford resorcylate 192. At the end of the synthesis a number of conditions were screened for 
the final deprotection.
[109] 
The optimal conditions were found to be TBAF in HMPA
[110]
 
which provided the cristatic acid methyl ester 183 in a 60% yield (Scheme 69).
[106]  
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SEMCl (2.1 equiv.),
KH (2.1 equiv.),
18-crown-6 (cat.),
THF, 5 h, rt, 84%
allyl bromide (0.5 equiv.),
HMPA (excess), -78 °C to 0 °C, 2 h
OMe
O
OMe
O
OMe
O
OMe
O
OMe
O
OMe
O
191 (1.0 equiv.)
(1.0 equiv.)
(1.0 equiv.)
 
Scheme 69: Fürstner’s Approach to Cristatic Acid Methyl Ester (183)[106]  
 
4.3 The Barrett Retrosynthetic Analysis of Cristatic Acid Methyl Ester 183 
It was envisaged that opening of isopropylidene protected resorcylate 193 with MeOH could 
provide cristatic acid methyl ester 183. Resorcylate 193 could be obtained from a Pd(0)-
decarboxylative, allylation and aromatisation sequence beginning with diketoester dioxinone 
194 which in turn could be available from acylation of ketoester-dioxinone 195. It was 
thought that a Claisen condensation could be facilitated between acid chloride 196 and 
dioxinone 33 in order to obtain ketoester dioxinone 195. Finally, it was predicated that 
deprotection of protected alcohol 198 and subsequent heating with Meldrum’s acid could 
afford acid 197. It is noteworthy that this strategy does not require phenolic group protection 
due to the late stage aromatisation to provide the aromatic core. 
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Scheme 70: Retrosynthetic Analysis of Cristatic Acid Methyl Ester 183 
 
4.4 Retrosynthetic Analysis for Protected Alcohol 198 
The aim of this retrosynthesis was to devise an elegant and novel concept enabling new 
intermediates for pharmaceutical and biological exploration that had not been utilised 
previously by Fürstner et al.
[106] 
or Joullié et al.
[107]
 It was hypothesised that the furan moiety 
could be put in place via a one-pot sequence involving a Nef reaction,
[111] 
t-butyl deprotection 
and decarboxylation
[112]
 and Paal-Knorr furan formation.
[113] 
It was envisaged that the nitro 
compound 199 could be generated via a Michael addition between keto-ester 200 and nitro 
olefin 201. Finally, it was thought that a Henry reaction
[114]
 on aldehyde 202 could facilitate 
the construction of nitro olefin 201 (Scheme 71). 
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Scheme 71: Strategy for the Protected Alcohol 198 
Scheme 72 below illustrates the proposed mechanism for furan formation. It was thought that 
a Nef reaction on nitro alkane 199 could provide aldehyde 203, under the reaction conditions 
the t-butyl ester would be removed facilitating decarboxylation. Attack of the ketone onto the 
aldehyde in a Paal–Knorr fashion could enable the formation of the 5- membered ring 204 
and finally dehydration of the hemiacetal would afford furan 198.  
O
O2N
PGO
Nef
Reaction
O
O
PGO
t-Butyl Deprotection
Ot-BuO Ot-BuO
O
O
PGO
OO
O
O
PGO
+H+
Dehydration
Aromatisation
Decarboxylation
O
PGO
198
Paal Knorr
Furan Formation
O
O
PGO
199 203
204  
Scheme 72: Stepwise Formation of Furan 198 
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4.5 Synthesis of t-Butyl-Ester-Keto 200 
Initially, it was decided to focus on the synthesis of t-butyl-ester-keto 200. t-Butyl ester-keto 
200 has previously been synthesised by Lavallée et al. in 1991 (Scheme 73).
[115]
 Aldehyde 
205 was treated with the zinc enolate of t-butyl acetate generated from zinc and t-
butylbromoacetate, the corresponding β-hydroxy ketone was then treated with MnO2 which 
provided keto-ester 200 in a 57% yield over the three steps. This reaction was found to be 
unreliable on scale due to problems generating the zinc enolate species. It was therefore not 
possible to synthesise the β-hydroxy ketone in significant quantities for the total synthesis. 
O
Ot -Bu
O
200
H
O
Ot-Bu
O
Br
205 (1.7 equiv.)
1. Zn (2.5 equiv.), THF, , 5 min
2.
Et2O, 0 C to rt, 1 h, 77% over 2 steps
3. MnO2 (excess), EtOAc, rt, 5h, 74%
(1.0 equiv.)
 
Scheme 73: Synthesis of t-Butyl-Ester-Keto 200 by Lavallée et al.
[115]
 
It was hypothesised that formation of enolate 206 followed by the addition of acid chloride 
207 would lead to the formation of ketoester 200 (Scheme 74). Unfortunately, only 
decomposition of the starting materials was observed due to competing reaction pathways. It 
was therefore decided to utilise a softer leaving group, thus benzotriazole was studied 
(Scheme 75).
[83][84]
 
Cl
O
Ot -Bu
O O
Ot-Bu
O
200
207
LDA (2.1 equiv.),
THF,
-78 °C, 30 min
-78 °C to rt, 18 h
Ot -Bu
O
206
Li
(2.0 equiv.)
(1.0 equiv.)
 
Scheme 74: Attempted Synthesis of t-Butyl-Ester-Keto 200 
Benzotriazole amide 208 was synthesised from the acid 209 in a 70% yield utilising a 
procedure developed within the Barrett group.
[82] 
The next step involved treating t-butylester 
210 with LDA to form the corresponding enolate 206, which was then added to benzotriazole 
amide 208, furnishing keto-ester 200 in an excellent 70% yield (Scheme 75).  
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Scheme 75: Synthetic of Benzotriazole Amide 208 and t-Butyl-Ester-Keto 200 
 
4.6 Studies Towards the Construction of Nitro Olefin 211 
4.6.1 Towards the Synthesis of Nitro Olefin 211 Utilising a Horner–Wadsworth–Emmons 
(HWE) Reaction 
A number of different strategies were identified for the introduction of the E-olefin 213. 
Initially, it was decided to investigate the use of a HWE reaction to install the E-olefin 213. It 
was envisaged that nitro olefin 211 could be formed via a one step TES deprotection and 
Swern reaction
[116]
 of silylether 212 followed by a Henry reaction.
[114] 
Silylether 212 could be 
produced by reduction of ester 213 to the alcohol followed by TBS protection. It was 
postulated that ester 213 could be obtained by performing a HWE reaction
 
on ketone 214. 
Ketone 214 could be furnished via a TES protection of alcohol 215 and then treatment with 
MeLi.
[117] 
Finally, it was hypothesised that amide 215 could be afforded by treatment of 
commercially available -valerolactone 216 with Weinreb amide (Scheme 76).[118] 
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Scheme 76: Retrosynthesis for the Construction of Nitro Alkene 211 
The synthesis began by treating -valerolactone 216 with N-methyl hydroxymethylamine 
hydrochloride to facilitate a Weinreb amination,
[118]
 utilising AlCl3 as a Lewis acid and 
providing amide 215 in a 60% yield. This procedure was chosen due to the low cost and 
commercial availability for the starting materials, the fast reaction time and minimal 
purification procedure.
 [118]
 Subsequent TES protection of alcohol 215 provided silylether 217 
in a 70% yield. It was decided to use the TES protecting group because later in the synthesis 
it was removed under Swern conditions enabling aldehyde 220 (Scheme 79) to be provided 
via a one-pot process.
[116] 
Treatment of amide 217 with MeLi provided ketone 214 in a 73% 
yield (Scheme 77).
[117]  
O
OTES
214
O
N OH
215 (1.0 equiv.)
O
O
O
+
NH.HCl
O
O
N OTES
217 (1.0 equiv.)
O
AlCl3 (15.0 equiv.),
CH2Cl2
0 C, 20 min, 60%
TESCl (1.0 equiv.),
imidazole (1.1 equiv.),
CH2Cl2, 0 C to rt,
1 h, 70%
MeLi (1.0 equiv.),
THF, 78 C
1 h, 73%
(216)
(1.5 equiv.)
(15.0 equiv.)
 
Scheme 77: Synthesis of Silylether 214
 
The next step involved a HWE reaction to install the E-olefin 213. A HWE approach for the 
construction of E-olefin was sought because Joullié et al.
[107] 
had previously reported a high 
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yielding and selective HWE procedure for the formation of E-olefin. Accordingly, treatment 
of ketone 214 with the ylid of ethyl 2-(diethoxyphosphoryl)acetate 218 afforded the product 
in 98% yield as a 3:1 mixture of E:Z isomers, respectively (Scheme 78). Regrettably, it was 
not possible to separate the two isomers. Presumably, Joullié et al. were able to separate their 
isomers due to the presence of different functionalities in the molecule.
 [107] 
Scheme 78 
demonstrates that a higher yield and selectivity was obtained compared to Joullié et al. and 
with the knowledge that the two isomers E-213 and Z-213 could be separable with different 
functionalities it was decided to continue the synthesis and try to separate at a later stage.  
EtO
OTES
213
O
O
OTES
214 (1.0 equiv.)
P
O
EtO
OEt
OEt
O
1. NaH (1.6 equiv.),
THF, 0 C, 45 min
rt, 6 h, 98%, 3:1 (E:Z)
2.
218 (1.5 equiv.)
 
Scheme 78: Horner–Wadsworth–Emmons Reaction 
Reduction of the ester 213 proceeded smoothly utilising DIBAL-H, affording alcohol 219 in 
a 63% yield (E:Z = 3:1). TBS protection of alcohol 219 furnished silylether 212, which was 
then subjected to Swern oxidation conditions
[116]
 facilitating a TES deprotection and 
subsequent oxidation in one step, providing aldehyde 220 in a 33% yield (E:Z = 3:1) 
(Scheme 79). Attempts to separate the E:Z mixture of alkenes after every synthetic step 
proved unsuccessful. Therefore, it was decided to investigate carboalumination
[119]
 for the 
introduction of the E-olefin because this method is regiospecific and would only provide the 
E-olefin (Scheme 80). 
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TBSO
H
220
TBSO
OTES
212
EtO
OTES
213 (1.0 equiv.)
O
DIBAL (3.0 equiv.),
CH2Cl2, 78 C
2 h, 63%, 3:1 (E:Z)
HO
OTES
219 (1.0 equiv.)
O
TBSCl (1.1 equiv.),
imidazole (1.2 equiv.)
CH2Cl2, 0 C to rt, 92%
3:1 (E:Z)
1.DMSO (10.0 equiv.),
(COCl)2 (5.0 equiv.), CH2Cl2, -80 C
2. 212 (1.0 equiv.), 2.5 h; -35 C, 1.5 h
3. Et3N (15.0 equiv.), -80 C,
40 min; rt, 10 min, 33%, 3:1 (E:Z)  
Scheme 79: Synthesis of Aldehyde 220 
4.6.2 Carboalumination 
The retrosynthesis begins with a one-pot TES deprotection and oxidation
[116]
 of silylether 212 
followed by a Henry reaction
[114]
 to afford nitro olefin 211. It was envisaged that silylether 
212 could be obtained via carboalumination
[119]
 of alkyne 221 followed by TBS protection of 
the subsequent alcohol. 
TBSO
OTES
212
TBSO
211
NO2
TES Deprotection
and Oxidation
Henry Reaction
TBS Protection
OTES
Carboalumination
221  
Scheme 80: Retrosynthetic Strategy Utilising Carboalumination 
In 2005, Dussault et al. published the total synthesis of plakinic acid A utilising a 
carboalumination step which inspired the retrosynthesis above (Scheme 80).
[120] 
It was 
envisaged that the carbometallation should take place in the presence of zirocene dichloride 
to provide the corresponding alkenyl metal derivative 222 in a high stereoselective and 
regioselective manner via a syn-addition.
[119] 
It has been proposed by Takahashi et al. that the 
addition of the Me-Al bond to alkynes is assisted by ZrCp2 and that Me2AlCl-Cp2ZrCl2 is a 
good methylaluminating agent.
[121] 
After formation of the Al-Me bond, transmetallation 
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utilising t-BuLi would occur followed by reaction with paraformaldehyde to provide alcohol 
219 (Scheme 81).
[120]
  
HO
OTES
219
OTES
221
Me
Me2Al
OTES
t-BuLi
Me
Li
OTES
(CHOH)n
222
Me3Al + Cp2ZrCl2 Me2Al ZrCp2Me
Cl
Cl
OTES
Al Me
Me
ClMeCp2Zr
Cl


OTES
Me
H
Al
+ Cp2ZrCl2
MeCl
Cl
Cp2Zr
 
Scheme 81: Carboalumination Conditions and Mechanism 
Prior to commencing with the synthetic Scheme 81 illustrated above it was decided to trap 
the alkenyl metal derivative 222 with iodine to ensure the selectivity of the reaction (Scheme 
82). Protection of alcohol 223 was achieved using TESCl in a 95% yield. Carboalumination
 
commenced by stirring zirconcene dichloride with AlMe3 and alkyne 221 for 18 h, the 
reaction was then quenched with iodine (Scheme 82).
[122] 
Unfortunately, the reaction yielded 
the desired product 224 in a 10% yield and the deprotected alcohol 225 in a 50% yield. It was 
therefore decided to change the protecting group to the bulkier and less sensitive TBDPS 
(Scheme 83).
[123]
 
OTES
I
OTES
221
224 10%
+
OH
225 50%
OH
223 (1.0 equiv.)
TESCl (1.1 equiv.),
imidazole (1.2 equiv.),
CH2Cl2, 0 C to rt,
3 h, 95%
1. ZrCl2Cp2 (1.0 equiv.),
CH2Cl2, 0 C, 5 min
2. AlMe3 (2.0 equiv.), 15 min
3. 221 (1.0 equiv.), rt, 18 h
4. I2 (1.4 equiv.), THF,
-23 C, 15 min
I
 
Scheme 82: Protection of Alcohol 223 and Subsequent Carboalumination 
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Protection of the alcohol 223 was achieved using TBDPSCl affording silylether 226 in 88% 
yield. Carboalumination
[121]
 commenced as before and trapping with iodine gave E-iodo-
olefin 227 in a pleasing 70% yield (Scheme 83).  
OH
TBDPSCl (1.1 equiv.),
imidazole (1.4 equiv.),
CH2Cl2, rt, 72 h, 88%
OTBDPS
OTBDPS
I
223 (1.0 equiv.) 226
227
1. ZrCl2Cp2 (1.0 equiv.),
CH2Cl2, 0 C, 5 min
2. AlCl3 (2.0 equiv.), 15 min
3. 226 (1.0 equiv.), rt, 18 h
4. I2 (2.0 equiv.), THF, -23 C, 15 min  
Scheme 83: Carboalumination with Alkyne 226 
Having successfully carried out the reaction with iodine as the electrophile it was decided to 
transmetallate and quench with paraformaldehyde, facilitating the elegant three step one-pot 
reaction (Scheme 84).
[120] 
The reaction progressed well giving a mixture of alcohol 228 and 
olefin 229 in low yield. It was apparent that a longer reaction time was required in order to 
drive the reaction to completion. Accordingly, the reaction was repeated and stirred for 120 h 
after the addition of paraformaldehyde. The yield of alcohol 228 increased to 53% and olefin 
229 to 22%. 
1. ZrCl2Cp2 (1.0 equiv.),
CH2Cl2, 0 C, 5 min
2. AlCl3 (2.0 equiv.), 15 min
3. 226 (1.0 equiv.), rt, 18 h
4. t-BuLi (2.0 equiv.),
hexanes, -78 C, 1 h
5. (CHOH)n (excess),
72 h, -78 C to r.t., 60%
OTBDPS
HO
OTBDPS
OTBDPS
228 20% 229 30%
+
226
 
Scheme 84: Carboalumination of Alkyne 226 
Upon scale-up it was evident that the reaction was not optimal as the yield of both the alcohol 
228 to 20% and olefin 229 to 6% were significantly reduced. Presumably, this was due to 
scaling up effects in particular the exothermic addition of t-BuLi in combination with a 
decrease in efficient mixing, creating reaction hotspots in the larger vessel which thereby led 
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to unwanted reactions and decomposition.
[124] 
It was therefore decided to investigate an 
alternative strategy for the formation of the E-olefin. 
 
4.6.3 Stereoselective and Regioselective Reduction of Alkynol 230 
The next strategy for a high yielding method for the introduction of E-olefin was to utilise a 
stereoselective and regioselective reduction of alkynol 230 utilising Red-Al.
[125] 
It was 
envisaged that nitro olefin 231 could be available from TBDPS deprotection of silylether 232, 
and then oxidation and a Henry reaction.
[114] 
Silylether 232 could be obtained via a PMB 
protection and methylation of vinyl iodide 233. Vinyl iodide 233 could be available following 
a stereoselctive and regioselective reduction of alkynol 230 utilising Red-Al.
[125] 
Finally, 
alkynol 230 could be obtained by deprotonation of alkyne 226 followed by coupling with 
paraformaldehyde (Scheme 85).
[126]
 
I OTBDPS
HO
OTBDPS
226
233
OTBDPS
230
OH
Me OTBDPS
PMBO
232
PMB Protection
Methylation
TBDPS Deprotection
Oxidation
Henry Reaction
Me
PMBO
231
NO2
Red-Al Reduction
Deprotonation
Coupling with
(CHOH)n  
Scheme 85: Retrosynthetic Analysis for Nitro-Olefin 231 
The synthesis began with the TBDPS protection of alcohol 223 obtaining silylether 226 in an 
88% yield. Deprotonation and subsequent addition of paraformaldehyde to alkyne 226 
provided alkynol 230 in 87% yield.
[126] 
Treatment of alkynol 230 with Red-Al followed by 
quenching with NIS afforded olefin 234 in 80% yield (Scheme 86).
[125] 
However, this step 
4 Towards the Total Synthesis of Cristatic Acid Methyl Ester (183) 
123 
 
also afforded deprotection of the TBDPS group, presumably due to prolonged stirring in Red-
Al. Thus it was decided to change the protecting group to PMB (Scheme 87).  
I OH
HO
OTBDPS
226 (1.0 equiv.)
234
1. n-BuLi (1.0 equiv.),
THF, -78 C, 1 h
2. (CHOH)n (2.0 equiv.),
-78 C to rt, 18 h, 87%
OTBDPS
230 (1.0 equiv.)OH
1. Red-Al (1.7 equiv.), THF,
0 C to rt, 18 h
2. NIS (1.8 equiv.), THF, -78 C to 0 C,
30 min, 80%
OH
223 (1.0 equiv.)
TBDPSCl (1.1 equiv.),
imidazole (1.4 equiv.),
CH2Cl2, rt, 72 h, 88%
 
Scheme 86: Synthetic Steps in the Construction of Alkene 234 
PMB protection of alcohol 223 using PMBCl, provided PMB ether 235 in an excellent 90% 
yield. Formation of alkynol 236 progressed smoothly in an 81% yield. Subsequent treatment 
with Red-Al followed by NIS furnished iodide 237 in an 83% yield (Scheme 87).
[125]
 
1. n-BuLi (1.0 equiv.),
THF, -78 C, 1 h
2. (CHOH)n (2.0 equiv.),
-78 C to rt, 18 h, 81%
1. Red-Al (1.7 equiv.), THF,
0 C to rt, 18 h
2. NIS (1.8 equiv.), THF, -78 C to 0 C,
30 min, 83%
I OPMB
HO
OPMB
235 (1.0 equiv.)
237
OPMB
236 (1.0 equiv.)OH
OH
223 (1.0 equiv.)
PMBCl (1.1 equiv.),
NaH (1.5 equiv.), DMF,
rt, 18 h, 90%
 
Scheme 87: Formation of Iodide Utilising the PMB Protecting Group 
Having successfully achieved the synthesis of iodide 237 the next step in the synthetic route 
was displacement of the iodide functionality for a methyl group.  
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4.7 Methyl Incorporation Studies 
4.7.1 Methyl Incorporation Utilising the Gilman Reagent 
The Gilman reagent discovered in 1966 by Henry Gilman has been shown to be extremely 
effective in exchanging alkyl groups with halides in alkenes.
[127]
 For this reason it was 
decided to investigate the use of Me2CuLi in the synthesis of olefin 238.
[129] 
Accordingly, a 
number of conditions were screened for the formation of olefin 238 utilising Me2CuLi these 
are illustrated below in Table 14.  
The reaction was successful on one occasion (Entry 1, Table 14) however olefin 239 was also 
isolated. It was thought that olefin 239 had arisen due to the reaction not going to completion, 
thus the reaction was stirred for 24 h (Entry 2, Table 14). Unfortuantely, the yield of olefin 
239 increased and methyl-olefin 238 decreased. The next strategy was to use a new bottle of 
MeLi with a higher concentration (Entry 3, Table 14). Interestingly, this led to the formation 
of olefin 239 and a new side product, alkyne 240, which was presumably formed via 
elimination of HI across the double bond. The reaction temperature was thus decreased to –
10 °C, nevertheless olefin 239 and alykne 240 were obtained (Entry 4, Table 14). Finally, the 
solvent was changed to Et2O, but again olefin 239 and alkyne 240 were provided (Entry 5, 
Table 14).  
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Table 14: Conditions Screened Utilising Me2CuLi 
HO
I OPMB
HO
OPMB
HO
OPMB
OPMB
HO
CuI (5.0 equiv.),
MeLi (10.0 equiv.)
239 240
238
237
 
Entry Temp. Solvent Time Conc. Of MeLi Products
a
 
1 0 °C to rt THF 6 h 0.3 M 239 10%, 238 60% 
2 0 °C to rt THF 24 h 0.3 M 239 40%, 238 40% 
3 0 °C to rt THF 15 h 1.3 M 239 40%, 240 40% 
4 –10 °C THF 15 h 1.3 M 239 40%, 240 40% 
5 0 °C Et2O 15 h 1.3 M 239 40%, 240 40% 
a
Isolated yield after column chromatography. 
It was hypothesised that the side products may have arisen from the different bottles of MeLi 
being used or from the coordinating nature of the free alcohol functionality preventing the 
iodide from being substituted for a methyl group. Consequently, the next strategy was to 
protect the alcohol as a TBDPS ether and attempt the reaction again (Scheme 88). Alcohol 
237 was successfully protected with the TBDPS protecting group. However, treatment with 
Me2CuLi unfortunately only led to decomposition of the starting material. Due to the 
inconsistency and capricious nature of this transformation it was decided to study a different 
strategy for the incorporation of the methyl group. 
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TBDPSO
OPMB
CuI (5.0 equiv.),
MeLi (10.0 equiv.), THF
242
HO
I OPMB
237 (1.0 equiv.)
TBDPSCl (1.1 equiv.),
imidazole (1.1. equiv.),
CH2Cl2, 0 C to rt, 18 h
80%
TBDPSO
I OPMB
241 (1.0 equiv.)
0 C to rt, 18 h
 
Scheme 88: TBDPS Protection Followed by Treatment with Me2CuLi 
 
4.7.2 Lithium Iodide Exchange Followed by MeI Addition 
The next approach for the introduction of the methyl group was to carry out a lithium-iodide 
exchange followed by the addition of MeI. Hudrlik et al.
[129] 
and Hopkins et al.
[130] 
had 
previously demonstrated that lithium iodine exchange using n-BuLi or t-BuLi, followed by 
the addition of MeI led to the incorporation of a methyl group. Treatment of iodide 242 with 
n-BuLi followed by the addition of MeI afforded only a mixture of olefin 243 and starting 
material 242 (Scheme 89). The reaction was therefore attempted again with t-BuLi, however 
this led to decomposition of the starting material.  
TBDPSO
I OPMB
241 (1.0 equiv.)
1. n-BuLi (1.2 equiv.),
THF, -78 C, 15 min
2. MeI (2.0 equiv.),
-78 C, 10 min
TBDPSO
OPMB
+
TBDPSO
I OPMB
241 40%243 20%  
Scheme 89: Lithium Iodide Exchange and Followed by MeI Addition  
The next strategy was to utilise an alternative protecting group to aid the lithiation. Bajwa et 
al.,
[131]
 Jamieson et al.
[132] 
and Winkle et al.
[133] 
have demonstrated the efficient directing 
group effects of the MOM ether. Therefore, alcohol 237 was protected as the MOM ether 244 
in a 98% yield. MOM ether 244 was then treated with n-BuLi followed by MeI and 
interestingly two new products were obtained; olefin 245 in a 60% yield and alkyne 246 in a 
30% yield (Scheme 90). 
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HO
I OPMB
OPMB
MOMO
237 (1.0 equiv.)
MOMCl (1.3 equiv.),
DIPEA (1.7 equiv.)
CH2Cl2, 0 C to rt,
3 h, 98%
MOMO
I OPMB
244 (1.0 equiv.)
1. n-BuLi (1.2 equiv.),
THF, -78 C, 15 min
2. MeI (1.5 equiv.), -78 C, 10 min
MOMO
OPMB
+
245 61% 246 30%  
Scheme 90: MOM Protection Followed by Lithium-Iodide Exchange and MeI Addition  
It was hypothesised that alkyne 246 could have been formed via deprotonation of the olefinic 
C-H bond followed by elimination of the iodide (Scheme 91). Furthermore, it was postulated 
that olefin 245 could have been obtained due to the ‘protective sphere’ provided by the 
coordination of the MOM group
[133] preventing attack from MeI (Scheme 91).  
OPMB
MOMO
MOMO
I OPMB
244
MOMO
I OPMB
n-Bu
H
246
Li
n-BuLi
O
Li OPMB
O
MOMO
OPMB
245  
Scheme 91: Proposed Mechanisms for the Formation of Alkene 245 and Alkyne 246 
It was apparent the utilising lithium in this reaction was leading to formation of unwanted 
side-products. Hence, it was decided to investigate the use of Pd cross coupling reactions for 
methyl incorporation.  
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4.7.3 Studies towards Kumada Cross Coupling 
It was hypothesised that the Kumada cross coupling, reported independently in 1972 by 
Corriu et al.
[134] 
and Kumada et al.,
[135] 
would be an excellent tool for the incorporation of the 
methyl group. Iodide 244/241 was treated with i-PrMgCl and Pd(PPh3)4 followed by the 
addition of MeI (Scheme 92). Pleasingly, the Kumada-type cross coupling conditions 
provided methyl-olefin 247 in a 47% yield (MOM protecting group) and methyl-olefin 242 in 
a 50% yield (TBDPS protecting group). Unfortunately, the reaction also afforded olefin 245 
(MOM protecting group) and 243 (TBDPS protecting group) and recovered starting material 
244 (MOM protecting group) and 241 (TBDPS protecting group) which all had very similar 
Rf values and as a result were very difficult to separate. Thus, it was decided to conduct 
studies towards the Negishi Cross Coupling.
[137] 
 
RO
I OPMB
1. i -PrMgCl (2.0 equiv.),
THF, 0 C, 1 h
2. Pd(PPh3)4 (5 mol%), 10 min
3. MeI (10.0 equiv.),
0 C to rt, 18 h
RO
OPMB
RO
I OPMB
RO
OPMB
R1= MOM, 244 (1.0 equiv.)
R2= TBDPS, 241 (1.0 equiv.)
R1= MOM, 245, 8%
R2= TBDPS, 243, 10%
R1= MOM, 247, 47%
R2= TBDPS, 242, 50%
R1= MOM, 244, 25%
R2= TBDPS, 241, 20%  
Scheme 92: Kumada-Type Cross Coupling 
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4.7.4 Negishi Cross Coupling 
Recent work by Fu et al.
[136] 
has demonstrated successful palladium-catalysed Negishi cross 
coupling of unactivated alkyl iodides and bromides. Accordingly, ZnBr2 was prestirred with 
MeMgBr in Et2O, Pd(PPh3)4 and iodide 241 were then added and the mixture stirred for 18 
h.
[137] 
Unfortunately, only decomposition of the starting material was observed (Scheme 93).  
TBDPSO
OPMB
242
TBDPSO
I OPMB
241
1. MgMeBr (1.1 equiv.),
ZnBr2 (1.1 equiv.), Et2O,
0C to rt, 30 min
2. Pd(PPh3)4 (5 mol%)
3. 241 (1.0 equiv.), 18 h  
Scheme 93: Negishi Cross Coupling 
The next strategy was to utilise a pre-formed zinc complex, ZnMe2. Thus, iodide 241 was 
stirred with Pd(PPh3)4 followed by treatment with ZnMe2. Pleasingly, these reaction 
conditions afforded alkene 242 in an excellent 95% yield. It was noteworthy that after the 
addition of ZnMe2 there was a colour change from colourless to yellow, presumably, 
indicating activation of the catalyst.
[138]
 When the reaction was complete the colour changed 
back to colourless (Scheme 94).  
TBDPSO
I OPMB
241 (1.0 equiv.)
TBDPSO
OPMB
242
1. Pd(PPh3)4 (5 mol%),
THF, 0 C, 1 h
2. ZnMe2 (3.0 equiv.),
0 C to rt, 18 h, 95%  
Scheme 94: Negishi Cross Coupling Utilising ZnMe2 
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4.8 Final Steps Towards the Synthesis of Nitro-Alkene 250 
PMB deprotection was achieved using DDQ in CH2Cl2:Buffer pH 7, affording alcohol 248 in 
a 70% yield. Swern oxidation of alcohol 248 provided aldehyde 249 in a 92% yield (Scheme 
95).  
OPMB
TBDPSO
242 (1.0 equiv.)
DDQ (1.2 equiv.),
CH2Cl2 : Buffer pH 7 (1:8)
0 C to rt, 1 h, 70%
OH
TBDPSO
248
1. (COCl)2 (2.0 equiv.),
DMSO (3.0 equiv.), CH2Cl2,
-78 C, 30 min
2. 248 (1.0 equiv.), -78 C, 1 h
3. Et3N (5.0 equiv.),
-78 C to rt, 3 h, 73%
TBDPSO
249
O
H
TBDPSO
250
NO2Henry
Reaction
 
Scheme 95: Final Steps Towards the Synthesis of Nitro-Alkene 250 
Prior to formation of nitro alkene 250 it was decided to conduct a model study in order to 
obtain optimised conditions for the Henry reaction,
[114] 
Michael Addition and one-pot Nef 
reaction,
[111] 
deprotection, decarboxylation
[112]
 and furan formation
[113]
 steps (Scheme 95). 
Instead of using valuable aldehyde 249 which had taken seven steps to prepare it was decided 
to conduct a model study using commercially available hexanal. 
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4.9 Model Study into the Furan Formation 
Scheme 96 below illustrates the retrosynthesis that the model study would encompass. It was 
envisaged that a furan 251 could be available following a Nef reaction,
[111] 
tert-butyl 
deprotection, decarboxylation
[112]
 and Paal Knorr furan formation
[113]
 beginning with nitro 
alkane 252. Nitro alkane 252 could be obtained via a Michael addition between nitro olefin 
253 and ketoester 200 and finally nitro-alkene 253 could be provided through a Henry 
reaction
[114]
 starting with hexanal.  
H
O
NO2
t-BuO
O O Henry
Reaction
Michael
Addition
O
Ot -BuO
O2N
O
Nef Reaction
Deprotection
Decarboxylation
Furan Formation
200
251
252
253
+
 
Scheme 96: Retrosynthesis for the Model Study 
 
4.9.1 Henry Reaction 
The Henry reaction
[114]
 is a C–C bond forming reaction between a carbonyl compound and a 
nitro alkane, leading to the formation of β-hydroxy nitro compounds. If acidic protons are 
available dehydration will follow resulting in the formation of a β-nitro alcohol.[139] Vergari et 
al. demonstrated a one-step highly efficient strategy for the preparation of nitro olefins.
[140] 
Accordingly, hexanal was treated with nitromethane and piperidine providing nitro-alkene 
253 in a 50% yield (Scheme 97). 
 
H
O
NO2
253
piperine (1.0 equiv.),
MeNO2 (2.0 equiv.),
CH2Cl2, 4 Å MS,
rt, 18 h, 50%
(1.0 equiv.)
 
Scheme 97: Henry Reaction 
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4.9.2 Michael Addition 
The next step in the model study was a Michael addition between nitro olefin 253 and 
ketoester 200. It was decided treat ketoester 200 with a catalytic amount of KOt-Bu for 10 
min, followed by the dropwise addition of nitro-alkene 253 in order to prevent 
polymerisation.
[141][142] 
Delightfully, nitro-alkene 252 was furnished in a 75% yield (Scheme 
98).
[142] 
 
O
Ot-BuO
O2N
252
t -BuO
O O
200 (1.0 equiv.)
NO2
1. KOt-Bu (0.2 equiv.),
t-BuOH/THF,
0 C, 10 min
2.
0 C, 30 min, 75%
253 (1.9 equiv.)
 
Scheme 98: Michael Addition 
4.9.3 Nef Reaction, t-Butyl Deprotection, Decarboxylation and Furan Formation 
The next step in the model study was to investigate the one-pot Nef reaction,
[111]
 
deprotection, decarboxylation
[112]
 and furan formation.
[113] 
A number of academic groups 
have demonstrated the formation of a furan ring starting from a molecule containing the nitro 
and dicarbonyl functionalities.
[143] 
For example Lee et al.
[144]
 showed that nitro alkane 254 
could be transformed into furan 255 under acidic conditions (Scheme 99). Lee et al. 
postulated a mechanism that protonation of the nitro group followed by intramolecular attack 
of the carbonyl oxygen towards the protonated nitro group would generate the allylic 
carbocation intermediate 256. This would then be followed by an intermolecular Friedel-
Crafts reaction with benzene and finally aromatisation to give furan 255.
[144][145]
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Ph
O2N
COOEt
O
254
H+
Ph
N
COOEt
O
HO
HO
Ph
N
COOEt
O
HO
HO
O
Ph
COOEt
N
HO
HO
PhH
-H+
O
Ph
COOEt
N
HO
HO
PhH
-HN(OH)2 O
Ph
EtOOC
Ph
256 255
O
Ph
N
COOEt
HO
HO
 
Scheme 99: Formation of Furan 255
[144]
 
Based on the reported precedent, it was decided to screen a number of conditions for the one-
pot reaction to provide the furan 251 (Table 15). The first conditions to be screened were 
those utilised by Lee et al.
[144] 
(Entry 1, Table 15), however, these harsh conditions led to 
decomposition of the starting material. Consequently, the next tactic was to utilise KMnO4 to 
perform an oxidative Nef reaction (Entry 2, Table 15), but this method afforded a complex 
mixture of products.
[146] 
As a result the use of CrCl2 was studied in order to facilitate a 
reductive Nef reaction (Entry 3, Table 15).
[147] 
It was also thought that the Lewis acid would 
aid in furan formation.
[113] 
Nonetheless, this condition yielded a complex mixture of products.  
 
The next strategy was to look at more traditional conditions for the Nef reaction, forming the 
nitronate salt followed by the addition of strong aqueous acid (Entries 4 & 5, Table 15).
 [147]
 
Furthermore, it was postulated that the acidic conditions would aid the deprotection, 
decarboxylation
[112]
 and furan formation steps.
 [113] 
Unfortunately, no reaction was observed 
and only recovered starting material was isolated. Yoshikoshi et al. demonstrated that 
refluxing a nitro compound and dicarbonyl in KF could lead to the formation of furan 
rings.
[148] 
Accordingly, these conditions were attempted; however, they led to the isolation of 
starting material (Entry 6, Table 15). Finally, Fuji et al. demonstrated the use of TiCl3 to 
facilitate a Nef reaction in the total synthesis of spirotryprostatin B (91).
[149]
 Additionally, it 
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was thought TiCl3 would act as Lewis acid aiding furan formation.
[113] 
Nevertheless, these 
conditions led to the formation of a complex mixture of products (Entry 7, Table 15).  
Table 15: Nef Reaction, Deprotection, Decarboxylation and Furan Formation 
O
Ot-BuO
O2N
252
O
251
Condit ions
 
Entry Conditions Outcome 
1 H2SO4 (excess), TFA (excess), C6H6, , 2 h
[144]
  Decomposition of 252 
2 NaH (2.0 equiv.), HOt-Bu, 10 min, 0°C; 
KMnO4 (excess), Pentane/H2O, 30 min, 0 °C to rt
[146]
 
Complex mixture 
3 NaOMe (2.0 equiv.), MeOH, 30 min, 0 °C; 
NH4OAc (25.0 equiv.), CrCl2 (3.0 equiv.), H2O, 0 °C 
to rt, 3 h
[147]
 
Complex mixture 
4 NaH (2.0 equiv.), THF, 0 °C, 30 min; 
1 M HCl, 0 °C to rt, 18 h
[147]
 
RSM 
5 NaH (2.0 equiv.), THF, 0 °C, 30 min; 
H2SO4 (conc.), 0 °C to rt, 18 h
[147]
 
RSM 
6 KF (excess), Xylene, , 18  [148] RSM 
7 NH4OAc (excess), MeOH/H2O, TiCl3 (20% aq., 4.0 
equiv.), 0 °C to rt, 5 h
[149]
 
Complex mixture 
 
Regrettably, formation of furan 251 in a one-pot reaction was not possible. It was apparent 
that the Nef reaction was not working successfully, either because the aldehyde was being 
formed and then decomposing (Entries 2, 3 & 7, Table 15) or not being formed at all (Entries 
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4, 5 & 6, Table 15). Therefore, it was decided to perform the t-butyl deprotection and 
decarboxylation reaction to afford nitro alkane 252 and then attempt the Nef reaction 
followed by furan formation. Accordingly, ester 252 was treated with TsOH and refluxed in 
benzene affording nitro ketone 257 in a pleasing 91% yield (Scheme 100).
[150]
 
O
Ot-BuO
O2N
252 (1.0 equiv.)
TsOH (0.2 equiv.),
C6H6,
, 4 h, 91%
O
O2N
257
 
Scheme 100: Deprotection and Decarboxylation of Ester 252 
The next step was to attempt a one-pot Nef reaction
[111]
 and furan formation.
[113] 
The 
conditions illustrated in Entries 2, 4 and 6 of Table 15 were attempted however only afforded 
degradation of the starting material. It was apparent that aldehyde 258 was being produced 
but then decomposing in the reaction mixture. Consequently, it was decided to form the 
aldehyde 258 via the Nef reaction,
[111] 
isolate the product and then perform the furan 
formation. Scheme 101 below illustrates the traditional Nef conditions utilised to furnish 
aldehyde 258 in a 71% yield.
[147] 
 
O
O2N
252 (1.0 equiv.)
1. NaH (2.2 equiv.), MeOH,
0 C, 30 min
2. HCl:MeOH: H2O (1:8:10)
0 C, 15 min, 71%
O
O
258
H
 
Scheme 101: Nef Reaction for the Formation of Aldehyde 258 
With aldehyde 258 in hand the Paal Knorr furan formation was attempted. The Paal Knorr 
furan synthesis proceeds under acidic conditions or by Lewis Acid activation.
[113] 
Under 
acidic conditions decomposition of the starting material occurred (Scheme 102).
  
O
O
258 (1.0 equiv.)
HCl (conc):H2O (1:1)
30 min, rt
O
251  
Scheme 102: Attempted Furan Formation under Acidic Conditions 
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However, when aldehyde 258 was treated with TiCl3, furan 251 was isolated in a 3% yield 
with a complex mixture of side products (Scheme 103). It was apparent that this reaction 
would require tedious optimisation in order to make a feasible synthetic route towards 
cristatic acid methyl ester 183. Due to this reason and the large number of steps in the 
synthesis it was decided to concentrate on an alternative route towards the synthesis of 
cristatic acid methyl ester 183. 
258 (1.0 equiv.)
TiCl3 (20% aq. soln., 4.0 equiv.),
NH4OAc (25 equiv.), H2O, 0 C to rt
4 h, 3%
O
251
O
O
 
Scheme 103: Furan Formation via Lewis Acid Activation 
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4.10 Strategy B for Protected Alcohol 198: Silylether 259 
Strategy B for the construction of silylether 259 was a more conservative retrosynthesis. It 
was envisaged that terpenoid 259 could be formed by activation of alcohol 260 as the 
mesylate followed by hydride addition.
[151] 
Furan 260 could be installed via a lithium halogen 
exchange on bromo-furan 261 followed by the addition of aldehyde 262.
[152]
 It was thought 
that oxidative cleavage of epoxide 263 could afford aldehyde 262. Finally, TBDPS protection 
of geraniol 265 followed by epoxidation of the olefin 264 could provide epoxide 263 
(Scheme 104).
[107][153]
 
TBDPSO
O
O
Br
Lithium-Halogen
Exchange
Addition of 260
+
261
TBDPSO
262
O
TBDPSO
263
O
TBDPSO
264
TBDPS
Protection
Epoxidiation
Oxidative
Cleavage
HO
265
259
TBDPSO
O
260 OH
Mesylation
Hydride Addition
 
Scheme 104: Strategy B for the Construction of Silylether 259 
4.11 Synthesis of Alcohol 260 
4.11.1 Synthesis of Aldehyde 262 
The synthesis began with the TBDPS protection of geraniol 265 to provide silylether 264. 
Epoxidation of olefin 264 using m-CPBA afforded epoxide 263 in a 71% yield. Finally, 
oxidative cleavage of epoxide 263 was achieved furnishing aldehyde 262 in a 74% yield 
(Scheme 105).
[151][153]
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TBDPSO
O
TBDPSO
263 (1.0 equiv.)
O
TBDPSO
264 (1.0 equiv.)
HO
265 (1.0 equiv.)
TBDPSCl (1.1 equiv.),
imidazole (1.1 equiv.), CH2Cl2,
0 C to rt, 18h, 88%
1. m-CPBA (1.2 equiv.),
CH2Cl2, 0 C, 2 h
2. Ca(OH)2 (4.3 equiv.),
1 h, 75%
H5IO6 (2.0 equiv.),
THF/ H2O (3:2)
0 C, 30 min, 74%
262  
Scheme 105: Synthesis of Aldehyde 262 
 
4.11.2 Synthesis of Bromo-Furan 261 
The next step in the synthetic route was the synthesis of olefin 261 via a Wittig reaction.
[154] 
This was achieved by first treating i-propyl(triphenyl)phosphonium iodide with n-BuLi at –
78 °C. The solution was then warmed to 0 °C, resulting in a colour change from orange to a 
deep red, presumably indicating the formation of the phosphonium ylide.
[155] 
This warming 
was essential and if it was not done the reaction did not work and decomposition of the 
starting material occurred. The solution was then cooled to –78 °C and commercially 
available aldehyde 266 added, after 1 h and consumption of the stating material the reaction 
was stopped, providing olefin 261 in a 20% yield (Scheme 106).
[107] 
 
O
Br
261
Ph3P
I
O O
Br
266 (1.0 equiv.)
2.
1. n-BuLi (1.2 equiv.),
THF, -78 C, 5 min;
0 C, 30 min
-78 C to 0 C, 1 h, 20%
(1.2 equiv.)
 
Scheme 106: Formation of Bromo-Furan 261 
It was postulated that the yield was low for this reaction due to the unstable nature of olefin 
261.
[107] 
This was demonstrated further because olefin 261 could only be stored in the freezer 
for around two weeks before it degraded, presumably via polymerisation For these reasons it 
was decided to protect aldehyde 266 prior to the lithium halogen exchange step and then 
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perform the Wittig reaction following the activation as the mesylate and reduction (Scheme 
107). Accordingly, aldehyde 266 was protected as the diethyl acetal 267 in a 77% 
yield.
[107][156]
 
O O
Br
HC(OEt)3 (4.0 equiv.),
NH4OAc (0.1 equiv.),
EtOH, , 2 h, 77%
O OEt
OEtBr
266 (1.0 equiv.) 267  
Scheme 107: Protection of Aldehyde 266 
 
4.11.3 Lithium-Halogen Exchange Followed by the Addition of Aldehyde 261 
Bromo-furan 267 was treated with n-BuLi in order to facilitate a lithium-bromine exchange, 
aldehyde 262 was then added to the reaction mixture providing alcohol 268 in a 10% yield 
and bromo-alcohol 269 in a 2% yield (Scheme 108).
[152] 
While the reaction was low yielding 
it was interesting that bromo-alcohol 269 was also isolated. Presumably, competition between 
lithium-bromine exchange and ortho-lithiation upon addition on n-BuLi gave rise to the two 
different products 268 and 269.
[157]
 
O OEt
OEtBr
1. n-BuLi (0.9 equiv.), THF,
-78 C, 15 min
TBDPSO O OEt
OEtTBDPSO
O267 (1.0 equiv.)
262 (0.9 equiv.) 268 10%
OH
+
TBDPSO
O
OEt
EtO
269 2%
OH
Br
-78 C to rt, 18 h
2.
 
Scheme 108: Addition of Bromo Furan 267 to Aldehyde 269 
Mesylation of alcohol 268 followed by the addition of NaBH4 was attempted (Scheme 
109).
[151][158] 
It was thought that following mesylation and upon addition NaBH4, a 
nucleophilic source of hydride,
[159] 
the mesyl group would readily leave because the partial 
positive charge α to the furan would be readily stabilised by the aromatic system. 
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Unfortunately, under these conditions decomposition of the starting material 269 was 
observed due to the sensitive nature of the furan moiety. 
TBDPSO O OEt
OEt
OH
TBDPSO O OEt
OEt
269 (1.0 equiv.)
270
1. MsCl (1.3 equiv.),
Et3N (2.0 equiv.),
CH2Cl2, 0 C, 1 h
2. NaBH4 (2.0 equiv), DMF,
0 C to rt, 2 h
 
Scheme 109: Mesylation Followed by Reduction 
Due to the low yield of alcohol 269 and unsuccessful nature of the mesylation and hydride 
reaction it was decided to synthesise the iodide 271 and then perform an alkylation with 
bromo-furan 267. This strategy was chosen because it was previously utilised successfully by 
Joullié et al.
[107]  
4.12 Alkylation Approach to Furan 259 
4.12.1 Retrosynthetic Analaysis 
It was thought that deprotection of diethyl acetate 270 and a subsequent Wittig reaction
[154]
 
on the corresponding aldehyde could provide terpenoid 259. An alkylation reaction between 
bromo-furan 267 and iodide 271 could give access to alkyl-furan 270. Iodide 271 could be 
available following mesylation of alcohol 272 and a Finkelstein reaction.
[107] 
Finally, alcohol 
272 could be obtained via a reduction of aldehyde 262 (Scheme 110).
[107] 
 
TBDPSO
O
O OEt
Br
TBDPSO
I
Alkylation
+
271267
TBDPSO
OH
272
TBDPSO
262
O
Mesylation
Finkelstein
Reaction
259
OEt
Reduction
TBDPSO
O OEt
270
OEt
Deprotection
Wittig Reaction
 
Scheme 110: Retrosynthesis for Furan 259 
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4.12.2 Synthesis of Iodide 271 
Reduction of aldehyde 262 utilising NaBH4 provided alcohol 272 in an 81% yield.
[153] 
Iodide 
271 was then formed via mesylation of alcohol 272 followed by an iodide substitution 
utilising NaI (Scheme 111).
[153] 
With iodide 271 in hand the cross coupling with bromo-furan 
267 was attempted. 
TBDPSO
O
262 (1.0 equiv.)
TBDPSO
OH
272 (1.0 equiv.)
2. NaI (1.0 equiv.),
Me2CO,
50 C, 18 h, 70%
1. MsCl (1.3 equiv.),
Et3N (2.0 equiv.),
30 min, 0 C, 80% TBDPSO
I
271
NaBH4 (2.0 equiv.),
EtOH
0 C, 3 h, 81%
 
Scheme 111: Synthesis of Iodide 271 
 
4.13.2 Alkylation of Bromo-Furan 267 with Iodide 271  
Bromo-furan 267 was treated with n-BuLi followed by the addition of HMPA. Iodide 271 
was then added furnishing furan 270 in a 60% yield and bromo-terpenoid 273 in a 10% yield 
(Entry 1, Table 16). The addition order was essential for this reaction and when HMPA was 
added prior to n-BuLi the only product obtained was bromo-terpenoid 273 (Entry 3, Table 
16). Presumably, this was due to pre-complexation of n-BuLi with HMPA
[160]
 promoting 
ortho-lithiation and drastically reducing the rate of lithium-halogen exchange.
[157] 
The 
reaction was attempted without the use of HMPA, however, the yield of both products 270 
and 273 dropped to 30% and 4%, respectively (Entry 2, Table 16). 
O OEt
OEtBr
1. n-BuLi (2.0 equiv.), THF,
-78 C, 5 min;
HMPA (2.4 equiv.), 30 min
TBDPSO O OEt
OEtTBDPSO
I
+
TBDPSO
O
OEt
EtO
273 10%
Br
267 (2.0 equiv.) 270 60%
-78 C to rt, 18 h
271 (1.0 equiv.)
2.
 
Scheme 112: Alkylation of Bromo-Furan 267 with Iodide 271 
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Due to the coordinating nature of HMPA
[160]
 in this reaction it was decided to investigate the 
alternative reagents DMPU
[161]
 and DMI
[162]
 (Entries 4 & 5, Table 16). The aim of this 
investigation was to see if these additives affected the yield or course of this reaction. 
Unfortunately, the yield of both terpenoid 270 and bromo-terpenoid 273 did not increase and 
HMPA was found to be the best reagent for this reaction. 
Table 16: Alkylation Conditions 
Entry Conditions prior to Iodide Addition
a
 Products
b
 
1 n-BuLi (2.0 equiv.), 5 min, –78 °C;  
HMPA (2.4 equiv.), 30 min 
270 60%, 273 10% 
2 n-BuLi (2.0 equiv.), –78 °C, 30 min 270 30%, 273 4% 
3 HMPA (2.4 equiv.), 5 min, –78 °C;  
n-BuLi (2.0 equiv.), 30 min 
273 71% 
4 n-BuLi (2.0 equiv.), 5 min, –78 °C;  
DMI (2.4 equiv.), 30 min 
270 33%, 273 6% 
5 n-BuLi (2.0 equiv.), 5 min, –78 °C;  
DMPU (2.4 equiv.), 30 min 
270 24%, 273 3% 
a
Iodide 271 was added to all reactions at –78 °C. The reaction was then allowed to warm to rt and 
stirred for 18h. 
b
Isolated yield after column chromatography. 
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4.14 Final Steps in the Synthesis of Alcohol 275  
The final steps in the synthesis of alcohol 275 involved deprotection of diethyl acetal 270, a 
Wittig reaction to install the olefin 259 and deprotection of the silylether (TBDPS).  
A number of conditions were investigated for the deprotection of diethyl acetate 270 (Table 
17). The first conditions (Entry 1, Table 17) demonstrated by Joullié et al.,
[107] 
involved 
treating diethyl acetal 270 in CDCl3 overnight, unfortunately this did not facilitate 
deprotection and starting material was recovered. Presumably, this reaction only works if the 
CDCl3 is acidic in nature. Therefore, the next strategy (Entry 2, Table 17) was to stir diethyl 
acetal 270 in 1 M HCl for 30 min, this provided aldehyde 274 in an excellent 89% yield. 
However, interestingly Gregg et al. demonstrated that diethyl acetal’s can be deprotected 
cleanly and efficiently utilising In(OTf)3 in acetone.
[163] 
Accordingly, diethyl acetal 270 was 
treated with In(OTf)3 and after 5 min the reaction was complete. Pleasingly, the reaction did 
not require purification and could be used crude in the next step. 
Table 17: Conditions for the Deprotection of Diethyl Acetate 270 
TBDPSO O OTBDPSO O OEt
OEt
270 274
Condit ions
 
Entry Conditions Products 
1 CDCl3, rt, 18 h RSM 
2 1 M HCl, 30 min, rt 274 89% 
3 In(OTf)3 (0.1 equiv.), Me2CO, 5 min, rt 274 <98% 
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The Wittig reaction
[154]
 was accomplished utilising the conditions discussed in Section 4.11.2 
which provided olefin 259 in a pleasing 70% yield,
[107] 
The deprotection of silylether 259 was 
achieved in 81% yield utilising TBAF (Scheme 113).  
1. n-BuLi (1.2 equiv.), THF,
-78 C, 5 min;
0 C, 30 min
Ph3P
TBDPSO O O
274 (1.0 equiv.)
HO O
275
TBAF (1.5 equiv.), THF,
rt, 18 h, 81%
I
2.
-78 C to 0 C, 30 min, 70%
TBDPSO O
259 (1.0 equiv.)
(1.2 equiv.)
 
Scheme 113: Alkene Formation and TBDPS Deprotection 
Having successfully completed the synthesis of alcohol 275 the next synthetic step involved 
heating with Meldrum’s acid to provide acid 259.  
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4.15 Towards the Synthesis of Acid 197 
The next step towards the synthesis of cristatic acid methyl ester 183 was to heat alcohol 275 
with Meldrum’s acid in order to perform a retro Diels-Alder reaction and provide acid 197 
(Scheme 114). Hence, alcohol 275 and Meldrum’s Acid were heated at 80 °C for 8 h, 
following a similar procedure reported by Tararov et al.
[74] 
Acid 197 could be seen by both 
1
H 
NMR and mass spectrometry, however, the sample was not clean and it was apparent that 
there were a number of side products present. For this reason the reaction was repeated, 
however, instead of the usual workup the crude material was put onto silica and purified by 
chromatography. Unfortunately, due to the nature of the material the separation took a long 
time and acid 197 could not be purified effectively. The next step in the synthesis involved 
formation of acid chloride 196 utilising oxalyl chloride (Scheme 114). It was known that this 
reaction would generate HCl within the reaction mixture. Therefore due to the senstivie 
nature of the furan moiety and the cumbersome separation it was decided to devise an 
alternative retrosynthesis. 
HO
O
O
OO
HO
O O O
OO
+
197275 (1.0 equiv.)
toluene, 80 C, 8 h
(1.0 equiv.)
Cl
O
O
OO
196
(COCl)2 (2.0 equiv.),
DMF (cat.), CHCl2  
Scheme 114: Retro-Diels Alder Reaction of Alcohol 275 and Meldrum's Acid 
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4.16 Second Retrosynthesis for Cristatic Acid Methyl Ester 183 
It was predicted that cristatic acid methyl ester 183 could be available via opening of 
isopropylidene protected resorcylate 193 with MeOH. Treatment of diketo-ester-dioxinone 
276 with acetate 277 and Pd(PPh3)4 could facilitate an external Pd(0)-decarboxylative 
allylation; subsequent ester deprotection and aromatisation could then furnish isopropylidene 
protected resorcylate 193.
[102][164] 
It was envisaged that acetate 277 could be obtained from 
alcohol 275. Formation of diketo-ester-dioxinone 276 could be accomplished utilising 
standard methodology from within the Barrett group (discussed in Chapter 2) (Scheme 
115).
[42][43] 
O
O O
O
O O
OO
TMS
O
276
Pd(0)-Decarboxylation
Allylation
Deprotection
Aromatisation
HO
O
Methanolysis
193
O
O
O
HO
O
183
OH
OMe
O
O
+
277
OHO
275
O O
O
O
O
O
TMS
+
Cl
O
Acylation
O
O
O
TMS
Cl
278
279
O O
O
33
HO
TMS
280
O O
OO
Claisen Condensation
Retro Diels-Alder
Reaction
Acid Chloride Formation
+
Acylation
 
Scheme 115: Alternative Retrosynthesis for Cristatic Acid Methyl Ester 183 
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4.17 Synthesis of Diketo-Ester-Dioxinone 276 
The synthesis of diketo-ester-dioxinone 276 began by refluxing Meldrum’s Acid with alcohol 
280, facilitating a retro Diels-Alder reaction providing acid 281 in a 90% yield.
[74] 
Acid 281 
was then transformed into the corresponding acid chloride 279 utilising oxalyl chloride and 
catalytic DMF. Treatment of dioxinone with LiHMDS followed by the addition of acid 
chloride 279 afforded keto-ester-dioxinone 278 in a 55% yield. Finally, the synthesis of 
diketo-ester-dioxine 276 was achieved by acylation of keto-ester-dioxinone 278 with acetyl 
chloride (Scheme 116).
[42][43]
  
O O
O
O O
OO
TMS
276
O O
O
O
O
O
TMS
O
O
O
TMS
HO
278 (1.0 equiv.)
281 (1.0 equiv.)
O O
O
33 (3.0 equiv.)
HO
TMS
O O
OO
+
100 C,
8 h, 90%
(COCl)2 (2.0 equiv.),
DMF (cat.),
CH2Cl2, 0 C, 1 h
quantitat ive
O
O
O
TMS
Cl
279
1. n-BuLi (3.1 equiv.),
HMDS (3.2 equiv.), THF,
-78 C, 30 min; 33, 1 h
O
O
O
TMS
Cl
279 (1.0 equiv.)
2.
1 h, 55%
1. MgCl2 (2.5 equiv.),
py (2.7 equiv.), CH2Cl2,
0 C, 30 min
2. acetyl chloride (1.5 equiv.),
30 min, 77%
(1.0 equiv.)
280
(1.5 equiv.)
 
Scheme 116: Synthesis of Diketo-Ester-Dioxinone 276 
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4.18 Synthesis of Acetate 277 and Subsequent Allylation with Diketo-Ester-
Dioxinone 276 
Acetate 277 was synthesised utilising a procedure from within the Barrett group.
[153]
 
Treatment of alcohol 275 with acetic anhydride, K2CO3 and DMAP provided acetate 277 in a 
60% yield (Scheme 117). With acetate 277 in hand the Pd(0)-catalysed decarboxylative 
allylation, ester deprotection and aromatisation could be attempted (Scheme 118). 
OO
O
277
OHO
275 (1.0 equiv.)
Ac2O (2.0 equiv.),
K2CO3 (2.0 equiv.),
DMAP (cat.),
EtOAc, rt, 18 h, 60%
 
Scheme 117: Synthesis of Acetate 277 
Following earlier work from within the Barrett group involving allylation
[102]
 and following 
the mechanistic studies (Chapter 3) it was envisaged that treatment of diketo-ester-dioxinone 
276 and acetate 277 with Pd(PPh3)4 would facilitate a decarboxylative allylation providing 
intermediate 282 (Scheme 118). The next step in the sequence would involve deprotection of 
the TMSE ester and subsequent decarboxylation and aromatisation to furnish isopropylidene 
resorcylate 193. Serrano-Wu et al.
[164] 
demonstrated that deprotection of TMSE esters and 
decarboxylation can take place utilising TBAF. It was further envisaged that the TBAF would 
provide a basic system enabling aromatisation to take place. Accordingly, diketo-ester 276 
and acetate 277 were treated with Pd(PPh3)4 followed by TBAF. Unfortunately, the reaction 
yielded resorcylate 283, with the TMSE ester still intact (Scheme 118).  
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O
O O
O
O O
OO
TMS
O
276 (1.2 equiv.)
HO
O
193
O
O
O
O
+
277 (1.0 equiv.)
Pd(PPh3)4 (10 mol%),
THF,
rt, 48 h
O O
O
O O
OO
TMS
282
O
TBAF (5.0 equiv.),
55 C,
2 h, 65%
O
HO
O O
O
O O
283
(desired product)
TMS
 
Scheme 118: Treatment of Diketo-Ester-Dioxinone 276 and Acetate 277 with Pd(PPh3)4 
Although the desired product 193 was not obtained, the results from the reaction were very 
encouraging, because the Pd(0)-decarboxylative allylation was successful. Therefore, it was 
apparent that different conditions were required for the deprotection of the TMSE ester that 
would enable deprotection prior to aromatisation. A model study was conducted into the 
Pd(0)-decarboxylative, allylation, deprotection and aromatisation sequence utilising farnesyl 
acetate 284. 
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4.19 Model Study into the Decarboxylative, Allylation, Deprotection and 
Aromatisation Sequence
VIII
 
Commercially available farnesyl 285 was treated with acetic anhydride to provide the 
corresponding acetate 284 for the model study in an 85% yield (Scheme 119). 
HO
285 (1.0 equiv.)
Ac2O (2.0 equiv.),
K2CO3 (2.0 equiv.),
DMAP (cat.),
EtOAc, rt, 18 h, 85%
O
284
O
 
Scheme 119: Synthesis of Acetate 284 
The first set of conditions to be screened were those reported by Serrano-Wu et al.
[164] 
(Entry 
1, Table 18). These conditions provided resorcylate 285 with the TMSE ester still present. It 
was therefore decided to screen TBAF•1H2O and TBAF•3H2O to see if an additive of water 
would positively affect the reaction (Entries 2 & 3, Table 18), however the reaction yielded 
resorcylate 285. The solvent was then changed from THF to DMF and DMSO respectively 
(Entries 4 & 5, Table 18), nevertheless resorcylate 285 was recovered again.
[165] 
 
Marlowe et al. demonstrated in 1993 that SiO2 in THF could be utilised for deprotection of 
the TMSE ester.
[166] 
These conditions were attempted but yielded resorcylate 285 (Entry 6, 
Table 18). The next strategy was to employ a different fluoride source, thus TAS-F,
[167] 
HF•NEt3 and H2SiF6 were screened (Entries 7, 8 & 9, Table 18) but unfortunately yielded 
resorcylate 285. It was thought that the basic nature of the system was leading to 
aromatisation prior to deprotection, accordingly, acetic acid was added into the system with 
TBAF to act as a buffering agent (Entry 10, Table 18),
[168] 
nonetheless resorcylate 285 was 
                                                          
VIII
Work in Section 4.19 was carried out in collaboration with Dr. Nicolas George. He is duly 
thanked for his contribution to the research. Specific experiments carried out by Dr. Nicholas 
George are clearly stated in Table 18 with an asterisk (*). 
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obtained. The final set of conditions to be screened was to utilise 1 M NaOH, however this 
led to the formation of resorcylate 285 (Entry 11, Table 18). 
Table 18: Decarboxylative, Allylation, Deprotection and Aromatisation Sequence 
O O
O
O O
OO
TMS
276 (1.0 equiv.)
+
1. Pd(PPh3)4 (10 mol%),
THF, rt, 48 h
2. Conditions
O
HO
O
O
O O
285
O
284 (1.0 equiv.)
O
O
HO
O
O
286
(desired product)
TMS
 
Entry Conditions Product
a
 
1 TBAF (5.0 equiv.), THF, , 2 h[164] Resorcylate 285 
2 TBAF•1H2O (5.0 equiv.), , 2 h* Resorcylate 285 
3 TBAF•3H2O (5.0 equiv.), , 2 h* Resorcylate 285 
4 TBAF (5.0 equiv.), DMF, , 2 h[165] Resorcylate 285 
5 TBAF (5.0 equiv.), DMSO, , 2 h[165] Resorcylate 285 
6 SiO2 (10.0 equiv.), THF, 5 h, rt*
[166]
 Resorcylate 285 
7 TAS-F (5.0 equiv.), THF, 4 h, rt
[167]
 Resorcylate 285 
8 H2SiF6 (5.0 equiv.), THF, 8 h, rt Resorcylate 285 
9 HF•Et3N (5.0 equiv.), THF, 1 h, rt* Resorcylate 285 
10 Acetic Acid (5.0 equiv.), TBAF (5.0 equiv.), 
THF, 2 h, rt
[168]
 
Resorcylate 285 
11 1M NaOH, 1 h, rt* Resorcylate 285 
a
Crude product isolated after workup. 
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Due to time constrains and the unsuccessful nature of the conditions that were screened 
(Table 18) it was decided to change the retrosynthetic route for the construction of cristatic 
acid methyl ester 183 (the strategy is discussed in Section 4.21). 
 
4.20 Conclusions  
Studies towards this total synthesis have exhibited a wide range of methodologies developed 
within the Barrett group, including dioxinone chemistry
[42][43]
 and the Pd(0)-decarboxylative 
allylation and aromatisation sequence. Unfortunately, some of the more ambitious plans to 
install the furan were unsuccessful that would have highlighted the development of new 
chemistry. Nevertheless, it was convenient that it was possible to fall back on the work of 
Joullié et al.
[107]
 in order to install the side-chain fragments. The research investigations have 
displayed some very interesting results; the competition between ortho-lithiation and lithium 
halogen exchange (Scheme 112), the colour change in the Negishi cross coupling (Scheme 
94) and the Pd(0)-decarboxylative allylation between farnesyl acetate 284 and diketo-ester-
dioxinone 276 providing the TMSE resorcylate 285 (Table 18).  
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4.21 The Synthesis of Cristatic Acid Methyl Ester 183
IX
 
It was postulated that following a methanolysis to form the methyl ester of cristatic acid 183, 
isopropylidene protected resorcylate 193 could be obtained via a Pd(0)-decarboxylative-
allylation and aromatisation sequence beginning with diketo-ester-dioxinone 194. Diketo-
ester-dioxinone 194 could be available from acylation of keto-ester-dioxinone 195
[43] which 
in turn could be formed via the coupling of amide 287 and keto-dioxinone 178. Finally, 
imidazole carboxylate 287 could be obtained by treating alcohol 275 with CDI (Scheme 
120).
[169]
 
OMe
OHO
O OO
O
OO
O
NNOO
OOOO
O
OO
OOOO
O
O
O
HO
O O
O
193
O
HO
O OH
183
178
275
287
195
194
Methanolysis
Pd(0)-Decarboxylative-
Allylation
Aromatisation
Acylation
Coupling
CDI Addition
 
Scheme 120: Retrosynthetic Analysis of Cristatic Acid Methyl Ester 183 
                                                          
IX
 Work in this Section 4.21 was carried out by Dr. Nicolas George. This section has been 
added into this thesis for clarity and to illustrate the end of the total synthesis of cristatic acid 
methyl ester 183. Dr. Nicolas George is duly thanked for finishing the total synthesis and for 
his contribution to this research. 
4 Towards the Total Synthesis of Cristatic Acid Methyl Ester (183) 
154 
 
The synthesis began with formation of the imidazole carboxylate 287 utilising standard 
conditions from within the Barrett group.
[82] 
Amide 287 was then coupled with diketo-
dioxinone 178 to furnish keto-ester-dioxinone 195 in a 20% yield.
[169]
 Acylation then took 
place, followed by the Pd(0)-decarboxylative allylation and aromatisation sequence to afford 
isopropylidene protected resorcylate 193 in a 42% yield. The final step in the total synthesis 
involved methanolysis to furnish cristatic acid methyl ester 183 in a 64% yield (Scheme 121).  
OMe
OHO
CDI (3.0 equiv.), THF,
-78C to rt, 18 h
O OO
O
1. LDA (4.5 equiv.), THF, -78 C,
10 min; -40 C, 1h
OO
O
N
N
OO
OOOO
O
1. MgCl2 (2.0 equiv.),
py (2.7 equiv.), CH2Cl2,
0°C, 30 min
2. acetyl chloride (1.2 equiv.),
30 min, quant itative
1. Pd(PPh3)4 (5 mol%),
THF, rt, 72 h
2. Cs2CO3 (3.0 equiv.),
rt, 15 h, 42%
OO
OOOO
O
O
O
HO
O O
O
193 (1.0 equiv.)
O
HO
O OH
183
MeONa (10.0 equiv.),
MeOH,
, sealed tube,
20 h, 64%
178 (2.2. equiv.)
2. Et2Zn (4.6 equiv.), 20 min
3. 287 (1.0 equiv.), -78 C, 45 min,
20% over 2 steps
275 (1.0 equiv.) 287
195 (1.0 equiv.)
194 (1.0 equiv.)
 
Scheme 121: Synthesis of Cristatic Acid Methyl Ester 183 
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4.22 Future Work 
4.22.1 Pd(0)-Decarboxylation Allylation, Ester Deprotection, Decarboxylation & 
Aromatisation 
It was significant that aromatisation took place prior to removal of the TMSE ester in diketo-
ester-dioxinone 282 providing TMSE resorcylate 283 over resorcylate 193. However, this 
might not be the case if a different protecting group
[170]
 was used in place of TMSE. Hence, it 
would be a good idea to study a number of different protecting groups for this transformation 
which might enable a number of new natural products to be harnessed where internal Pd(0)-
decarboxylative allylation is not possible (Scheme 122).  
O O
O
O O
OPGO
288
+
Pd(PPh3)4, THF,
rt, 48 h
O
HO
R2
R1 O
O
291
R2R1
O
289
O
O O
O
O O
OPGO
290
R1 R2
1. Deprotection
2. Aromatisation
PG= Protecting Group  
Scheme 122: Pd(0)-Decarboxylative Allylation, Deprotection and Aromatisation 
There are a number of potential protecting groups that could be studied. Firstly, 2,2,2-
trichloroethyl ester (RCO2CH2CCl3), removed with zinc dust
[170][171]
 could be considered. If 
zinc dust was added after Pd(0)-decarboxylative allylation had taken place it might allow 
deprotection prior to aromatisation. Secondly, 2-methylthioethyl ester (RCO2CH2CH2SCH3), 
removed by oxidation (H2O2, (NH4)6Mo7O24, Me2CO)
[170][172]
 could be investigated. Thirdly, 
2-(p-methoxyphenyl)ethyl ester (p-CH3OC6H4CH2CH2O2CR), removed via treatment with 
1% TFA
[170][173]
 or dichloroacetic acid in CH2Cl2 by DDQ
[170][174]
 could be studied.  
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4.22.2 Total Synthesis of Resorcylate Natural Products Utilising the Pd(0)-Decarboxylative 
Allylation 
In the future it would be advantageous to complete the first total synthesis of cristatic acid 
(5). Chapter five discusses studies towards the opening of the isopropyliene protected 
resorcylate 286 to the corresponding acid (92) which could be applied to cristatic acid methyl 
ester 183. Additionally, it would be good to apply the Pd(0)-decarboxylative allylation and 
aromatisation sequence to the total synthesis of other terpenoidal resorcylate natural 
products.
[69] 
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5 Towards the Total Synthesis of Grifolic Acid (92) 
5.1 Aims of the Synthetic Study 
Grifolic acid (92) (Figure 19) was isolated in 1981 by Steglich et al. from the mushroom 
Albatrellus cristatus,
[6][69] 
and has been shown to display GPR120 agonistic activity. The 
GPR120 is a G-protein-coupled receptor found within the intestinal tract and thought to play 
an important role in insulin release.
[70] 
Grifolic acid (92) was chosen as a synthetic target to 
exhibit the Pd(0)-decarboxylative allylation and aromatisation sequence developed in Chapter 
2. Furthermore, the target was chosen in order to conduct thorough investigations for the 
opening of the isopropylidene protecting group to the corresponding acid. This is because a 
number of terpenoidal resorcylate natural products including cristatic acid (5) contain the acid 
functionality.
[175]
 
OOH
OH
HO
grifolic acid (92)  
Figure 19: Grifolic Acid (92) 
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5.2 Retrosynthetic Analysis 
Scheme 123 below illustrates the proposed retrosynthetic analysis for the construction of 
grifolic acid (92). It was envisaged that saponification of isopropylidene resorcylate 286 
could afford grifolic acid (92). Resorcylate 286 could in turn be accessed via a Pd(0)-
decarboxylative allylation and aromatisation sequence from diketo-ester-dioxinone 292. A 
Claisen condensation of dioxinone 233 with acid chloride 294 followed by acylation could 
provide diketo-ester-dioxinone 292. Finally, a retro Diels-Alder reaction between Meldrum’s 
acid and farnesyl 285 could furnish the acid which subsequently could be transformed into 
acid chloride 294 (Scheme 123).
[42][43]
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O
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+
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+
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(92) 286
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33 294
285  
Scheme 123: Retrosynthetic Analysis of Grifolic Acid (92) 
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5.3 Synthesis of Isopropylidence Protected Resorcylate 286 
The synthesis began by heating Meldrum’s acid with farnesyl 285 in order to perform a retro 
Diels-Alder reaction affording acid 295
[74]
 which was then transformed into the 
corresponding acid chloride 294 through treatment with oxalyl chloride and catalytic DMF. 
In this case amylene was employed in order to mop up excess HCl, preventing addition onto 
the farnesyl double bonds (Scheme 124). 
HO
O O
OO
+
285 (1.0 equiv.)
80 C, 6 h, 81% O O
OHO
295 (1.0 equiv.)
O O
OCl
294
(COCl)2 (1.2 equiv.),
amylene (excess),
CH2Cl2, DMF (cat.),
0 C, 1 h, quantitat ive
(1.0 equiv.)
 
Scheme 124: Synthesis of Acid Chloride 294 
Deprotonation of dioxinone 33 with LiHMDS followed by the addition of acid chloride 294 
afforded keto-ester-dioxinone 293 in a 65% yield. Subsequent treatment with MgCl2 and 
pyridine followed by the addition of acetyl chloride furnished diketo-ester-dioxinone 292 in 
an excellent 98% yield. Finally, facilitation of the Pd(0)-decarboxylative allylation and 
aromatisation sequence afforded resorcylate 286 in a 66% yield (Scheme 125). 
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292 (1.0 equiv.)
293 (1.0 equiv.)33 (3.0 equiv.)
294 (1.0 equiv.)
1. LiHMDS (3.1 equiv.),
THF, -78 C, 1 h
2 h, 65%
1. MgCl2 (2.5 equiv.), py (2.7 equiv.),
CH2Cl2, 0 C, 30 min
2. acetyl chloride (1.5 equiv.),
30 min, 98%
Pd(PPh3)4 (10 mol%),
Cs2CO3 (3.0 equiv.), THF
rt, 2 h, 66%
2.
 
Scheme 125: Synthesis of Resorcylate 286 
 
5.4 Studies Towards the Formation of Grifolic Acid (92) 
5.4.1 Saponification of Isopropylidene Resorcylate 286 
Having successfully achieved the synthesis of resorcylate 286 the next goal was to conduct 
investigations into the formation of grifolic acid (92) through opening of the isopropylidene 
moiety. General conditions for the opening of isopropylidene groups involve treatment with 
an acid such as TFA.
[176] 
However, during studies towards the total synthesis of angelicoin A 
(6) it was discovered that the use of acidic conditions (TFA) led to cyclisation of the phenol 
onto the protonated olefin (Scheme 126) (Chapter 2, Section 2.5). As a result, it was decided 
to investigate a number of non-acidic conditions for the opening of isopropylidene protected 
resorcylate 286 (Table 19).  
OH
HO
O
O
OOH
112
O
O
 
Scheme 126: Cyclisation under Acidic Conditions 
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The first conditions to be screened (Entry 1, Table 19) were demonstrated by Fürstner et al. 
in 2000
[177]
 and involved treating isopropylidene resorcylate 286 with BCl3. The reaction was 
started at 0 °C, however, after no consumption of the starting material, the reaction was 
allowed to warm to rt and stirred for 18 h. Unfortunately, only starting material was afforded 
indicating that the Lewis acid was not strong enough to activate the hydrolysis.  
 
The next strategy was to utilise the basic conditions reported by Porco, Jr. et al.
[178] 
in 2002 
(Entry 2, Table 19). But, after the addition of 1.0 equivalent of KOH there was no reaction, 
hence the equivalents of KOH was increased from 1.0 to 10.0 while monitoring the reaction 
and stirring at rt. The starting material was still present; consequently the reaction was gently 
heated to reflux with monitoring, and then allowed to stir for 72 h. After 72 h the starting 
material had been consumed, but a complex mixture of products had been obtained. It was 
postulated after studying the 
1
H NMR that one of the products might be the decarboxylated 
resorcylate 286 (due to the presence of the Ar-H and there being no carboxylic acid proton) 
(Figure 20).
[189]
 
HO
OH
296  
Figure 20: Decarboxylated Resorcylate 296 
Regrettably, due to the complex nature of products present in the reaction mixture and the 
small scale of the reaction the decarboxylated product 286 could not be isolated and fully 
identified. The reaction was repeated with NaOH (Entry 3, Table 19) and LiOH (Entry 4, 
Table 19), but nevertheless the same outcome occurred as with KOH. Presumably, the 
reaction did not work because the base deprotonated the free phenol leading to an increased 
electron density on the carbonyl moiety reducing its reactivity towards hydrolysis (Scheme 
127).
[180]
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Scheme 127: Phenolate Production 
The last step in the total synthesis of amorfrutin A (8) involved a saponifaction utilising KOH 
(40%) in refluxing DMSO (Scheme 128).
X
 These conditions were applied to isopropylidene 
resorcylate 286 (Entry 5, Table 19) however, led to decomposition of the starting material. 
Seemingly because in the formation of amorfrutin A (8) the free phenol was methylated 
preventing deprotonation and so allowing saponification at the carbonyl moiety. 
MeO
299 (1.0 equiv.)
MeO
amorfrutin A (8)
OO
O
OOH
KOH (40%), DMSO,
, 12 h, 83%
OH
 
Scheme 128: Formation of Amorfrutin A (8) via Saponification 
The next approach was inspired by the work of Lovrić et al.[181] who revealed that treatment 
of esters with KOTMS led to the formation of the corresponding carboxylic acid. 
Accordingly, isopropylidene protected resorcylate 286 was treated with 1.0 equivalent of 
KOTMS, which was gradually increased to 10.0 equivalents after there was no initial 
consumption of the starting material (Entry 6, Table 19). The reaction mixture was then 
allowed to slowly heat to reflux and stirred for 18 h, but residual starting material was 
observed indicating that the nucleophilicity of KOTMS was not strong enough to open the 
isopropylidene group. Alternatively, KOTMS could have been deprotonating the phenol and 
preventing the carboxyl moiety from reacting (Scheme 127).  
 
                                                          
X
 The total synthesis of amorfrutin A (8) has been published, please see Laclef, S.; Anderson, 
K.; White, A. J. P.; Barrett, A. G. M. Tetrahedron Lett. 2012, 53, 225–227. 
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The final strategy was to add TMSCl into the reaction in addition to KOTMS with the 
intention of protecting the phenol in situ allowing the saponification to take place. 
Regrettably, after the addition of excess TMSCl and KOTMS and heating the reaction to 
reflux the reaction only yielded starting material (Entry 7, Table 19). 
Table 19: Conditions Screened Towards the Formation of Grifolic Acid (92) 
HO
OO
O
HO
OOH
OH
Condit ions
286 (92)  
Entry Conditions Outcome 
1 BCl3 (1.0 to 10.0 equiv.), CH2Cl2, 0 °C to rt, 18 h
[177]
 RSM 
2 KOH (1.0 to 10.0 equiv.), THF/H2O (1:1), rt to , 72 h
[178]
 Complex mixture 
3 NaOH (1.0 to 10.0 equiv.), THF/H2O (1:1), rt to , 72 h Complex mixture 
4 LiOH (1.0 to 10.0 equiv.), THF/H2O (1:1), rt to , 72 h Complex mixture 
5 KOH (40%), DMSO, , 18 h Decomposition 
6 KOTMS (1.0 to 10.0 equiv.), THF, rt to , 18 h[181] RSM 
7 KOTMS (1.0 to 10.0 equiv.), TMSCl (1.0 to 10.0 equiv.), 
THF, rt to , 18 h 
RSM 
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5.4.2 Formation of Methyl Ester 300 and Subsequent Saponification Attempts 
The methyl ester of resorcylate 300 was synthesised utilising previous conditions from within 
the Barrett group.
[169] 
Resorcylate 286 was heated with MeOH and Cs2CO3 in a sealed tube 
providing methyl ester 300 in a 98% yield (Scheme 129). With methyl ester 300 in hand a 
number of saponification conditions were attempted (Table 20). 
HO
OO
O
HO
OOH
OMe
286 (1.0 equiv.)
300
Cs2CO3 (2.0 equiv.),
MeOH, ,
72 h, 98%
 
Scheme 129: Preparation of Methyl Ester 300 
The first strategy for the conversion of the methyl ester 300 to the corresponding acid (92) 
was to utilise traditional saponification conditions,
[182] 
hence methyl ester 300 was treated 
with LiOH in MeOH/H2O at rt. The equivalents of the base were increased but the 
temperature remained the same because previously this had led to decomposition of the 
starting material and suspected decarboxylation (Entry 4, Table 20). Unfortunately, the 
reaction yielded residual starting material, thus NaOH (Entry 2, Table 20) and KOH (Entry 3, 
Table 20) were investigated, yet the same result was observed. Presumably, the reaction did 
not work because the base deprotonated the two phenolic moieties leading to an increased 
electron density on the carbonyl moiety, reducing its reactivity towards hydrolysis (Scheme 
127). 
 
The next synthetic approach was to attempt the conditions of Lovrić et al. [181] hence methyl 
ester 300 was treated with KOTMS (Entry 4, Table 20). Unfortunately, the reaction yielded 
residual starting material, and, with in situ protection of the phenol moieties with TMSCl in 
the presence of KOTMS, (Entry 5, Table 20) having no effect. 
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Table 20: Saponification Conditions 
HO
OOH
OH
(92)
HO
OOH
OMe
300
Condit ions
 
Entry Conditions Outcome 
1 LiOH (1.0 to 10.0 equiv.), MeOH/H2O (1:1), rt, 72 h RSM 
2 NaOH (1.0 to 10.0 equiv.), MeOH/H2O (1:1), rt, 72 h RSM 
3 KOH (1.0 to 10.0 equiv.), MeOH/H2O (1:1), rt, 18 h RSM 
4 KOTMS (1.0 to 10.0 equiv.), THF, rt to , 18 h[181] RSM 
5 KOTMS (1.0 to 10.0 equiv.), TMSCl (1.0 to 10.0 equiv.) 
THF, rt to , 18 h 
RSM 
 
5.4.3 Protection of Phenol Followed by Saponification 
It was apparent that saponification was not effective on either isopropylidene protected 
resorcylate 286 or methyl ester 300. Thus the next strategy was to protect the free phenol 
with the sterically stable and bulky TBDPS protecting group.
[183] 
Accordingly, phenol 286 
was treated with TBDPSCl and imidazole, providing silylether 301 in an 88% yield (Scheme 
130).  
286 (1.0 equiv.) 301
OO
O
TBDPSO
OO
O
HO
TBDPSCl (1.2 equiv.),
imidazole (1.5 equiv.),
CH2Cl2, rt, 18 h, 88%
 
Scheme 130: Formation of Silylether 301 
A range of conditions for the saponification of resorcylate 301 were attempted and are 
illustrated in Table 21. Basic conditions utilising KOH were attempted but led to the 
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deprotection of the silylether (Entry 1, Table 21).
[178]
 It was thus decided to utilise the Lewis 
acid conditions demonstrated by Fürstner et al.,
[177] 
nevertheless treatment of resorcylate 301 
with BCl3 led to deprotection of the silylether (Entry 2, Table 21). Finally, KOTMS was tried 
(Entry 3, Table 21),
[181] 
but led to deprotection. These results were interesting considering the 
inherent stability of the TBDPS group.
[183][184]
 
Table 21: Saponification Conditions of Resorcylate Silylether 301 
OO
O
TBDPSO
Conditions
OOH
OH
TBDPSO
301 302  
Entry Conditions Outcome 
1 KOH (1.0 to 5.0 equiv.), THF/H2O (1:1), rt, 6 h
[182]
 Resorcylate 286 
2 BCl3 (1.0 to 10.0  equiv.), CH2Cl2, rt, 18 h
[177]
 Resorcylate 286 
3 KOTMS (1.0 to 5.0 equiv.), THF, rt, 18 h
[181]
 Resorcylate 286 
 
5.4.4 Thermal Opening of Isopropylidene 286 
Due to the success in the formation of methyl ester 300 via treatment with MeOH in the 
presence of Cs2CO3 it was decided to utilise these conditions using TMSCH2CH2OH 280 in 
place of MeOH.
[169] 
The intention of this was to create the protected carboxylic acid 303 and 
subsequently deprotect in order to furnish griflic acid (92). Hence, silylether resorcylate 301 
was treated with TMSCH2CH2OH 280 in the presence of Cs2CO3 and delightfully, 
resorcylate 303 was afforded in a 63% yield. However, deprotection of the silylether 302 also 
occurred, thus the reaction was repeated beginning with resorcylate 286. Pleasingly, the 
reaction was successful and silylether 303 was isolated in a 75% yield (Scheme 131).  
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OO
O
RO
OH
HO
THF, Sealed Tube, , 18 h
Beginning with 301 Yield = 63%
Beginning with 286 Yield = 75%
O
O
TMS
301 R= TBDPS (1.0 equiv.)
286 R= H (1.0 equiv.)
303
OH
HO
OH
O
grifolic acid (92)
TBAF
HO
TMS
280 (excess)
Cs2CO3 (2.0 equiv.),
 
Scheme 131: Synthesis of Resorcylate 303 
The last step in the total synthesis was the deprotection of the TMSE protecting group 
(Scheme 131), however due to time constraints this was not possible. Nonetheless, a very 
robust route for the opening of isopropylidene resoryclates had been established which with 
the subsequent deprotection could afford the corresponding acids. 
 
5.5 Conclusions 
In conclusion, the synthesis of resorcylate 286 has been accomplished in four linear steps 
from dioxinone 33 in an overall yield of 32%. The synthesis has successfully exhibited both 
dioxinone methodology
[42][43]
 and the Pd(0)-decarboxylative allylation and aromatisation 
sequence. The project has demonstrated that the opening of the isopropylidene protected 
resorcylate 286 is not possible under a number of basic and Lewis acid conditions. This study 
has established that conversion of the methyl ester 300 to the corresponding acid (92) is not 
trivial. Nevertheless, the study has discovered that isopropylidene protected resorcylate 286 
can be opened upon treatment with TMSCH2CH2OH 280 in the presence of Cs2CO3 to 
provide the TMSE protected acid 303 which could in turn be deprotected to furnish the 
corresponding acid (92). This methodology can now be applied to the synthesis of other 
resorcylate natural products containing similar functionalities.
[175] 
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5.6 Future Work 
5.6.1 Synthesis of the Grifolin Family of Natural Products 
The findings from this project can be applied towards the total synthesis of the Grifolin 
family of natural products (Scheme 132).
[69] 
In 1988, Nozoe et al. conducted a detailed study 
into the Grifolin family of natural products, isolating and confirming the structure of grifolin 
(304), o-methylgrifolin (305), grifolic acid (92) and isopentenylphenol (308) from Polyporus 
dispansus.
[69] 
They established that these structures were similar to those of farnesyl phenol 
(307) and grifolin (304) extracted from the roots of Grifola confluens,
[6] 
neogriflin isolated 
from Albatrellus confluens,
[6] 
and cristatic acid (5), isolated from the European A. Cristatus 
and the closely related American Albatrellus species.
[6] 
 
The work discussed in this chapter would enable the possiblity to synthesis grifolin (304), o-
methylgrifolin (305), farnesyl phenol (307) and grifolic acid (92) from resorcylate 286 
(Scheme 132). It is thought that grifolin (304) could be obtained through formation of the 
acid followed by decarboxylation under basic conditions at reflux. (It should be noted that the 
decarboxylation conditions would require optimisation). o-Methylgrifolin (305) could then be 
provided through selective phenol methylation. Methylation of phenol 286 followed by 
saponification could afford farnesyl phenol (307) and finally formation of TMSE ether 303 
followed by deprotection could furnish grifolic acid (92) (Scheme 132).  
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OO
O
HO
KOH, THF/ H2O, 
OH
HO
grifolin (304)
MeI, K2CO3,
Me2CO, 
OO
O
MeO
OOH
OH
MeO
farnesyl phenol (307)
KOH (40%), DMSO
80 C
OOH
OH
HO
grifolic acid (92)
MeI, K2CO3,
Me2CO, 
OH
MeO
o-methylgrifolin (305)
306286
HOCH2CH2TMS 280, Cs2CO3,
THF, sealed tube, , 18 h
75%
OOH
O
HO
TMS
303
TBAF
 
Scheme 132: Proposed Synthesis Towards the Griflin Family of Natural Products 
The grifolin family of natural products have been shown to have a range of biological 
properties such as antibiotic activity,
[6] 
antimicrobial activity,
[179][185] 
plant growth 
inhibitory,
[186] 
promotion of melanin synthesis by B16 melanoma cells,
[187] 
anticholesteremic 
activities level in blood and liver,
[188] 
activity on human and rat vanilloid receptor 1 (VR1)
[189] 
hence their synthesis and biological testing would be desirable. 
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5.6.2 The Synthesis of Isopentenylphenol (308) 
As stated above Nozoe et al. isolated isopentenylphenol (308) from the mushroom Polyporus 
dispansus.
[69] 
It was envisaged that this natural product would be available from resorcylate 
142, a product obtained from the mechanistic studies (Section 3.5) into the Pd(0)-
deacrboxylative allylation and aromatisation sequence. Hence, resorcylate 142 was treated 
with MeOH in the presence of Cs2CO3
[169] and pleasingly, isopentenylphenol (308) was 
obtained in a 90% yield and is currently awaiting biological testing (Scheme 133). 
OH O
HO
OMe
308
HO
142 (1.0 equiv.)
OO
O
MeOH,
Cs2CO3 (2.0 equiv.),
, 18 h, 90%
 
Scheme 133: Synthesis of Isopentenylphenol (308) 
 
5.6.3 The Synthesis of Cristatic Acid (5) 
Section 4.21 above described the total synthesis of cristatic acid methyl ester 183. In the 
future it would be exciting to complete the first total synthesis of cristatic acid (5) via opening 
of the isopropylidene protected resorcylate 193 to TMSE ester 309 and subsequent 
deprotection (Scheme 134). 
O
O
HO
O O
O
193
O
HO
O OH
309
Si
O
HO
O OH
OH
cristatic acid (5)
HOCH2CH2TMS 280, Cs2CO3,
THF, sealed tube, , 18 h
TBAF
 
Scheme 134: Proposed Synthesis of Cristatic Acid (5) 
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6 Experimental  
6.1 General Experimental Procedures 
All reactions were carried out in flame-dried or oven-dried glassware in an atmosphere of dry 
N2 or Ar unless otherwise stated. Room temperature was taken as 25 °C and temperatures 
other than this were recorded as the bath temperature, unless otherwise stated. Prolonged 
periods of vessel cooling were attained by the use of CryoCool apparatus.  
The following reaction solvents were distilled under N2: Et2O and THF from Na/Ph2CO 
ketyl; PhMe from Na; CH2Cl2, MeOH, pyridine and Et3N from CaH2. H2O refers to distilled 
H2O. Other solvents and all reagents were obtained from commercial suppliers and were used 
as obtained, if purity was >98%.  
Flash column chromatography was performed using Merck silica gel 60, particle size 40-63 
mm (eluants are given in parenthesis). Thin layer chromatography (TLC) was performed on 
pre-coated aluminum backed plates (Merck Kieselgel 60 F254), visualisation was 
accomplished under UV light (254 nm) and/or by staining using aqueous potassium 
permanganate or vanillin followed by gentle heating with a heat gun.  
Melting points were obtained using a Reichert-Thermovar melting point apparatus and are 
uncorrected.  
Optical rotations were recorded at 25 °C on a Perkin-Elmer 241 Polarimeter with a path 
length of 1 dm, using the 589.3 nm Na D-line. Concentrations (c) are quoted in g/100 mL.  
Infrared spectra were recorded using a Mattson 5000 FTIR apparatus with automatic 
background subtraction. The samples were coated on diamond; solid samples were pressed 
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on the diamond at 120 Nm. Indicative features of each spectrum are given with adsorptions 
(vmax) reported in wavenumber (cm
-1
). Selected stretches (>1500 cm
-1
) have been assigned. 
1
H NMR and 
13
C NMR spectra were recorded operating at 400 (Bruker DRX-400 
spectrometer) or 500 (Bruker AM 500 Spectrometer) and 100 (Bruker DRX-400 
spectrometer) or 125 MHz (Bruker AM 500 Spectrometer) respectively with chemical shifts 
() quoted in parts per million (ppm) and referenced to a residual solvent peak. CDCl3 (H 
7.26, C 77.16), d6-CD3OD (H 3.31, C 49.05), d6-C6D6 (H 7.16, C 128.39). Coupling 
constants (J) are quoted in Hertz (Hz) to the nearest 0.1 Hz. Spectra recorded at 500 (
1
H 
NMR) and 125 MHz (
13
C NMR) were carried out by the Imperial College Department of 
Chemistry NMR Service. Proton and carbon assignments have been made for each 
compound, therefore HSQC, HMBC, 1D NOESY, 2D NOESY, DEPT 135, DEPT 90, DEPT 
45 and 
1
H-
1
H COSY NMR experiments were utilised where necessary. 
Microanalysis was determined by the London Metropolitan University Analytical Service.  
Low and high resolution mass spectra (EI, CI, ESI) were recorder by Imperial College Mass 
Spectrometry Service using a Micromass Platform II and Micromass AutoSpec-Q 
spectrometer.  
X-ray diffraction data were recorded by the Imperial College Department of Chemistry X-ray 
diffraction service.  
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6.2 Procedures and Compound Characterisation 
3-(Allyloxy)-3-oxopropanoic acid (100) 
2 31 O
4
5
O
6
HO
7
O
H
H a
b
100   
Based on a procedure by Tararov et al.
[74] 
Meldrum's acid (30.0 g, 208 mmol, 1.0 equiv.) and 
allyl alcohol (27.0 mL, 416 mmol, 2.0 equiv.) were heated at 80 °C for 8 h. The reaction was 
quenched with a saturated aqueous solution of NaHCO3 (200 mL) and the resulting solution 
stirred for 8 h at rt. The reaction mixture was extracted with Et2O : hexanes (1 : 1, 3 x 150 
mL) and the aqueous acidified to pH 3 using 1 M HCl. The resulting aqueous was extracted 
with EtOAc (3 x 200 mL), dried (MgSO4) and rotary evaporated to afford carboxylic acid 
100
[82]
 as a colourless oil (20.0 g, 70%):  
Rf 0.43 (1 : 1 hexanes : EtOAc);  
IR (neat) νmax 3300 (br., H-O), 2949 (m, C-H), 1713 (s, C=O), 1651 (m, C=C), 1369 (m), 
1312 (w), 1201 (w), 1150 (s), 1092 (w) cm
-1
; 
HRMS (CI) calc. for C6H12O4N [M+NH4]
+: requires 162.0766, found 162.0759 (Δ –4.3 
ppm);  
1
H NMR (400 MHz, CDCl3) 8.00 (br. s, 1H, 1), 5.99-5.90 (m, 1H, 6), 5.41-5.36 (m, 1H, 7a), 
5.33-5.29 (m, 1H, 7b), 4.71 (dt, J = 6.0, 0.5 Hz, 2H, 5), 3.50 (s, 2H, 3);  
13
C NMR (100 MHz, CDCl3) δ 170.6 (2), 166.7 (4), 131.2 (6), 119.2 (7), 65.9 (5), 40.6 (3);  
Anal. Calc. for C6H8O4: C, 50.00; H, 5.59. Found: C, 49.97; H, 5.44. 
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Allyl 4-(2,2-dimethyl-4-oxo-4H-1,3-dioxin-6-yl)-3-oxobutanoate (102) 
O
1
2
3
O4
7
8
9
10 O
O O
11
O
5 6
12
13
H
H a
b
102  
Based on a procedure by Navarro et al.
[82] 
Carboxylic acid 100 (900 mg, 6.25 mmol, 0.8 
equiv.) was stirred in CH2Cl2 (10 mL) at 0 °C. Oxalyl chloride (1.40 mL, 16.0 mmol, 2.0 
equiv.) and 3 drops of DMF (cat.) were added and the reaction mixture stirred for 30 min at 0 
°C followed by 30 min at rt.  The reaction mixture was rotary evaporated to afford acid 
chloride 101 as a yellow oil which was used without further purification.  
 
HMDS (6.9 mL, 33 mmol, 4.1 equiv.) was stirred in THF (250 mL) at –78 °C. n-BuLi in 
hexanes (16 mL, 32 mmol, 2.3 M, 4.0 equiv.) was added dropwise and the mixture stirred for 
30 min. Dioxinone 33 (3.2 mL, 24 mmol, 3.0 equiv.) was added dropwise to the stirring 
solution which was stirred for a total of 1 h. Acid chloride 101 in THF (10 mL) was added 
dropwise to the stirring solution. The reaction mixture was stirred for 2 h and then quenched 
with a saturated aqueous solution of NH4Cl (150 mL), acidified to pH 3 utilising 1 M HCl 
and extracted with EtOAc (3 x 100 mL). The organics were combined, washed with brine 
(100 mL), dried (MgSO4), rotary evaporated and chromatographed (7 : 3 hexanes : Et2O) to 
afford keto-allylester-dioxinone 102
[82] 
(1.06 g, 65%) as a yellow oil:  
Rf 0.30 (1 : 2 hexanes : Et2O);   
IR (neat) νmax 2999 (w, C-H), 2947 (w, C-H), 1721 (s, C=O), 1637 (m, C=C), 1376 (m), 
1273 (m), 1254 (sh.), 1202 (sh.), 1016 (w), 1091 (w), 1062 (w) cm
-1
;
  
HRMS (ESI) calc. for C13H17O6 [M+H]
+
: requires 269.1025, found 269.1031 (Δ +2.2 ppm);  
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1
H NMR (400 MHz, CDCl3) δ 5.99-5.89 (m, 1H, 12), 5.40 (s, 1H, 2), 5.35-5.31 (m, 2H, 13a 
& 13b), 4.68 (d, J = 6.0 Hz, 2H, 11), 3.58 (s, 2H, 9), 3.53 (s, 2H, 7), 1.74 (s, 6H, 5 & 6);  
13
C NMR (125 MHz, CDCl3) δ 195.4 (8), 166.0 (1), 163.4 (10), 160.4 (3), 131.2 (12), 119.4 
(13), 107.4 (4), 97.2 (2), 66.3 (11), 49.0 (9), 47.0 (7), 25.0 (2C, 5 & 6). 
 
(S)-3-(Tri-Isopropylsilyloxy)butanoic acid (311) 
HO1 2 3
O
4 5
O
312
Si 6 7
MeO
O OH
310
HO
O O
311
Si
 
Based on a procedure by Tschaen et al.
[85] 
2,6-Lutidine (11.0 mL, 94.8 mmol, 1.6 equiv.) 
followed by TIPSOTf (16.0 mL, 59.3 mmol, 1.0 equiv.) were added with stirring to alcohol 
310 (7.00 g, 59.3 mmol, 1.0 equiv.) in CH2Cl2 (90 mL) at 0 °C and stirred for an additional 1 
h at 0 °C. The reaction mixture was allowed to warm to rt and stirred for 3 h. The reaction 
mixture was quenched with 1 M HCl (200 mL) and stirred for 10 min. The resulting solution 
was extracted with Et2O (2 x 200 mL), the organics combined, washed with H2O (2 x 200 
mL), dried (MgSO4) and rotary evaporated to afford silylether 311 as a colourless oil which 
was used without further purification.  
Methyl ester 311 was added with stirring to aqueous NaOH (1 M; 110 mL, 109 mmol, 1.8 
equiv.) and THF (100 mL) and stirred for 72 h. The resulting solution was acidified to pH 3 
using 1 M HCl and extracted with CH2Cl2 (3 x 200 mL). The combined organic layers were 
washed with brine (2 x 250 mL), dried (MgSO4) and rotary evaporated to afford carboxylic 
acid 310
[85]
 (11.5 g, 77%) as a pale yellow oil:  
Rf 0.52 (1 : 9 MeOH : CH2Cl2);  
25
D][ = ‒0.5 (c 0.2, CHCl3);  
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IR (neat) νmax 3250 (br., O-H), 2942 (m, C-H), 2866 (m, C-H), 1710 (sh., C=O), 1463 (w), 
1412 (w), 1381 (w), 1247 (w), 1203 (w), 1128 (w), 1096 (sh.), 1005 (sh.) cm
-1
;  
HRMS (ESI) calc. for C13H27O3Si [M+H]
+
: requires 259.1729, found 259.1743 (Δ +5.4 
ppm);  
1
H NMR (400 MHz, CDCl3) 10.28 (br. s, 1H, 1), 4.42 (app. sextet, J = 4.0 Hz, 1H, 4), 2.64 - 
2.54 (m, 2H, 3), 1.34 (d, J = 4.0 Hz, 3H, 5), 1.12 - 1.08 (m, 21H, 6 & 7);  
13
C NMR (100 MHz, CDCl3) 175.2 (2), 65.8 (4), 44.0 (3), 23.5 (5), 17.9 (6C, 7), 12.3 (3C, 
6);  
Anal. Calc. for C13H28O3Si: C, 59.95; H, 10.84. Found: C, 60.02; H, 10.77. 
 
(5S)-Allyl 2-(2-(2,2-dimethyl-4-oxo-4H-1,3-dioxin-6-yl)acetyl)-3-oxo-5-(tri-
isopropylsilyloxy)hexanoate (104) 
O
1
2
3
O4
7
8 9
O
O
5
17
O
6
O
18 19
20
10 11
OH16
12 13
O
Si 14 15
HHa b
HH
a b
104  
Based on a procedure by Navarro et al.
[82] 
Oxalyl chloride (0.50 mL, 5.30 mmol, 2.0 equiv.) 
and 3 drops of DMF (cat.) were added sequentially with stirring to carboxylic acid 312 (823 
mg, 2.70 mmol, 1.0 equiv.) in CH2Cl2 (10 mL) at 0 °C and stirred for 1 h. The resulting 
solution was rotary evaporated to afford acid chloride 103 as a pale yellow oil which was 
used without further purification. 
Keto-allylester-dioxinone 102 (710 mg, 2.60 mmol, 1.0 equiv.) in CH2Cl2 (3 mL) was added 
to MgCl2 (500 mg, 5.30 mmol, 2.0 equiv.) and pyridine (0.60 mL, 7.10 mmol, 2.7 equiv.) in 
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CH2Cl2 (20 mL) at 0 °C. The resulting mixture was stirred for 30 min at 0 °C. Acid chloride 
103 in CH2Cl2 (3 mL) was added dropwise and the resulting solution stirred for 1 h at 0 °C. 
The reaction was quenched with brine (200 mL), extracted with EtOAc (2 x 200 mL), the 
organics combined, dried (MgSO4), rotary evaporated and chromatographed (1 : 4 EtOAc : 
hexanes) to afford diketo-allylester-dioxinone 104
[82] 
 (942 mg, 70%) as a pale yellow oil:  
Rf 0.66 (2 : 1 Et2O : hexanes);  
25
D][ = +17.48 (c 1.2, CHCl3);  
IR (neat) νmax 2944 (m, C-H), 2867 (m, C-H), 1734 (s, C=O), 1665 (m, C=C), 1378 (m), 
1272 (m), 1206 (m), 1160 (m), 1128 (w), 1067 (w) cm
-1
; 
HRMS (ESI) calc. for C26H43O8Si [M+H]
+
: requires 511.2727, found 511.2720 (Δ –1.4 
ppm);  
1
H NMR (400 MHz, CDCl3)  17.56 (s, 1H, 16), 6.05 - 5.95 (m, 1H, 19), 5.44 - 5.33 (m, 2H, 
20a & 20b), 5.36 (s, 1H, 2), 4.74 (d, J = 8.0 Hz, 2H, 18), 4.53 - 4.45 (app. sextet, J = 8.0 Hz, 
1H, 12), 3.70 (s, 2H, 7), 3.02 (dd, J = 12.0, 8.0 Hz, 1H, 11b), 2.83 (dd, J = 12.0, 4.0 Hz, 1H, 
11a), 1.71 (s, 6H, 5 & 6), 1.26 (d, J = 8.0 Hz, 3H, 13), 1.05 (br. s, 21H, 14 & 15);  
13
C NMR (125 MHz, CDCl3)  195.5 (8), 193.2 (10), 166.0 (1), 165.0 (17), 160.7 (3), 131.4 
(4), 119.8 (19), 109.3 (20), 107.2 (9), 96.6 (2), 66.5 (12), 66.0 (18), 47.2 (7), 43.0 (11), 25.0 
(2C, 5 & 6), 24.3 (13), 18.0 (6C, 15), 12.3 (3C, 14);  
Anal. Calc. for C26H42O8Si: C, 61.15; H, 8.29. Found: C, 61.01; H, 8.22. 
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(S)-Methyl 2,4-dihydroxy-6-(2-(tri-isopropylsilyloxy)propyl)benzoate (105) 
3
4
5
6
12
OH
15
HO14
7 OMe 8
O
9
10
O11
Si
12
13
H
H
a
b
105  
Morpholine (0.10 mL, 0.96 mmol, 3.3 equiv.) was added with stirring to diketo-allylester-
dioxinone 104 (150 mg, 0.29 mmol, 1.0 equiv.) in THF (1.5 mL) at 0 °C, followed 
immediately by the addition of Pd(PPh3)4 (33 mg, 0.03 mmol, 10 mol%) in THF (1.5 mL). 
After 25 min at 0 °C, the mixture was allowed to warm to rt and stirred for 30 min. The 
reaction mixture was quenched with a saturated aqueous solution of NH4Cl (5 mL), followed 
by H2O (10 mL) and was then acidified to pH 4 using 1 M HCl. The resulting aqueous layer 
was extracted with EtOAc (3 x 20 mL), the organics combined, dried (MgSO4) and rotary 
evaporated to afford polyketide 108 as a colourless oil which was used without further 
purification. 
 
Polyketide 108 was dissolved in toluene (2 mL) and MeOH (30 μL, 0.73 mmol, 2.5 equiv.) 
and heated to reflux for 1 h. The resulting solution was rotary evaporated, the crude residue 
dissolved in MeOH (5 mL), Cs2CO3 (472 mg, 1.45 mmol, 5.0 equiv.) in MeOH (1 mL) added 
and the resulting mixture stirred at rt for 3 h. AcOH (0.20 mL, 2.90 mmol, 10.0 equiv.) was 
added and the resulting mixture stirred for 18 h. The reaction was quenched with a saturated 
aqueous solution of NaHCO3 (10 mL), extracted with Et2O (3 x 20 mL), the organics 
combined, washed with brine (15 mL), dried (MgSO4), rotary evaporated and 
chromatographed (1 : 2 Et2O : hexanes) to give resorcylate 105 (43.0 mg, 39% over 4 steps) 
as a colourless solid:  
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m.p. 50-52 °C (hexanes);  
Rf 0.38 (1 : 3 Et2O : hexanes);  
25
D][ = +35.5 (c 0.3, CHCl3);  
IR (neat) νmax 3365 (br., O-H), 2926 (m, C-H), 2865 (m, C-H), 1652 (m, C=C), 1625 (sh., 
C=C), 1586 (m, C=C), 1462 (m), 1386 (sh.), 1318 (m), 1263 (sh.), 1194 (sh.), 1173 (w), 
1134 (sh.), 1108 (m), 1082 (w), 1025 (w) cm
-1
; 
HRMS (ESI) calc. for C20H35O5Si [M+H]
+
: requires 383.2254, found 383.2236 (Δ –4.70 
ppm);  
1
H NMR (500 MHz, CDCl3) δ 11.63 (s, 1H, 15), 6.31 (d, J = 2.0 Hz, 1H, 5), 6.29 (d, J = 
2.0 Hz, 1H, 3), 5.37 (s, 1H, 14), 4.17 - 4.11 (m, 1H, 10), 3.92 (s, 3H, 8), 3.14 (dd, J = 12.0, 
4.0 Hz, 1H, 9b), 2.93 (dd, J = 12.0, 8.0 Hz, 1H, 9a), 1.17 (d, J = 4.0 Hz, 3H, 11), 0.98 (br. s, 
3H, 12) 0.97 (br. s, 18H, 13);  
13
C NMR (125 MHz, CDCl3) δ 171.8 (7), 165.2 (2), 160.0 (4), 145.0 (6), 113.2 (5), 105.4 
(3), 101.8 (1), 69.8 (10), 52.0 (8), 46.7 (9), 24.4 (11), 18.1 (6C, 13), 12.6 (3C, 12). 
 
(S)-7-Hydroxy-2,2-dimethyl-5-(2-(triisopropylsilyloxy)propyl)-4H-benzo[d][1,3]dioxin-
4-one (107) 
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107  
Diketo-allylester-resorcylate 104 (30 mg, 0.10 mmol, 1.0 equiv.) was stirred with Pd(PPh3)4 
(6.0 mg, 4.85 μmol, 10 mol%) and morpholine (100 μL, 0.32 mmol, 3.3 equiv.) in THF (0.5 
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mL) at 0 °C for 30 min and then allowed to warm to rt and stirred for 18 h. The reaction 
mixture was quenched with a saturated aqueous solution of NH4Cl (10 mL), extracted with 
Et2O (2 x 10 mL), dried (MgSO4), rotary evaporated and chromatographed (1 : 1 Et2O : 
hexanes) to afford isopropylidene protected resorcylate 107 as a white solid (20 mg, 80%):  
m.p. = 98-100 °C (pentane);  
Rf 0.5 (1 : 1 EtOAc : hexanes);  
25
D][ = +4.4 (c 1.0, CHCl3);  
IR (neat) νmax 3365 (s, O-H), 2941 (m, C-H), 2891 (m, C-H), 2866 (m, C-H), 1691 (sh., 
C=O), 1614 (sh., C=O), 1581 (sh., C=O), 1462 (w), 1387 (w), 1293 (m), 1283 (m), 1257 
(w), 1192 (sh.), 1172 (sh.), 1133 (w), 1099 (w) cm
-1
;  
HRMS (ESI) calc. for C22H37O5Si [M+H]
+
: requires 409.2410, found 409.2403 (Δ –1.7 
ppm);  
1
H NMR (500 MHz, CDCl3) δ 6.34 (d, J = 2.0 Hz, 1H, 5), 6.17 (d, J = 2.0 Hz, 1H, 3), 5.42 
(br. s, 1H, 12), 4.58-4.51 (m, 1H, 8), 3.51 (dd, J = 15.0, 4.0 Hz, 1H, 7b), 3.24 (dd, J = 15.0, 
8.0 Hz, 1H, 7a), 1.35 (s, 3H, 9), 1.32-1.31 (m, 6H, 15 & 16), 1.10 (br. s, 3H, 10), 1.09 (br. s, 
18H, 11);  
13
C NMR (125 MHz, CDCl3) δ 161.9 (13), 160.2 (4), 159.5 (2), 147.3 (6), 115.9 (1), 105.5 
(5), 104.7 (14), 102.1 (3), 69.4 (8), 45.6 (7), 25.5 (9), 25.3, 24.6 (15 & 16), 18.3 (6C, 11), 
12.9 (3C, 10);  
Anal. Calc. for C22H36O5Si: C, 64.67; H, 8.88. Found: C, 64.58; H, 9.03. 
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(S)-6,8-Dihydroxy-3-methylisochroman-1-one (106) 
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H2SiF6 in H2O (20% w/w; 60 µL, 90 μmol, 0.6 equiv.) was added to silyl ether 107 (53 mg, 
0.14 mmol, 1.0 equiv.) in MeCN (2.1 mL) at 0 °C. The reaction mixture was allowed to 
warm to rt and stirred for 2 h. The reaction was quenched with H2O (20 mL), extracted with 
EtOAc (2 x 20 mL), dried (MgSO4) and rotary evaporated to give alcohol 313 as a colourless 
solid which was used without further purification.  
One micro spatula tip of p-TsOH.H2O (~3 mg, cat.) was added to isopropylidene protected 
resorcylate 313 (32 mg, 0.14 mmol, 1.0 equiv.) in THF (5 mL) and the mixture heated at 
reflux for 2 h. The reaction was quenched with a saturated aqueous solution of NaHCO3 
(10 mL), extracted with Et2O (3 x 25 mL), the organics combined, dried (MgSO4), rotary 
evaporated and chromatographed (2 : 1 Et2O : hexanes) to give lactone 106
[190] 
(21 mg, 80% 
over 2 steps) as a white solid:  
m.p. = 138-140 °C (benzene);  
Rf 0.32 (1 : 1 Et2O : hexanes);  
25
D][ = +3.31 (c 0.016, CHCl3);  
IR (neat) vmax 3206 (m, O-H), 2924 (m, C-H), 2855 (m, C-H), 1739 (w, C=O), 1634 (sh., 
C=C), 1440 (w), 1366 (m), 1229 (w), 1217 (sh.), 1209 (sh.) cm
-1
;  
HRMS (ESI) calc. for C10H11O4 [M+H]
+: requires 195.0657, found 195.0663 (Δ +3.1 ppm);  
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1
H NMR (500 MHz, CD3OD) δ 6.21 (s, 1H, 5), 6.19-6.17 (m, 1H, 3), 4.83 (br. s. 2H, 10 & 
11), 4.68 - 4.62 (m, 1H, 8), 2.91-2.89 (m, 1H, 7b), 2.79-2.78 (m, 1H, 7a), 1.46 (d, J = 6.0 Hz, 
3H, 12);  
13
C NMR (125 MHz, CD3OD) δ 171.7 (9), 166.2 (2), 165.6 (4), 143.5 (6), 107.9 (3), 102.2 
(5), 101.5 (1), 77.2 (8), 35.5 (7), 20.9 (12);  
Anal. Calc. for C10H10O4: C 61.85; H 5.19. Found: C, 61.90; H 5.21. 
 
Angelicoin B: (S)-8-Hydroxy-6-methoxy-3-methylisochroman-1-one (7) 
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Lactone 106 (18 mg, 90 μmol, 1.0 equiv.) was stirred in Me2CO (3.72 mL) for 2 min. MeI (9 
μL, 0.15 mmol, 1.6 equiv.) and K2CO3 (13 mg, 90 μmol, 1.0 equiv.) were then added and the 
resulting solution heated at reflux for 1 h. The reaction was quenched with water (5 mL), 
extracted with EtOAc (2 x 20 mL), dried (MgSO4), rotary evaporated and chromatographed 
(1 : 2 Et2O : hexanes) to afford Angelicoin B (7)
[9]
 (15 mg, 79%) as a white solid: 
m.p. 58-60 °C (pentane);  
Rf  0.25 (1 : 3 Et2O : hexanes);  
25
D][ = +30.6 (c 0.5, MeOH), lit. 
25
D][ = +31.5 (c 0.5, MeOH); 
IR (neat) vmax 2980 (w, C-H), 2929 (w, C-H), 1664 (s, C=C), 1627 (m, C=C), 1440 (w), 
1371 (w), 1250 (sh.), 1203 (w), 1159 (m), 1118 (w), 1069 (w) cm
-1
;  
HRMS (ESI) calc. for C11H13O4 [M+H]
+: requires 209.0814, found 209.0811 (Δ +1.4 ppm);  
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1
H NMR (500 MHz, CDCl3) δ 11.25 (s, 1H, 11), 6.37 (d, J = 2.0 Hz, 1H, 5), 6.25 - 6.24 (m, 
1H, 3), 4.71 - 4.64 (m, 1H, 8), 3.83 (s, 3H, 12), 2.91 - 2.84 (m, 2H, 7a & b), 1.51 (d, J = 6.0 
Hz, 3H, 9);  
13
C NMR (125 MHz, CDCl3) δ 169.8 (10), 165.8 (4), 164.6 (2), 140.9 (6), 106.2 (5), 101.6 
(1), 99.4 (3), 75.5 (8), 55.6 (12), 34.9 (7), 20.7 (9);  
Anal. Calc. for C11H12O4: C, 63.45; H, 5.81. Found: C, 63.56; H, 5.78.  
 
3-(3-Methyl-2-buten-1-yl) malonate 114 
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Based on a procedure by Tararov et al.
[74] 
Prenyl alcohol (14.3 mL, 141 mmol, 1.5 equiv.) 
and Meldrum’s acid (13.6 g, 94.0 mmol, 1.0 equiv.) were stirred at 120 °C for 12 h. The 
mixture was poured into a saturated aqueous solution NaHCO3 (400 mL) and stirred for 6 h. 
The aqueous layer was extracted with EtOAc (3 x 200 mL) and then acidified to pH 3.0 using 
1 M HCl. The resulting aqueous layer was extracted with EtOAc (2 x 400 mL), the organic 
layers combined, dried (MgSO4) and rotary evaporated to afford carboxylic acid 114 (15.3 g, 
94%) as a pale yellow solid:  
m.p. 34-36 °C (hexanes);  
Rf 0.40 (1 : 9 MeOH : CH2Cl2);  
IR (neat) νmax 3350 (br. O-H), 2978 (w, C-H), 2937 (w, C-H), 1714 (s, C=O), 1416 (w), 
1378 (w), 1339 (m), 1312 (w), 1277 (m), 1151 (sh.), 1048 (m) cm
-1
;  
HRMS (CI) calc. for C8H16NO4 [M+H]
+
: requires
 190.1079, found 190.1077 (Δ –1.1 ppm);  
1
H NMR (400 MHz, CDCl3) δ 7.50 (br. s, 1H, 1) 5.38 (t, J = 8.0 Hz, 1H, 6), 4.71 (d, J = 
8.0 Hz, 2H, 5), 3.47 (s, 2H, 3), 1.80 (s, 3H, 9), 1.75 (s, 3H, 8);  
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13
C NMR (100 MHz, CDCl3) δ 171.1 (2), 167.2 (4), 140.4 (7), 117.6 (6), 62.9 (5), 40.6 (3), 
25.7 (9), 18.0 (8);  
Anal. Calc. for C8H12O4: C, 55.81; H 7.02. Found: C, 55.87; H, 7.18. 
 
3-Methylbut-2-enyl 3-(1H-benzo[d][1,2,3]triazol-1-yl)-3-oxopropanoate (116) 
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Based on a procedure by Navarro et al.
[82] 
SOCl2 (0.84 mL, 11.6 mmol, 1.0 equiv.) was added 
to benzotriazole (4.40 g, 36.6 mmol, 3.0 equiv.) in CH2Cl2 (47 mL) and the resulting mixture 
was stirred for 1 h. Carboxylic acid 114 (2.0 g, 11.6 mmol, 1.0 equiv.) in CH2Cl2 (20 mL) 
was added and the resulting mixture stirred for 24 h. The mixture was filtered and the filtrate 
was rotary evaporated. The crude residue was dissolved in CH2Cl2 (300 mL), washed with 
NaOH (0.5 M) (3 x 150 mL) and then pH 9 buffer (2 x 250 mL). The combined organic 
layers were dried (MgSO4) and rotary evaporated to afford benzotriazole amide 116 (2.5 g, 
81%) as a colourless oil:  
Rf 0.70 (1 : 1 : 6 CH2Cl2 : EtOAc : hexanes);  
IR (neat) νmax 2962 (w, C-H), 1726 (s, C=O), 1380 (s), 1267 (m), 1209 (m), 1146 (w) cm
-1
;  
HRMS (CI) calc. for C14H16N3O3 [M+H]
+
: required
 
274.1192, found
 274.1197 (Δ +1.8 ppm);  
1
H NMR (400 MHz, C6D6) δ 8.22 (d, J = 8.0 Hz, 1H, 2 / 5), 7.84 (d, J = 8.0 Hz, 1H, 2 / 5), 
7.13 - 7.09 (m, 1H, 3 / 4), 6.99 - 6.95 (m, 1H, 3 / 4), 5.36 - 5.33 (m, 1H, 11), 4.62 (d, J = 8.0 
Hz, 2H, 10), 4.06 (s, 2H, 8), 1.54 (s, 3H, 14), 1.46 (s, 3H, 13);   
13
C NMR (100 MHz, CD3OD)  165.7 (7), 164.9 (14), 146.6 (5), 139.3 (12), 131.0 (1), 130.1 
(3), 125.9 (4), 120.1 (5), 118.4 (11), 114.2 (2), 62.4 (10), 42.6 (8), 25.3 (14), 17.5 (13). 
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3-Methylbut-2-enyl 4-(2,2-dimethyl-4-oxo-4H-1,3-dioxin-6-yl)-3-oxobutanoate (113) 
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Based on a procedure by Navarro et al.
[82] 
Dioxinone 33 (2.40 mL, 17.4 mmol, 3.0 equiv.) in 
THF (5 mL) was added dropwise to a freshly prepared solution of LiN(SiMe3) in THF (1 M; 
20.3 mL, 20.3 mmol, 3.5 equiv.) in THF (250 mL) at –78 °C and the resulting solution stirred 
for 1 h. Benzotriazole amide 116 (684 mg, 5.80 mmol, 1.0 equiv.) in THF (20 mL) was then 
added dropwise and the resulting mixture stirred for 2 h. The reaction was quenched with a 
saturated aqueous solution of NH4Cl (300 mL) and acidified to pH 3 with 1 M HCl. The 
resulting solution was extracted with EtOAc (3 x 200 mL), the organics combined, washed 
with brine (100 mL), dried (MgSO4), rotary evaporated and chromatographed (7 : 3 hexanes : 
Et2O) to afford keto-prenylester-dioxinone 113 (1.58 g, 93%) as a yellow oil:  
Rf 0.31 (2 : 1 Et2O : hexanes);  
IR (neat) νmax 3381 (br., O-H), 2831 (w, C-H), 1738 (sh., C=O), 1730 (sh., C=O), 1640 (m, 
C=C), 1376 (m), 1274 (m), 1217(w), 1017 (sh.), 903 (w) cm
-1
;  
HRMS (ESI) calc. for C15H21O6 [M+H]
+
: required 297.1338, found 297.1329 (Δ –3.0 ppm);  
1
H NMR (400 MHz, CDCl3) δ 5.37 (s, 1H, 2), 5.36 - 5.33 (m, 1H, 12), 4.66 (d, J = 8.0 Hz, 
2H, 15), 3.53 (s, 2H, 9), 3.52 (s, 2H, 7), 1.78 (s, 3H, 11), 1.72 (s, 9H, 5, 6 & 14);  
13
C NMR (100 MHz, CDCl3) δ 195.7 (7), 166.3 (1), 163.6 (10), 160.4 (13), 140.3 (3), 117.6 
(12), 107.3 (4), 97.0 (2), 62.5 (11), 49.1 (9), 46.9 (8), 25.7 (2C, 5 & 6), 24.9 (15), 18.0 (14);  
Anal. Calc. for C15H20O6: C, 60.80; H, 6.80. Found: C, 60.89; H, 6.81. 
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(R)-3-(Triisopropylsilyloxy)butanoic acid (118) 
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Based on a procedure by Tschaen et al.
[74] 
Alcohol 119 (5.0 g, 42 mmol, 1.0 equiv.) was 
stirred in CH2Cl2 (100 mL) at 0 °C. 2,6-Lutidine (7.9 mL, 68 mmol, 1.6 equiv.) was 
added dropwise followed by TIPSOTf (11.4 mL, 42.3 mmol, 1.0 equiv.) dropwise and the 
resulting solution stirred for 1 h at 0 °C, allowed to warm to rt and stirred for 3 h. The 
reaction mixture was quenched with 1 M HCl (200 mL), stirred for 10 min and extracted 
with Et2O (2 x 200 mL). The organics were combined, washed with H2O (2 x 200mL), 
dried (MgSO4) and rotary evaporated to afford silylether 314 which was used without 
further purification.  
Methyl ester 314 was added to a solution of 1 M NaOH (50 mL) and THF (50 mL). The 
reaction mixture was allowed to stir at rt for 72 h before being acidified to pH 3.0 using 1 
M HCl and extracted with CH2Cl2 (3 x 200 mL). The organics were combined, washed 
with brine (2 x 250 mL), dried (MgSO4) and rotary evaporated to afford carboxylic acid 
118 (7.22 g, 90% over 2 steps) as a pale yellow oil:   
Rf  0.52 (1 : 9 MeOH : CH2Cl2);  
25
D][ = +3.3 (c 0.875, CHCl3);  
IR (neat) νmax 2940 (m, C-H), 2867 (m, C-H), 1710 (sh., C=O), 1463 (w), 1129 (m), 
1096 (w), 1004 (m) cm
-1
;
  
HRMS (ESI) calc. for C13H28O3Si [M+H]
+
: requires 261.1886, found 261.1874 (Δ –4.6 
ppm);  
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1
H NMR (400 MHz, CDCl3) 10.75 (br. s, 1H, 1), 4.43-4.41 (m, 1H, 4), 2.63 (dd, J = 10.0, 
6.0 Hz, 2H, 3b), 2.57 (dd, J = 10.0, 3.0 Hz, 2H, 3a), 1.35 (d, J = 4.0 Hz, 3H, 5), 1.11 (br. 
s, 18H, 7), 1.10 (br. s, 3H, 6);  
13
C NMR (100 MHz, CDCl3) 174.5 (2), 65.9 (4), 43.8 (3), 23.4 (5), 18.0 (6C, 7), 12.3 
(3C, 6). 
 
(R)-N-Methoxy-N-methyl-3-(triisopropylsilyloxy)butanamide (120) 
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Carboxylic acid 118 (1.00 g, 3.25 mmol, 1.0 equiv.) was stirred in CH2Cl2 (10 mL) at 0 °C. 
Oxalyl chloride (0.60 mL, 7.17 mmol, 2.0 equiv.) and DMF (25 μL, 0.30 mmol, 0.1 equiv.) 
were added and the reaction mixture stirred for 1 h at 0 °C followed by 2 h at rt.  The reaction 
mixture was rotary evaporated to afford acid chloride 117 as an orange oil which was used 
without further purification.  
N,O-Dimethylhydroxylamine hydrochloride (332 mg, 3.40 mmol, 0.95 equiv.) was stirred 
with pyridine (0.60 mL, 7.16 mmol, 2.0 equiv.) in CH2Cl2 (10 mL) for 30 min, acid chloride 
117 was then added and the reaction mixture stirred at rt for 3 h.  The reaction mixture was 
poured into brine (50 mL), extracted with Et2O and CH2Cl2 (1 : 1), dried (MgSO4) and rotary 
evaporated to afford Weinreb amide 120 (900 mg, 82%) as a pale yellow oil:  
Rf 0.5 (EtOAc);  
25
D][ = –11.23 (c 3.08, CHCl3);  
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IR (neat) νmax 2944 (s, C-H), 2867 (s, C-H), 1667 (m, C=O), 1463 (m), 1179 (m), 1122 (sh.), 
1092 (w) cm
-1
;  
MS (CI) [M+H]
+
: requires 304, found 304;  
1
H NMR (400 MHz, CDCl3) δ 4.53-4.46 (m, 1H, 5), 3.72 (s, 3H, 2), 3.20 (s, 3H, 1), 2.79 (dd, 
J = 15.0, 5.0 Hz, 1H, 4b), 2.49 (dd, J = 15.0, 7.0 Hz, 1H, 4a), 1.29 (d, J = 6.0 Hz, 3H, 6), 
1.09 (br. s, 18H, 8), 1.08 (br. s, 3H, 7);  
13
C NMR (100 MHz, CDCl3) δ 189.2 (3), 65.9 (5), 61.3 (2), 42.2 (4), 24.3 (1), 18.1 (6), 17.7 
(6C, 8), 12.4 (3C, 7).  
 
(5R)-3-Methylbut-2-enyl 2-(2-(2,2-dimethyl-4-oxo-4H-1,3-dioxin-6-yl)acetyl)-3-oxo-5-
(tri-isopropylsilyloxy)hexanoate (111) 
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Based on a procedure by Navarro et al.
[82] 
Oxalyl chloride (1.50 mL, 16.9 mmol, 2.0 equiv.) 
and DMF (30 μL, 0.44 mmol, 0.1 equiv.) were added to carboxylic acid 118 (2.20 g, 8.40 
mmol, 1.0 equiv.) in CH2Cl2 (50 mL) at 0 °C and stirred for 1 h. The reaction mixture was 
rotary evaporated to afford acid chloride 117 as a pale yellow oil, which was used without 
further purification.  
Keto-prenylester-dioxinone 113 (100 mg, 0.34 mmol, 1.0 equiv.) in CH2Cl2 (1 mL) was 
added dropwise to a mixture of MgCl2 (64 mg, 0.67 mmol, 2.0 equiv.) and pyridine (80 μL, 
0.92 mmol, 2.7 equiv.) in CH2Cl2 (2 mL) at 0 °C. The resulting solution was stirred for 30 
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min and then acid chloride 117 in CH2Cl2 (0.5 mL) was added dropwise and the resulting 
solution stirred for 1 h. The reaction mixture was quenched with brine (20 mL), extracted 
with EtOAc (2 x 50 mL), the organics combined, dried (MgSO4), rotary evaporated and 
chromatographed (1 : 4 Et2O : hexanes) to afford diketo-prenylester-dioxinone 111 (148 mg, 
81%) as a yellow oil:  
Rf 0.74 (2 : 1 Et2O : hexanes);  
25
D][ = –6.7 (c 0.82, CHCl3);  
IR (neat) νmax 2941 (m, C-H), 2867 (m, C-H), 1733 (sh., C=O), 1712 (sh., C=O), 1641 (w, 
C=C), 1464 (m), 1391 (m), 1273 (w), 1250 (sh.), 1204 (w), 1126 (sh.), 1068 (sh.), 1015 (w) 
cm
-1
;  
HRMS (ESI) calc. for C28H47O8Si [M+H]
+
: requires 539.3032, found 539.3040 (Δ –1.5 
ppm);  
1
H NMR (400 MHz, CDCl3) δ 17.47 (s, 1H, 22), 5.45 - 5.41 (m, 1H, 18), 5.37 (s, 1H, 2), 
4.74 (d, J = 8.0 Hz, 2H, 17), 4.49-4.47 (m, 1H, 12), 3.70 (s, 2H, 7), 2.98 (dd, J = 14.0, 7.0 Hz, 
1H, 11b), 2.84 (dd, J = 14.0, 4.0 Hz, 1H, 11a), 1.81 (s, 3H, 20), 1.78 (s, 3H, 21), 1.72 (s, 6H, 
5 & 6), 1.25 (d, J = 6.0 Hz, 3H, 13), 1.06 (br. s, 21H, 14 & 15);  
13
C NMR (100 MHz, CDCl3) δ 195.2 (8), 193.0 (10), 166.3 (1), 165.0 (16), 160.7 (19), 140.4 
(3), 117.7 (18), 109.6 (4), 107.1 (9), 96.5 (2), 66.5 (12), 62.0 (17), 47.1 (7), 42.9 (11), 25.7 
(20), 24.9 (2C, 5 & 6), 24.8 (13), 24.3 (21), 18.0 (6C, 15), 12.4 (3C, 14);  
Anal. Calc. for C28H46O8Si: C, 62.42; H, 8.61. Found: C, 62.36; H, 8.64. 
 
 
 
 
 
6 Experimental 
190 
 
(R)-1-(1H-Benzo[d][1,2,3]triazol-1-yl)-3-(triisopropylsilyloxy)butan-1-one (121) 
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Based on a procedure by Navarro et al.
[82] 
Benzotriazole (720 mg, 6.05 mmol, 3.2 equiv.) was 
stirred in CH2Cl2 (12 mL) at rt. Thionyl chloride (0.14 mL, 1.92 mmol, 1.0 equiv.) was added 
and the mixture stirred for 45 min. Carboxylic acid 118 (500 mg, 1.92 mmol, 1.0 equiv.) in 
CH2Cl2 (8 mL) was added and the mixture allowed to stir for 2 h. The reaction mixture was 
filtered and the filtrate rotary evaporated to afford benzotriazole amide 121 (643 mg, 93%) as 
a yellow oil:  
Rf 0.64 (2 : 1 hexanes : EtOAc);  
25
D][ = –0.301 (c 1.06, CHCl3);  
IR (neat) νmax 2943 (m, C-H), 2867 (m, C-H), 1736 (sh., C=O), 1450 (w), 1375 (sh.), 1128 
(sh.) cm
-1
; 
HRMS (ESI) calc. for C19H31 N3O2Si [M+NH]
+
: requires 361.2264, found 362.2257 ( –1.9 
ppm);  
1
H NMR (400 MHz, C6D6) δ 8.41 (d, J = 8.0 Hz, 1H, 2 / 5), 7.92 (d, J = 8.0 Hz, 1H, 2 / 5), 
7.21-7.14 (m, 1H, 3 / 4), 7.04-7.01 (m, 1H, 3 / 4), 4.82-4.76 (m, 1H, 9), 3.67 (dd, J = 8.0, 5.0 
Hz, 1H, 8b), 3.24 (dd, J = 8.0, 2.5 Hz, 1H, 8a), 1.31 (d, J = 3.0 Hz, 3H, 10), 1.15 (br. s, 3H, 
11), 1.13 (br. s, 18H, 12);  
13
C NMR (100 MHz, CDCl3) δ 200.4 (7), 170.3 (6), 130.7 (1), 129.9 (3), 125.8 (4), 120.1 
(5), 114.4 (2), 66.2 (9), 45.5 (8), 24.1 (10), 18.0 (6C, 12), 12.5 (3C, 11) 
 
6 Experimental 
191 
 
(R)-7-Hydroxy-2,2-dimethyl-8-(3-methylbut-2-enyl)-5-(2-(tri-isopropylsilyloxy)propyl)-
4H-benzo[d][1,3]dioxin-4-one (124) and (2R)-7-(2,2-dimethyl-4-oxo-4H-1,3-dioxin-6-yl)-
8,8-dimethyl-2-(tri-isopropylsilyloxy)dec-9-ene-4,6-dione (123) 
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Pd(PPh3)4 (38 mg, 33 μmol, 10 mol%) and Cs2CO3 (348 mg, 0.99 mmol, 3.0 equiv.) were 
stirred in THF (1 mL) for 10 min at 0 °C. Diketo-prenylester-dioxinone 111 (150 mg, 0.33 
mmol, 1.0 equiv.) in THF (1 mL) was added dropwise and the resulting solution stirred for 18 
h at rt. The reaction was quenched with brine (20 mL), extracted with EtOAc (2 x 50 mL), 
the organics combined, dried (MgSO4), rotary evaporated and chromatographed (1 : 1 : 12 
CH2Cl2 : EtOAc : hexanes) to give prenyl-resorcylate 124 as a white solid (79 mg, 50%) and 
diketo-dioxinone 123 as a colourless oil (16 mg, 10%). 
Prenyl-resorcylate 124:  
m.p. 79-81 °C (benzene);  
Rf 0.60 (1 : 1 : 6 CH2Cl2 : EtOAc : hexanes);
  
25
D][ = –31.33 (c 1.0, CHCl3);  
IR (neat) νmax 3286 (br., O-H), 2941 (m, C-H), 2866 (m, C-H), 1702 (sh., C=O), 1695 (sh. 
C=O), 1594 (m), 1375 (w), 1298 (w), 1108 (sh.) cm
-1
;  
HRMS (ESI) calc. for C27H45O5Si [M+H]
+
: requires 477.3028, found 477.3036 (Δ –1.7 
ppm);  
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1
H NMR (400 MHz, CDCl3) δ 6.52 (s, 1H, 5), 6.47 (s, 1H, 21), 5.18 (t, J = 8.0 Hz, 1H, 17), 
4.30-4.28 (m, 1H, 8), 3.33 (d, J = 8.0 Hz, 2H, 16), 3.26 (dd, J = 12.0, 5.0 Hz, 1H, 7a), 3.09 
(dd, J = 12.0, 7.0 Hz, 1H, 7b), 1.81 (s, 3H, 20), 1.74 (s, 3H, 19), 1.70 (s, 6H, 14 & 15), 1.20 
(d, J = 5.0 Hz, 3H, 9), 1.0 (br. s, 21H, 10 & 11);  
13
C NMR (100 MHz, CDCl3) δ 160.9 (12), 159.6 (2), 156.1 (4), 143.8 (6), 134.3 (18), 121.1 
(17), 115.4 (3), 113.6 (5), 105.1 (13), 104.7 (1), 69.0 (8), 44.7 (7), 25.8 (9), 25.6 (20), 24.2 
(2C, 14 & 15), 22.0 (16), 18.1 (19), 17.9 (6C, 11), 12.5 (3C, 10);  
Anal. Calc. for C27H44O5Si: C, 68.02; H, 9.30. Found: C, 67.95; H, 9.17.  
 
Diketo-dioxinone 123: (Mixture of diastereoisomers in a 1:1 ratio)  
Rf 0.55 (1 : 1 : 6 CH2Cl2 : EtOAc : hexanes); 
IR (neat) νmax 2943 (m, C-H), 2867 (m, C-H), 1731 (sh., C=O), 1612 (m, C=C), 1463 (w), 
1376 (m), 1250 (w), 1068 (w) cm
-1
;  
HRMS (ESI) calc. for C27H47O6Si [M+H]
+
: requires 495.3146, found 495.3155 (Δ –1.8 
ppm); 
1
H NMR (400 MHz, CDCl3) δ 15.44 (br. s, 1H, 21), 6.03 (dd, J = 17.0, 10.0 Hz, 0.5 H, 11), 
5.99 (dd, J = 17.0, 10.0 Hz, 0.5 H, 11), 5.59 (s, 0.5 H, 14), 5.58 (s, 0.5 H, 14), 5.53 (s, 0.5 H, 
2), 5.52 (s, 0.5 H, 2), 5.05 (d, J = 10.0 Hz, 1 H, 12a), 5.03 (d, J = 17.0 Hz, 1 H, 12b), 4.41-
4.39 (m, 1H, 17), 2.94 (s, 1H, 7), 2.52 (dd, J = 14.0, 5.0 Hz, 1H, 16b), 2.41 - 2.35 (m, 1H, 
16a), 1.71 (s, 3H, 5 / 6), 1.69 (s, 3H, 5 / 6), 1.26 (d, J = 5.0 Hz, 3H, 18), 1.22 (s, 6H, 9 & 10), 
1.07 (br. s, 3H, 19), 1.06 (br. s, 18H, 20); 
13
C NMR (100 MHz, CDCl3) δ 191.6 (13), 189.4 (15), 166.9 (1), 160.8 (3), 144.5 (11), 112.7 
(12), 106.6 (4), 102.9 (14), 96.6 (2), 66.3 (17), 62.6 (7), 48.2 (16), 40.5 (8), 25.9 (2C, 9 & 
10), 25.6 (2C, 5 & 6), 24.6 (18), 18.0 (6C, 20), 12.4 (3C, 19).  
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(R)-7-Hydroxy-5-(2-hydroxypropyl)-2,2-dimethyl-8-(3-methylbut-2-enyl)-4H-
benzo[d][1,3]dioxin-4-one (128) 
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Bu4NF in THF (1 M; 2.18 mL, 2.18 mmol, 8.0 equiv.) was added to silylether 124 (130 mg, 
0.27 mmol, 1.0 equiv.) in THF (4 mL) and stirred for 48 h. The reaction was quenched with 
H2O (20 mL), extracted with EtOAc (2 x 30 mL), the organics combined, dried (MgSO4), 
rotary evaporated and chromatographed (1 : 6 hexanes : EtOAc) to give alcohol 128 (87 mg, 
97%) as a colourless gum:  
Rf 0.64 (EtOAc);  
25
D][ = –23.7 (c 1.5, CHCl3);  
IR (neat) νmax 3204 (br., O-H), 2981 (w, C-H), 2930 (w, C-H), 1723 (m, C=O), 1606 (m, 
C=C), 1420 (w), 1374 (m), 1274 (sh.), 1237 (sh.), 1166 (w), 1043 (m) cm
-1
;  
HRMS (ESI) calc. for C18H25O5 [M+H]
+
: requires 321.1711, found 321.1702 (Δ +2.8 ppm);   
1
H NMR (400 MHz, CDCl3) δ 7.97 (br. s, 1H, 20), 6.42 (s, 1H, 5), 5.14 (t, J = 8.0 Hz, 1H, 
12), 4.18 - 4.09 (m, 1H, 8), 3.48 (s, 1H, 10), 3.24 (d, J = 8.0 Hz, 2H, 11), 2.99 (dd, J = 12.0, 
8.0 Hz, 2H, 7), 1.78 (s, 3H, 15), 1.72 (s, 3H, 14), 1.70 (s, 3H, 18 / 19), 1.68 (s, 3H, 18 / 19), 
1.35 (d, J = 8.0 Hz, 3H, 9);  
13
C NMR (125 MHz, CDCl3) δ 162.4 (16), 160.7 (2), 156.4 (4), 142.3 (6), 133.1 (13), 121.1 
(12), 114.8 (3), 114.3 (5), 105.0 (1), 104.9 (17), 69.8 (8), 43.1 (7), 26.0 (18 / 19), 25.8 (18 / 
19), 25.2 (15), 23.5 (9), 21.9 (11), 17.9 (14).  
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Angelicoin A: ((R)-6,8-Dihydroxy-3-methyl-7-(3-methylbut-2-enyl)isochroman-1-one) 
(6) 
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KOH in EtOH (1 M; 8.70 mL, 8.70 mmol, 56.0 equiv.) was added to alcohol 128 (50 mg, 
0.16 mmol, 1.0 equiv.) and the mixture heated to reflux for 30 min, allowed to cool, and 
acidified to pH 2.0 using 1 M HCl. The aqueous phase was extracted with EtOAc (2 x 50 
mL) and the combined organic layers were dried (MgSO4), rotary evaporated and 
chromatographed (1 : 2 hexanes : EtOAc) to afford angelicoin A 6
[9] (37 mg, 90%) as a white 
solid:  
m.p. 118-120 °C (pentane);  
Rf  0.38 (1 : 2 EtOAc : hexanes);  
25
D][ = –32.3 (c 0.37, MeOH), lit. 
 25
D][ = –37.1 (c 0.50, MeOH)
 
IR (neat) νmax 3161 (br., O-H), 2988 (w, C-H), 1746 (m, C=O), 1614 (sh., C=C), 1365 (m), 
1222 (m), 1216 (sh.), 1205 (w) cm
-1
; 
HRMS (ESI) calc. for C15H17O4 [M+H]
+: requires 261.1127, found 261.1133 (Δ +2.3 ppm);  
1
H NMR (400 MHz, CDCl3) δ 11.55 (s, 1H, 17), 6.40 (br. s, 1H, 16), 6.35 (s, 1H, 5), 5.28 (t, 
1H, J = 7.0 Hz, 1H, 12), 4.72-4.64 (m, 1H, 8), 3.44 (d, J = 7.0 Hz, 2H, 11), 2.86-2.84 (m, 2H, 
7), 1.85 (s, 3H, 15), 1.78 (s, 3H, 14), 1.50 (d, J = 8.0 Hz, 3H, 10);  
13
C NMR (105 MHz, CDCl6) δ 170.3 (9), 161.7 (4), 161.2 (2), 138.6 (6), 136.0 (13), 121.0 
(12), 112.4 (3), 106.4 (5), 101.4 (1), 75.6 (8), 34.6 (7), 25.8 (15), 21.8 (11), 20.7 (10), 17.9 
(14);  
Anal. Calc. for C15H18O4: C, 68.68; H, 6.92. Found: C, 68.63; H, 6.83. 
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(R)-3-Methylbut-2-enyl 7-hydroxy-2,2-dimethyl-4-oxo-5-(2-(tri-
isopropylsilyloxy)propyl)-4H-benzo[d][1,3]dioxine-6-carboxylate (129) 
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Et3N (1.50 mL, 10.6 mmol, 20.0 equiv.) was added to diketo-prenylester-dioxinone 111 (285 
mg, 0.53 mmol, 1.0 equiv.) in CH2Cl2 (50 mL) and stirred for 24 h. The reaction was 
quenched with a saturated aqueous solution of NH4Cl (10 mL) and acidified to pH 2 using 1 
M HCl. The aqueous layer was extracted with EtOAc (2 x 100 mL) and the combined organic 
layers were dried (MgSO4), rotary evaporated and chromatographed (10 : 1 : 1 hexanes : 
EtOAc : CH2Cl2) to afford isopropylidene-protected resorcylate 129 (110 mg, 40%) as a clear 
oil:  
Rf 0.62 (1 : 1 : 6 EtOAc : CH2Cl2 : hexanes);  
25
D][ = +17.21 (c 0.83, CHCl3);  
IR (neat) νmax 2968 (w, C-H), 2866 (w, C-H), 1735 (s, C=O), 1659 (m, C=C), 1594 (m, C-
C), 1450 (w), 1377 (m), 1233 (sh.), 1209 (sh.), 1123 (w), 1105 (w), 1038 (w) cm
-1
;  
HRMS (ESI) calc. for C28H45O7Si [M+H]
+
: requires 521.2935, found 521.2938 (Δ +0.6 
ppm); 
1
H NMR (500 MHz, CDCl3) δ 11.22 (br. s, 1H, 21), 6.41 (s, 1H, 3), 5.49 (app. t of quin, J = 
7.0, 0.5, 1H, 14), 4.92-4.88 (m, 2H, 13), 4.85-4.83 (m, 1H, 8), 4.18 - 4.12 (m, 1H, 7a), 4.00 
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(br. s, 1H, 7b), 1.80 (s, 3H, 17), 1.78 (s, 3H, 16), 1.69 (s, 3H, 19 / 20), 1.66 (s, 3H, 19 / 20), 
1.21 (br. s, 3H, 9), 0.92 (br. s, 18H, 11), 0.91 (br. s, 3H, 10);  
13
C NMR (125 MHz, CDCl3) δ 170.9 (16), 166.2 (4), 160.7 (12), 159.6 (2), 151.1 (6), 140.9 
(15), 117.4 (14), 113.0 (1), 106.0 (5), 104.7 (18), 103.5 (3), 70.5 (8), 62.9 (13), 39.5 (7), 26.0 
(9), 25.8 (2C, 19 & 20), 25.4 (17), 18.1 (16), 17.9 (6C, 11), 12.6 (3C, 10). 
 
(S)-6-Hydroxy-3,3,9-trimethyl-9,10-dihydro-[1,3]dioxino[5,4-f]isochromene-1,7-dione 
(130) 
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Bu4NF in THF (1 M; 0.80 mL, 0.40 mmol, 4.4 equiv.) was added to silylether-resorcylate 
129 (46 mg, 90 μmol, 1.0 equiv.) in THF (1 mL) and stirred for 48 h at rt. The reaction was 
quenched with brine (10 mL), extracted with EtOAc (2 x 20 mL), the organic layers 
combined, dried (MgSO4), rotary evaporated and chromatographed (1 : 1 hexanes : EtOAc) 
to afford tricycle 130 (15 mg, 63%) as a white solid:  
m.p. = 178-180 °C (pentane);  
Rf 0.30 (1 : 1 EtOAc : hexanes);  
25
D][ = ‒13.24 (c 0.73, CHCl3);  
IR (neat) νmax 2922 (m, C-H), 1738 (s, C=O), 1679 (w, C=C), 1596 (w, C-C), 1371 (m), 
1230 (m) cm
-1
;  
HRMS (EI) calc. for C14H16O6 [M+H]
+
: requires 279.0869, found 279.0865 (Δ –1.4 ppm);  
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1
H NMR (500 MHz, CDCl3) δ 12.77 (br. s, 1H, 15), 6.35 (d, J = 0.5 Hz, 1H, 3), 3.74 - 3.67 
(m, 1H, 8), 2.46 - 2.40 (m, 2H, 7), 1.27 (s, 3H, 13 / 14), 1.24 (s, 3H, 13 / 14), 0.89 (d, J = 8.0 
Hz, 3H, 9);  
13
C NMR (125 MHz, CDCl3) δ 169.6 (10), 168.5 (11), 162.3 (4), 158.7 (2), 147.4 (6), 105.7 
(1), 105.4 (5), 103.5 (12), 103.0 (3), 74.6 (8), 32.4 (7), 25.9 (13 / 14), 25.0 (13 / 14), 20.2 (9);  
Anal. Calc. for C14H15O6: C, 60.43; H, 5.07. Found: C, 60.88; H, 4.65. 
 
(R)-Methyl 3-(benzyloxy)butanoate (138) 
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Alcohol 136 (2.0 g, 17.0 mmol, 1.0 equiv.) was stirred in cyclohexane (113 mL) and CH2Cl2 
(56 mL). Benzyl 2,2,2-trichloroacetimidate (8.56 g, 33.9 mmol, 2.0 equiv.) followed by TSA 
(10 μL, 0.85 mmol, 0.1 equiv.) were added and the mixture stirred at rt for 18 h. The reaction 
mixture was quenched with a saturated aqueous solution of NaHCO3 (100 mL), extracted with 
CH2Cl2 (3 x 100 mL), dried (MgSO4), rotary evaporated and chromatographed (1 : 9 EtOAc : 
hexanes) to afford benzyl-protected alcohol 137 (2.66 g, 76%) as a clear oil which was used 
without further purification. 
Methyl ester 137 was stirred in NaOH (1 M, 22.0 mL, 22.1 mmol, 1.8 equiv.) and THF (20 
mL) for 72 h. The reaction was acidified to pH 3 using 1 M HCl, extracted with CH2Cl2 (3 x 
200 mL), the organics combined, washed with brine (150 mL), dried (MgSO4) and rotary 
evaporated to afford carboxylic acid 138 (1.94 g, 83%) as a clear oil:  
Rf 0.4 (1 : 9 MeOH : CH2Cl2);  
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25
D][ = –0.83 (c 0.113, CHCl3);  
IR (neat) νmax 3029 (br., O-H), 2975 (w, C-H), 2930 (w, C-H), 1706 (sh., C=O), 1454 (w), 
1377 (w), 1305 (w), 1204 (m), 1134 (w), 1075 (m) cm
-1
;  
HRMS (CI) calc. for C11H18NO [M+NH]
+
: requires 212.1287, found 212.1297 ( +4.7 ppm);  
1
H NMR (500 MHz, C6D6) δ 7.25-7.24 (m, 2H, 8), 7.17-7.14 (m, 2H, 7), 7.08-7.05 (m, 1H, 9), 
4.27 (q, J = 13.0 Hz, 2H, 5), 3.80-3.74 (m, 1H, 3), 2.44 (dd, J = 15.0, 7.0 Hz, 1H, 2b), 2.13 
(dd, J = 15.0, 5.0 Hz, 1H, 2a), 0.96 (d, J = 6.0 Hz, 3H, 4);  
13
C NMR (125 MHz, C6D6) δ 177.3 (1), 139.1 (6), 128.2 (8), 128.0 (9), 127.8 (7), 71.7 (5), 
70.8 (3), 41.8 (2), 19.6 (4);  
Anal. Calc. for C11H14O3: C, 68.02; H, 7.27. Found: C, 68.13; H, 7.14. 
 
(5R)-3-Methylbut-2-enyl 5-(benzyloxy)-2-(2-(2,2-dimethyl-4-oxo-4H-1,3-dioxin-6-
yl)acetyl)-3-oxohexanoate (132) 
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Based on a procedure by Navarro et al.
.[82]
 Carboxylic acid 138 (490 mg, 2.52 mmol, 1.5 
equiv.) was stirred in CH2Cl2 (10 mL). Oxalyl chloride (0.45 mL, 5.04 mmol, 3.0 equiv.) and 2 
drops of DMF (cat.) were added and the mixture stirred at 0 °C for 30 min. The reaction 
mixture was rotary evaporated to afford acid chloride 139 which was used without further 
purification.  
6 Experimental 
199 
 
Keto-prenylester-dioxinone 113 (500 mg, 1.68 mmol, 1.0 equiv.), MgCl2 (352 mg, 3.7 mmol, 
2.2 equiv.) and pyridine (0.4 mL, 4.54 mmol, 2.7 equiv.) were stirred in CH2Cl2 (10 mL) for 
30 min. Acid chloride 139 in CH2Cl2 (5 mL) was added to the reaction mixture which was 
stirred for 30 min at 0 °C. The reaction mixture was quenched with brine (50 mL), extracted 
with EtOAc (2 x 100 mL), dried (MgSO4), rotary evaporated and chromatographed (1 : 1 : 4 
CH2Cl2 : EtOAc : hexanes) affording  diketo-prenylester-dioxinone 132 (500 mg, 65%) as a 
pale yellow oil:  
Rf  0.60 (1 : 1 : 6 CH2Cl2 : EtOAc : hexanes);  
25
D][ = –40.95 (c 0.61, CHCl3);  
IR (neat) νmax 2975 (w, C-H), 2937 (w, C-H), 1728 (s, C=O), 1638 (m, C=C), 1564 (w, C-
C), 1374 (s), 1271 (m), 1250 (m), 1202 (w), 1126 (w), 1065 (m), 1015 (w) cm
-1
;  
HRMS (ESI) calc. for C26H32O8Na [M+Na]
+
: requires 495.1995, found 495.1993 ( –0.4 
ppm);  
1
H NMR (500 MHz, C6D6) δ 17.50 (s, 1H, 25), 7.25-7.23 (m, 3H, 16 & 18), 7.07 (tt, J = 7.5, 
1.0 Hz, 2H, 17), 5.29 (app. t of quin. J = 7.0, 0.5 Hz, 1H, 21), 5.2 (s, 1H, 2), 4.56-4.53 (m, 
2H, 20), 4.34 (d, J = 12.0 Hz, 1H, 14), 4.25 (d, J = 12.0 Hz, 1H, 14), 3.91-3.87 (m, 1H, 12), 
3.34 (s, 2H, 7), 3.15 (dd, J = 14.0, 3.0 Hz, 1H, 11a), 2.65 (dd, J = 14.0, 5.5 Hz, 1H, 11b),  
1.51 (d, J = 0.5 Hz, 3H, 24), 1.45 (d, J = 0.5 Hz, 3H, 23), 1.31 (s, 6H, 5 & 6), 1.04 (d, J = 6.0 
Hz, 3H, 13);   
13
C NMR (125 MHz, C6D6) δ 195.8 (8), 193.5 (10), 166.1 (1), 164.2 (19), 159.6 (22), 139.9 
(3), 139.1 (15), 127.5 (2C, 17), 127.3 (3C, 16 & 18), 118.6 (21), 110.1 (4), 106.7 (9), 97.4 
(2), 72.6 (12), 70.8 (14), 61.8 (20), 44.6 (11), 42.9 (7), 25.6 (2C, 5 & 6), 24.7 (23), 20.0 (24), 
17.8 (13);  
Anal. Calc. for C26H32O8: C, 66.09; H, 6.83. Found: C, 66.22; H, 6.74. 
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(R)-5-(2-(benzyloxy)propyl)-7-hydroxy-2,2-dimethyl-8-(3-methylbut-2-enyl)-4H-
benzo[d][1,3]dioxin-4-one (133) 
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133  
Pd(PPh3)4 (91 mg, 79 μmol, 0.1 equiv.) and Cs2CO3 (770 mg, 2.37 mmol, 3.0 equiv.) were 
stirred in THF (4 mL) at 0 °C for 2 min. Diketo-prenylester-dioxinone 132 (375 mg, 0.79 
mmol, 1.0 equiv.) in THF (1 mL) was added to the stirring solution which was then allowed 
for stir for 20 min. The reaction mixture was allowed to warm to rt and stirred for 18 h. The 
reaction mixture was quenched with a saturated aqueous solution of NH4Cl (50 mL), 
extracted with EtOAc (2 x 50 mL), dried (MgSO4), rotary evaporated and chromatographed 
(1 : 1 : 4 CH2Cl2 : EtOAc : hexanes) affording prenyl resorcylate 133 (100 mg, 31%) as a 
white solid: (traces of diketo-dioxinone 134 could be seen by crude NMR but could not be 
isolated) 
m.p. 72-74 °C (pentane);  
Rf 0.6 (1 : 1 : 6 CH2Cl2 : EtOAc : hexanes);  
25
D][ = –31.5 (c 0.21, CHCl3);  
IR (neat) vmax 3264 (br., O-H), 2971 (w, C-H), 2929 (w, C-H), 1724 (sh., C=O), 1693 (m, 
C=C), 1606 (m, C=C), 1419 (m), 1376 (s), 1285 (sh.), 1207 (s), 1166 (w), 1108 (m) cm
-1
;  
HRMS (ESI) calc. for C25H31O5 [M+H]
+
: requires 411.2157, found 411.2171 (Δ –1.5 ppm);  
1
H NMR (500 MHz, C6D6) δ 7.18-7.15 (m, 2H, 12), 7.12-7.09 (m, 2H, 13), 7.04-7.01 (m, 
1H, 14), 6.36 (s, 1H, 24), 6.31 (s, 1H, 5), 5.37 (app. t of quin., J = 7.0, 0.5 Hz, 1H, 20), 4.45 
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(d, J = 12.0 Hz, 1H, 10), 4.29 (d, J = 12.0 Hz, 1H, 10), 4.01-3.95 (m, 1H, 8), 3.52 (dd, J = 
12.0, 4.0 Hz, 1H, 7b), 3.43 (d, J = 7.0 Hz, 2H, 19), 3.28 (dd, J = 12.0, 7.0 Hz, 1H, 7a), 1.69 
(d, J = 0.5 Hz, 3H, 23), 1.61 (d, J = 0.5 Hz, 3H, 22), 1.33 (s, 6H, 17 & 18), 1.29 (d, J = 6.0 
Hz, 3H, 9);  
13
C NMR (125 MHz, C6D6) 160.7 (15), 159.8 (4), 156.8 (2), 143.5 (6), 139.6 (11), 132.2 
(21), 129.2 (2C, 13), 128.6 (14), 127.4 (2C, 12), 122.4 (20), 115.1 (1), 114.7 (3), 105.6 (16), 
104.6 (5), 76.3 (8), 70.9 (10), 42.3 (7), 25.6 (22), 22.4 (17 & 18), 21.5 (19), 20.4 (9), 17.8 
(23).  
 
3-Methylbut-2-enyl 2-acetyl-4-(2,2-dimethyl-4-oxo-4H-1,3-dioxin-6-yl)-3-oxobutanoate 
(140) 
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Based on a procedure by Navarro et al.
[82] 
Keto-prenylester-dioxinone 113 (450 mg, 1.52 
mmol, 1.0 equiv.) was added to MgCl2 (173 mg, 1.82 mmol, 2.0 equiv.) and pyridine (0.3 
mL, 3.9 mmol, 2.7 equiv.) in CH2Cl2 (40 mL) at 0 °C and stirred for 30 min. Acetyl chloride 
(0.15 mL, 2.13 mmol, 1.4 equiv.) was added and the resulting solution stirred for 1 h at 0 °C. 
The reaction mixture was quenched with brine (100 mL), extracted with EtOAc (2 x 100 
mL), the organics combined, dried (MgSO4), rotary evaporated and chromatographed (3 : 7 
Et2O : hexanes to Et2O) to afford diketo-prenylester-dioxinone 140 (301 mg, 86%) as a 
yellow oil:  
Rf 0.50 (2 : 1 Et2O : hexanes);  
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IR (neat) νmax 2934 (w, C-H), 1722 (s, C=O), 1706 (s, C=O), 1636 (m, C=C), 1375 (m), 
1272 (sh.), 1201 (m) cm
-1
;  
HRMS (ESI) calc. for C9H12O4 [M+H]
+
: requires 339.1444, found 339.1440 (Δ –1.2 ppm);  
1
H NMR (500 MHz, C6D6) δ 18.00 (s, 1H, 18), 5.28-5.25 (m, 1H, 14), 5.20 (s, 1H, 2),  4.54 
(d, J = 7.5 Hz, 2H, 13), 3.38 (s, 2H, 7), 2.03 (s, 3H, 11), 1.53 (s, 3H, 17), 1.45 (s, 3H, 16), 
1.31 (s, 6H, 5 & 6);  
13
C NMR (125 MHz, C6D6) δ 195.9 (8), 194.2 (10), 165.9 (1), 164.4 (12), 159.6 (15), 139.6 
(3), 118.7 (14), 108.8 (4), 106.7 (9), 97.3 (2), 61.6 (13), 43.1 (7), 25.6 (17), 25.1 (11), 24.68 
(2C, 5 & 6), 17.77 (16); 
Anal. Calc. for C17H22O7: C, 6.035; H, 6.55. Found: C, 60.43; H, 6.50. 
 
5-(2,2-Dimethyl-4-oxo-4H-1,3-dioxin-6-yl)-6,6-dimethyloct-7-ene-2,4-dione (141), 7-
Hydroxy-2,2,5-trimethyl-8-(3-methylbut-2-enyl)-4H-benzo[d][1,3]dioxin-4-one (142), 3-
Methylbut-2-enyl 7-hydroxy-2,2,5-trimethyl-8-(3-methylbut-2-enyl)-4-oxo-4H-
benzo[d][1,3]dioxine-6-carboxylate (159) and 7-Hydroxy-2,2,5-trimethyl-4H-
benzo[d][1,3]dioxin-4-one (155) 
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Pd(PPh3)4 (164 mg, 142 μmol, 0.1 equiv.) and Cs2CO3 (1.40 g, 4.26 mmol, 3.0 equiv.) were 
stirred in THF (7.1 mL for a concentration of 0.2 M and 100 mL for a concentration of 0.014 
M) at 0 °C, diketo-prenylester-dioxinone 140 (480 mg, 1.42 mmol, 1.0 equiv.) was added and 
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the resulting solution stirred for 3 h. The reaction mixture was quenched with a saturated 
aqueous solution of NH4Cl (10 mL), extracted with EtOAc (2 x 50 mL), dried (MgSO4), 
rotary evaporated and chromatographed (1 : 1 : 10 to 1 : 1 : 5 CH2Cl2 : EtOAc : hexanes) to 
afford diketo-dioxinone 141 (42 mg, 10% at 0.2 M, 2 mg, 0.5% at 0.014 M) as a yellow oil, 
prenyl-resorcylate 142 (195 mg, 50% at 0.2 M, 12 mg, 3% at 0.014 M) as a white solid, 
prenylester-prenyl-resorcylate 159 (11 mg, 2% at 0.2 M, 231 mg, 42% at 0.014 M) as a clear 
oil and resorcylate 155
[42]
 (9 mg, 3% at 0.2 M, 121 mg, 41% at 0.014 M) as a colourless oil.  
Diketo-dioxinone 141:  
Rf 0.5 (1 : 1 : 6 EtOAc : CH2Cl2 : hexanes);  
IR (neat) vmax 2979 (w, C-H), 2961 (w, C-H), 1740 (s, C=O), 1395 (w), 1365 (m), 1217 
(sh.), 1222 (m), 1019 (w) cm
-1
;  
HRMS (ESI) calc. for C16H23O5 [M+H]
+: requires 295.1545, found 295.1530 (Δ –5.1 ppm);  
1
H NMR (500 MHz, C6D6) δ 16.0 (br. s, 1H, 17), 5.91 (dd, J = 17.0, 11.0 Hz, 1H, 13), 5.52 
(s, 1H, 2), 5.04 (s, 1H, 9), 4.88 (dd, J = 11.0, 2.0 Hz, 1H, 14a), 4.85 (dd, J = 17.0, 2.0 Hz, 1H, 
14b), 2.60 (s, 1H, 7), 1.50 (s, 3H, 11), 1.27 (s, 6H, 15 & 16), 1.04 (s, 6H, 5 & 6);  
13
C NMR (125 MHz, C6D6) δ 192.1 (8), 188.7 (10), 166.3 (1), 159.8 (3), 145.1 (13), 122.4 
(14), 106.4 (4), 101.7 (9), 97.6 (2), 62.5 (7), 40.4 (12), 25.7 (2C, 15 & 16), 25.3 (2C, 5 & 6), 
23.4 (11). 
 
Prenyl- resorcylate 142:  
m.p. 121-124 °C (pentane);  
Rf 0.55 (1 : 1 : 6 EtOAc : CH2Cl2 : hexanes);  
IR (neat) vmax 3213 (br., O-H), 2998 (w, C-H), 1689 (sh., C=C), 1605 (sh., C=C), 1518 (w, 
C-C), 1378 (w), 1324 (m), 1296 (sh.), 1279 (sh.), 1240 (w), 1167 (m), 1048 (w) cm
-1
;  
HRMS (ESI) calc. for C16H21O4 [M+H]
+
: requires 277.1440, found 277.1437 ( –1.1 ppm);  
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1
H NMR (500 MHz, C6D6) δ 5.94 (s, 1H, 17), 5.63 (s, 1H, 5), 5.29 (app. t of quin., J = 7.0, 
0.5 Hz, 1H, 13), 3.36 (d, J = 7.0 Hz, 2H, 12), 2.70 (s, 3H, 7), 1.65 (d, J = 0.5 Hz, 3H, 16), 
1.58 (d, J = 0.5 Hz, 3H, 15), 1.33 (s, 6H, 10 & 11);  
13
C NMR (125 MHz, C6D6) δ 160.6 (8), 159.8 (4), 156.6 (2), 142.6 (6), 132.6 (14), 122.2 
(13), 113.7 (3), 113.5 (5), 106.0 (1), 104.6 (9), 30.4 (16), 25.5 (2C, 10 & 11), 22.3 (12), 22.2 
(7), 17.8 (15);  
Anal. Calc. for C16H20O4: C, 69.54; H, 7.30. Found: C, 68.01; H, 7.53.   
 
Prenylester-prenyl-resorcylate 159:   
Rf 0.85 (1 : 1 : 6 EtOAc : CH2Cl2 : hexanes);  
IR (neat) vmax 2924 (w, C-H), 1736 (s, C=O), 1654 (w, C=C), 1586 (C-C), 1447 (w), 1376 
(m), 1266 (m), 1034 (w) cm
-1
;  
HRMS (ESI) calc. for C22H29O6 [M+H]
+
: requires 389.1964, found 389.1960 ( –1.0 ppm);  
1
H NMR (500 MHz, C6D6) δ 12.48 (s, 1H, 23), 5.43 (app. t of quin., J = 7.0, 0.5 Hz, 1H, 13), 
5.25 (app. t of quin., J = 7.0, 0.5 Hz, 1H, 19), 4.54 (d, J = 7.0 Hz, 2H, 18), 3.50 (d, J = 7.0 
Hz, 2H, 12), 3.06 (s, 3H, 7), 1.75 (d, J = 0.5 Hz, 3H, 22), 1.65 (d, J = 0.5 Hz, 3H, 16), 1.46 
(d, J = 0.5 Hz, 3H, 21), 1.39 (d, J = 0.5 Hz, 3H, 15), 1.30 (s, 6H, 10 & 11);  
13
C NMR (125 MHz, C6D6) δ 171.9 (8), 165.2 (17), 159.4 (2), 158.5 (4), 147.1 (6), 140.3 
(20), 131.8 (14), 122.1 (13), 118.1 (19), 115.7 (3), 110.8 (5), 107.3 (1), 104.3 (9), 62.6 (18), 
25.8 (2C, 10 & 11), 25.5 (2C, 16 & 22), 22.4 (12), 20.5 (2C, 15 & 21), 17.89 (7). 
 
Resorcylate 155:  
Rf  0.2 (1 : 3 Et2O : hexanes); 
IR (neat) νmax 3328 (br., O-H), 2989 (w, C-H), 1684 (s, C=C), 1615 (s, C=C), 1578 (m, C-
C), 1480 (m), 1654 (m), 1286 (sh.), 1199 (m), 1066 (m) cm
-1
;  
6 Experimental 
205 
 
HRMS (ESI) calc. for C11H13O4 [M+H]
+: requires 209.0814, found 209.0809 (Δ –2.4 ppm);  
1
H NMR (500 MHz, CDCl3) δ 7.56 (s, 1H, 12), 6.37 (s, 1H, 5), 6.22 (d, J = 2.0 Hz, 1H, 3), 
2.58 (s, 3H, 7), 1.66 (s, 6H, 10 & 11);  
13
C NMR (125MHz, CDCl3) δ 165.6 (8), 162.8 (4), 160.5 (2), 146.7 (6), 114.9 (5), 106.2 (1), 
104.9 (9), 102.2 (3), 25.7 (2C, 10 & 11), 22.3 (7);  
Anal. Calc. for C11H13O4: C, 63.45; H, 5.81. Found: C, 63.56; H, 5.92. 
 
Methyl 2,4-dihydroxy-6-methyl-3-(2-methylbut-3-en-2-yl)benzoate (144) 
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Diketo-allylester-dioxinone 141 (20 mg, 66 μmol, 1.0 equiv.) was refluxed in MeOH (2 mL) 
and toluene (5 mL) for 18 h. The resulting mixture was rotary evaporated and 
chromatographed (1 : 7 Et2O : pentane) to afford allyl-resorcylate 144 (12 mg, 80%) as a 
colourless gum:  
Rf 0.85 (1 : 3 : 4 CH2Cl2 : EtOAc : hexanes);  
IR (neat) νmax 2926 (m, C-H), 1739 (s, C=O), 1654 (w, C=C), 1439 (w), 1366 (m), 1217 
(m), 1230 (m) cm
-1
;  
HRMS (ESI) calc. for C14H119O4 [M+H]
+
: requires 251.1283, found 251.1278 (Δ –2.0 ppm);  
1
H NMR (500 MHz, C6D6) δ 13.22 (s, 1H, 16), 7.21 (s, 1H, 15), 6.42 (s, 1H, 5), 6.20 (dd, J = 
17.0, 10.0 Hz, 1H, 11), 5.02 (d, J = 17.0 Hz, 1H, 12a), 4.81 (d, J = 10.0 Hz, 1H, 12b), 3.26 
(s, 3H, 9), 2.28 (s, 3H, 7), 1.62 (s, 6H, 13 & 14); 
13
C NMR (125 MHz, C6D6) δ 173.39 (8), 165.6 (4), 160.4 (2), 150.3 (11), 141.2 (6), 119.8 
(1), 116.2 (3), 113.6 (5), 112.5 (12), 51.2 (9), 30.2 (10), 27.0 (2C, 13 & 14), 24.1 (7). 
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Allyl 2-acetyl-4-(2,2-dimethyl-4-oxo-4H-1,3-dioxin-6-yl)-3-oxobutanoate 153 
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Based on a procedure by Navarro et al.
[82] 
Keto-allylester-dioxinone 102 (700 mg, 2.60 
mmol, 1.0 equiv.) was added to MgCl2 (300 mg, 3.12 mmol, 2.0 equiv.) and pyridine (500 
mg, 0.50 mL, 6.76 mmol, 2.7 equiv.) in CH2Cl2 (50 mL) at 0 °C and stirred for 30 min. 
Acetyl chloride (332 mg, 3.64 mmol, 1.4 equiv.) was added and the resulting solution stirred 
for 1 h at 0 °C. The reaction mixture was quenched with brine (100 mL), extracted with 
EtOAc (2 x 50 mL), the organics combined, dried (MgSO4), rotary evaporated and 
chromatographed (2 : 8 Et2O : hexanes to Et2O) to afford diketo-allylester-dioxinone 153 
(665 mg, 83%) as a yellow oil (665 mg, 83%):  
Rf 0.36 (2 : 1 Et2O : hexanes);  
IR (neat) νmax 2990 (w, C-H), 2870 (w, C-H), 1724 (s, C=O), 1637 (m, C=C), 1564 (m, C-
C), 1270 (sh.), 1074 (sh.) cm
-1
;  
HRMS (ESI) calc. for C15H19O7 [M+H]
+
: requires 311.1131, found 311.1123 ( –2.6 ppm);  
1
H NMR (400 MHz, CDCl3) δ 17.81 (s, 1H, 16), 6.03–5.92 (m, 1H, 14), 5.41–5.30 (m, 3H, 2 
& 15), 4.71 (d, J = 6.0 Hz, 2H, 13), 3.74 (s, 2H, 7), 2.43 (s, 3H, 11), 1.70 (s, 6H, 5 & 6);  
13
C NMR (100 MHz, CDCl3) δ 196.1 (8), 193.8 (10), 165.9 (1), 165.1 (12), 160.7 (3), 131.5 
(14), 119.7 (15), 108.2 (4), 107.2 (9), 96.5 (2), 65.9 (13), 43.2 (7), 25.6 (2C, 5 & 6), 24.9 
(11). 
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8-Allyl-7-hydroxy-2,2,5-trimethyl-4H-benzo[d][1,3]dioxin-4-one (154) and 7-Hydroxy-
2,2,5-trimethyl-4H-benzo[d][1,3]dioxin-4-one (155) 
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Pd(PPh3)4 (37 mg, 32 μmol, 0.1 equiv.) and Cs2CO3 (313 mg, 0.96 mmol, 3.0 equiv.) were 
stirred in THF (3 mL) at 0 °C for 5 min. Diketo-allylester-dioxinone 153 (100 mg, 0.32 
mmol, 1.0 equiv.) in THF (1 mL) was added to the stirring solution which was allowed to 
warm from 0 °C to rt and stirred for 18 h. The mixture was quenched with a saturated 
aqueous solution of NaHCO3 (10 mL), extracted with Et2O (2 x 50 mL), dried (MgSO4), 
rotary evaporated and chromatographed (1 : 20 to 1 : 5 Et2O : hexanes) to afford a mixture of  
allyl-resorcylate 154  and resorcylate 155
[42]
 (44 mg, 60%) in a 1:1 ratio as a white solid:  
Rf  0.2 (1 : 3 Et2O : hexanes); 
Allyl-resorcylate 154: 
IR (neat) νmax 3243 (br., O-H), 2989 (w, C-H), 1710 (m, C=O), 1694 (m, C=C), 1611 (sh. 
C=C), 1591 (m, C-C), 1274 (sh.), 1207 (s), 1126 (m) cm
-1
;
  
HRMS (ESI) calc. for C14H17O4 [M+H]
+
: requires 249.1127, found 249.1120 ( –2.8 ppm);  
1
H NMR (500 MHz, C6D6) δ 5.87-5.79 (m, 1H, 13), 5.73 (s, 1H, 15), 5.00-4.91 (m, 2H, 14), 
4.81 (s, 1H, 3), 3.26 (dt, J = 5.0, 0.5 Hz, 12), 2.68 (s, 3H, 11), 1.30 (s, 6 H, 8 & 9);  
13
C NMR (125 MHz, C6D6) δ 160.2 (10), 159.3 (4), 156.7 (6), 143.1 (2), 135.7 (13), 115.3 
(14), 113.3 (5), 111.7 (3), 106.2 (1), 104.6 (7), 27.1 (12), 25.4 (8 & 9), 22.2 (11). 
 
Resorcylate 155: characterised as described earlier. 
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(E)-3-(But-2-enyloxy)-3-oxopropanoic acid (315) 
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Based on a procedure by Tararov et al.
[74] 
E-crotyl-alcohol (17.2 mL, 208 mmol, 1.5 equiv.) 
and Meldrum’s acid (20.0 g, 139 mmol, 1.0 equiv.) were stirred at 120 °C for 18 h. The 
reaction mixture was poured into a saturated aqueous solution of NaHCO3 (400 mL) and 
washed with EtOAc (3 x 200 mL). The aqueous layer was acidified to pH 3.0 using 1 M HCl 
and extracted with EtOAc (2 x 400 mL). The organics were combined and rotary evaporated 
to afford crotylester-carboxylic acid 315
[191]
 (19.5 g, 89%) as a pale yellow oil: 
Rf  0.42 (1 : 9 MeOH : CH2Cl2);   
IR (neat) νmax 3501 (br., O-H), 2948 (w, C-H), 1731 (sh. C=O), 1378 (m), 1146 (sh.), 965 
(sh.) cm
-1
;
  
MS (CI) [M+NH4]
+
: requires 176, found 176;  
1
H NMR (400 MHz, CDCl3) δ 8.00 (br. s, 1H, 1), 5.80 - 5.91 (m, 1H, 7), 5.57 - 5.66 (m, 1H, 
6), 4.62 (d, J = 7.0 Hz, 2H, 5), 3.44 (s, 2H, 3), 1.74-1.73 (m, 3H, 8);  
13
C NMR (CDCl3, 100 MHz)  169.8 (4), 165.0 (2), 132.1 (7), 124.5 (6), 66.8 (5), 40.1 (3), 
17.8 (8). 
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(E)-But-2-enyl 4-(2,2-dimethyl-4-oxo-4H-1,3-dioxin-6-yl)-3-oxobutanoate (317) 
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Based on a procedure by Navarro et al.
[82] 
Crotylester-carboxylic acid 315 (4.0 g, 25.3 mmol, 
1.0 equiv.) was stirred in CH2Cl2 (20 mL) at 0 °C. Oxalyl chloride (4.40 mL, 50.6 mmol, 2.0 
equiv.) and 4 drops of DMF (cat.) were added and the reaction mixture stirred for 1 h at 0 °C.  
The reaction mixture was rotary evaporated to afford acid chloride 316 as a brown oil which 
was used without further purification.  
n-BuLi in hexanes (63.5 mL, 1.4 M, 88.6 mmol, 3.5 equiv.) and HMDS (18.5 mL, 88.6 
mmol, 3.5 equiv.) was stirred in THF (100 mL) at –78 °C for 20 min. Dioxinone 33 (11.7 
mL, 88.6 mmol, 3.0 equiv.) was added dropwise to the stirring solution which was stirred for 
1 h. Acid chloride 316 in THF (10 mL) was added dropwise to the stirring solution. The 
resulting solution was stirred for 1 h. The reaction mixture was poured into a saturated 
aqueous solution of NH4Cl (250 mL), acidified to pH 3 utilising 1 M HCl and extracted with 
EtOAc (3 x 200 mL). The organics were combined, washed with brine (100 mL), dried 
(MgSO4), rotary evaporated and chromatographed (7 : 3 hexanes : Et2O) to afford diketo-
crotylester-dioxinone 317 (4.0 g, 56%) as a yellow oil:  
Rf  0.32 (2 : 1 Et2O : hexanes);  
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IR (neat) νmax 2945 (w, C-H), 1719 (m, C=O), 1635 (m, C=C), 1272 (sh.), 1201 (sh.), 1015 
(w) cm
-1
;  
HRMS (ESI) calc. for C14H19O6 [M+H]
+: requires 283.1182, found 283.1185 (Δ +1.1 ppm);  
1
H NMR (400 MHz, CDCl3)  5.88-5.79 (m, 1H, 13), 5.62-5.55 (m, 1H, 12), 5.40 (s, 1H, 2), 
4.57 (d, J = 6.0 Hz, 2H, 11), 3.53 (s, 2H, 9), 3.51 (s, 2H, 7), 1.74 (d, J = 6.0 Hz, 3H, 14), 1.71 
(s, 6H, 5 & 6);  
13
C NMR (100 MHz, CDCl3) δ 195.6 (8), 166.2 (1), 163.6 (10), 160.6 (3), 132.7 (13), 124.2 
(12), 107.4 (4), 97.1 (2), 66.5 (11), 49.1 (7), 47.0 (9), 25.0 (2C, 5 & 6), 17.8 (14). 
 
(E)-But-2-enyl 2-acetyl-4-(2,2-dimethyl-4-oxo-4H-1,3-dioxin-6-yl)-3-oxobutanoate (156) 
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Based on a procedure by Navarro et al.
[82] 
Keto-crotylester-dioxinone 317 (500 mg, 1.77 
mmol, 1.0 equiv.) was added to MgCl2 (333 mg, 3.50 mmol, 2.0 equiv.) and pyridine (0.14 
mL, 4.77 mmol, 2.7 equiv.) in CH2Cl2 (20 mL) at 0 °C and stirred for 30 min. Acetyl chloride 
(0.2 mL, 2.66 mmol, 1.5 equiv.) was added to the reaction mixture which was stirred for 1 h 
hour at 0 °C. The reaction mixture was quenched with brine (50 mL), extracted with EtOAc 
(2 x 100 mL), the organics combined, dried (MgSO4), rotary evaporated and 
chromatographed (3 : 7 Et2O : hexanes to Et2O) to afford diketo-crotylester-dioxinone 156 
(260 mg, 46%) as a pale yellow oil:  
Rf 0.40 (2 : 1 hexanes : Et2O);  
IR (neat) νmax 2943 (w, C-H), 1727 (sh., C=O), 1638 (m, C=C), 1564 (m, C-C), 1390 (m), 
1201 (sh.), 1070 (sh.) cm
-1
;  
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HRMS (ESI) calc. for C16H20O7 [M+H]
+: requires 325.1287, found  325.1280 (Δ –2.2 ppm);  
1
H NMR (400 MHz, CDCl3)  17.0 (s, 1H, 17), 5.94-5.58 (m, 1H, 15), 5.99-5.63 (m, 1H, 
14), 5.37 (s, 1H, 2), 4.67 (d, J = 6.0 Hz, 2H, 13), 3.76 (s, 2H, 7), 2.44 (s, 3H, 11), 1.77 (d, J = 
6.0 Hz, 3H, 16), 1.72 (s, 6H, 5 & 6);  
13
C NMR (100 MHz, CDCl3)  195.9 (8), 193.6 (10), 165.2 (1), 132.7 (12), 129.0 (3), 125.3 
(15), 124.4 (14), 96.5 (4), 67.9 (9), 65.9 (2), 53.4 (13), 43.2 (7), 29.4 (2C, 5 & 6), 25.6 (11), 
17.8 (16). 
 
(E)-8-(But-2-enyl)-7-hydroxy-2,2,5-trimethyl-4H-benzo[d][1,3]dioxin-4-one (157) 
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Pd(PPh3)4 (70 mg, 60 μmol, 0.1 equiv.) and Cs2CO3 (606 mg, 1.86 mmol, 3.0 equiv.) were 
stirred in THF (1 mL) for 5 min at 0 °C . Diketo-crotylester-dioxinone 156 (200 mg, 0.62 
mmol, 1.0 equiv.) in THF (1 mL) was added and the reaction was allowed to warm from 0 °C 
to rt and stirred for 18 h.  The reaction mixture was quenched with brine (20 mL), extracted 
with EtOAc (2 x 50 mL), dried (MgSO4), rotary evaporated and chromatographed (1 : 1 
EtOAc : hexanes) to afford crotyl-resorcylate 157 (50 mg, 30%) as a colourless gum:  
Rf 0.45 (1 : 1 : 6 CH2Cl2 : EtOAc : hexanes);  
IR (neat) νmax 3255 (br., O-H), 2995 (w, C-H), 1692 (m, C=C), 1607 (m, C=C), 1592 (w, C-
C), 1452 (m), 1322 (w), 1284 (sh.), 1209 (sh.) cm
-1
;
  
HRMS (ESI) calc. for C15H18O4 [M+H]
+
: requires 263.1283, found 263.1287 ( +1.5 ppm);  
1
H NMR (500 MHz, C6D6) δ 8.21 (s, 1H, 16), 5.95 (s, 1H, 5), 5.50-5.38 (m, 2H, 13 & 14), 
3.27 (d, J = 5.0 Hz, 2H, 12), 3.16 (s, 3H, 7), 1.48-1.49 (m, 3H, 15), 1.31 (s, 6H, 10 & 11);  
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13
C NMR (125 MHz, C6D6) δ 160.5 (8), 159.8 (4), 156.6 (2), 143.0 (6), 126.2 (13), 114.4 (3), 
113.5 (5), 112.6 (14), 106.1 (1), 104.6 (9), 26.0 (12), 25.5 (2C, 10 & 11), 22.2 (7), 17.8 (15). 
 
(R)-5-(2-(Benzyloxy)propyl)-7-hydroxy-2,2-dimethyl-8-(3-methylbut-2-enyl)-4H-
benzo[d][1,3]dioxin-4-one (163), (R)-5-(2-(Benzyloxy)propyl)-7-hydroxy-2,2-dimethyl-
4H-benzo[d][1,3]dioxin-4-one (165) and (R)-5-(2-(benzyloxy)propyl)-7-hydroxy-2,2-
dimethyl-8-(3-methylbut-2-enyl)-4H-benzo[d][1,3]dioxin-4-one (133) 
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Diketo-prenylester-dioxinone 132 (100 mg, 0.21 mmol, 1.0 equiv.), Pd(PPh3)4 (12 mg, 10 
μmol, 5 mol%) and Cs2CO3 (205 mg, 0.63 mmol, 3.0 equiv.) were stirred in THF (15 mL) at 
0 °C for 30 min. The reaction mixture was allowed to warm to rt and stirred for 18 h. The 
reaction mixture was quenched with a saturated aqueous solution of NH4Cl (50 mL), 
extracted with EtOAc (2 x 50 mL), dried (MgSO4), rotary evaporated and chromatographed 
(1 : 1 : 4 CH2Cl2 : EtOAc : hexanes) to afford prenylester-prenyl-resorcylate 163 (35 mg, 
32%) as a colourless oil, resorcylate 365 (24 mg, 33%) as a colourless gum and prenyl-
resorcylate 133 (2 mg, 2%) as a white solid: 
Prenylester-prenyl-resorcylate 163:  
Rf 0.90 (1 : 1 : 6 CH2Cl2 : EtOAc : hexanes);  
25
D][ = –33.3 (c 0.46, CHCl3);  
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IR (neat) vmax 2970 (w, C-H), 1730 (m, C=O), 1655 (w, C=C), 1585 (w, C-H), 1452 (w), 
1376 (m), 1266 (sh.), 1207 (s), 1118 (w), 1042 (w) cm
-1
;
  
HRMS (ESI) calc. for C31H39O7 [M+H]
+
: requires 523.2696, found 523.2701 (Δ +1.0 ppm);  
1
H NMR (500 MHz, CDCl3) δ 11.30 (br. s, 1H, 30), 7.22-7.17 (m, 3H, 16 & 18), 7.10-7.04 
(m, 2H, 17), 5.43 (app. t of quin., J = 7.0, 0.5 Hz, 1H, 21), 5.20 (app. t of quin., J =  7.0, 0.5 
Hz, 1H, 26),  4.80 (d, J = 7.0 Hz, 2H, 20),  4.40 (d, J = 12.0 Hz, 1H, 14), 4.19 (d, J = 12.0 
Hz, 1H, 14), 4.10 (q, J = 7.0, 1H, 12), 3.75 (br. s, 1H, 11a), 3.54 (br. s, 1H, 11b), 3.31 (d, J = 
7.0, 2H, 25), 1.78 (s, 6H, 9 & 10), 1.74 (br. s, 3H, 24), 1.70 (br. s, 3H, 29), 1.62 (br. s, 3H, 
23), 1.53 (br. s, 3H, 28), 1.21 (d, J = 7.0 Hz, 3H, 13);  
13
C NMR (125 MHz, CDCl3) δ 171.3 (7), 163.5 (19), 160.4 (4), 157.8 (2), 146.7 (22), 140.7 
(15), 138.9 (6), 132.2 (27), 128.3 (5), 128.0 (2C, 17), 127.7 (18), 127.3 (2C, 16), 121.2 (21), 
117.5 (26), 115.7 (3), 104.4 (2C, 8 & 1), 76.5 (12), 70.5 (14), 62.7 (20), 36.3 (11), 26.5 (2C, 
9 & 10), 25.8 (24), 24.8 (29), 22.0 (28), 19.9 (23), 18.1 (25), 17.8 (13).  
 
Resorcylate 165:  
Rf 0.4 (1 : 1 : 6 CH2Cl2 : EtOAc : hexanes);  
25
D][ = –3.0 (c 0.3, CHCl3);  
IR (neat) vmax  2971 (w, C-H), 1738 (s, C=O), 1366 (m), 1217 (m) cm
-1
.  
HRMS (ESI) calc. for C20H23O5 [M+H]
+
:  requires 343.1545, found 3431552 (Δ +2.0 ppm);  
1
H NMR (500 MHz, C6D6) δ 7.21-7.19 (m, 2H, 17), 7.13-7.10 (m, 2H, 16), 7.05-7.02 (m, 
1H, 18), 6.28 (d, J = 2.5 Hz, 1H, 5), 6.24 (d, J = 2.5 Hz, 3), 5.74 (s, 1H, 19), 4.47 (d, J = 12.0 
Hz, 1H, 14), 4.30 (d, J = 12.0 Hz, 1H, 14), 3.97-3.91 (m, 1H, 12), 3.48 (dd, J = 12.0, 6.0 Hz, 
1H, 11b), 3.30 (dd, J = 12.0, 3.0 Hz, 1H, 11a), 1.30 (s, 3H, 9 / 10), 1.29 (s, 3H, 9 / 10), 1.26 
(d, J = 6.0 Hz, 13);  
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13
C NMR (125 MHz, C6D6) δ 161.9 (7), 160.2 (4), 159.5 (2), 147.0 (6), 139.7 (15), 128.5 
(2C, 17), 127.5 (18), 127.4 (2C, 16), 115.4 (5), 105.5 (1), 104.7 (8), 102.1 (3), 76.0 (12), 70.9 
(14), 42.3 (11), 25.6 (9 / 10), 25.2 (9 / 10), 20.3 (13).  
 
Prenyl-Resorcylate 133: characterised as described earlier. 
Ethyl 4-(2,2-dimethyl-4-oxo-4H-1,3-dioxin-6-yl)-3-oxobutanoate (318) 
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Based on a procedure by Navarro et al.
[82] 
n-BuLi in hexanes (4.10 mL, 10.2 mmol, 3.1 
equiv.; 2.5 M) was slowly added to HMDS (2.20 mL, 10.6 mmol, 3.2 equiv.) in THF (160 
mL) at –78 °C and stirred for 30 min. Dioxinone 33 (1.30 mL, 10.0 mmol, 3.0 equiv.) was 
added dropwise to the stirring solution which was then allowed to stir for 1 h at –78 °C. Ethyl 
3-chloro-3-oxopropanoate (319) (500 mg, 3.30 mmol, 1.0 equiv.) in THF (10 mL) was added 
dropwise to the stirring solution. The reaction mixture was stirred at –78 oC for a 1 h. The 
reaction mixture was quenched with a saturated aqueous solution of NH4Cl (20 mL), 
acidified to pH 3 utilising 1 M HCl and extracted with EtOAc (3 x 200 mL). The organics 
were combined, washed with brine (100 mL), dried (MgSO4), rotary evaporated and 
chromatographed eluting with (7 : 3 hexanes : Et2O) to afford keto-ethylester-dioxinone 
318
[102]
 (512 mg, 62%) as a yellow oil:  
Rf 0.20 (2 : 1 Et2O : hexanes);  
IR (neat) νmax 2994 (w, C-H), 1720 (s, C=O), 1638 (w, C=C), 1375 (w), 1271 (sh.), 1202 
(sh.), 1015 (w) cm
-1
;  
HRMS (ESI) calc. for C12H17O6 [M+H]
+
: requires 257.1025, found 257.1024 ( –0.4 ppm);  
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1
H NMR (500 MHz, CDCl3) δ 5.36 (s, 1H, 2), 4.22 (q, J = 5.0 Hz, 2H, 11), 3.51 (s, 2H, 9), 
3.50 (s, 2H, 7), 1.71 (s, 6H, 5 & 6), 1.29 (t, J = 5.0 Hz, 3H, 12);  
13
C NMR (125 MHz, CDCl3) δ 195.7 (8), 166.3 (1), 163.5 (10), 160.7 (3), 107.3 (4), 97.1 
(2), 61.8 (11), 49.1 (9), 47.0 (7), 25.0 (2C, 5 & 6), 14.2 (12). 
 
Ethyl 2-acetyl-4-(2,2-dimethyl-4-oxo-4H-1,3-dioxin-6-yl)-3-oxobutanoate (174) 
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Based on a procedure by Navarro et al.
[82] 
Pyridine (0.42 mL, 5.13 mmol, 2.7 equiv.) and 
MgCl2 (450 mg, 4.69 mmol, 2.5 equiv.) were stirred in CH2Cl2 (15 mL) for 2 min at 0 °C for 
2 min. Keto-ethylester-dioxinone 318 (480 mg, 1.90 mmol, 1.0 equiv.) was added in CH2Cl2 
(1.5 mL) and the resulting solution stirred for 30 min. Acetyl chloride (0.21 mL, 2.90 mmol, 
1.5 equiv.) was added dropwise and the mixture stirred at 0 °C for 30 min. The reaction was 
quenched with brine (100 mL), extracted with EtOAc (2 x 200 mL), dried (MgSO4), rotary 
evaporated and chromatographed (1 : 1 : 10 EtOAc : CH2Cl2 : hexanes) to afford diketo-
ethylester-dioxinone 174
[102]
 (451 mg, 80%) as a pale yellow oil:  
Rf 0.80 (2 : 1 : 5 EtOAc : CH2Cl2 : hexanes);  
IR (neat) vmax 2995 (w, C-H), 1725 (s, C=O), 1637 (m, C=C), 1565 (m, C-C), 1373 (sh.), 
1270 (sh.), 1250 (sh.), 1201 (s), 1103 (sh), 1077 (sh.), 901 (w), 810 (w) cm
-1
;  
HRMS (ESI) calc. for C14H19O7 [M+H]
+
: requires 299.1131, found 299.1137 ( +2.0 ppm);  
1
H NMR (500 MHz, CDCl3) δ 18.00 (s, 1H, 15), 5.34 (s, 1H, 2), 4.29 (q, J = 6.0 Hz, 2H, 11), 
3.74 (s, 2H, 7), 2.42 (s, 3H, 14), 1.70 (s, 6H, 5 & 6), 1.35 (t, J = 6.0 Hz, 3H, 12);  
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13
C NMR (125 MHz, CDCl3) δ 195.9 (8), 193.6 (13), 166.2 (1), 165.2 (10), 160.8 (9), 180.5 
(3), 107.2 (4), 96.4 (2), 61.1 (11), 43.2 (7). 25.6 (14), 24.9 (2C, 5 & 6), 14.2 (12). 
 
Ethyl 8-allyl-7-hydroxy-2,2,5-trimethyl-4-oxo-4H-benzo[d][1,3]dioxine-6-carboxylate 
(177) 
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Diketo-ethylester-dioxinone 174 (96 mg, 0.32 mmol, 1.0 equiv.) and allyl chloride (29 μL, 
0.35 mmol, 1.1 equiv.) were stirred in THF (1.6 mL) at 0 °C. Pd(PPh3)4 (37 mg, 32 μmol, 0.1 
equiv.) was added followed by Cs2CO3 (105 mg, 0.32 mmol, 1.0 equiv.) and the resulting 
solution stirred for 1 h. The reaction was quenched with a saturated aqueous solution of 
NH4Cl (20 mL), extracted with Et2O (2 x 20 mL), the organics combined, dried (MgSO4), 
rotary evaporated and chromatographed (1 : 9 Et2O : pentane) to afford allyl-resorcylate 
177
[102] (90 mg, 88%) as a white solid:  
m.p. = 42-45 °C (hexanes) 
Rf 0.65 (Et2O : pentane 3 : 9);  
HRMS (ESI) calc. for C17H21O6 [M+H]
+
: requires 321.1338, found 321.1349 ( +3.4 ppm);  
IR vmax 2987 (w, C-H), 1730 (m, C=O), 1653 (m, C=C), 1583 (w, C-C), 1377 (w), 1264 (m), 
1233 (s), 1208 (sh.), 1028 (m), 1013 (m), 901 (w) cm
−1
;  
1
H NMR (C6D6, 400 MHz) δ 12.53 (s, 1H, 18), 6.03-5.93 (m, 1H, 13), 5.14-5.09 (m, 1H, 
14a), 5.02-4.98 (m, 1H, 14b), 3.82 (q, J = 6.0 Hz, 2H, 16), 3.46 (dt, J = 8.0, 0.5 Hz, 2H, 12), 
2.99 (s, 3H, 7), 1.29 (s, 6H, 10 & 11), 0.81 (t, J = 6.0 Hz, 3H, 17);  
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13
C NMR (C6D6, 100 MHz) δ 171.4 (15), 165.3 (8), 159.4 (2), 158.7 (4), 147.6 (6), 135.0 
(13), 115.3 (14), 113.8 (3), 110.6 (5), 107.2 (1), 104.4 (9), 62.0 (16), 27.2 (12), 25.4 (2C, 10 
& 11), 20.5 (7), 13.7 (17).  
 
2,2-Dimethyl-6-(2-oxopropyl)-4H-1,3-dioxin-4-one (178) 
O
1
2
3
O4
5 6
O
7
8 9
O
178  
Based on a procedure by Navarro et al.
[82] 
n-BuLi in hexanes (1.6 M; 29.0 mL, 46.4 mmol, 
1.1 equiv.) and HMDS (9.7 mL, 46.4 mmol, 1.1 equiv.) were stirred in THF (50mL) at –78 
°C for 30 min. Dioxinone 33 (6.0 g, 5.6 mL, 42.2 mmol, 1.0 equiv.) was added dropwise to 
the stirring solution and the resulting reaction mixture was stirred for 1 h. Acetyl chloride 
(1.8 mL, 25.3 mmol, 0.6 equiv.) was added dropwise and the resulting solution stirred for 3 h. 
The reaction mixture was poured into a saturated aqueous solution of NH4Cl and 1 M HCl (1 
: 1, 100 mL) and stirred for 30 min at rt. The pH was adjusted to pH 2 using 1 M HCl and the 
aqueous was extracted with Et2O (2 x 250mL). The organics were combined, dried (MgSO4), 
rotary evaporated and chromatographed (2 : 1 to 1 : 1 hexanes : Et2O) to afford keto-
dioxinone 178
[82]
 (900 mg, 22%) as a pale yellow solid: 
m.p. 47 – 50 °C (pentane);  
Rf 0.30 (2 : 1 Et2O : hexanes);  
IR (neat) νmax 2997 (w, C-H), 1721 (sh., C=O), 1637 (m, C=C), 1376 (sh.), 1272 (sh.), 1201 
(sh.), 1012 (w) cm
-1
;  
MS (CI) [M+H]
+
: requires 185, found 185;  
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1
H NMR (400 MHz, CDCl3) δ 5.36 (s, 1H, 2), 3.37 (s, 2H, 7), 2.26 (s, 3H, 9), 1.73 (s, 6H, 5 
& 6);  
13
C NMR (100 MHz, CDCl3) δ 200.9 (8), 164.3 (1), 160.6 (3), 107.2 (4), 96.7 (2), 48.0 (7), 
30.2 (9), 25.0 (5 & 6). 
 
4-(2,2-Dimethyl-4-oxo-4H-1,3-dioxin-6-yl)-1-phenylbutane-1,3-dione (179) 
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n-BuLi in hexanes (2.5 M, 3.6 mL, 8.4 mmol, 2.0 equiv.) was added dropwise with stirring to 
i-Pr2NH (1.2 mL, 8.4 mmol, 2.0 equiv.) in THF (20 mL) at –78 °C and the resulting solution 
stirred for 20 min. Keto-dioxinone 178 (0.74 g, 4.0 mmol, 1.0 equiv.) in THF (2.0 mL) was 
added dropwise and the mixture stirred for 40 min. Et2Zn in hexanes (1.0 M, 8.4 mL, 8.4 
mmol, 2.4 equiv.) was added slowly and after 20 min, the reaction mixture was allowed to 
warm to –20 °C. N-Methoxy-N-methylbenzamide (182) (0.33 g, 2.0 mmol, 0.5 equiv.) in 
THF (3.0 mL) was added and the mixture stirred at –10 °C for 2 h. The reaction was 
quenched with a saturated aqueous solution of NH4Cl (30 mL) and 1.0 M HCl (10 mL) and 
the aqueous layer acidified to pH 2 using 1.0 M HCl. The product was extracted with EtOAc 
(2 x 50 mL), the organics combined, dried (MgSO4), rotary evaporated and chromatographed 
(5: 1 to 2 : 1 hexanes : EtOAc) to afford diketo-phenyl-dioxinone 179 (0.44 g, 76%) as a pale 
yellow solid:  
m.p. 59 - 60 °C (hexanes);  
Rf 0.71 (1 : 1 EtOAc : hexanes);  
IR (neat) vmax 2988 (w, C-H), 1725 (sh., C=O), 1602 (m, C=C), 1571 (m, C-C), 1456 (w), 
1373 (sh.), 1252 (m), 1017 (m), 927 (w) cm
-1
;
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HRMS (ESI) calc. for C16H17O5 [M+H]
+
: requires 289.1076, found 289.1086 (Δ +3.4 ppm);  
1
H NMR (CDCl3, 400 MHz)  15.73 (s, 1H, 15), 7.87 (d, J = 7.5 Hz, 2H, 12),  7.57 (t, J = 7.5 
Hz, 1H, 14), 7.47 (t, J = 7.5 Hz, 2H, 13),  6.21 (s, 1H, 9), 5.45 (s, 1H, 2), 3.36 (s, 2H, 7), 1.71 
(s, 6H, 5 & 6);  
13
C NMR (CDCl3, 100 MHz)  190.2 (8), 182.4 (10), 165.0 (1), 160.7 (3), 133.7 (11), 132.9 
(14), 128.8 (2C, 13), 127.0 (2C, 12), 107.2 (4), 96.5 (9), 96.4 (2), 44.1 (7), 24.9 (2C, 5 & 6). 
 
8-Allyl-7-hydroxy-2,2-dimethyl-5-phenyl-4H-benzo[d][1,3]dioxin-4-one (181) 
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Allyl acetate (69 mg, 0.69 mmol, 1.0 equiv.) and Pd(PPh3)4 (20 mg, 17 μmol, 2.5 mol%) 
were stirred in THF (3.5 mL) at rt for 2 min. Diketo-phenyl-dioxinone 179 (200 mg, 0.69 
mmol, 1.0 equiv.) was added in THF (0.5 mL) and the resulting solution stirred for 2 h. After 
consumption of the starting material by TLC, Cs2CO3 (678 mg, 2.07 mmol, 3.0 equiv.) was 
added and stirring continued for 12 h. The reaction was quenched with a saturated aqueous 
solution of NH4Cl (20 mL), extracted with EtOAc (2 x 30 mL), the organics combined, dried 
(MgSO4), rotary evaporated and chromatographed (1 : 9 EtOAc : hexanes) to give allyl-
resorcylate 181 (148 mg, 69%) as a white solid:  
m.p. 72 - 75 °C (pentane);  
Rf 0.55 (1 : 3 EtOAc : hexanes);  
IR (neat) vmax 3016 (m, C-H), 2970 (m, C-H), 1740 (s, C=O), 1435 (w), 1366 (m), 1228 
(sh.), 1206 (sh.) cm
-1
; 
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HRMS (ESI) calc. for C19H18O4 [M+H]
+: requires 311.1283, found 311.1280 (Δ –1.0 ppm);  
1
H NMR (CDCl3, 400 MHz)  7.85-7.83 (m, 2H, 16), 7.55 (t, J = 7.5 Hz, 1H, 17), 7.47 (t, J = 
7.5 Hz, 2H, 15),  6.21 (s, 1H, 18), 5.67-60 (m, 1H, 12), 5.51 (s, 1H, 5), 5.17 (br. s, 1H, 13a), 
5.15 (br. s, 1H, 13b), 2.64 (d, J = 6.0 Hz, 2H, 11), 1.65 (s, 6H, 9 & 10);  
13
C NMR (CDCl3, 100 MHz)  170.8 (7), 160.9 (2), 135.2 (4), 133.7 (6), 132.7 (14), 131.3 
(12), 128.8 (2C, 16), 126.9 (2C, 15), 120.0 (17), 115.9 (13), 106.8 (3), 95.6 (5 / 8), 95.1 (5 / 
8), 94.2 (1), 35.2 (11), 25.0 (2C, 9 & 10). 
 
1-(1H-Benzo[d][1,2,3]triazol-1-yl)-3-methylbut-2-en-1-one (208) 
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Based on a procedure by Navarro et al.
[82]
 Benzotriazole (19.0 g, 160 mmol, 3.2 equiv.) was 
stirred in CH2Cl2 (260 mL) for 5 min. Thionyl chloride (3.6 mL, 50 mmol, 1.0 equiv.) was 
added to the mixture which was stirred for 1 h. 3-Methylbut-2-enoic acid (209) (5.0 g, 50 
mmol, 1.0 equiv.) was added in CH2Cl2 (100 mL) quickly into the stirring mixture which was 
then stirred for 18 h. The reaction mixture was filtered, the filtrate rotary evaporated, the 
resulting oil suspended in CH2Cl2 (500 mL), washed with buffer pH 9 (4 x 250 mL), water (2 
x 100 mL) and then brine (300 mL). The organics were combined, dried (MgSO4) and rotary 
evaporated to afford benzotriazole amide 208
[192]
 (7.0 g, 70%) as an off white solid:  
m.p. 97 - 98 °C (CH2Cl2 : hexanes);  
Rf  0.60 (1 : 7 EtOAc : hexanes);  
IR (neat) νmax 2979 (w, C-H), 1740 (s, C=O), 1623 (m, N-H), 1449 (sh.), 1222 (sh.), 1067 
(w) cm
-1
;  
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HRMS (ESI) calc. for C11H12N3O [M+H]
+
: requires  202.0982, found 202.0980 (Δ +1.0 
ppm);  
1
H NMR (400 MHz, MeOD) δ 8.38 (d, J = 8.0 Hz, 1H, 11 / 8), 8.13 (d, J = 8.0 Hz, 1H, 11 / 
8), 7.74-7.71 (m, 1H, 9 / 10), 7.60-7.56 (m, 1H, 9 / 10), 4.92 (s, 1H, 4), 2.45 (s, 3H, 2), 2.20 
(s, 3H, 1);  
13
C NMR (100 MHz, MeOD) δ 166.2 (5), 164.5 (3), 147.3 (7), 132.8 (6), 131.3 (10), 127.3 
(9), 120.7 (8), 115.7 (4), 115.4 (11), 28.5 (2), 21.7 (1);  
Anal. Calc. for C11H11ON3: C, 65.66; H, 5.51; N, 20.88. Found: C, 65.54; H, 5.48; N, 20.79. 
 
t-Butyl 5-methyl-3-oxohex-4-enoate (200) 
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i-Pr2NH (10.0 mL, 71.1 mmol, 2.2 equiv.) was added into THF (200 mL) followed by the 
addition of n-BuLi in hexanes (27.1 mL, 2.5 M, 67.8 mmol, 2.1 equiv.) and the resulting 
mixture was stirred for 30 min at –78 °C. t-Butylacetate (8.7 mL, 64.6 mmol, 2.0 equiv.) was 
added and the mixture stirred for 1 h. Benzotriazole amide 208 (6.5 g, 32.3 mmol, 1.0 equiv.) 
in THF (20 mL) was added and the mixture was allowed to warm to rt and stirred for 18 h. 
The reaction mixture was quenched with a saturated aqueous solution of NH4Cl (200 mL), 
acidified to pH 2 using 1 M HCl and extracted with EtOAc (2 x 150 mL). The organics were 
combined, dried (MgSO4), rotary evaporated and chromatographed (1 : 9 EtOAc : hexanes) 
to give t-butyl ester-keto-olefin 200
[115]
 (9.0 g, 70%) as an orange oil:  
Rf  0.60 (1 : 7 EtOAc : hexanes);  
IR (neat) νmax 2979 (w, C-H), 2933 (w, C-H), 1731 (m, C=O), 1688 (m, C=C), 1620 (m, 
C=O), 1254 (w), 1142 (w) cm
-1
;  
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HRMS (CI) calc. for C11H22NO3 [M+NH4]
+
: requires 216.1602, found 216.1600 (Δ +0.9 
ppm);  
1
H NMR (400 MHz, CDCl3) δ 6.14 (s, 1H, 4), 3.37 (s, 2H, 6), 2.19 (s, 3H, 2), 1.94 (s, 3H, 1), 
1.49 (s, 9H, 9);  
13
C NMR (125 MHz, CDCl3) δ 192.5 (5), 167.1 (7), 157.7 (3), 122.8 (4), 81.5 (8), 52.0 (6), 
28.0 (3C, 9), 27.7 (2), 21.0 (1). 
 
5-Hydroxy-N-methoxy-N-methylpentanamide (215) 
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Based on a procedure by Flick et al.
[118] 
Weinreb amide hydrochloride salt (22 .0g, 22.5 
mmol, 15.0 equiv.) was stirred in CH2Cl2 (5 mL) at 0 
o
C for 5 min. AlCl3 in CH2Cl2 (12.5 
mL, 1.8 M, 22.5 mmol, 15.0 equiv.) was added dropwise and the mixture stirred for 20 min. 
Tetrahydro-2H-pyran-2-one (216) (1.40 mL, 14.9 mmol, 1.5 equiv.) was added dropwise to 
the stirring solution which was then stirred for 20 min at 0 °C. The mixture was dried 
(MgSO4) and rotary evaporated to afford amide 215
[191] (1.11 g, 50%) as a colourless oil:  
Rf 0.20 (EtOAc);  
IR (neat) vmax 3399 (br., O-H), 2969 (w, C-H), 2941 (m, C-H), 2871 (m, C-H), 1736 (s, 
C=O), 1637 (s), 1419 (m), 1382 (m), 1228 (m), 1203 (sh.), 1179 (sh.), 1068 (w) cm
-1
; 
HRMS (ESI) calc. for C7H16NO3 [M+H]
+
: requires 162.1130, found 162.1123 (Δ –4.3 ppm);  
1
H NMR (400 MHz, CDCl3) δ 3.68 (s, 3H, 2), 3.64 (t, J = 8.0 Hz, 2H, 7), 3.18 (s, 3H, 1), 
2.47 (t, J = 8.0 Hz, 2H, 4), 1.74 (quin., J = 8.0 Hz, 2H, 5), 1.64-1.58 (m, 2H, 6);  
13
C NMR (100 MHz, CDCl3) δ 174.6 (3), 62.1 (2), 61.2 (7), 32.3 (2C, 1 & 4), 31.3 (6), 20.3 
(5);  
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Anal. Calc. for C7H15NO3: C, 52.16; H, 9.38; N, 8.69. Found: C, 52.17; H, 9.37; N, 8.62. 
 
N-Methoxy-N-methyl-5-(triethylsilyloxy)pentanamide (217) 
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Alcohol 215 (6.10 g, 37.9 mmol, 1.0 equiv.) was stirred in CH2Cl2 (130 mL) and imidazole 
(2.84 g, 41.7 mmol, 1.1 equiv.) was added followed by TESCl (6.40 mL, 37.9 mmol, 1.0 
equiv.) dropwise at 0 °C, the resulting mixture was then stirred for 1 h. The reaction was 
quenched with H2O (100 mL), extracted with CH2Cl2 (2 x 200 mL), washed with brine (100 
mL), the organics combined, dried (MgSO4), rotary evaporated and chromatographed (2 : 6 to 
1 : 1 EtOAc : hexanes) to afford silylether 217 (6.7 g, 70%) as a colourless oil:  
Rf  0.5 (2 : 6 EtOAc : hexanes);  
IR (neat) vmax 2911 (w, C-H), 2876 (m, C-H), 1739 (m, C=O), 1668 (s), 1459 (m), 1414 (m), 
1381 (sh.), 1320 (w), 1231 (w), 1216 (w), 1177 (sh.) cm
-1
;  
HRMS (ESI) calc. for C13H30NO3Si [M+H]
+
: requires 276.1995, found 276.1998 (Δ +1.1 
ppm);  
1
H NMR (400 MHz, CDCl3) δ 3.70 (s, 3H, 2), 3.65 (t, J = 8.0 Hz, 2H, 7), 3.20 (s, 3H, 1), 
2.47 (t, J = 8.0 Hz, 2H, 4), 1.75-1.68 (m, 2H, 5), 1.64-1.57 (m, 2H, 6), 0.98 (t, J = 7.0 Hz, 9H, 
9), 0.62 (q, J = 7.0 Hz, 6H, 8);   
13
C NMR (125 MHz, CDCl3) δ 174.5 (3), 62.6 (2), 61.1 (7), 32.5 (2C, 1 & 4), 31.7 (6), 21.1 
(5), 6.76 (3C, 9), 4.4 (3C, 8);  
Anal. Calc. for C13H29NO3Si: C, 56.68; H, 10.61; N, 5.08. Found: C, 56.79; H, 10.70; N, 
5.02. 
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6-(Triethylsilyloxy)hexan-2-one (214) 
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Based on a procedure by Zanardi et al.
[117] 
Amide 217 (6.70 g, 24.3 mmol, 1.0 equiv.) was 
stirred in THF (120 mL) at –78 °C, MeLi in hexanes (16.2 mL, 24.3 mmol, 1.5 M, 1.0 equiv.) 
was added dropwise to the stirring solution which was then stirred for 1 h. The reaction was 
quenched with water (150 mL), extracted with EtOAc (2 x 200mL), the organics combined, 
dried (MgSO4), rotary evaporated and chromatographed (2 : 8 EtOAc : hexanes) giving 
ketone 214
[193]
 (4.0 g, 73%) as a colourless oil:  
Rf  0.81 (1 : 1 EtOAc : hexanes);  
IR (neat) vmax 2953 (m, C-H), 2911 (m, C-H), 2876 (m, C-H), 1717 (sh. C=O), 1459 (w), 
1414 (w), 1358 (w), 1237 (w), 1006 (sh.) cm
-1
;  
HRMS (ESI) calc. for C12H27O2Si [M+H]
+: requires 231.1780, found 231.1777 (Δ –1.3 
ppm);  
1
H NMR (400 MHz, CDCl3) δ 3.64 (t, J = 6.0 Hz, 2H, 6), 2.49 (t, J = 6.0 Hz, 2H, 3), 2.70 (s, 
3H, 1), 1.70-1.60 (m, 2H, 5), 1.59-1.52 (m, 2H, 4), 0.98 (t, J = 7.0 Hz, 9H, 8), 0.62 (q, J = 7.0 
Hz, 6H, 7);  
13
C NMR (125 MHz, CDCl3) δ 209.0 (2), 62.5 (6), 43.5 (3), 32.2 (5), 29.8 (1), 20.3 (4), 6.8 
(3C, 8), 4.4 (3C, 7);  
Anal. Calc. for C12H26O2Si: C, 62.04; H, 10.41. Found: C, 62.17; H, 10.37. 
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(E)-Ethyl 3-methyl-7-(triethylsilyloxy)hept-2-enoate (E-213) and (Z)-Ethyl 3-methyl-7-
(triethylsilyloxy)hept-2-enoate (Z-213) 
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Based on a procedure by Joullié et al.
[107]
 Diethyl 2-oxobutylphosphonate 218 (1.1 mL, 5.4 
mmol, 1.5 equiv.) was stirred in THF (20 mL) and NaH (232 mg (60% suspension in oil), 5.8 
mmol, 1.6 equiv.) was added at 0 °C for 45 min. Ketone 214 (1.0 g, 3.6 mmol, 1.0 equiv.) in 
THF (5 mL) was added dropwise and the mixture stirred at rt for 6 h. The mixture was 
quenched with H2O (50 mL), extracted with Et2O (2 x 100 mL), dried (MgSO4), rotary 
evaporated and chromatographed (2 : 8 to 1 : 1 EtOAc : hexanes) giving (E)-olefin E-213 and 
(Z)-olefin Z-213 in a 3 : 1 ratio (1.04 g, 98%) as a colourless oil:  
Rf  0.85 (1 : 1 EtOAc : hexanes);  
IR (neat) vmax 2952 (m, C-H), 2937 (w, C-H), 2876 (m, C-H), 1717 (sh., C=O), 1649 (w, 
C=C), 1459 (w), 1416 (w), 1221 (sh.), 1144 (sh.), 1095 (sh.), 1007 (w) cm
-1
;  
HRMS (ESI) calc. for C16H33O3Si [M+H]
+: requires 301.2199, found 301.2201 (Δ +0.7 
ppm). 
 
(E)-Olefin E-213:  
1
H NMR (400 MHz, C6D6) δ 5.82-5.81 (m, 1H, 4), 4.04 (q, J = 7.0 Hz, 2H, 2), 3.46-3.43 (m, 
2H, 10), 2.20 (s, 3H, 6), 1.83 (t, J = 7.0 Hz, 2H, 7), 1.38-1.35 (m, 4H, 8 & 9), 1.03-0.98 (m, 
12H, 1 & 12), 0.63-0.56 (m, 6H, 11);  
13
C NMR (125 MHz, C6D6) δ 166.4 (3), 159.4 (5), 116.3 (4), 62.5 (10), 59.3 (2), 40.6 (7), 
32.6 (9), 23.9 (8), 18.6 (6), 14.4 (1), 7.1 (3C, 12), 4.8 (3C, 11). 
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(Z)-Olefin Z-213:  
1
H NMR (400 MHz, C6D6) δ 5.75 (br. s, 1H, 4), 4.03-4.01 (m, 2H, 2), 3.58 (t, J = 7.0 Hz, 
2H, 10), 2.76 (t, J = 7.0 Hz, 2H, 7), 2.20 (s, 3H, 6), 1.60-1.58 (m, 2H, 9), 1.36-1.34 (m, 2H, 
8), 1.03-0.98 (m, 12H, 1 & 12), 0.63-0.56 (m, 6H, 11);  
13
C NMR (125 MHz, C6D6) δ 166.4 (3), 160.2 (5), 116.9 (4), 62.7 (10), 59.3 (2), 40.6 (7), 
33.1 (9), 24.8 (8), 18.6 (6), 14.4 (1), 7.1 (3C, 12), 4.8 (3C, 11). 
 
(E)-3-Methyl-7-(triethylsilyloxy)hept-2-en-1-ol (E-219) and (Z)-3-Methyl-7-
(triethylsilyloxy)hept-2-en-1-ol (Z-219) 
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A mixture of (E)-olefin E-213 and (Z)-olefin Z-213 in a 3 : 1 ratio (500 mg, 1.67 mmol, 1.0 
equiv.) was stirred in CH2Cl2 (15 mL) at –78 °C. DIBAL in CH2Cl2 (5.0 mL, 1 M, 5.0 mmol, 
3.0 equiv.) was added dropwise and the mixture stirred for 2 h. The reaction was poured into 
a saturated aqueous solution of Rochelle’s salt (50 mL) and MeOH (1 : 1 200 mL). The 
aqueous layer was extracted with EtOAc, dried (Na2SO4), rotary evaporated and 
chromatographed (1 : 1 EtOAc : hexanes) to give (E)-olefin-alcohol E-219 and (Z)-olefin-
alcohol E-219 in a 3 : 1 ratio (267 mg, 63%) as a colourless oil:  
Rf 0.70 (2 : 1 EtOAc : hexanes);  
IR (neat) vmax 3326 (br., O-H), 2936 (m, C-H), 2911 (m, C-H), 2876 (m, C-H), 1669 (w, 
C=C), 1458 (w), 1238 (w), 1096 (w), 1003 (sh.) cm
-1
;  
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HRMS (ESI) calc. for C14H31O2Si [M+H]
+: requires 259.2093, found 259.2094 (Δ +0.4 
ppm). 
 
(E)-Olefin-alcohol E-219:  
1
H NMR (400 MHz, CDCl3) δ 5.42-5.39 (m, 1H, 3), 4.15 (d, J = 7.0 Hz, 2H, 2), 3.60 (t, J = 
8.0 Hz, 2H, 9), 2.03 (t, J = 8.0 Hz, 2H, 6), 1.66 (s, 3H, 5), 1.55-1.42 (m, 4H, 7 & 8), 1.17 (br. 
s, 1H, 1), 0.95 (t, J = 7.0 Hz, 9H, 11), 0.59 (q, J = 7.0 Hz, 6H, 10);  
13
C NMR (100 MHz, CDCl3) δ 139.9 (4), 123.4 (3), 62.7 (9), 59.4 (2), 39.3 (6), 32.4 (8), 
23.8 9 (7), 16.1 (5), 6.8 (3C, 11), 4.4 (3C, 10).  
 
(Z)-Olefin-alcohol Z-219:  
1
H NMR (400 MHz, CDCl3) δ 5.44-5.39 (m, 1H, 3), 4.14 (d, J = 7.0 Hz, 2H, 2), 3.60 (t, J = 
8.0 Hz, 2H, 9), 2.09 (t, J = 8.0 Hz, 2H, 6), 1.73 (s, 3H, 5), 1.55-1.42 (m, 4H, 7 & 8), 1.17 (br. 
s, 1H, 1), 0.95 (t, J = 7.0 Hz, 9H, 11), 0.59 (q, J = 7.0 Hz, 6H, 10);
  
13
C NMR (100 MHz, CDCl3) δ 139.9 (4), 123.4 (3), 62.7 (9), 59.4 (2), 39.3 (6), 32.4 (8), 
23.8 9 (7), 16.1 (5), 6.8 (3C, 11), 4.4 (3C, 10). 
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(E)-13,13-Diethyl-2,2,3,3,7-pentamethyl-4,12-dioxa-3,13-disilapentadec-6-ene (E-212) 
and (Z)-13,13-Diethyl-2,2,3,3,7-pentamethyl-4,12-dioxa-3,13-disilapentadec-6-ene (Z-
212) 
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A mixture of (E)-olefin-alcohol E-219 and (Z)-olefin-alcohol Z-219 in a 3 : 1 ratio (267 mg, 
1.03 mmol, 1.0 equiv.) were added to a solution of imidazole (84 mg, 1.24 mmol, 1.2 equiv.) 
and TBSCl (171 mg, 1.13 mmol, 1.1 equiv.) in DMF (1 mL) and stirred at rt for 12 h. The 
reaction mixture was quenched with H2O (100 mL) and extracted with a mixture of pentane 
and CH2Cl2 (9 : 1, 2 x 200 mL). The organics were combined, dried (MgSO4), rotary 
evaporated and chromatographed (1 : 9 Et2O : pentane) to afford (E)-olefin-silylether E-212 
and (Z)-olefin-silylether Z-212  in a 3 : 1 ratio (350 mg, 92%) as a colourless oil:  
Rf 0.82 (1 : 9 EtOAc : hexanes);  
IR (neat) vmax 2952 (m, C-H), 2932 (m, C-H), 2877 (m, C-H), 2858 (m, C-H), 1670 (w, 
C=C), 1461 (w), 1381 (w), 1252 (sh.), 1089 (s) cm
-1
;
  
HRMS (CI) calc. for C20H48NO2Si2 [M+NH4]
+: requires 390.3234, found 390.3216 (Δ –2.0 
ppm);  
 
(E)-Olefin-silylether E-212: 
1
H NMR (400 MHz, CDCl3) δ 5.31-5.28 (m, 1H, 5), 4.17 (d, J = 7.0 Hz, 2H, 4), 3.60 (t, J = 
8.0 Hz, 2H, 11), 2.05 (t, J = 8.0 Hz, 2H, 8), 1.61 (s, 3H, 7), 1.54-1.39 (m, 4H, 9 & 10), 0.95 
(t, J = 7.0 Hz, 9H, 13), 0.90 (s, 9H, 1), 0.60 (q, J = 7.0 Hz, 6H, 12), 0.06 (s, 6H, 3);  
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13
C NMR (100 MHz, CDCl3) δ 137.0 (6), 124.4 (5), 62.8 (11), 60.3 (4), 39.3 (8), 32.5 (10), 
26.0 (3C, 1), 23.3 (9), 18.43 (2), 16.2 (7), 6.8 (3C, 13), 4.4 (3C, 12), –5.1 (2C, 3).  
 
(Z)-Olefin-silylether Z-212: 
1
H NMR (400 MHz, CDCl3) δ 5.33-5.31 (m, 1H, 5), 4.15 (d, J = 7.0 Hz, 2H, 4), (t, J = 8.0 
Hz, 2H, 11), 2.03 (t, J = 8.0 Hz, 2H, 8), 1.59 (s, 3H, 7), 1.54-1.39 (m, 4H, 9 & 10), 0.95 (t, J 
= 7.0 Hz, 9H, 13), 0.90 (s, 9H, 1), 0.60 (q, J = 7.0 Hz, 6H, 12), 0.06 (s, 6H, 3);  
13
C NMR (100 MHz, CDCl3) δ 137.7 (6), 125.1 (5), 63.1 (11), 59.9 (4), 39.3 (8), 32.7 (10), 
26.0 (3C, 1), 24.4 (9), 18.43 (2), 16.2 (7), 6.8 (3C, 13), 4.4 (3C, 12), –5.1 (2C, 3). 
 
(E)-7-(t-Butyldimethylsilyloxy)-5-methylhept-5-enal (E-220) and (Z)-7-(t-
Butyldimethylsilyloxy)-5-methylhept-5-enal (Z-220) 
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Based on a procedure by Zanoni et al.
[116] 
DMSO (0.95 ml, 13.4 mmol, 10.0 equiv.) was 
added dropwise to a stirring solution of oxalyl chloride (0.58 ml, 6.70 mmol, 5.0 equiv.) in 
CH2Cl2 (3.35 mL) at –80 °C and stirred for 1 h. A solution of (E)-olefin silylether E-212 and 
(Z)-olefin silylether E-212 in a 3 : 1 ratio (500 mg, 1.34 mmol, 1.0 equiv.) in CH2Cl2 (18 mL) 
was added dropwise and the resulting solution stirred for 2.5 h. The temperature was warmed 
to –35 °C and the reaction mixture stirred for 1.5 h. The mixture was cooled to –80 °C and 
Et3N (2.8 mL, 20.1 mmol, 15.0 equiv.) was added dropwise and the resulting mixture stirred 
for 40 min. The mixture was allowed to warm to rt and quenched with brine (100 ml), 
extracted with EtOAc (2 x 100 ml), the organics combined, dried (MgSO4), rotary evaporated 
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and chromatographed (1 : 8 EtOAc : hexanes to EtOAc) giving  (E)-olefin aldehyde E-220 
and (Z)-olefin aldehyde Z-220 in a 3 : 1 ratio (130 mg, 33%) as a colourless oil:  
Rf 0.65 (1 : 7 EtOAc : hexanes);  
IR (neat) νmax 2930 (m, C-H), 2856 (m, C-H), 1726 (sh., C=O), 1462 (w), 1253 (sh.), 1056 
(s) cm
-1
;  
HRMS (ESI) calc. for C14H29O2Si [M+H]
+: requires 257.1937, found 257.1932 (Δ –1.9 
ppm);  
Anal. Calc. for C14H28O2Si: C, 65.57; H, 11.00. Found: C, 65.46; H, 10.92. 
 
(E)-Olefin-aldehyde E-220: 
1
H NMR (400 MHz, CDCl3) δ 9.76 (t, J = 1.0 Hz, 1H, 12), 5.33-5.30 (m, 1H, 5), 4.18 (d, J = 
8.0 Hz, 2H, 4), 2.41 (dt, J = 8.0, 1.0 Hz, 2H, 10), 2.03 (t, J = 8.0 Hz, 2H, 8), 1.76 (quin., J = 
8.0 Hz, 2H, 9), 1.61 (s, 3H, 7), 0.90 (s, 9H, 1), 0.06 (s, 6H, 3);  
13
C NMR (125 MHz, CDCl3) δ 202.2 (11), 135.6 (6), 125.5 (5), 60.1 (4), 43.1 (10), 38.6 (8), 
25.9 (3C, 1), 20.2 (9), 19.9 (2), 15.9 (7), –5.2 (2C, 3). 
 
(Z)-Olefin-aldehyde Z-220:  
1
H NMR (400 MHz, CDCl3) δ 9.76 (t, J = 1.0 Hz, 1H, 12), 5.35-5.32 (m, 1H, 5), 4.10 (d, J = 
8.0 Hz, 2H, 4), 2.41 (dt, J = 8.0, 1.0 Hz, 2H, 10), 2.04 (t, J = 8.0 Hz, 2H, 8), 1.72-1.70 (m, 
2H, 9), 1.61 (s, 3H, 7), 0.90 (s, 9H, 1), 0.06 (s, 6H, 3);  
13
C NMR (125 MHz, CDCl3) δ 202.0 (11), 136.4 (6), 126.1 (5), 59.6 (4), 43.2 (10), 38.6 (8), 
31.0 (9), 25.9 (3C, 1), 23.1 (2), 20.17 (7), –5.17 (2C, 3).  
 
 
 
6 Experimental 
231 
 
Triethyl(hex-5-ynyloxy)silane (221) 
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Hex-5-yn-1-ol 223 (6.90 mL, 62.7 mmol, 1.0 equiv.) was stirred in CH2Cl2 (186 mL) for 2 
min. Imidazole (4.50 g, 75.2 mmol, 1.2 equiv.) was added followed by TESCl (10.2 mL, 69.0 
mmol, 1.1 equiv.) and the resulting mixture stirred for 3 h. The reaction mixture was 
quenched with H2O (300 mL), extracted with CH2Cl2 (2 x 100 mL), dried (MgSO4), rotary 
evaporated and chromatographed (1 : 15 EtOAc : hexanes) to afford triethyl(hex-5-
ynyloxy)silane (221)
[194] 
as a colourless oil (13.0 g, 95%):  
Rf 0.90 (1 : 1 EtOAc : hexanes);  
IR (neat) νmax 3311 (w, C≡CH), 2954 (m, C-H), 2877 (m, C-H), 1459 (w), 1216 (w), 1237 
(w), 1103 (sh.), 1006 (sh.) cm
-1
; 
HRMS (CI) calc. for C12H25OSi [M+H]
+
:  requires 213.1675, found 213.1677 (Δ +0.9 ppm);  
1
H NMR (400 MHz, CDCl3) δ 3.66 (t, J = 8.0 Hz, 2H, 6), 2.25 (td, J = 8.0, 0.5 Hz, 2H, 3), 
1.97 (t, J = 0.5 Hz, 1H, 1), 1.70-1.58 (m, 4H, 4 & 5), 0.98 (t, J = 7.0 Hz, 9H, 8), 0.62 (q, J = 
7.0 Hz, 6H, 7);  
13
C NMR (100 MHz, CDCl3) δ 84.5 (2), 68.3 (1), 62.3 (6), 31.8 (5), 24.9 (4), 18.2 (3), 6.8 
(3C, 8), 4.4 (3C, 7). 
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(E)-Triethyl(6-iodo-5-methylhex-5-enyloxy)silane (224) and (E)-6-Iodo-5-methylhex-5-
en-1-ol (225) 
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Based on a procedure by Welzel et al.
[122]
 Zirocene dichloride (1.4 g, 4.7 mmol, 1.0 equiv.) 
was stirred in CH2Cl2 (22 mL) at 0 °C. AlMe3 in CH2Cl2 (4.72 mL, 2.0 M, 9.44 mmol, 2.0 
equiv.) was added dropwise and the reaction mixture stirred for 15 min. Alkyne 221 (1.0 g, 
4.7 mmol, 1.0 equiv.) was added in CH2Cl2 (3 mL) and the mixture was allowed to warm to rt 
and stirred for 18 h. Iodine (840 mg, 6.61 mmol, 1.4 equiv.) in THF (4 mL) was added at –18 
°C and the mixture stirred for 5 min. The reaction was quenched with a saturated aqueous 
solution of NH4Cl (8 mL) and a saturated aqueous solution of Na2S2O3 (4 mL), extracted with 
CH2Cl2 (1 x 500 mL), the organics combined, dried (MgSO4), rotary evaporated and 
chromatographed (29 : 1 EtOAc : hexanes) to afford (E)-olefin silylether 224 (170 mg, 10%) 
and (E)-olefin alcohol 225
[195]
 (840 mg, 50%) as colourless oils.  
 
(E)-Olefin-silylether 224:  
Rf 0.9 (1 : 7 EtOAc : hexanes);  
IR (neat) vmax 2952 (m, C-H), 2910 (m, C-H), 2875 (m, C-H), 1457 (m), 1413 (m), 1377 (w), 
1235 (m), 1072 (s), 1003 (s) cm
-1
;
  
HRMS (CI) calc. for C13H28OSiI [M+H]
+: requires 355.0954, found 355.0954 (Δ 0.0 ppm);  
1
H NMR (500 MHz, C6D6) δ 5.69 (sextet, J = 0.5 Hz, 1H, 1), 3.45 (t, J = 7.0 Hz, 2H, 7), 
1.86-1.83 (m, 2H, 4), 1.64 (d, J = 0.5 Hz, 3H, 3), 1.36-1.26 (m, 4H, 5 & 6), 1.0 (t, J = 8.0 Hz, 
9H, 9), 0.60 (q, J = 8.0 Hz, 6H, 8);  
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13
C NMR (500 MHz, C6D6) δ 147.89 (2), 75.13 (1), 62.48 (7), 39.24 (4), 32.42 (6), 24.14 (5), 
23.62 (3), 7.09 (3C, 9), 4.83 (3C, 8);  
Anal. Calc. for C13H27OISi: C, 44.06; H, 7.68. Found: C, 43.94; H, 7.51. 
 
(E)-Olefin-alcohol 225:  
Rf 0.2 (1 : 7 EtOAc : hexanes);  
IR (neat) vmax 3321 (br., O-H), 2934 (s, C-H), 2862 (m, C-H), 1739 (w), 1616 (w, C=C), 
1433 (w), 1375 (m), 1271 (sh.), 1141 (sh.), 1033 (sh.), 1058 (sh.) cm
-1
;  
HRMS (CI) calc. for C7H17NOI [M+NH4]
+: requires 258.0355, found 258.0352 (Δ –1.2 
ppm);  
1
H NMR (500 MHz, C6D6) δ 5.64 (s, 1H, 1), 3.19 (t, J = 6.0 Hz, 2H, 7), 1.76 (t, J = 6.0 Hz, 
2H, 4), 1.61 (s, 3H, 3), 1.11 (quin., J = 6.0 Hz, 4H, 5 & 6);  
13
C NMR (500 MHz, C6D6) δ 147.8 (2), 75.1 (1), 62.2 (7), 39.2 (4), 32.2 (6), 23.9 (5), 23.6 
(3);  
Anal. Calc. for C7H13OI: C, 35.02; H, 5.46. Found: C, 35.01; H, 5.39 
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t-Butyl(hex-5-ynyloxy)diphenylsilane (226) 
1
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Hex-5-yn-1-ol 223 (5.5 mL, 51 mmol, 1.0 equiv.) and imidazole (4.86 g, 71.4 mmol, 1.4 
equiv.) were stirred in CH2Cl2 (150 mL) at 0 °C, TBDPSCl (14.6 mL, 56.1 mmol, 1.1 equiv.) 
was added and the reaction mixture was allowed to warm to rt and stirred for 72 h. The 
reaction was quenched with H2O (300 mL), extracted with CH2Cl2 (2 x 300 mL), the organics 
combined, washed with brine (200 mL), dried (MgSO4), rotary evaporated and 
chromatographed (1 : 99 Et2O : hexanes) affording silylether 226
[196]
 (15.0 g, 88%) as a 
colourless oil:  
Rf 0.95 (1 : 7 EtOAc : hexanes);  
IR (neat) vmax 3309 (w, C≡CH), 2932 (w, C-H), 2858 (w, C-H), 1472 (w), 1427 (sh.), 1106 
(w) cm
-1
;  
HRMS (ESI) calc. for C22H29OSi [M+H]
+
: requires 337.1988, found 337.1997 ( +2.7 ppm);  
1
H NMR (500 MHz, C6D6) δ 7.75-7.73 (m, 4H, 11), 7.23-7.21 (m, 6H, 10 & 12), 3.55 (t, J = 
6.0 Hz, 2H, 6), 1.92 (td, J = 6.0, 1.0 Hz, 2H, 3), 1.74 (t, J = 1.0 Hz, 1H, 1), 1.57-1.51 (m, 2H, 
5), 1.49-1.43 (m, 2H, 4), 1.15 (s, 9H, 8);  
13
C NMR (125 MHz, C6D6) δ 136.0 (6C, 10 & 12), 134.3 (2C, 9), 129.9 (4C, 11), 84.3 (1), 
68.9 (2), 63.6 (6), 31.8 (5), 27.1 (3C, 8), 25.2 (4), 19.4 (7), 18.3 (3);  
Anal. Calc. for C22H28OSi: C, 78.51; H, 8.39. Found: C, 78.61; H, 8.29. 
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(E)-t-Butyl(6-iodo-5-methylhex-5-enyloxy)diphenylsilane (227) 
1 2 3
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Based on a procedure by Welzel et al.
[122] 
Zirocene dichloride (2.6 g, 8.9 mmol, 1.0 equiv.) 
was stirred in CH2Cl2 (45 mL) at 0 °C. AlMe3 in CH2Cl2 (10.0 mL, 1.8 M, 18.0 mmol, 2.0 
equiv.) was added dropwise and the reaction mixture allowed to stir for 15 min. Alkyne 226 
(3.0 g, 8.9 mmol, 1.0 equiv.) was added in CH2Cl2 (10 mL) and the mixture was allowed to 
warm to rt and stirred for 18 h. Iodine (4.5 g, 18.0 mmol, 2.0 equiv.) in THF (60 mL) was 
added at –23 °C and the mixture allowed to warm to 0 °C and stirred for 15 min. The reaction 
was quenched with a saturated aqueous solution of NH4Cl (15 mL) and a saturated aqueous 
solution of Na2S2O3 (8 mL) and extracted with CH2Cl2 (2 x 200 mL). The organics were 
combined, dried (MgSO4), rotary evaporated and chromatographed (1 : 99 Et2O : hexanes) to 
afford (E)-olefin 227 (2.6 g, 63%) as a colourless oil:  
Rf 0.9 (1 : 7 Et2O : hexanes);  
IR (neat) vmax 2930 (w, C-H), 2857 (w, C-H), 1472 (w), 1427 (sh.), 1105 (s) cm
-1
;  
HRMS (CI) calc. for C23H32OSiI [M+H]
+
: requires 479.1267, found 479.1269 ( +0.4 ppm);  
1
H NMR (500 MHz, CDCl3) δ 7.70-7.65 (m, 4H, 11), 7.44-7.37 (m, 6H, 10 & 12), 5.83 (app. 
sextet, J = 0.5 Hz, 1H, 9),  3.66 (t, J = 6.0 Hz, 2H, 6), 2.19-2.17 (m, 2H, 3), 1.80 (d, J = 0.5 
Hz, 3H, 1), 1.52 (quin., J = 6.0 Hz, 4H, 4 & 5), 1.05 (s, 9H, 8);  
13
C NMR (125 MHz, CDCl3) δ 148.0 (2), 135.6 (4C, 11), 134.0 (2C, 13), 129.6 (4C, 12), 
127.6 (2C, 10), 74.6 (9), 63.5 (6), 39.2 (3), 31.8 (5), 23.9 (3C, 8), 23.9 (4), 23.7 (7), 19.2 (1);  
Anal. Calc. for C23H31IOSi: C, 57.73; H, 6.53. Found: C, 57.89; H, 6.60.   
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(E)-7-(t-Butyldiphenylsilyloxy)-3-methylhept-2-en-1-ol (228) and t-Butyl(5-methylhex-5-
enyloxy)diphenylsilane (229) 
228
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Based on a procedure by Dai et al.
[120]
 Zirocene dichloride (2.6 g, 8.9 mmol, 1.0 equiv.) was 
stirred in CH2Cl2 (45 mL) at 0 °C. AlMe3 in CH2Cl2 (18 mL, 1.0 M, 18 mmol, 2.0 equiv.) 
was added dropwise and the reaction mixture allowed to stir for 15 min. Alkyne 226 (3.0 g, 
8.9 mmol, 1.0 equiv.) was added in CH2Cl2 (10 mL) and the mixture was allowed to warm to 
rt and stirred for 18 h. The reaction mixture was rotary evaporated and the resulting residue 
triturated with hexanes (3 x 20 mL) under an inert atmosphere. The resulting solution was 
cooled to –78 °C and t-BuLi in hexanes (11.3 mL, 1.6 M, 18.0 mmol, 2.0 equiv.) was added 
dropwise. The reaction mixture was allowed to stir for 2 h and then transferred by cannula 
into paraformaldehyde (8.04 g, 268 mmol, 30.0 equiv.) in hexanes (20 mL). The resulting 
solution was allowed to warm to rt and stirred for 120 h. The reaction was quenched with 
H2O (100 mL), extracted with Et2O (300 mL), the organics combined, dried (MgSO4), rotary 
evaporated and chromatographed (1 : 9 EtOAc : hexanes) to afford olefin alcohol 228
[197]
 (1.8 
g, 53%) and olefin 229
[198]
 (650 mg, 22%) both as colourless oils.  
Olefin alcohol 228:  
Rf 0.5 (3 : 5 EtOAc : hexanes);  
IR (neat) vmax 3335 (br., O-H), 2931 (m, C-H), 2858 (m, C-H), 1472 (sh.), 1427 (sh.), 1388 
(w), 1361 (w), 1106 (s) cm
-1
;  
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HRMS (CI) calc. for C24H38NO2Si [M+NH4]
+
: requires 400.2672, found 400.2677 ( +1.2 
ppm);  
1
H NMR (500 MHz, CDCl3) δ 7.69-7.67 (m, 4H, 14), 7.44-7.37 (m, 6H, 13 & 15), 5.39 (app. t 
of sextet, J = 7.0, 0.5 Hz, 1H, 3), 4.15 (d, J = 7.0 Hz, 2H, 2), 3.68 (t, J = 6.0 Hz, 2H, 9), 2.01 (t, 
J = 6.0 Hz, 2H, 6), 1.66 (br. s, 3H, 5), 1.58-1.47 (m, 4H, 7 & 8), 1.06 (s, 9H, 11);  
13
C NMR (125 MHz, CDCl3) δ 139.9 (4135.6 (4C, 14), 134.1 (2C, 12), 129.5 (2C, 15), 127.6 
(4C, 13), 123.3 (3), 63.7 (9), 59.4 (2), 39.1 (6), 32.1 (8), 26.9 (3C, 11), 23.8 (7), 19.2 (10), 16.1 
(5);  
Anal. Calc. for C24H34O2Si: C, 75.27; H, 8.96. Found: C, 75.34; H, 9.03. 
 
Olefin 229:  
Rf 0.95 (3 : 5 EtOAc : hexanes);  
IR (neat) vmax 2931 (m, C-H), 2858 (m, C-H), 1462 (sh.), 1428 (sh.), 1106 (s) cm
-1
;  
HRMS (CI) calc. for C23H33OSi [M+H]
+
: requires 353.2301, found 353.2305 ( +1.1 ppm);  
1
H NMR (500 MHz, CDCl3) δ 7.69-7.67 (m, 4H, 12), 7.44-7.67 (m, 6H, 11 & 13), 4.70 (br. 
s, 1H, 1a), 4.66 (br. s, 1H, 1b), 3.86 (t, J = 6.0 Hz, 2H, 7), 2.00 (t, J = 6.0 Hz, 2H, 4), 1.71 (s, 
3H, 3), 1.60-1.49 (m, 4H, 5 & 6), 1.06 (s, 9H, 11);  
13
C NMR (125 MHz, CDCl3) δ 146.0 (2), 135.6 (2C, 10), 129.5 (6C, 11 & 13), 127.6 (4C, 
12), 109.8 (1), 63.4 (7), 37.5 (4), 32.2 (6), 26.9 (3C, 9), 23.8 (5), 22.3 (3), 19.2 (3C, 8); 
Anal. Calc. for C24H34O2Si: C, 78.35, H, 9.15. Found: C, 78.43; H, 9.21. 
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7-(t-Butyldiphenylsilyloxy)hept-2-yn-1-ol (230) 
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Based on a procedure by Lindsay et al.
[126] 
Alykne 226 (1.50 g, 3.58 mmol, 1.0 equiv.) was 
stirred in THF (4 mL) at –78 °C. n-BuLi in hexanes (1.50 mL, 0.48 mmol, 1.0 equiv., 2.4 M) 
was added dropwise and the solution stirred for 1 h. The reaction mixture was transferred by 
cannula into paraformaldehyde (215 mg, 7.16 mmol, 2.0 equiv.). The reaction mixture was 
allowed to warm to rt and stirred for 18 h. The reaction was quenched with a saturated 
aqueous solution of NH4Cl (20 mL), extracted with Et2O (2 x 30 mL), the organics combined, 
dried (MgSO4), rotary evaporated and chromatographed (1 : 9 EtOAc : hexanes) to afford 
alkyne alcohol 230
[199]
 (1.4 g, 87%) as a colourless oil:  
Rf 0.4 (1 : 1 EtOAc : hexanes);  
IR (neat) vmax 3370 (br., O-H), 2931 (w, C-H), 2856 (w, C-H), 1472 (w), 1428 (sh.), 1389 
(w), 1187 (w), 1106 (m), 1007 (m), 999 (w) cm
-1
;  
HRMS (CI) calc. for C23H34NO2Si [M+NH4]
+
: requires 384.2359, found 384.2368 ( +2.3 
ppm);  
1
H NMR (500 MHz, CDCl3) δ 7.67-7.66 (m, 4H, 13), 7.44-7.36 (m, 6H, 12 & 14), 4.24 (d, J 
= 6.0 Hz, 2H, 2), 3.68 (t, J = 7.0 Hz, 2H, 8), 2.24-2.21 (m, 2H, 5), 1.69-1.58 (m, 4H, 6 & 7), 
1.42 (t, J = 6.0 Hz, 1H, 1), 1.06 (s, 9H, 10);  
13
C NMR (125 MHz, CDCl3) δ 135.6 (4C, 13), 134.0 (2C, 11), 129.5 (4C, 12), 127.6 (2C, 
14), 86.4 (4), 78.5 (3), 63.4 (8), 51.4 (2), 31.7 (7), 26.9 (3C, 10), 25.0 (6), 19.2 (9), 18.5 (5);  
Anal. Calc. for C23H30O2Si: C, 75.36; H, 8.25. Found: C, 75.27; H, 8.35. 
 
6 Experimental 
239 
 
(Z)-3-Iodohept-2-ene-1,7-diol (234) 
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Based on a procedure by Yamazaki
 
et al.
[125] 
Alkyne 230 (750 mg, 2.0 mmol, 1.0 equiv.) was 
stirred in THF (5 mL) and Red-Al (1.0 mL, 3.32 mmol, 1.7 equiv., 65 w.t.% in toluene) was 
added at 0 
o
C. The reaction mixture was allowed to warm to rt and stirred for 18 h. NIS (810 
mg, 3.6 mmol, 1.8 equiv.) in THF (3 mL) was added dropwise to the stirring solution at –78 
°C over 20 min. The reaction mixture was warmed to 0 °C and stirred for 30 min. The 
reaction was quenched with a saturated aqueous solution of Rochelle’s salt (10 mL) and a 
saturated aqueous solution of Na2S2O3 (10 mL), extracted with Et2O (2 x 50 mL), the 
organics combined, dried (MgSO4), rotary evaporated and chromatographed (1 : 9 EtOAc : 
hexanes to EtOAc) to afford (Z)-3-iodohept-2-ene-1,7-diol (234) (400 mg, 80%) as a 
colourless oil:  
Rf 0.2 (7 : 3 EtOAc : hexanes);  
IR (neat) vmax 3313 (br., O-H), 2935 (w, C-H), 2861 (w, C-H), 1738 (m), 1644 (w, C=C), 
1451 (w), 1366 (w), 1228 (w), 1217 (w), 1060 (w), 1018 (w) cm
-1
;  
1
H NMR (400 MHz, CDCl3) δ 5.90 (t, J = 7.0 Hz, 1H, 3), 4.24 (d, J = 7.0 Hz, 2H, 2), 3.70 (t, 
J = 7.5 Hz, 2H, 8), 2.57 (t, J = 7.5 Hz, 2H, 5), 1.70-1.56 (m, 5H, 6, 7 & 9), 1.36 (br. s, 1H, 1);  
13
C NMR (125 MHz, CDCl3) δ 133.9 (3), 110.1 (4), 67.2 (2), 62.6 (8), 44.8 (5), 31.2 (7), 
25.4 (6);  
Anal. Calc. for C7H13IO2: C, 32.83; H, 5.12. Found: C, 25.15; H, 4.85. 
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1-((Hex-5-ynyloxy)methyl)-4-methoxybenzene (235) 
1
2 3
4
5
6
O
7
8
11
10
9
O
12
235  
Hex-5-yn-1-ol (223) (5.0 g, 51 mmol, 1.0 equiv.) and NaH (2.91 g, 76.5 mmol, 1.5 equiv., 
(60% suspension in oil)) were stirred in DMF (50 mL) at 0 °C for 1 h. PMBCl (7.6 mL, 56 
mmol, 1.1 equiv.) was added dropwise and the solution was allowed to warm to rt and stirred 
for 18 h. The reaction mixture was quenched with a saturated aqueous solution of NH4Cl 
(100 mL), extracted with Et2O (2 x 200 mL), the organics combined and washed with brine 
(3 x 300 mL), dried (MgSO4), rotary evaporated and chromatographed (1 : 9 EtOAc : 
hexanes) to afford PMB ether 235
[196] (10 g, 90%) as a colourless oil:  
Rf 0.55 (3 : 7 EtOAc : hexanes);  
HRMS (ESI) calc. for C14H18O2Na [M+Na]
+
: requires 241.1204, found 241.1231 ( +11.2 
ppm);  
IR (neat) vmax 3293 (w, C≡CH), 2938 (w, C-H), 2859 (w, C-H), 1612 (sh., C=C), 1511 (sh., 
C-C), 1301 (w), 1244 (sh.), 1093 (sh.), 1034 (sh.) cm
-1
;  
1
H NMR (CDCl3, 500 MHz) δ 7.26 (d, J = 9.0 Hz, 2H, 9), 6.88 (d, J = 9.0 Hz, 2H, 10), 4.43 
(s, 2H, 7), 3.81 (s, 3H, 12), 3.47 (t, J = 6.0 Hz, 2H, 6), 2.21 (td, J = 6.0, 1.0 Hz, 2H, 3), 1.94 
(t, J = 1.0 Hz, 1H, 1), 1.75-1.69 (m, 2H, 5), 1.64-1.59 (m, 2H, 4);  
13
C NMR (CDCl3, 125 MHz) δ 159.1 (11), 130.7 (8), 129.2 (2C, 9), 113.8 (2C, 10), 84.4 (2), 
72.5 (7), 69.4 (6), 68.34 (1), 55.3 (12), 28.8 (5), 25.2 (4), 18.2 (3);  
Anal. Calc. for C14H18O2: C, 77.03; H, 8.31. Found: C, 76.89; H, 8.23. 
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7-(4-Methoxybenzyloxy)hept-2-yn-1-ol (236) 
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Based on a procedure by Lindsay et al.
[126] 
Alkyne 235 (6.80 g, 29.8 mmol, 1.0 equiv.) was 
stirred in THF (150 mL) at –78 °C. n-BuLi in hexanes (13.1 mL, 32.8 mmol, 1.1 equiv., 2.5 
M) was added dropwise and the solution stirred for 1 h. The reaction mixture was transferred 
by cannula into paraformaldehyde (4.50 g, 149 mmol, 5.0 equiv.). The reaction mixture was 
allowed to warm to rt and stirred for 18 h. The reaction was quenched with a saturated 
aqueous solution of NH4Cl (300 mL), extracted with Et2O (2 x 200 mL), the organics 
combined, dried (MgSO4), rotary evaporated and chromatographed (3 : 7 EtOAc : hexanes) 
to afford alcohol 236
[126]
 (6.0 g, 81%) as a colourless oil:  
Rf  0.48 (1 : 1 EtOAc : hexanes);  
IR (neat) vmax 3399 (br., O-H), 2938 (w, C-H), 2862 (w, C-H), 1738 (sh.), 1611 (sh., C=C), 
1511 (sh., C-C), 1365 (w), 1244 (sh.), 1078 (m), 1030 (sh.), 1011 (sh.) cm
-1
;  
HRMS (ESI) calc. for C15H20O3Na [M+Na]
+
: requires 271.1310, found 271.1309 ( –0.4 
ppm);  
1
H NMR (CDCl3, 500 MHz) δ 7.25 (d, J = 9.0 Hz, 2H, 11), 6.88 (d, J = 9.0 Hz, 2H, 12), 4.43 
(s, 2H, 9), 4.24-4.22 (m, 2H, 2), 3.81 (s, 3H, 14), 3.46 (t, J = 6.0 Hz, 2H, 8), 2.24 (t, J = 6.0 
Hz, 2H, 5), 1.73-1.68 (m, 2H, 6), 1.63-1.57 (m, 3H, 1 & 7);  
13
C NMR (CDCl3, 125 MHz) δ 159.1 (13), 130.6 (10), 129.2 (2C, 8), 113.8 (2C, 9), 86.2 (4), 
78.6 (3), 72.5 (9), 69.5 (8), 55.3 (14), 51.4 (2), 28.9 (6), 25.3 (7), 18.5 (5);  
Anal. Calc. for C15H20O3: C, 72.55; H, 8.12. Found: C, 71.96; H, 8.32. 
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(Z)-3-Iodo-7-(4-methoxybenzyloxy)hept-2-en-1-ol (237) 
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Based on a procedure by Yamazaki
 
et al.
[125a] 
Alkyne 236 (280 mg, 1.13 mmol, 1.0 equiv.) 
was stirred in THF (3 mL) at 0 °C for 2 min and then Red-Al (0.60 mL, 1.79 mmol, 1.7 
equiv., 60 w.t.% in toluene) was added dropwise. The reaction mixture was allowed to warm 
to rt and stirred for 18 h. NIS (440 mg, 2.0 mmol, 1.8 equiv.) in THF (2 mL) was added 
dropwise to the stirring solution at –78 °C over 20 min. The reaction mixture was warmed to 
0 °C and stirred for 30 min. The reaction was quenched with a saturated aqueous solution of 
Rochelle’s salt (3 mL) and a saturated aqueous solution of Na2S2O3 (4 mL), extracted with 
Et2O (2 x 20 mL), the organics combined, dried (MgSO4), rotary evaporated and 
chromatographed (3 : 7 EtOAc : hexanes) to afford olefin alcohol 237 (400 mg, 83%) as a 
colourless oil:  
Rf 0.5 (1 : 1 EtOAc : hexanes);  
IR (neat) vmax 3409 (br., O-H), 2935 (w, C-H), 2858 (w, C-H), 1611 (w, C=C), 1512 (sh., C-
C), 1454 (w), 1360 (w), 1301 (w), 1244 (sh.), 1172 (w), 1080 (sh.), 1032 (sh.) cm
-1
;  
HRMS (ESI) calc. for C15H21O3NaI [M+Na]
+
: requires 399.0433, found 399.0444 ( +2.8 
ppm);  
1
H NMR (CDCl3, 500 MHz) δ 7.27 (d, J = 9.0 Hz, 2H, 11), 6.88 (d, J = 9.0 Hz, 2H, 12), 5.83 
(tt, J = 6.0, 0.5 Hz, 1H, 3), 4.43 (s, 2H, 9), 4.18 (d, J = 6.0, 2H, 2), 3.81 (s, 3H, 14), 3.45 (t, J 
= 6.0 Hz, 2H, 8), 2.51 (t, J = 6.0 Hz, 2H, 5), 1.62-1.58 (m, 5H, 1, 6 & 7);  
13
C NMR (CDCl3, 125 MHz) δ 159.2 (13), 133.8 (3), 130.6 (10), 129.3 (2C, 11), 133.8 (2C, 
12), 110.3 (4), 72.6 (9), 69.6 (8), 67.3 (2), 55.3 (14), 44.9 (5), 28.3 (7), 25.8 (6). 
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(E)-7-(4-Methoxybenzyloxy)-3-methylhept-2-en-1-ol (238) and (E)-7-(4-
Methoxybenzyloxy)hept-2-en-1-ol (239) 
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Based on a procedure by Holler et al.
[130] 
MeLi in hexanes (8.06 mL, 2.66 mmol, 10.0 equiv. 
0.33 M) was added dropwise to a solution of CuI (253 mg, 1.33 mmol, 5.0 equiv.) in THF (3 
mL) at 0 °C. The solution went yellow followed by grey and was stirred for 30 min at 0 °C. 
Alkyne alcohol 236 (100 mg, 0.27 mmol, 1.0 equiv.) in THF (0.5 mL) was added dropwise to 
the reaction mixture which was stirred for 5 h at rt. The reaction mixture was quenched with a 
saturated aqueous solution of NH4Cl (10 mL), extracted with Et2O (20 mL), dried (MgSO4), 
rotary evaporated and chromatographed (3 : 7 EtOAc : hexanes) to afford methylhept-2-en-1-
ol 238 (43 mg, 60%) and hept-2-en-1-ol 239
[200]
 (6 mg, 9%) both as a colourless oils: 
Methylhept-2-en-1-ol 238:  
Rf 0.48 (1 : 1 EtOAc : hexanes);  
IR (neat) vmax 3385 (br., O-H), 2935 (m, C-H), 2858 (m, C-H), 1612 (w, C=C), 1512 (sh., C-
C), 1245 (sh.), 1173 (w), 1097 (sh.), 1034 (sh.), 1010 (w) cm
-1
;  
HRMS (ESI) calc. for C16H25O3 [M+H]
+
: requires 265.1804, found 265.1799 ( –1.9 ppm);  
1
H NMR (CDCl3, 500 MHz) δ 7.26 (d, J = 9.0 Hz, 2H, 12), 6.88 (d, J = 9.0 Hz, 2H, 13), 
5.41-5.37 (m, 1H, 3), 4.43 (s, 2H, 10), 4.14 (d, J = 6.0 Hz, 2H, 2), 3.80 (s, 3H, 15), 3.44 (t, J 
= 6.0 Hz, 2H, 9), 2.02 (t, J = 6.0 Hz, 2H, 6), 1.66 (s, 3H, 5), 1.61-1.56 (m, 2H, 8), 1.52-1.46 
(m, 2H, 7), 1.26 (br. s, 1H, 1);  
13
C NMR (CDCl3, 125 MHz) δ 159.1 (14), 139.7 (4), 130.7 (11), 129.2 (2C, 12), 123.5 (3), 
113.7 (2C, 13), 72.5 (10), 69.9 (9), 63.7 (2), 55.2 (15), 39.2 (6), 29.2 (8), 24.2 (7), 16.1 (5).  
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Alcohol: 239:  
Rf 0.52 (1 : 1 EtOAc : hexanes);  
IR (neat) vmax 3399 (br., O-H), 2934 (m, C-H), 2856 (m, C-H), 1611 (w, C=C), 1512 (sh., C-
C), 1457 (w), 1363 (w), 1301 (w), 1244 (sh.), 1173 (w), 1087 (m), 1033 (sh.) cm
-1
;  
HRMS (ESI) calc. for C15H23O3 [M+H]
+
: requires 251.1647, found 251.1648 ( +0.4 ppm).  
1
H NMR (CDCl3, 500 MHz) δ 7.26 (d, J = 9.0 Hz, 2H, 11), 6.88 (d, J = 9.0 Hz, 2H, 12), 
5.71-5.60 (m, 2H, 3 & 4), 4.43 (s, 2H, 9), 4.08 (t, J = 6.0 Hz, 2H, 2), 3.80 (s, 3H, 14), 3.44 (t, 
J = 6.0 Hz, 2H, 8), 2.08-2.04 (m, 2H, 5), 1.64-1.58 (m, 2H, 6), 1.49-1.43 (m, 2H, 7), 1.29-
1.25 (m, 1H, 1);  
13
C NMR (CDCl3, 125 MHz) δ 159.1 (13), 133.0 (4), 130.7 (10), 129.2 (3C, 3 & 11), 133.7 
(2C, 12), 72.5 (9), 69.9 (8), 63.8 (2), 55.3 (14), 31.9 (5), 29.2 (6), 25.7 (7);  
Anal. Calc. for C15H22O3: C, 71.97; H, 8.86, found: C, 71.83; H, 8.77. 
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(Z)-tert-Butyl(3-iodo-7-(4-methoxybenzyloxy)hept-2-enyloxy)diphenylsilane (241) 
8
9
10I
11
12
13
O
14
15
18
17
16
O
19
7
241
O
Si
3
1
4
56
2
 
Alcohol 237 (540 mg, 1.44 mmol, 1.0 equiv.) was stirred in CH2Cl2 (7.2 mL) at 0 °C for 5 
min and imidazole (107 mg, 1.58 mmol, 1.1 equiv.) was added at 0 °C and the resulting 
solution stirred for 10 min. TBDPSCl (0.41 mL, 1.58 mmol, 1.1 equiv.) was added dropwise 
and the solution was allowed to warm to rt and stirred for 18 h. The reaction mixture was 
quenched with a saturated aqueous solution of NH4Cl (20 mL), extracted with Et2O (2 x 20 
mL), the organics combined, dried (MgSO4), rotary evaporated chromatographed (1 : 9 
EtOAc : hexanes) affording silylether 241 (700 mg, 80%) as a colourless oil:  
Rf 0.8 (3 : 7 EtOAc : hexanes);  
IR (neat) vmax 2931 (w, C-H), 2856 (w, C-H), 1612 (w, C=C), 1512 (w, C-C), 1472 (w), 
1427 (sh.), 1246 (w), 1172 (w), 1104 (m), 1037 (sh.) cm
-1
;  
HRMS (ESI) calc. for C31H43NO3SiI [M+NH4]
+
: requires 632.2057, found 632.2040 ( 
+11.5 ppm);  
1
H NMR (CDCl3, 500 MHz) δ 7.68-7.67 (m, 4H, 5), 7.44-7.37 (m, 6H, 4 & 6), 7.27 (d, J = 
9.0 Hz, 2H, 16), 6.89 (d, J = 9.0 Hz, 2H, 17), 5.84 (tt, J = 6.0, 0.5 Hz, 1H, 8), 4.44 (s, 2H, 
14), 4.26 (d, J = 6.0 Hz, 2H, 7), 3.80 (s, 3H, 19), 3.45 (t, J = 7.0 Hz, 2H, 13), 2.46-2.44 (m, 
2H, 10), 1.59-1.56 (m, 4H, 11 & 12), 1.06 (s, 9H, 2);  
13
C NMR (CDCl3, 125 MHz) δ 159.1 (18), 135.6 (4C, 5), 134.7 (7), 133.5 (2C, 3), 130.7 
(15), 129.7 (6C, 4 & 6), 127.7 (2C, 16), 113.8 (2C, 17), 107.1 (9), 72.6 (14), 69.7 (13), 69.0 
(8), 55.3 (19), 44.7 (10), 28.3 (12), 26.8 (3C, 2), 25.9 (11), 19.2 (1);  
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Anal. Calc. for C31H39IO3Si: C, 60.58; H, 6.40. Found: C, 60.62; H, 6.47. 
 
(E)-t-Butyl(7-(4-methoxybenzyloxy)-3-methylhept-2-enyloxy)diphenylsilane (242) and 
(E)-t-Butyl(7-(4-methoxybenzyloxy)hept-2-enyloxy)diphenylsilane (243) 
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i
PrMgCl in hexanes (0.25 mL, 0.29 mmol, 2.0 equiv.; 1.3 M) was added to iodo-olefin 241 
(90 mg, 0.15 mmol, 1.0 equiv.) in THF (0.5 mL) at 0 °C and the solution stirred for 1 h. 
Pd(PPh3)4 (9 mg, 7.0 μmol, 5 mol%) in THF (0.5 mL) was added and the solution stirred for 
10 min. MeI in hexanes (0.15 M; 0.1 mL, 1.5 mmol, 10.0 equiv.) was added and the reaction 
mixture was allowed to warm to rt and stirred for 18 h. The reaction mixture was quenched 
with a saturated aqueous solution of NH4Cl (10 mL), extracted with Et2O (2 x 20 mL), the 
organics combined, dried (MgSO4), rotary evaporated and chromatographed (1 : 9 EtOAc : 
hexanes) to afford methyl-olefin 242 (37 mg, 50%) and olefin 243 (7 mg, 10%) and iodo-
olefin 241 (starting material) (18 mg, 20%) as colourless oils: 
Methyl-olefin 242:  
Rf 0.81 (3 : 7 EtOAc : hexanes);  
IR (neat) vmax 2932 (w, C-H), 2856 (w, C-H), 1613 (w, C=C), 1512 (m, C-C), 1462 (w), 
1423 (w), 1361 (w), 1246 (m), 1111 (m), 1036 (m) cm
-1
;  
HRMS (ESI) calc. for C32H42O3SiNa [M+Na]
+
: requires 525.2801, found 525.2780 ( –4.0 
ppm);  
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1
H NMR (CDCl3, 500 MHz) δ 7.70-7.68 (m, 4H, 5), 7.42-7.35 (m, 6H, 4 & 6), 7.27 (d, J = 
9.0 Hz, 2H, 17), 6.87 (d, J = 9.0 Hz, 2H, 18), 5.38-5.35 (m, 1H, 8), 4.43 (s, 2H, 15), 4.22 (d, J 
= 6.0 Hz, 2H, 7), 3.80 (s, 3H, 20), 3.44 (t, J = 6.0 Hz, 2H, 14), 1.97 (t, J = 6.0 Hz, 2H, 11), 
1.60-1.56 (m, 2H, 13), 1.48-1.43 (m, 2H, 12), 1.42 (s, 3H, 10), 1.04 (s, 9H, 1);  
13
C NMR (CDCl3, 125 MHz) δ 159.1 (19), 137.0 (9), 135.6 (2C, 3), 134.1 (2C, 5), 130.8 
(16), 129.3 (6C, 4 & 6), 127.6 (2C, 17), 124.2 (8), 113.8 (18), 72.5 (15), 70.0 (14), 61.1 (7), 
55.3 (20), 39.2 (11), 29.3 (13), 26.8 (3C, 1), 24.2 (12), 19.2 (2), 16.2 (10);  
Anal. Calc. for C32H42O3Si: C, 76.45; H, 8.42, found: C, 76.39; H, 8.42. 
 
Olefin 243:  
Rf 0.80 (3 : 7 EtOAc : hexanes);  
IR (neat) vmax 2931 (w, C-H), 2856 (w, C-H), 1612 (w, C=C), 1512 (w, C-C), 1427 (w), 
1246 (sh.), 1105 (m), 1037 (sh.) cm
-1
;  
1
H NMR (400 MHz, CDCl3) δ 7.71-7.70 (m, 4H, 5), 7.46-7.38 (m, 6H, 4 & 6), 7.28 (d, J = 
9.0 Hz, 2H, 16), 6.90 (d, J = 9.0 Hz, 2H, 17), 5.70-5.53 (m, 2H, 8 & 9), 4.46 (s, 2H, 14), 4.17 
(d, J = 6.0 Hz, 2H, 7), 3.82 (s, 3H, 19), 3.46 (t, J = 6.0 Hz, 2H, 13), 2.07-2.05 (m, 2H, 10), 
1.66-1.57 (m, 2H, 11), 1.49-1.42 (m, 2H, 12), 1.07 (s, 9H, 1);  
13
C NMR (CDCl3, 125 MHz) δ 159.1 (18), 135.6 (2C, 4), 134.8 (2C, 3), 133.9 (9), 130.9 (8), 
130.8 (15), 129.6 (2C, 16), 129.5 (2C, 6), 128.9 (4C, 5), 113.7 (2C, 17),  72.5 (14), 69.9 (13), 
64.6 (7), 55.3 (19), 31.9 (10), 29.3 (12), 26.8 (3C, 1), 25.8 (11), 19.2 (2);  
Anal. Calc. for C31H40O3Si; C76.18, H 8.25; found C, 76.13; H, 8.26.  
 
Method 2 for the preparation of (E)-t-Butyl(7-(4-methoxybenzyloxy)-3-methylhept-2-
enyloxy)diphenylsilane (242): Iodo-olefin 241 (120 mg, 0.20 mmol, 1.0 equiv.) was stirred in 
THF (1 mL) at 0 °C for 2 min and Pd(PPh3)4 (9.5 mg, 0.8 μmol, 5 mol%) was added. The 
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resulting solution was stirred for 1 h. ZnMe2 in hexanes (0.5 mL, 0.48 mmol, 3.0 equiv., 1.0 
M) was added to the stirring solution which went from colourless to yellow after warming to 
rt and stirring for 18 h. The reaction mixture was quenched with a saturated aqueous solution 
of NH4Cl (10 mL), extracted with Et2O (2 x 20 mL), the organics combined, dried (MgSO4), 
rotary evaporated and chromatographed (1 : 9 EtOAc : hexanes) to afford methyl-olefin 242 
(95 mg, 95%) as a colourless oil. Characterisation as described above.  
Method 2 for the preparation of (E)-t-Butyl(7-(4-methoxybenzyloxy)hept-2-
enyloxy)diphenylsilane243: Iodo-olefin 241 (50 mg, 80 μmol, 1.0 equiv.) was stirred in THF 
(0.5 mL) at –78 °C. n-BuLi in hexanes (60 μL, 1.6 M, 0.96 mmol, 1.2 equiv.) was added and 
the resulting solution stirred for 15 min. MeI (10 μL, 0.16 mmol, 2.0 equiv.) was added to the 
mixture which was stirred for 10 min. The reaction was quenched with a saturated aqueous 
solution of NH4Cl (5 mL), extracted with Et2O (2 x 10 mL), the organics combined, dried 
(MgSO4), rotary evaporated and chromatographed (1 : 9 EtOAc : hexanes) to afford olefin 
243 (8 mg, 20%) and iodo-olefin 241 (starting material) (16 mg, 40%) as colourless oils. 
Characterisation as described above. 
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(Z)-1-((5-Iodo-7-(methoxymethoxy)hept-5-enyloxy)methyl)-4-methoxybenzene (244) 
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Hunig’s base (0.3 mL, 1.8 mmol, 1.7 equiv.) was added into a stirring solution of alcohol 237 
(400 mg, 1.06 mmol, 1.0 equiv.) in CH2Cl2 (5 mL) at 0 °C, MOMCl (0.11 mL, 1.38 mmol, 
1.3 equiv.) was added and the resulting solution stirred for 3 h. The reaction mixture was 
quenched with a saturated aqueous solution of NH4Cl (10 mL) and a saturated aqueous 
solution of NaHCO3 (20 mL), extracted with Et2O (3 x 20 mL), the organics combined, dried 
(MgSO4), rotary evaporated and chromatographed (1 : 9 EtOAc : hexanes) to afford MOM 
ether 244 (440 mg, 98%) as a colourless oil:  
Rf 0.6 (3 : 7 EtOAc : hexanes);  
IR (neat) vmax 2935 (w, C-H), 2857 (w, C-H), 1738 (w), 1612 (w, C=C), 1512 (sh., C-C), 
1455 (w), 1365 (w), 1301 (w), 1245 (m), 1150 (w), 1099 (m), 1033 (sh.) cm
-1
;  
HRMS (ESI) calc. for C17H25O4NaI [M+Na]
+
: requires 443.0695, found 443.0698 ( +0.7 
ppm);  
1
H NMR (CDCl3, 500 MHz) δ 7.26 (d, J = 9.0 Hz, 2H, 12), 6.88 (d, J = 9.0 Hz, 2H, 13), 5.80 
(tt, J = 6.0, 0.5 Hz, 1H, 4), 4.64 (s, 2H, 10), 4.43 (s, 2H, 2), 4.12 (d, J = 6.0 Hz, 2H, 3), 3.81 
(s, 3H, 15), 3.45 (t, J = 6.0 Hz, 2H, 9), 3.39 (s, 3H, 1), 2.52 (t, J = 6.0 Hz, 2H, 6), 1.65-1.57 
(m, 4H, 7 & 8);  
13
C NMR (CDCl3, 125 MHz) δ 159.1 (14), 131.5 (4), 130.6 (11), 129.2 (2C, 12), 113.8 (2C, 
13), 110.6 (2), 96.1 (5), 72.6 (10), 71.8 (3), 69.6 (9), 55.4 (15), 55.2 (1), 45.0 (6), 28.3 (8), 
25.9 (7).  
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1-Methoxy-4-((7-(methoxymethoxy)hept-5-ynyloxy)methyl)benzene (245) and (E)-1-
Methoxy-4-((7-(methoxymethoxy)hept-5-enyloxy)methyl)benzene (246) 
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Iodo-olefin 244 (130 mg, 0.31 mmol, 1.0 equiv.) in THF (1 mL) was allowed to stir at –78 
°C. n-BuLi in hexanes (0.15 mL, 0.37 mmol, 1.2 equiv.; 2.5 M) was added dropwise and the 
mixture stirred for 15 min. MeI in hexanes (0.29 mL, 0.47 mmol, 1.5 equiv.; 1.6 M) was 
added and the reaction mixture stirred for 15 min. The reaction mixture was quenched with a 
saturated aqueous solution of NH4Cl (5 mL), extracted with Et2O (2 x 10 mL), the organics 
combined, dried (MgSO4), rotary evaporated and chromatographed (1 : 9 EtOAc : hexanes) 
to afford alkyne 246 (29 mg, 30%) and olefin 245 (56 mg, 61%) as colourless oils.  
 
Olefin 245:  
Rf 0.70 (3 : 7 EtOAc : hexanes);  
IR (neat) vmax  2934 (w, C-H), 2857 (w, C-H), 1739 (m), 1612 (w, C=C), 1512 (sh., C-C), 
1365 (w), 1245 (sh.), 1099 (m), 1034 (sh.) cm
-1
;  
HRMS (ESI) calc. for C17H26O4Na [M+Na]
+
: requires 317.1729, found 317.1718 ( –3.5 
ppm);  
1
H NMR (400 MHz, CDCl3)  7.28 (d, J = 9.0 Hz, 2H, 12), 6.90 (d, J = 9.0 Hz, 2H, 13), 
5.77-5.70 (m, 1H, 4), 5.61-5.51 (m, 1H, 5), 4.65 (s, 2H, 10), 4.45 (s, 2H, 2), 4.02 (d, J = 6.0 
Hz, 2H, 3), 3.82 (s, 3H, 15), 3.46 (t, J = 7.0 Hz, 2H, 9), 3.39 (s, 3H, 1), 2.10-2.08 (m, 2H, 6), 
1.67-1.60 (m, 2H, 7), 1.52-1.45 (m, 2H, 8);  
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13
C NMR (CDCl3, 125 MHz) δ 159.1 (14), 134.7 (5), 130.7 (11), 129.2 (2C, 12), 126.0 (4), 
113.7 (2C, 13), 95.4 (2), 72.5 (10), 69.9 (3), 67.9 (9), 55.3 (15), 55.2 (1), 32.0 (6), 29.3 (8), 
25.7 (7);  
Anal. Calc. for C17H26O4: C, 69.36; H, 8.90. Found C, 69.42; found 8.98.  
 
Alkyne 246:  
Rf 0.75 (3 : 7 EtOAc : hexanes);  
IR (neat) vmax 2938 (w, C-H), 2862 (w, C-H), 1738 (w), 1612 (w, C=C), 1512 (sh., C-C), 
1361 (w), 1245 (sh.), 1148 (w), 1097 (sh.), 1039 (m) cm
-1
;  
HRMS (ESI) calc. for C17H24O4Na [M+Na]
+
: requires 315.1572, found 315.1566 ( –1.9 
ppm);  
1
H NMR (CDCl3, 500 MHz) δ 7.26 (d, J = 9.0 Hz, 2H, 12), 6.88 (d, J = 9.0 Hz, 2H, 13), 4.70 
(s, 2H, 10), 4.43 (s, 2H, 2), 4.16 (br. s, 2H, 3), 3.80 (s, 3H, 15), 3.46 (t, J = 7.0 Hz, 2H, 9), 
3.37 (s, 3H, 1), 2.26-2.23 (m, 2H, 6), 1.73-1.68 (m, 2H, 7), 1.63-1.57 (m, 2H, 8);  
13
C NMR (CDCl3, 125 MHz) δ 159.1 (14), 130.7 (11), 129.2 (2C, 12), 113.8 (2C, 13), 94.6 
(2), 86.7 (5), 75.6 (4), 72.5 (3), 69.5 (10), 55.5 (9), 55.3 (1), 54.7 (15), 28.9 (8), 25.3 (7), 18.6 
(6).  
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(E)-1-Methoxy-4-((7-(methoxymethoxy)-5-methylhept-5-enyloxy)methyl)benzene (247) 
and (E)-1-Methoxy-4-((7-(methoxymethoxy)hept-5-enyloxy)methyl)benzene (245) 
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i-PrMgCl in hexanes (1.6 mL, 0.5 mmol, 2.0 equiv.; 0.3 M) was added to iodo-olefin 241 
(100 mg, 0.24 mmol, 1.0 equiv.) in THF (1.2 mL) at 0 
o
C and the resulting solution stirred for 
1 h. Pd(PPh3)4 (14 mg, 12 μmol, 5 mol%) in THF (0.5 mL) was added and the solution stirred 
for 10 min. MeI in hexanes (0.15 mL, 0.24 mmol, 10.0 equiv.; 1.6 M) was added and the 
reaction mixture was allowed to warm to rt and stirred for 18 h. The reaction mixture was 
quenched with a saturated aqueous solution of NH4Cl (10 mL), extracted with Et2O (2 x 20 
mL), the organics combined, dried (MgSO4), rotary evaporated and chromatographed (1 : 9 
EtOAc : hexanes) to afford methyl-olefin 247 (35 mg, 47%), iodo-olefin 241 (25 mg, 25%) 
(starting material) and olefin 245 (6 mg, 8%) as colourless oils.  
Methyl-olefin 247:   
Rf 0.62 (3 : 7 EtOAc : hexanes);  
IR (neat) vmax 2935 (w, C-H), 2858 (w, C-H), 1739 (w), 1612 (w, C=C), 1512 (sh., C-C), 
1442 (w), 1364 (w), 1301 (w), 1245 (sh.), 1097 (sh.), 1033 (sh.) cm
-1
;  
HRMS (ESI) calc. for C18H28O4Na [M+Na]
+
: requires 331.1885, found 331.1872 ( +0.9 
ppm);  
1
H NMR (CDCl3, 500 MHz) δ 7.26 (d, J = 9.0 Hz, 2H, 13), 6.87 (d, J = 9.0 Hz, 2H, 14), 
5.36-5.33 (m, 1H, 4), 4.63 (s, 2H, 11), 4.43 (s, 2H, 2), 4.07 (d, J = 6.0 Hz, 2H, 3), 3.80 (s, 3H, 
16), 3.44 (t, J = 7.0 Hz, 2H, 10), 3.38 (s, 3H, 1), 2.04 (t, J = 7.0 Hz, 2H, 7), 1.67 (s, 3H, 6), 
1.62-1.56 (m, 2H, 8), 1.53-1.47 (m, 2H, 7);  
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13
C NMR (CDCl3, 125 MHz) δ 159.1 (15), 140.9 (5), 130.7 (12), 129.2 (2C, 13), 120.3 (4), 
113.7 (2C, 14), 95.5 (2), 72.5 (11), 69.9 (10), 63.6 (3), 55.2 (2C,1 & 16), 39.3 (7), 29.4 (9), 
24.3 (8), 16.2 (6). 
 
Olefin 245: Characterised as described earlier. 
 
(E)-7-(t-Butyldiphenylsilyloxy)-5-methylhept-5-en-1-ol (248) 
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PMB ether 242 (200 mg, 0.40 mmol, 1.0 equiv.) was stirred in a solution of CH2Cl2 : Buffer 
pH 7 (10:1) (4.5 mL) at 0 °C. DDQ (108 mg, 0.48 mmol, 1.2 equiv.) was added and the 
resulting solution was stirred for 1 h. The reaction mixture was quenched with a saturated 
aqueous solution of NH4Cl (20 mL) and filtered through celite. The resulting solution was 
extracted with Et2O (2 x 50 mL), the organics combined, dried (MgSO4) and 
chromatographed (1 : 1 EtOAc : hexanes) to afford alcohol 248 (107 mg, 70%) as a 
colourless oil: 
Rf 0.4 (1 : 1 EtOAc : hexanes);  
IR (neat) vmax 3347 (br., O-H), 2932 (m, C-H), 2857 (m, C-H), 1473 (w), 1428 (sh.), 1389 
(w), 1112 (s), 1054 (m) cm
-1
;  
HRMS (CI) calc. for C24H38NO2Si [M+NH4]
+
: requires 400.2672, found 400.2673 ( +0.2 
ppm);  
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1
H NMR (CDCl3, 500 MHz) δ 7.80-7.79 (m, 4H, 5), 7.23-7.22 (m, 6H, 4 & 6), 5.35-5.42 (m, 
1H, 8), 4.22 (d, J = 5.0 Hz, 2H, 7), 3.65 (br. s, 2H, 14), 1.98 (t, J = 5.0, 2H, 11), 1.51-1.63 (m, 
4H, 12 & 13), 1.50 (s, 3H, 10), 1.20 (br. s, 1H, 15), 1.05 (s, 9H, 1); 
13
C NMR (CDCl3, 125 MHz) δ 136.9 (9), 135.6 (4C, 5), 134.0 (2C, 3), 129.5 (4C, 4), 127.6 
(2C, 6), 124.2 (8), 62.9 (14), 61.1 (7), 39.1 (11), 32.3 (13), 26.8 (3C, 1), 23.8 (12), 19.2 (2), 
16.1 (10). 
Anal. Calc. for C24H34O2Si: C, 75.34; H, 8.96. Found: C, 75.28; H, 8.97. 
 
(E)-7-(t-Butyldiphenylsilyloxy)-5-methylhept-5-enal (249) 
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Oxalyl chloride (30 μL, 0.36 mmol, 2.0 equiv.) and DMSO (40 μL, 0.54 mmol, 3.0 equiv.) 
were stirred in CH2Cl2 (1.2 mL) at –78 °C for 30 min. Alcohol 248 (70 mg, 0.18 mmol, 1.0 
equiv.) in CH2Cl2 (0.2 mL) was added dropwise and the resulting solution stirred for 1 h. 
Et3N (0.15 mL, 0.90 mmol, 5.0 equiv.) was added dropwise and the reaction mixture was 
allowed to warm to rt over 2 h. The reaction was quenched with H2O (2 mL), extracted with 
Et2O (2 x 10 mL), the organics combined, dried (MgSO4), rotary evaporated and 
chromatographed (1 : 9 EtOAc : hexanes) to afford aldehyde 249 (50 mg, 73%) as a 
colourless oil:  
Rf 0.45 (1 : 9 EtOAc : hexanes);  
IR (neat) vmax  2931 (m, C-H), 2857 (m, C-H), 1673 (sh., C=O), 1428 (sh.), 1107 (sh.) cm
-1
;  
HRMS (CI) calc. for C24H36NO2Si [M+NH4]
+
: requires 398.2515, found 398.2529 ( +3.5 
ppm);  
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1
H NMR (CDCl3, 500 MHz) δ 9.28 (t, J = 2.0 Hz, 1H, 15), 7.82-7.80 (m, 4H, 5), 7.24-7.23 
(m, 6H, 4 & 6), 5.47-5.45 (m, 1H, 8), 4.28 (d, J = 5.0 Hz, 2H, 7), 1.74 (td, J = 5.0 , 2.0 Hz, 
2H, 13), 1.67 (t, J = 5.0 Hz, 2H, 11), 1.37 (quin. J = 5.0 Hz, 2H, 12), 1.19 (s, 3H, 10), 1.18 (s, 
9H, 1);  
13
C NMR (CDCl3, 125 MHz) δ 200.5 (14), 136.2 (9), 136.0 (4C, 5), 134.4 (2C, 3), 129.9 
(6C, 4 & 6), 125.4 (8), 61.3 (7), 43.0 (13), 38.7 (11), 27.0 (3C, 1), 20.0 (12), 19.4 (2), 15.9 
(10). 
 
(E)-1-Nitrohept-1-ene (253) 
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Based on a procedure by Vergari et al.
[140] 
Hexanal (0.50 mL, 4.16 mmol, 1.0 equiv.) was 
stirred in CH2Cl2 (8 mL) with molecular sieves (4 Å, 5 g) at rt for 2 min. Piperidine (0.45 
mL, 4.16 mmol, 1.0 equiv.) was added followed by MeNO2 (0.45 mL, 8.32 mmol, 2.0 equiv.) 
and the resulting solution was stirred for 12 h. The reaction mixture was filtered and the 
resulting filtrate rotary evaporated. The resulting residue was chromatographed (1 : 6 Et2O : 
pentane) to afford (E)-1-nitrohept-1-ene (253)
[201] 
(400 mg, 50%) as a yellow oil:  
Rf 0.85 (1 : 9 Et2O : pentane); 
IR (neat) vmax 2958 (m, C-H), 2931 (m, C-H), 2861 (w, C-H), 1649 (w, C=C), 1523 (s, N-
O), 1350 (s, N-O) cm
-1
;  
1
H NMR (CDCl3, 500 MHz) δ 7.31-7.25 (m, 1H, 6), 6.98 (dt, J = 11.0, 0.5, 1H, 7), 2.27 (app. 
td, J= 7.0, 4.0 Hz, 2H, 5), 1.53-1.50 (m, 2H, 2), 1.35-1.31 (m, 4H, 3 & 4), 0.92-0.89 (m, 3H, 
1);  
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13
C NMR (CDCl3, 125 MHz) δ 124.8 (7), 139.5 (6), 31.2 (3), 28.4 (5), 27.4 (4), 22.3 (2), 
13.9 (1);  
Anal. Calc. for C7H13NO2: C, 58.72; H, 9.15; N, 9.78. Found: C, 57.63; H, 7.82; N, 7.66. 
 
t-Butyl 2-(3-methylbut-2-enoyl)-3-(nitromethyl)octanoate (252) 
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Keto t-butylester 200 (270 mg, 1.86 mmol, 1.0 equiv.) was added into a stirring solution of 
KOt-Bu (42 mg, 0.37 mmol, 0.2 equiv.) in
 
t-BuOH (10 mL) and THF (10 mL) at 0 °C and the 
resulting solution stirred for 30 min. (E)-1-Nitrohept-1-ene (253) (370 mg, 1.86 mmol, 1.0 
equiv.) in THF (2 mL) was added dropwise at 0 °C. The reaction mixture was stirred for 1 h 
and then quenched with a saturated aqueous solution of NH4Cl (50 mL) and extracted with 
Et2O (2 x 50 mL). The organics were combined, dried (MgSO4), rotary evaporated and 
chromatographed (1 : 9 Et2O : pentane) to afford nitro-ketoester 252 (560 mg, 88%) as a pale 
yellow oil (mixture of diastereoisomers in a 1 : 1 ratio):  
Rf 0.70 (1 : 9 Et2O : pentane);  
IR (neat) vmax 2933 (m, C-H), 2862 (m, C-H), 1730 (m, C=O), 1687 (w, C=C), 1616 (w, 
C=C), 1551 (s, N-O), 1445 (w), 1369 (m, N-O), 1154 (s), 1035 (w) cm
-1
; 
HRMS (ESI) calc. for C18H31NO5Na [M+Na]
+
: requires 364.2100, found 364.2098 ( –0.5 
ppm);  
1
H NMR (CDCl3, 500 MHz) δ 6.17 (app. t, J = 1.0 Hz, 0.5H, 13), 6.15 (app. t, J = 1.0 Hz, 
0.5H, 13), 4.68-4.61 (m, 0.5H, 7), 4.55-4.51 (m, 0.5H, 7), 3.62 (d, J = 5.0 Hz, 0.5H, 8), 3.58 
(d, J = 5.0 Hz, 0.5H, 8), 2.87-2.81 (m, 1H, 6), 2.17 (d, J = 0.5 Hz, 1.5H, 16), 2.16 (d, J = 0.5 
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Hz, 1.5H, 16), 1.94 (d, J = 0.5 Hz, 1.5H, 15), 1.93 (d, J = 0.5 Hz, 1.5H, 15), 1.46 (s, 4.5H, 
11), 1.44 (s, 4.5H, 11), 1.37-1.25 (m, 8H, 2, 3, 4 & 5), 0.87 (t, J = 8.0Hz, 3H, 1);  
13
C NMR (CDCl3, 125 MHz) δ 193.4, 193.3 (12), 167.9, 167.8 (9), 159.4, 159.0 (14), 123.1, 
122.5 (13), 82.5 (10), 76.5 (7), 61.4, 61.1 (8), 36.6, 36.5 (3), 31.6 (5), 30.0 (3C, 11), 29.4 
(15), 27.9, 27.9 (4), 26.2, 26.1 (2), 22.4 (6), 21.2, 21.1 (16), 13.9 (1);  
Anal. Calc. for C18H31 NO5: C, 63.32; H, 9.15; N, 4.10. Found: C, 63.26; H, 9.05; N, 4.10. 
 
2-Methyl-6-(nitromethyl)undec-2-en-4-one (257) 
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Based on a procedure by Geach et al.
[150] 
t-Butylester 252 (250 mg, 0.73 mmol, 1.0 equiv.) 
was refluxed with TsOH (28 mg, 0.15 mmol, 0.2 equiv.) in benzene (20 mL) for 4 h. The 
reaction mixture was allowed to cool to rt, rotary evaporated and chromatographed (1 : 9 
Et2O : pentane) to afford nitro-ketone 257 (125 mg, 72%) as a colourless oil:  
Rf 0.65 (1 : 9 Et2O : pentane);   
IR (neat) vmax 2930 (m, C-H), 2860 (w, C-H), 1686 (sh., C=O), 1618 (sh., C=C), 1547 (s, N-
O), 1439 (w), 1379 (m, N-O), 1125 (w), 1038 (w), 1100 (w) cm
-1
;  
HRMS (ESI) calc. for C13H24NO3: requires 242.1756, found 242.1766 ( +4.1 ppm);   
1
H NMR (CDCl3, 500 MHz) δ 6.05 (app. quin. J = 0.5 Hz, 1H, 10), 4.49-4.40 (m, 2H, 7), 
2.67 (app. septet, J = 5.0 Hz, 1H, 6), 2.54 (dd, J = 10.0, 5.0 Hz, 2H, 8), 2.16 (d, J = 0.5 Hz, 
3H, 12), 1.90 (d, J = 0.5 Hz, 3H, 13), 1.40-1.24 (m, 8H, 2, 3, 4 & 5), 0.88 (t, J = 5.0 Hz, 3H, 
1);  
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13
C NMR (CDCl3, 125 MHz) δ 198.3 (9), 156.7 (11), 123.5 (10), 78.7 (7), 45.1 (8), 33.4 (5), 
31.6 (3), 31.5 (12), 27.8 (4), 26.2 (6), 22.4 (2), 20.9 (13), 14.0 (1). 
 
6-Methyl-4-oxo-2-pentylhept-5-enal (258) 
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Nitro compound 257 (18 mg, 75 μmol, 1.0 equiv.) was stirred with NaH (7 mg, 0.17 mmol, 
2.2 equiv. (60% suspension in oil)) in MeOH (0.4 mL) at 0 °C for 30 min. A solution of (HCl 
(conc.) : MeOH : H2O 1 : 8 : 10) (1.9 mL) was then added dropwise and the reaction was 
stirred for 15 min. The reaction mixture was quenched with a saturated aqueous solution of 
NaHCO3 (10 mL), extracted with Et2O (2 x 10 mL), the organics combined, dried (MgSO4), 
rotary evaporated and chromatographed (1 : 9 Et2O : pentane) to afford aldehyde 258 (10 mg, 
71%) as a clear gum:  
Rf 0.55 (1 : 9 Et2O : pentane);  
IR (neat) vmax 2930 (s, C-H), 2858 (m, C-H), 1726 (w, C=O), 1687 (s, C=O), 1622 (s, C=C), 
1445 (m), 1379 (w), 1114 (m), 1074 (m) cm
-1
;  
HRMS (EI) calc. for C13H22O2: requires 210.1620, found 210.1622 ( +1.0 ppm);  
1
H NMR (500 MHz, CDCl3)  9.72 (br. s, 1H, 14), 6.04 (app. quin. J = 0.5 Hz, 10), 2.88-
2.82 (m, 1H, 8b), 2.57-2.46 (m, 1H, 8a), 2.30-2.26 (m, 1H, 6), 1.87 (d, J = 0.5 Hz, 3H, 12), 
1.85 (d, J = 0.5 Hz, 3H, 13), 1.32-1.21 (m, 8H, 2, 3, 4 & 5), 0.85 (t, J = 6.0 Hz, 3H, 1);  
13
C NMR (CDCl3, 125 MHz) δ 203.8 (7), 200.5 (9), 156.1 (11), 124.4 (10), 46.9 (6), 43.8 
(8), 37.1 (3), 28.6 (5), 27.6 (12), 26.6 (4), 22.5 (2), 20.8 (13), 13.9 (1).  
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2-(2-Methylprop-1-enyl)-4-pentylfuran (251) 
5
4
3
2
1 6 8
9O
7
10
11
13
12
251  
Aldehyde 258 (292 mg, 1.39 mmol, 1.0 equiv.) in MeOH (1 mL) was added dropwise to a 
stirring solution of TiCl3 (20% aqueous solution, 1.54 mL, 5.56 mmol, 4.0 equiv.) and 
NH4OAc (2.68 g, 35.0 mmol, 25.0 equiv.) in H2O (1.5 mL). The reaction mixture was 
allowed to warm to rt and stirred for 4 h. The reaction was quenched with a saturated aqueous 
solution of NaHCO3 (10 mL), extracted with Et2O (2 x 10 mL), the organics combined, dried 
(MgSO4), rotary evaporated and chromatographed (2 : 8 Et2O : pentane) to afford 2-(2-
methylprop-1-enyl)-4-pentylfuran (251) (5 mg, 3%) as a colourless gum:  
Rf 0.95 (1 : 9 Et2O : pentane);  
IR (neat) vmax 2928 (w, C-H), 2858 (w, C-H), 1720 (s, C=O (furan)), 1376 (m), 1142 (m) 
cm
-1
;  
HRMS (EI) calc. for C13H20O [M+H]
+: requires 192.1514, found 192.1524 (Δ +5.2 ppm);  
1
H NMR (CDCl3, 400 MHz)  7.12 (s, 1H, 7), 6.08 (s, 1H, 8), 6.04 (s, 1H, 10), 2.40 (t, J = 
7.0 Hz, 2H, 5), 2.00 (s, 3H, 12 / 13), 1.91 (s, 3H, 12 / 13), 1.61-1.54 (m, 2H, 4), 1.39-1.28 (m, 
4H, 2 & 3), 0.94-0.90 (m, 3H, 1);  
13
C NMR (CDCl3, 100 MHz)  153.6 (9), 136.7 (11), 134.7 (7), 125.8 (6), 114.6 (10), 108.8 
(8), 31.5 (4), 29.7 (3), 27.0 (5), 24.9 (13), 22.5 (2), 20.0 (12), 14.1 (1). 
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(E)-t-Butyl(3,7-dimethylocta-2,6-dienyloxy)diphenylsilane (264) 
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Geraniol (265) (2.70 g, 17.3 mmol, 1.0 equiv.) was stirred in CH2Cl2 (90 mL) at 0 °C, 
imidazole (1.30 g, 19.0 mmol, 1.1 equiv.) was then added followed by TBDPSCl (5.0 mL, 
19.0 mmol, 1.1 equiv.) and the reaction mixture was allowed to warm to rt and stirred for 12 
h. The reaction mixture was quenched with H2O (100 mL), extracted with CH2Cl2 (2 x 100 
mL), the organics combined, dried (MgSO4), rotary evaporated and chromatographed (1 : 9 to 
2 : 8 EtOAc : hexanes) to afford silylether 264
[202] (6.0 g, 88%) as a colourless oil:  
Rf 0.8 (2 : 8 EtOAc : hexanes);  
IR (neat) vmax 2960 (w, C-H), 2930 (m, C-H), 2857 (m, C-H), 1473 (w), 1428 (sh.), 1379 
(w), 1110 (s), 1056 (sh.) cm
-1
;  
HRMS (CI) calc. for C26H40NO2Si [M+NH4]
+
: requires 426.2828, found 426.2842 ( +3.3 
ppm);  
1
H NMR (CDCl3, 400 MHz) δ 7.71-7.68 (m, 4H, 5), 7.44-7.35 (m, 6H, 4 & 6), 5.40-5.36 (m, 
1H, 8), 5.12-5.08 (m, 1H, 13), 4.22 (d, J = 8.0 Hz, 2H, 7), 2.09-1.96 (m, 4H, 11 & 12), 1.68 
(d, J = 0.5 Hz, 3H, 15), 1.61 (s, 3H, 16), 1.43 (s, 3H, 10), 1.04 (s, 9H, 1);  
13
C NMR (CDCl3, 100 MHz) δ 137.0 (9), 135.6 (4C, 5), 135.2 (2C, 3), 134.1 (14), 131.5 
(2C, 6), 129.5 (4C, 4), 124.1, 124.0 (2C, 8 & 13), 61.2 (7), 39.5 (11), 26.8 (3C, 1), 26.4 (12), 
25.7 (16), 19.2 (2), 17.7 (15), 16.3 (10);  
Anal. Calc. for C26H36OSi: C, 79.53; H, 9.24. Found: C, 74.07; H, 8.76. 
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(E)-t-Butyl(5-(3,3-dimethyloxiran-2-yl)-3-methylpent-2-enyloxy)diphenylsilane (263) 
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Based on a procedure by Tago et al.
[153] 
Olefin 264 (5.20 g, 13.2 mmol, 1.0 equiv.) was 
stirred in CH2Cl2 (50 mL) at 0 °C. m-CPBA (3.60 g, 15.8 mmol, 1.2 equiv.) in CH2Cl2 (50 
mL) was added dropwise and the reaction mixture stirred for 2 h. The mixture was filtered 
and Ca(OH)2 (4.20 g, 56.8 mmol, 4.3 equiv.) was added and the resulting solution stirred for 
1 h. The reaction mixture was filtered, rotary evaporated and chromatographed (3 : 7 Et2O : 
pentane) to afford epoxide 263
[202]
 (4.0 g, 75%) as a colourless oil:  
Rf  0.65 (3 : 7 Et2O : pentane);  
IR (neat) vmax 2931 (m, C-H), 2959 (m, C-H), 2857 (m, C-H), 1473 (w), 1428 (sh.), 1378 
(w), 1112 (s), 1057 (m) cm
-1
; 
HRMS (ESI) calc. for C26H36O2NaSi [M+Na]
+
: requires 431.2382, found 431.2369 ( –3.0 
ppm);
  
1
H NMR (CDCl3, 400 MHz) δ 7.70-7.67 (m, 4H, 5), 7.44-7.35 (m, 6H, 4 & 6), 5.43-5.39 (m, 
1H, 8), 4.22 (d, J = 6.0, 2H, 7), 2.71 (t, J = 5.0 Hz, 1H, 13),  2.19-2.03 (m, 2H, 11), 1.71-1.59 
(m, 2H, 12), 1.46 (s, 3H, 10), 1.30 (s, 3H, 15), 1.26 (s, 3H, 14), 1.07 (s, 9H, 1);  
13
C NMR (CDCl3, 100 MHz) δ 136.1 (9), 135.6 (4C, 5), 134.0 (2C, 3), 129.5 (2C, 6), 127.6 
(4C, 4), 124.6 (8), 64.0 (13), 61.0 (7), 58.4 (16), 36.1 (11), 27.2 (12), 26.8 (2C, 1), 24.9 (15), 
19.2 (2), 18.7 (14), 16.3 (10). 
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(E)-6-(t-Butyldiphenylsilyloxy)-4-methylhex-4-enal (262) 
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Based on a procedure by Tago et al.
[153]
 Epoxide 263 (4.0 g, 9.8 mmol, 1.0 equiv.) was stirred 
in THF (32 mL). H5IO6 (4.14 g, 19.5 mmol, 2.0 equiv.) in H2O (20 mL) was added dropwise 
to the stirring solution at 0 °C and stirred for 30 min. The reaction mixture was quenched 
with a saturated aqueous solution of NaHCO3 (50 mL), extracted with Et2O (2 x 200 mL), the 
organics combined, dried (MgSO4), rotary evaporated and chromatographed (3 : 7 Et2O : 
pentane) to afford aldehyde 262
[202]
 (2.0 g, 60%) as a colourless oil:  
Rf 0.60 (3 : 7 Et2O : pentane);  
IR (neat) vmax 2931 (m, C-H), 2857 (m, C-H), 1722 (w, C=O), 1472 (w), 1428 (sh.), 1390 
(w), 1111 (s), 1069 (m) cm
-1
;
  
MS (CI) [M+NH4]
+
: requires 340, found
 
340; [M+H]
+
: requires 323, found
 
323;
  
1
H NMR (CDCl3, 500 MHz) δ 9.75 (t, J = 1.0 Hz, 1H, 14), 7.69-7.67 (m, 4H, 5), 7.42-7.36 
(m, 6H, 4 & 6), 5.40-5.37 (m, 1H, 8), 4.22 (d, J = 6.0 Hz, 2H, 7), 2.50 (td, J = 6.0, 1.0, Hz, 
2H, 12), 2.30 (t, J = 6.0 Hz, 2H, 11), 1.45 (s, 3H, 10), 1.04 (s, 9H, 1);  
13
C NMR (CDCl3, 125 MHz) δ 202.2 (13), 135.6 (2C, 3), 134.9 (9), 133.9 (4C, 4), 129.6 
(2C, 6), 127.6 (4C, 5), 125.0 (8), 60.9 (7), 41.8 (12), 31.5 (11), 26.8 (3C, 1), 19.1 (2), 16.4 
(10). 
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4-Bromo-2-(2-methylprop-1-enyl)furan (261) 
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Based on a procedure by Joullié et al.
[107] 
Isopropyl(triphenyl)phosphonium iodide (164 mg, 
0.38 mmol, 1.2 equiv.) was stirred in THF (2.5 mL) at –78 oC. n-BuLi in hexanes (0.15 mL, 
0.38 mmol, 1.2 equiv.) was added dropwise. The solution was allowed to stir at 0 °C for 30 
min and then cooled to –78 °C. 4-Bromofuran-2-carbaldehyde (266) (50 mg, 0.31 mmol, 1.0 
equiv.) in THF (0.6 mL) was added dropwise and the resulting solution stirred for 1 h. The 
reaction was quenched with a saturated aqueous solution of NH4Cl (20 mL), extracted with 
Et2O (2 x 20 mL), the organics combined, dried (MgSO4), rotary evaporated and 
chromatographed (1 : 19 Et2O : pentane) to afford olefin 261
[107] 
(12 mg, 20%) as a colourless 
oil:  
Rf 0.90 (1 : 9 Et2O : pentane);  
IR (neat) vmax 2971 (m, C-H), 2870 (w, C-H), 1738 (m, C-O (furan)), 1365 (m), 1227 (m), 
1143 (sh.), 1002 (sh.) cm
-1
;  
HRMS (CI) calc. for C8H10OBr [M+H]
+
: requires 200.9915, found 200.9907 ( –4.0 ppm);  
1
H NMR (CDCl3, 400 MHz)  7.33 (s, 1H, 1), 6.22 (s, 1H, 3), 6.02 (s, 1H, 5), 1.97 (s, 3H, 8), 
1.93 (s, 3H, 7);  
13
C NMR (CDCl3, 125 MHz)  175.1 (4), 138.5 (1), 137.5 (6), 113.7 (3), 110.1 (5), 100.8 
(2), 27.0 (8), 20.1 (7). 
 
 
 
6 Experimental 
264 
 
4-Bromo-2-(diethoxymethyl)furan (267) 
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Based on a procedure by Joullié et al.
[107]
 Aldehyde 266 (100 mg, 0.63 mmol, 1.0 equiv.) was 
refluxed in EtOH (3.15 mL) with NH4NO3 (3 mg, 32 μmol, 5 mol%.) and HC(OEt3) (0.42 
mL, 2.52 mmol, 4.0 equiv.) for 2 h. The reaction mixture was allowed to cool to rt and rotary 
evaporated. The resulting material was suspended between brine (50 mL) and Et2O (50 mL). 
The organics were combined, dried (MgSO4), rotary evaporated and chromatographed (1 : 49 
Et2O : pentane) to afford 4-bromo-2-(diethoxymethyl)furan (267)
[107]
 (120 mg, 77%) as a 
pale yellow oil:  
Rf 0.90 (1 : 9 Et2O : pentane);  
IR (neat) vmax  2975 (w, C-H), 2885 (w, C-H), 1737 (m, C-O (furan), 1372 (m), 1320 (m), 
1218 (m), 1138 (s), 1050 (m) cm
-1
;  
HRMS (EI) calc. for C9H13O3Br [M+H]
+: requires 248.0048, found 248.0041 (Δ –2.8 ppm);  
1
H NMR (CDCl3, 400 MHz) δ 7.40 (d, J = 0.5 Hz, 1H, 1), 6.47 (d, J = 0.5 Hz, 1H, 3), 5.49 
(s, 1H, 5), 3.66-3.54 (m, 4H, 6), 1.23 (t, J = 8.0 Hz, 6H, 7);  
13
C NMR (CDCl3, 100 MHz) δ 152.8 (4), 140.5 (1), 111.6 (3), 100.0 (2), 95.8 (5), 61.4 (2C, 
6), 15.1 (2C, 7);  
Anal. Calc. for C9H13O3Br: requires C, 43.39; H, 5.26. Found, C 43.46; H, 5.18. 
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(E)-6-(t-Butyldiphenylsilyloxy)-1-(5-(diethoxymethyl)furan-3-yl)-4-methylhex-4-en-1-ol 
(269) and (E)-1-(4-Bromo-2-(diethoxymethyl)furan-3-yl)-6-(t-butyldiphenylsilyloxy)-4-
methylhex-4-en-1-ol (268) 
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4-Bromo-2-(diethoxymethyl)furan (267) (180 mg, 0.73 mmol, 1.0 equiv.) was stirred in THF 
(2 mL) at –78 °C for 5 min. n-BuLi in hexanes (260 μL, 2.5 M, 0.65 mmol, 0.9 equiv.) was 
added dropwise and the solution stirred for 15 min. Aldehyde 262 (240 mg, 0.65 mmol, 0.9 
equiv.) in THF (0.5 mL) was added dropwise and the resulting solution allowed to warm to rt 
and stirred for 18 h. The reaction mixture was quenched with a saturated aqueous solution of 
NH4Cl (40 mL), extracted with Et2O (2 x 30 mL), dried (MgSO4), rotary evaporated and 
chromatographed (1 : 9 Et2O : pentane) to afford alcohol furan 268 (40 mg, 10%) as a clear 
gum and bromo-alcohol furan 269 (10 mg, 2%) as a colourless oil.  
 
Alcohol-furan 268: 
Rf 0.60 (4 : 6 Et2O : pentane);  
IR (neat) vmax 3016 (m, C-H), 2971 (m, C-H), 2945 (m, C-H), 2858 (w, C-H), 1746 (s, C-O 
(furan)), 1428 (m), 1366 (s), 1229 (s), 1111 (m), 1051 (m) cm
-1
;  
HRMS (ESI) calc. for C32H44O5NaSi [M+Na]
+
: requires 559.2856, found 559.2863 ( +1.3 
ppm);  
1
H NMR (CDCl3, 500 MHz) δ 7.70-7.67 (m, 4H, 3), 7.43-7.36 (m, 6H, 2 & 4), 6.44 (d, J = 
0.5 Hz, 1H, 15), 5.48 (d, J = 5.0 Hz, 1H, 17), 5.41-5.39 (m, 1H, 8), 4.76-4.72 (m, 1H, 21), 
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4.21 (d, J = 6.0 Hz, 2H, 7), 3.67-3.54 (m, 5H, 13 & 19), 2.09-1.91 (m, 4H, 11 & 12), 1.45 (s, 
3H, 9), 1.26-1.20 (m, 6H, 20), 1.05 (s, 9H, 6);  
13
C NMR (CDCl3, 125 MHz) δ 151.9 (16), 151.6 (15), 135.9 (10), 135.6 (4C, 2), 134.0 (2C, 
1), 129.5 (4C, 3), 127.6 (2C, 4), 124.9 (14), 112.1 (8), 97.7 (17), 95.9 (18), 65.7 (13), 61.6 
(2C, 19), 61.0 (7), 35.3 (12), 33.2 (11), 26.8 (3C, 6), 19.2 (5), 16.2 (9), 15.1 (2C, 20). 
 
Bromo-alcohol furan 269: 
Rf 0.65 (4 : 6 Et2O : pentane);  
IR (neat) vmax 2970 (m, C-H), 2930 (m, C-H), 2857 (w, C-H), 1738 (s, C-O (furan)), 1428 
(w), 1366 (m), 1217 (sh.), 1110 (sh.), 1047 (m) cm
-1
;  
HRMS (ESI) calc. for C32H43O5NaBrSi [M+Na]
+
: requires 637.1961, found 637.1953 ( –
1.3 ppm);  
1
H NMR (CDCl3, 500 MHz) δ 7.74-7.73 (m, 4H, 3), 7.43-7.39 (m, 6H, 2 & 4), 6.48 (s, 1H, 
16), 5.54 (s, 1H, 18), 5.45 (br. s, 1H, 8), 4.60 (m, 1H, 21), 4.27-4.25 (m, 3H, 7 & 13), 3.71-
3.60 (m, 4H, 19), 2.17-2.00 (m, 2H, 11), 1.91-1.77 (m, 2H, 12), 1.48 (s, 3H, 10), 1.27 (t, J = 
8.0 Hz, 6H, 20), 1.09 (s, 9H, 6);  
13
C NMR (CDCl3, 125 MHz) δ 152.4 (17), 138.6 (16), 136.4 (2C, 1), 135.4 (4C, 2), 133.8 
(9), 129.4 (2C, 4), 127.5 (4C, 3), 124.3 (8), 106.8 (14), 96.2 (2C, 15 & 18), 66.3 (13), 60.9 
(2C, 19), 58.0 (7), 35.4 (11), 35.3 (12), 19.0 (3C, 6), 18.2 (5), 16.2 (10), 15.0 (2C, 20). 
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(E)-6-(t-Butyldiphenylsilyloxy)-4-methylhex-4-en-1-ol (272) 
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Based on a procedure by Tago et al.
[153] 
Aldehyde 262 (1.60 g, 4.34 mmol, 1.0 equiv.) was 
stirred with NaBH4 (330 mg, 8.67 mmol, 2.0 equiv.) in EtOH (80 mL) at 0 °C for 3 h. The 
reaction mixture was rotary evaporated and then quenched with a saturated aqueous solution 
of NaHCO3 (100 mL), extracted with EtOAc (2 x 200 mL), the organics combined, dried 
(MgSO4), rotary evaporated and chromatographed (2 : 1 Et2O : pentane) to afford alcohol 272 
(1.3 g, 81%) as a colourless oil:  
Rf 0.55 (2 : 1 Et2O : pentane);  
IR (neat) vmax 3343 (br., O-H), 2931 (m, C-H), 2857 (m, C-H), 1473 (sh.), 1428 (sh.), 1112 
(sh.), 1052 (s) cm
-1
;
  
HRMS (ESI) calc. for C23H36NO2Si [M+NH4]
+
: requires 386.2515, found 386.2517 ( +0.5 
ppm);
  
1
H NMR (CDCl3, 500 MHz) δ 7.70-7.68 (m, 4H, 5), 7.44-7.36 (m, 6H, 4 & 6), 5.43-5.40 (m, 
1H, 8), 4.22 (d, J = 7.0 Hz, 2H, 7), 4.63 (app. q, J = 6.0 Hz, 2H, 13), 2.05 (t, J = 6.0 Hz, 2H, 
11), 1.69-1.63 (m, 2H, 12), 1.46 (s, 3H, 10), 1.28 (t, J = 6.0 Hz, 1H, 14), 1.04 (s, 9H, 1);  
13
C NMR (CDCl3, 125 MHz) δ 136.8 (9), 135.6 (2C, 3), 134.0 (4C, 4), 129.5 (2C, 6), 127.6 
(4C, 5), 124.4 (8), 62.7 (13), 61.0 (7), 35.7 (11), 30.5 (12), 26.8 (3C, 1), 19.1 (2), 16.2 (10);  
Anal. Calc. for C23H32O2Si: C, 74.95; H, 8.75. Found: C, 74.87; H, 8.75. 
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(E)-6-(tert-Butyldiphenylsilyloxy)-4-methylhex-4-enyl methanesulfonate 320 
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Based on a procedure by Joullié et al.
[107] 
Alcohol 272 (1.6 g, 4.3 mmol, 1.0 equiv.) was 
stirred in CH2Cl2 (25 mL) at 0 °C. Et3N (1.2 mL, 8.6 mmol, 2.0 equiv.) was added dropwise 
followed by MsCl (0.5 mL, 5.64 mmol, 1.3 equiv.) dropwise. The resulting solution was 
stirred for 30 min and then quenched with a saturated aqueous solution of NH4Cl (100 mL), 
extracted with Et2O (2 x 100 mL), the organics combined, washed with brine (100 mL), dried 
(MgSO4), rotary evaporated and chromatographed (1 : 1 Et2O : pentane) to afford mesylate 
320 (1.5 g, 80%) as a colourless oil:  
Rf  0.5 (1 : 1 Et2O: pentane);  
IR (neat) vmax 2931 (w, C-H), 2857 (w, C-H), 1428 (w), 1355 (m), 1173 (m), 1111 (sh.), 
1051 (m) cm
-1
;  
HRMS (ESI) calc. for C24H34O4NaSiS [M+Na]
+: requires 469.1845, found 469.1837 (Δ –0.2 
ppm);  
1
H NMR (CDCl3, 400 MHz)  7.71-7.69 (m, 4H, 3), 7.47-7.39 (m, 6H, 2 & 4), 5.42 (app. td, 
J = 6.0, 0.5 Hz, 1H, 8), 4.25-4.19 (m, 4H, 7 & 13), 3.01 (s, 3H, 14), 2.10 (t, J = 8.0 Hz, 2H, 
11), 1.86 (quin. J = 8.0 Hz, 2H, 12), 1.47 (s, 3H, 9), 1.06 (s, 9H, 6);  
13
C NMR (CDCl3, 100 MHz)  135.6 (4C, 2), 135.0 (10), 133.9 (2C, 1), 129.6 (2C, 4), 127.6 
(4C, 3), 125.4 (8), 69.5 (13), 60.9 (7), 37.3 (14), 34.9 (11), 26.9 (12), 26.8 (3C, 6), 19.2 (5), 
16.1 (9).  
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(E)-t-Butyl(6-iodo-3-methylhex-2-enyloxy)diphenylsilane (271) 
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Based on a procedure by Joullé et al.
[107] 
Methanesulphonate 320 (1.5 g, 3.4 mmol, 1.0 
equiv.) and NaI (504 mg, 3.36 mmol, 1.0 equiv.) were heated at 50 °C in acetone (20 mL) for 
18 h. The reaction mixture was quenched with a 1 : 1 mixture of a saturated aqueous solution 
of Na2S2O3 and a saturated aqueous solution of NaHCO3 (100 mL), extracted with Et2O (2 x 
100 mL), dried (MgSO4), rotary evaporated and chromatographed (1 : 99 Et2O : pentane) to 
afford iodide 271 (1.15 g, 70%) as a colourless oil.  
Rf 0.90 (1 : 9 Et2O : pentane);  
IR (neat) vmax 2930 (m, C-H), 2856 (m, C-H), 1427 (sh.), 1388 (w), 1217 (w), 1110 (s), 1051 
(m) cm
-1
;
   
HRMS (CI) calc. for C23H35NOSiI [M+NH4]
+
: requires 496.1533, found 496.1542 ( +1.8 
ppm);  
1
H NMR (CDCl3, 500 MHz) δ 7.72-7.71 (m, 4H, 5), 7.46-7.39 (m, 6H, 4 & 6), 5.46-5.43 (m, 
1H, 8), 4.25 (d, J = 6.0 Hz, 2 H, 7), 3.14 (t, J = 7.0 Hz, 2H, 13), 2.08 (t, J = 7.0 Hz, 2H, 11), 
1.91 (quin., J = 7.0 Hz, 2H, 12), 1.44 (s, 3H, 10), 1.07 (s, 9H, 1);  
13
C NMR (CDCl3, 125 MHz) δ 135.6 (9), 134.9 (2C, 10), 133.9 (4C, 4), 129.5 (2C, 6), 127.6 
(4C, 5), 125.4 (8), 61.0 (7), 39.8 (11), 31.3 (12), 26.8 (3C, 1), 19.1 (2), 16.1 (10), 6.4 (13);  
Anal. Calc. for C23H31ISiO: C, 57.73; H, 6.53. Found: C, 57.85; H, 6.62. 
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(E)-t-Butyl(6-(5-(diethoxymethyl)furan-3-yl)-3-methylhex-2-enyloxy)diphenylsilane 
(270) and (E)-(6-(4-bromo-2-(diethoxymethyl)furan-3-yl)-3-methylhex-2-enyloxy)(t-
butyl)diphenylsilane (273) 
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Based on a procedure by Joullié et al.
[107] 
4-Bromo-2-(diethoxymethyl)furan (267) (270 mg, 
1.09 mmol, 2.0 equiv.) was stirred in THF (4 mL) at –78 °C for 5 min. n-BuLi in hexanes 
(0.9 mL, 1.2 M, 1.09 mmol, 2.0 equiv.) was added dropwise and the solution stirred for 5 
min. HMPA (0.25 mL, 1.42 mmol, 2.6 equiv.) was added dropwise and the solution stirred 
for 30 min. Iodide-olefin 271 (261 mg, 0.55 mmol, 1.0 equiv.) in THF (1 mL) was added 
dropwise and the resulting solution allowed to warm to rt and stirred for 18 h. The reaction 
mixture was quenched with a saturated aqueous solution of NH4Cl (50 mL), extracted with 
Et2O (2 x 50 mL), dried (MgSO4), rotary evaporated and chromatographed (1 : 29 to 3 : 27 
Et2O : pentane) to afford furan 270 (175 mg, 60%) as a clear gum and bromo-furan 273 (32 
mg, 10%) as a clear oil: 
 
Furan 270:  
Rf 0.70 (1 : 9 Et2O : pentane);  
IR (neat) vmax 2930 (w, C-H), 2857 (w, C-H), 1683 (w), 1461 (w), 1427 (w), 1361 (w), 1109 
(sh.), 1051 (sh.), 1005 (m) cm
-1
;  
HRMS (ESI) calc. for C32H44O5NaSi [M+Na]
+: requires 559.2856, found 599.2856 (Δ 0.0 
ppm);  
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1
H NMR (CDCl3, 500 MHz) δ 7.71-7.69 (m, 4H, 3), 7.42-7.36 (m, 6H, 2 & 4), 7.17 (d, J = 
0.5 Hz, 1H, 15), 6.30 (br. s, 1H, 17), 5.50 (s, 1H, 18), 5.40-5.37 (m, 1H, 8), 4.24 (d, J = 6.0 
Hz, 2H, 7), 3.67-3.58 (m, 4H, 19), 2.35 (t, J = 7.0 Hz, 2H, 13), 2.00 (d, J = 7.0 Hz, 2H, 11), 
1.63 (quin. J = 7.0 Hz. 2H, 12), 1.44 (s, 3H, 9), 1.25 (t, J = 8.0 Hz, 6H, 20), 1.05 (s, 9H, 6);  
13
C NMR (CDCl3, 125 MHz) δ 151.8 (16), 138.6 (15), 136.7 (10), 135.6 (4C, 3), 134.1 (2C, 
1), 129.5 (2C, 4), 127.6 (4C, 2), 125.5 (14), 124.4 (8), 109.4 (17), 96.4 (18), 61.3 (2C, 19), 
61.1 (7), 38.9 (11), 27.7 (12), 26.8 (3C, 6), 24.3 (13), 19.2 (5), 19.2 (9), 15.15 (2C, 20). 
 
Bromo-furan 273:   
Rf 0.75 (1 : 9 Et2O : pentane);  
IR (neat) vmax  2930 (w, C-H), 2856(w, C-H), 1684 (m, C=O (furan)), 1518 (w), 1427 (w), 
1283 (w), 1109 (m), 1057 (m) cm
-1
;  
HRMS (ESI) C32H43O4NaSiBr [M+Na]
+
: requires 621.2012, found 621.2013 ( +0.2 ppm);  
1
H NMR (CDCl3, 500 MHz) δ 7.70-7.68 (m, 4H, 3), 7.41-7.36 (m, 6H, 2 & 4), 6.38 (s, 1H, 
16), 5.45 (s, 1H, 18), 5.40-5.38 (m, 1H, 8), 4.22 (d, J = 6.0 Hz, 2H, 7), 3.65-3.54 (m, 4H, 19), 
2.59 (t, J = 7.0 Hz, 2H, 13), 1.99 (t, J = 7.0 Hz, 2H, 11), 1.72 (quin, J = 7.0 Hz, 2H, 12), 1.42 
(s, 3H, 10), 1.22 (t, J = 8.0 Hz, 6H, 20), 1.04 (s, 9H, 6);  
13
C NMR (CDCl3, 125 MHz) δ 152.8 (17), 150.1 (16), 136.2 (9), 135.6 (4C, 2), 134.0 (2C, 
1), 129.5 (2C, 4), 127.6 (4C, 3), 124.7 (14), 111.8 (15), 96.3 (8), 96.0 (18), 61.3 (2C, 19), 
61.1 (11), 38.7 (7), 26.8 (3C, 6), 25.7 (12), 25.6 (13), 19.2 (5), 16.1 (10), 15.1 (2C, 20). 
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(E)-4-(6-(t-Butyldiphenylsilyloxy)-4-methylhex-4-enyl)furan-2-carbaldehyde (274) 
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Method 1: Diethoxymethyl-furan 270 (190 mg, 0.35 mmol, 1.0 equiv.) was stirred in 1 M 
HCl (1 mL) and THF (1 mL) at rt for 30 min. The reaction was quenched with a saturated 
aqueous solution of NaHCO3 (10 mL), extracted with Et2O (2 x 10 mL), dried (MgSO4) and 
rotary evaporated to afford aldehyde 274 (141 mg, 89%) as a colourless oil:  
Rf 0.40 (2 : 9 Et2O : pentane);  
IR (neat) vmax  2931 (m, C-H), 2856 (m, C-H), 1683 (s, C=O), 1504 (sh.), 1428 (sh.), 1384 
(w), 1110 (s), 1059 (m) cm
-1
;  
HRMS calc. for C28H38NO3Si [M+NH4]
+
: requires 464.2621, found 464.2638 ( +3.7 ppm);  
1
H NMR (CDCl3, 500 MHz)  9.60 (s, 1H, 19), 7.70-7.68 (m, 4H, 3), 7.45 (s, 1H, 15) 7.42-
7.35 (m, 6H, 2 & 4), 7.11 (s, 1H, 17), 5.39-5.36 (m, 1H, 8), 4.24 (d, J = 6.0 Hz, 2H, 7), 2.42 
(t, J = 7.0 Hz, 2H, 13), 2.01 (t, J = 7.0 Hz, 2H, 11), 1.67 (quin. J = 7.0 Hz, 2H, 12), 1.44 (s, 
3H, 9), 1.05 (s, 9H, 6);  
13
C NMR (CDCl3, 125 MHz)  177.9 (18), 152.9 (16), 144.9 (15), 136.1 (10), 135.6 (4C, 2), 
133.9 (2C, 1), 129.5 (2C, 4), 128.2 (14), 127.6 (4C, 3), 124.8 (2C, 8 & 17), 61.0 (7), 38.6 
(11), 27.5 (12), 26.8 (3C, 6), 23.8 (13), 19.2 (5), 16.1 (9).   
 
Method 2: Based on a procedure by Gregg et al.
[163] 
Diethoxymethyl-furan 270 (500 mg, 0.91 
mmol, 1.0 equiv.) was stirred in acetone (18.2 mL) for 5 min. In(OTf)3 (51 mg, 90 μmol, 0.1 
equiv.) was added and the resulting solution stirred for 5 min. The reaction was quenched 
with a saturated aqueous solution of NH4Cl (20 mL), extracted with Et2O (2 x 50 mL), the 
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organics combined, dried (MgSO4) and rotary evaporated to afford aldehyde 274 (380 mg, 
93%) as a colourless oil. The product was used without further purification. Characterised as 
described previously.  
 
(E)-t-Butyl(3-methyl-6-(5-(2-methylprop-1-enyl)furan-3-yl)hex-2-enyloxy)diphenylsilane 
(259) 
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Based on a procedure by Joullié et al.
[107] 
Isopropyltriphenylphosphonium iodide (182 mg, 
0.42 mmol, 1.2 equiv.) was stirred in THF (3.5 mL) at –78 °C. n-BuLi in hexanes (0.35 mL, 
1.2 M, 0.42 mmol, 1.2 equiv.) was added dropwise and the solution turned orange. The 
resulting solution was stirred at 0 °C for 30 min and the colour turned deep red. The reaction 
mixture was cooled to –78 °C and aldehyde 274 (141 mg, 0.32 mmol, 1.0 equiv.) in THF (0.5 
mL) was added dropwise and the resulting solution stirred for 30 min. The reaction was 
quenched with a saturated aqueous solution of NH4Cl (20 mL), extracted with Et2O (2 x 40 
mL), the organics combined, washed with brine (30 mL), dried (MgSO4), rotary evaporated 
and chromatographed (2 : 98 Et2O : pentane) to afford olefin 259 (120 mg, 70%) as a 
colourless oil:  
Rf 0.95 (1:9 Et2O : pentane);  
IR (neat) vmax 2930 (m, C-H), 2856 (m, C-H), 1472 (w), 1428 (w), 1261 (w), 1111 (sh.), 
1059 (m) cm
-1;  
HRMS (CI) calc. for C31H41O2Si [M+H]
+
: requires 473.2876, found 473.2874 (Δ –0.4 ppm);  
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1
H NMR (CDCl3, 400 MHz)  7.72-7.70 (m, 4H, 3), 7.44-7.38 (m, 6H, 2 & 4), 7.11 (s, 1H, 
15), 6.07 (s, 1H, 17), 6.04 (s, 1H, 18), 5.40 (t, J = 6.0 Hz, 1H, 8), 4.25 (d, J = 6.0 Hz, 2H, 7), 
2.37 (t, J = 8.0 Hz, 2H, 13), 2.02 (t, J = 8.0 Hz, 2H, 11), 2.00 (s, 3H, 19 / 20), 1.91 (s, 3H, 19 
/ 20), 1.65 (quin. J = 8.0 Hz, 2H, 12), 1.45 (s, 3H, 9), 1.06 (s, 9H, 6);  
13
C NMR (CDCl3, 100 MHz)  153.7 (16), 136.8 (21), 135.6 (4C, 2), 134.8 (2C, 1), 134.1 
(2C, 10 & 15), 129.5 (2C, 4), 127.6 (4C, 3), 126.4 (14), 124.4 (8), 114.6 (18), 108.7 (17), 
61.13 (7), 38.9 (11), 27.9 (12), 27.0 (13), 26.9 (3C, 6), 24.4 (20), 20.1 (5), 19.2 (19), 16.2 (9). 
  
(E)-3-Methyl-6-(5-(2-methylprop-1-enyl)furan-3-yl)hex-2-en-1-ol (275) 
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Silylether 259 (60 mg, 0.12 mmol, 1.0 equiv.) was stirred in THF (0.6 mL) and TBAF (0.2 
mL, 0.18 mmol, 1.5 equiv.) was added dropwise. The resulting solution was stirred for 18 h. 
The reaction mixture was quenched with a saturated aqueous solution of NaHCO3 (20 mL), 
extracted with Et2O, the organics combined, washed with brine (10 mL), dried (MgSO4), 
rotary evaporated and chromatographed (1 : 1 Et2O : pentane) to afford alcohol 275 (25 mg, 
81%) as a colourless gum:  
Rf 0.42 (1 : 1 Et2O : pentane);  
IR (neat) vmax 3453 (br., O-H) 2970 (m, C-H), 2937 (m, C-H), 2867 (w, C-H), 1739 (s, C=O 
(furan)), 1441 (w), 1366 (m), 1217 (m), 1229 (m), 1206 (m) cm
-1
;  
HRMS (EI) calc. for C15H22O2 [M+H]
+: requires 234.1620, found 234.1635 (Δ +6.4 ppm);  
1
H NMR (CDCl3, 500 MHz)  7.10 (s, 1H, 10), 6.04 (s, 1H, 11), 6.01 (s, 1H, 13), 5.43-5.40 
(m, 1H, 3), 2.31 (d, J = 6.0 Hz, 2H, 2), 2.59 (br. s, 1H, 1), 2.37 (t, J = 8.0 Hz, 2H, 8), 2.09-
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2.04 (m, 2H, 6), 1.96 (s, 3H, 15 / 16), 1.88 (s, 3H, 15 / 16), 1.80-1.70 (m, 2H, 7), 1.67 (s, 3H, 
5);  
13
C NMR (CDCl3, 125 MHz)  153.7 (12), 139.6 (14), 136.8 (10), 134.9 (4), 126.3 (3), 123.5 
(9), 114.5 (13), 108.6 (11), 59.4 (2), 39.0 (6), 27.9 (7), 27.0 (8), 24.5 (16), 20.1 (15), 16.2 (5). 
 
3-Oxo-3-(2-(trimethylsilyl)ethoxy)propanoic acid (281) 
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Based on a procedure by Tararov et al.
[74] 
Meldrum's acid (30.0 g, 208 mmol, 1.0 equiv.) and 
2-(trimethylsilyl)ethanol (280) (36.8 g, 312 mmol, 1.5 equiv.) were heated at 100 °C for 8 h. 
The reaction was quenched with a saturated aqueous solution of NaHCO3 (200ml) and the 
resulting solution stirred for 8 h at rt. The reaction mixture was extracted with Et2O : hexanes 
(1:1, 3 x 150 mL), the aqueous acidified to pH 3 using 1 M HCl, extracted with EtOAc (3 x 
200 mL), dried (MgSO4) and rotary evaporated to afford carboxylic acid 281
[203]
 (38.0 g, 
90%) as a yellow oil:  
Rf 0.45 (1 : 1 Et2O : pentane);  
IR (neat) vmax 2954 (m, C-H), 1736 (s, C=O), 1380 (w), 1322 (w), 1249 (m), 1217 (w), 1151 
(m) cm
-1
;  
HRMS (EI) calc. for C8H16O4Si [M+H]
+: requires 204.0818, found 204.0826 (Δ +3.9 ppm);  
1
H NMR (CDCl3, 400 MHz)  9.68 (br. s, 1H, 1), 4.30 (t, J = 8.0 Hz, 2H, 5), 3.44 (s, 2H, 4), 
1.06 (t, J = 8.0 Hz, 2H, 6), 0.07 (s, 9H, 7);  
13
C NMR (CDCl3, 100 MHz)  167.8 (2), 166.9 (4), 64.7 (5), 40.3 (3), 17.2 (6), –1.6 (3C, 7). 
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2-(Trimethylsilyl)ethyl 4-(2,2-dimethyl-4-oxo-4H-1,3-dioxin-6-yl)-3-oxobutanoate (278) 
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Based on a procedure by Navarro et al.
[82] Carboxylic acid 281 (3.0 g, 14.4 mmol, 1.0 equiv.) 
was stirred in CH2Cl2 (30 mL) for 1 min. Oxalyl chloride (2.5 mL, 28.8 mmol, 2.0 equiv.) 
and DMF (60 μL, 1.44 mmol, 0.1 equiv.) were added at 0 °C and the reaction mixture stirred 
for 30 min. The reaction mixture was rotary evaporated to afford acid chloride 279 (3.0 g, 
93%) which was used crude in the next step.  
n-BuLi in hexanes (18.0 mL, 44.6 mmol, 2.5 M, 3.1 equiv.) was added to HMDS (9.6 mL, 
46.1 mmol, 3.2 equiv.) in THF (500 mL) at –78 °C and the resulting solution stirred for 30 
min. Dioxinone 33 (5.7 mL, 43.2 mmol, 3.0 equiv.) was added dropwise and the resulting 
solution stirred for 1 h. Acid chloride 279 was added in THF (20 mL) and the resulting 
solution stirred for 1 h. The reaction mixture was quenched with a saturated aqueous solution 
of NH4Cl (20 mL), acidified to pH 2 using 1 M HCl, extracted with Et2O (2 x 300 mL), the 
organics combined, washed with brine (200 mL), dried (MgSO4), rotary evaporated and 
chromatographed (2 : 8 to 1 : 1 Et2O : pentane) to afford ketoester-dioxinone 278 (2.6 g, 
55%) as a yellow oil:  
Rf 0.45 (1 : 1 Et2O : pentane);  
IR (neat) vmax 2954 (w, C-H), 1719 (s, C=O), 1638 (m, C=C), 1390 (m), 1375 (m), 1319 
(m), 1271 (m), 1249 (m), 1201 (m), 1176 (sh.), 1015 (sh.) cm
-1
;  
HRMS (ESI) calc. for C15H23O6Si [M+H]
+: requires 327.1264, found 327.1287 (Δ +7.0 
ppm);  
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1
H NMR (CDCl3, 500 MHz)  5.34 (s, 1H, 2), 4.23-4.19 (m, 2H, 11), 3.48 (s, 2H, 9), 3.47 (s, 
2H, 7), 1.68 (s, 6H, 5 & 6), 1.00-0.97 (m, 2H, 12), 0.02 (s, 9H, 13);  
13
C NMR (CDCl3, 100 MHz)  195.7 (8), 166.4 (1), 163.6 (10), 160.4 (3), 107.2 (4), 96.9 
(2), 64.1 (11), 49.2 (9), 46.9 (7), 24.9 (2C, 5 & 6), 17.2 (12), –1.4 (3C, 13).  
 
2-(Trimethylsilyl)ethyl 2-acetyl-4-(2,2-dimethyl-4-oxo-4H-1,3-dioxin-6-yl)-3-
oxobutanoate (276) 
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Based on a procedure by Navarro et al.
[82] 
Ketoester-dioxinone 278 (470 mg, 1.41 mmol, 1.0 
equiv.) in CH2Cl2 (2 mL) was added to MgCl2 (353 mg, 2.50 mmol, 2.5 equiv.) and pyridine 
(0.31 mL, 3.81 mmol, 2.7 mmol) in CH2Cl2 (7 mL) at 0 °C for 20 min. Acetyl chloride (150 
μL, 2.12 mmol, 1.5 equiv.) was added dropwise and the resulting solution stirred for 30 min. 
The reaction mixture was quenched with a saturated aqueous solution of NH4Cl (50 mL), 
extracted with Et2O (2 x 50 mL), dried (MgSO4), rotary evaporated, chromatographed (1 : 1 : 
4 CH2Cl2 : EtOAc : pentane) to afford diketo-ester-dioxinone 276 (402 mg, 77%) as a yellow 
oil:  
Rf 0.65 (1 : 1 Et2O : pentane);  
IR (neat) vmax 2954 (w, C-H), 1730 (s, C=O), 1639 (m, C=C), 1391 (m), 1376 (m), 1272 
(m), 1250 (m), 1204 (w), 1071 (w), 1016 (w) cm
-1
;  
HRMS (CI) calc. for C17H27O7Si [M+H]
+
: 388.1792, found 388.1798 (Δ +1.5 ppm);  
6 Experimental 
278 
 
1
H NMR (CDCl3, 500 MHz)  17.58 (s, 1H, 16), 5.34 (s, 1H, 2), 4.31-4.28 (m, 2H, 11), 3.73 
(s, 2H, 7), 2.42 (s, 3H, 15), 1.70 (s, 6H, 5 & 6), 1.09-1.05 (m, 2H, 12), 0.07 (s, 9H, 13);  
13
C NMR (CDCl3, 125 MHz)  195.7 (14), 193.4 (8), 166.4 (1), 165.2 (10), 160.7 (3), 108.7 
(4), 107.2 (9), 96.5 (2), 63.5 (11), 43.1 (7), 25.5 (15), 24.9 (2C, 5 & 6), 17.6 (12), -1.6 (3C, 
13).  
 
(E)-3-Methyl-6-(5-(2-methylprop-1-enyl)furan-3-yl)hex-2-enyl acetate (277) 
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Based on a procedure by Tago et al.
[153] 
Alcohol 275 (30 mg, 0.13 mmol, 1.0 equiv.) was 
stirred in EtOAc (1.0 mL). K2CO3 (36 mg, 0.26 mmol, 2.0 equiv.), 1 micro stapula head tip 
of DMAP and Ac2O (24 μL, 0.26 mmol, 2.0 equiv.) were added and the resulting solution 
stirred for 2 h. The reaction mixture was filtered and the filtrate rotary evaporated. The 
resulting residue was suspended between EtOAc (20 mL) and a saturated aqueous solution of 
NaHCO3 (20 mL), the organics combined, washed with brine (10 mL), dried (MgSO4), rotary 
evaporated and chromatographed (3 : 7 Et2O : pentane) to afford acetate 277 (20 mg, 60%) as 
a clear gum:  
Rf 0.52 (2 : 8 Et2O : pentane);  
IR (neat) vmax 2938 (w, C-H), 1736 (s, C=O), 1442 (w), 1382 (w), 1233 (m), 1166 (w), 1023 
(m) cm
-1
;  
HRMS (EI) calc. for C17H24O3 [M+H]
+
: requires 276.1725, found 276.1739 ( +5.1 ppm);  
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1
H NMR (CDCl3, 400 MHz)  7.12 (s, 1H, 11), 6.06 (s, 1H, 12), 6.03 (s, 1H, 14), 5.37 (t, J = 
7.0 Hz, 1H, 4), 4.61 (d, J = 7.0 Hz, 2H, 3), 2.39 (t, J = 8.0 Hz, 2H, 9), 2.11-2.07 (m, 5H, 1 & 
7), 1.99 (s, 3H, 16 / 17), 1.91 (s, 3H, 16 / 17), 1.74-1.66 (m, 5H, 6 & 8);  
13
C NMR (CDCl3, 125 MHz)  171.1 (2), 153.7 (13), 142.0 (15), 136.8 (11), 134.9 (5), 126.2 
(10), 119.3 (4), 114.5 (14), 108.6 (12), 60.4 (3), 38.7 (7), 26.9 (8), 25.8 (9), 25.3 (17), 24.6 
(1), 24.4 (16), 22.2 (6).  
 
 (E)-2-(Trimethylsilyl)ethyl 7-hydroxy-2,2,5-trimethyl-8-(3-methyl-6-(5-(2-methylprop-
1-enyl)furan-3-yl)hex-2-enyl)-4-oxo-4H-benzo[d][1,3]dioxine-6-carboxylate (283) 
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Furan acetate 277 (80 mg, 0.29 mmol, 1.0 equiv.) and diketo-ester-dioxinone 276 (90 mg, 
0.24 mmol, 1.2 equiv.) were stirred in THF (3 mL). Pd(PPh3)4 (27 mg, 24 μmol, 0.1 equiv.) 
was added and the resulting solution stirred for 48 h. TBAF in THF (1.45 mL, 1.0 M, 1.45 
mmol, 5.0 equiv.) was added and the resulting solution heated at 55 °C for 2 h. The reaction 
was quenched with a saturated aqueous solution of NH4Cl (50 mL), extracted with Et2O (2 x 
50 mL), the organics combined, washed with brine (20 mL), dried (MgSO4), rotary 
evaporated and chromatographed (2 : 8 Et2O : pentane) to afford furan-resorcylate 283 (89 
mg, 65%) as a colourless oil:  
Rf 0.70 (3 : 7 Et2O : pentane);  
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IR (neat) vmax 2933 (m, C-H), 1733 (sh., C=O), 1653 (sh., C=C), 1584 (sh., C-C), 1448 (w), 
1387 (w), 1265 (sh.), 1234 (sh.), 1173 (w), 1031 (w) cm
-1
;  
HRMS (CI) calc. for C32H45O7Si [M+H]
+: requires 425.2328, found 425.2319 (Δ –2.1 ppm);  
1
H NMR (CDCl3, 400 MHz) δ 11.92 (s, 1H, 31), 7.05 (s, 1H, 24), 6.01 (s, 1H, 25), 5.99 (br. 
s, 1H, 27), 5.16-5.12 (m, 1H, 17), 4.49-4.45 (m, 2H, 13), 3.31 (d, J = 7.0 Hz, 2H, 16), 2.88 (s, 
3H, 7), 2.32 (t, J = 8.0 Hz, 2H, 22), 1.99 (t, J = 8.0 Hz, 2H, 20), 1.88 (s, 3H, 30), 1.76 (s, 3H, 
29), 1.69 (s, 3H, 19), 1.68 (s, 6H, 10 & 11), 1.60-1.56 (m, 2H, 21), 1.21-1.15 (m, 2H, 14), 
0.09 (s, 9H, 15);  
13
C NMR (CDCl3, 100 MHz) δ 171.7 (12), 164.6 (8), 160.3 (2), 158.0 (4), 153.6 (26), 146.7 
(28), 136.7 (6), 135.5 (24), 134.8 (18), 126.4 (23), 121.3 (17), 115.4 (3), 114.5 (27), 110.8 
(25), 108.7 (5), 106.4 (1), 104.6 (9), 64.8 (13), 39.2 (20), 28.1 (21 / 22), 26.9 (22 / 21), 25.8 
(2C, 10 & 11), 24.4 (29), 20.3 (30), 20.1 (2C, 7 & 16), 17.5 (14), 16.0 (19), -1.6 (3C, 15).  
 
(2E,6E)-3,7,11-Trimethyldodeca-2,6,10-trienyl acetate (284) 
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Based on a procedure by Tago et al.
[153] 
Farnesyl alcohol 285 (1.0 g, 4.5 mmol, 1.0 equiv.) 
was stirred in EtOAc (35 mL), K2CO3 (1.24 g, 9.0 mmol, 2.0 equiv.), 1 micro spatula head tip 
of DMAP (cat.) and Ac2O (0.85 mL, 9.0 mmol, 2.0 equiv.) were added and the resulting 
solution stirred for 18 h. The reaction mixture was filtered and the filtrate rotary evaporated. 
The resulting residue was suspended between EtOAc (100 mL) and a saturated aqueous 
solution of NaHCO3 (100 mL), the organics combined, washed with brine (50 mL), dried 
(MgSO4) and rotary evaporated to afford acetate 284
[203]
 (1.0 g, 85%) as a colourless oil:  
Rf 0.9 (1 : 9 Et2O : pentane);  
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IR (neat) vmax 2970 (m, C-H), 2924 (m, C-H), 1740 (s, C=O), 1441 (w), 1365 (m), 1228 (s), 
1021 (w), 954 (w) cm
-1
;  
HRMS (EI) calc. for C17H28O2 [M+H]
+: requires 264.2089, found 264.2094 (Δ +1.9 ppm);  
1
H NMR (CDCl3, 400 MHz)  5.36 (t, J = 7.0 Hz, 1H, 4), 5.12 (br. s, 2H, 9 & 14), 4.61 (d, J 
= 7.0 Hz, 2H, 3), 2.15-2.05 (m, 9H, 1, 7, 8, 12, 13), 1.73 (s, 3H, 6), 1.70 (s, 3H, 11), 1.62 (s, 
6H, 16 & 17);  
13
C NMR (CDCl3, 100 MHz)  171.1 (2), 142.3 (5), 135.5 (10), 131.3 (15), 124.3 (9), 123. 
(14), 118.2 (4), 61.4 (3), 39.7 (12), 39.5 (7), 26.7 (8), 26.2 (13), 25.7 (17), 21.1 (1), 17.7 (16), 
16.5 (11), 16.0 (6).  
 
2-(Trimethylsilyl)ethyl 7-hydroxy-2,2,5-trimethyl-4-oxo-8-((2E,6E)-3,7,11-
trimethyldodeca-2,6,10-trienyl)-4H-benzo[d][1,3]dioxine-6-carboxylate (285) 
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Acetate 284 (120 mg, 0.45 mmol, 1.0 equiv.) and diketo-ester-dioxinone 276 (200 mg, 0.54 
mmol, 1.2 equiv.) were stirred in THF (3 mL). Pd(PPh3)4 (52 mg, 45 μmol, 0.1 equiv.) was 
added and the resulting solution stirred for 36 h. The reaction was quenched with a saturated 
aqueous solution of NH4Cl (50 mL), extracted with Et2O (2 x 50 mL), the organics combined, 
washed with brine (20 mL), dried (MgSO4), rotary evaporated and chromatographed (2 : 8 
Et2O : pentane) to afford silylester-farnesyl-resorcylate 285 (150 mg, 60%) as a colourless 
oil:  
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Rf 0.65 (2 : 8 Et2O : pentane);  
IR (neat) vmax 2917 (w, C-H), 1731 (m, C=O), 1654 (sh., C=C), 1584 (sh., C-C), 1448 (w), 
1387 (w), 1298 (m), 1265 (m), 1235 (m), 1172 (w), 1033 (w) cm
-1
;  
HRMS (ESI) calc. for C32H47O6Si [M+H]
+: requires 555.3142, found 555.3119 (Δ –4.1 
ppm);  
1
H NMR (CDCl3, 500 MHz)  11.88 (s, 1H, 31), 5.15 (t, J = 7.0 Hz, 1H, 17), 5.08-5.05 (m, 
2H, 22 & 27), 4.49-4.45 (m, 2H, 13), 3.31 (d, J = 7.0 Hz, 2H, 16), 2.88 (s, 3H, 7), 2.07-1.91 
(m, 8H, 20, 21, 25, 26), 1.77 (s, 3H, 19), 1.69 (s, 6H, 24 & 30), 1.66 (s, 3H, 29), 1.57 (s, 3H, 
10 / 11), 1.56 (s, 3H, 10 / 11), 1.19-1.16 (m, 2H, 14), 0.05 (s, 9H, 15);  
13
C NMR (CDCl3, 125 MHz)  171.6 (12), 164.6 (8), 160.2 (2), 158.0 (4), 146.6 (6), 135.8 
(18), 135.0 (23), 131.2 (28), 124.3 (22), 124.0 (27), 121.0 (17), 115.4 (3), 110.8 (5), 106.4 
(1), 104.5 (9), 64.7 (13), 39.7 (2C, 20 & 25), 26.6 (2C, 21 & 26), 25.7 (3C, 10, 11 & 30), 21.8 
(16), 20.2 (29), 17.6 (14), 17.5 (7), 16.1 (2C, 19 & 24), -1.6 (3C, 15). 
 
3-Oxo-3-((2E,6E)-3,7,11-trimethyldodeca-2,6,10-trienyloxy)propanoic acid (295) 
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Based on a procedure by Tararov et al.
[74] 
Meldrum's acid (6.5 g, 45 mmol, 1.0 equiv.) and 
farnesyl 285 (11 mL, 45 mmol, 1.0 equiv.) were heated at 80 
o
C for 6 h. The reaction was 
quenched with a saturated aqueous solution of NaHCO3 (100 mL) and the resulting solution 
stirred for 30 min at rt. The reaction mixture was extracted with EtOAc (2 x 200 mL) and the 
aqueous acidified to pH 3 using 1 M HCl. The resulting aqueous was extracted with EtOAc 
(3 x 200 mL), the organics combined, dried (MgSO4) and rotary evaporated to afford 
carboxylic acid 295
[204]
 (11.0 g, 81%) as a colourless oil:  
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Rf 0.2 (1 : 9 MeOH : CH2Cl2);  
IR (neat) vmax 3521 (br., O-H), 2922 (m, C-H), 1719 (s, C=O), 1382 (m), 1151 (s) cm
-1
;  
HRMS (CI) calc. for C18H32NO4 [M+NH4]
+
: requires 326.2331, found 326.2328 (Δ –0.9 
ppm);  
1
H NMR (CDCl3, 400 MHz) δ 10.25 (br. s, 1H, 1), 5.37 (t, J = 7.0 Hz, 1H, 6), 5.11 (t, J = 7.0 
Hz, 2H, 11 & 16), 4.73 (d, J = 7.0 Hz, 2H, 5), 3.46 (s, 2H, 3), 2.14-1.97 (m, 8H, 9, 10, 14 & 
15), 1.71 (s, 3H, 19), 1.70 (s, 3H, 8 / 13), 1.62 (s, 6H, 8 / 13 & 18);  
13
C NMR (CDCl3, 100 MHz) δ 172.0 (2), 168.2 (4), 143.8 (7), 135.6 (12), 131.4 (17), 124.3 
(11), 123.5 (16), 117.2 (6), 63.0 (5), 40.1 (3), 39.7 (14), 39.5 (9), 26.7 (15), 26.1 (10), 25.7 
(19), 17.7 (18), 16.5 (13), 16.0 (8).  
 
(2E,6E)-3,7,11-Trimetyldodeca-2,6,10-trienyl 4-(2,2-dimethyl-4-oxo-4H-1,3-dioxin-6-yl)-
3-oxobutanoate (293) 
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Based on a procedure by Navarro et al.
[82] 
Acid 295 (4.0 g, 13 mmol, 1.0 equiv.) was stirred 
in CH2Cl2 (40 mL) and amylene (44.0 mL, 400 mmol, 30 equiv.) at 0 °C for 5 min. Oxalyl 
chloride (1.4 mL, 16 mmol, 1.2 equiv.) and 4 small drops of DMF (cat.) were added and the 
reaction mixture stirred for 30 min at 0 °C followed by 30 min at rt.  The reaction mixture 
was rotary evaporated to afford acid chloride 294 as a yellow oil which was used without 
further purification.  
 
HMDS (8.7 mL, 42 mmol, 3.2 equiv.) was stirred in THF (300 mL) at –78 °C. n-BuLi in 
hexanes (16.2 mL, 41.0 mmol, 2.5 M, 3.1 equiv.) was added dropwise and the mixture stirred 
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for 30 min. Dioxinone 33 (5.2 mL, 40 mmol, 3.0 equiv.) was added dropwise and the solution 
was stirred for 1 h. Acid chloride 294 in THF (10 mL) was added dropwise to the stirring 
solution. The reaction mixture was stirred for 2 h and then quenched with a saturated aqueous 
solution of NH4Cl (150 mL), acidified to pH 3 utilising 1 M HCl and extracted with EtOAc 
(3 x 100 mL). The organics were combined, washed with brine (100 mL), dried (MgSO4), 
rotary evaporated and chromatographed (7 : 3 hexanes : Et2O) to afford keto-farnesylester-
dioxinone 293 (1.09 g, 65%) as a yellow oil:  
Rf 0.35 (1 : 2 hexanes : Et2O);   
IR (neat) vmax 2917 (w, C-H), 1722 (sh., C=O), 1638 (m, C=C), 1374 (m), 1271 (sh.), 1203 
(sh.), 1015 (sh.) cm
-1
;  
HRMS (EI) calc. for C25H36O6 [M+H]
+: requires 432.2512, found 432.2518 (Δ +1.4 ppm);  
1
H NMR (CDCl3, 400 MHz) δ 5.38-5.32 (m, 2H, 2 & 12), 5.12-5.09 (m, 2H, 17 & 22), 4.69 
(d, J = 7.0 Hz, 2H, 11), 3.53 (s, 2H, 9), 3.52 (s, 2H, 7), 2.14-1.97 (m, 8H, 15, 16, 20 & 21), 
1.73 (s, 9H, 14, 19 & 25), 1.70 (s, 3H, 24), 1.62 (s, 6H, 5 & 6);  
13
C NMR (CDCl3, 100 MHz) δ 195.7 (8), 166.4 (1), 163.5 (10), 143.7 (13), 135.6 (3), 131.4 
(18), 124.3 (23), 123.4 (17), 117.8 (22), 117.3 (12), 107.2 (4),4? 97.1 (2), 62.6 (11), 49.1 (9), 
46.9 (7), 39.5 (20), 39.4 (15), 26.7 (16), 26.2 (21), 25.7 (25), 24.9 (2C, 5 & 6), 17.7 (24), 16.5 
(19), 16.0 (14).  
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(2E,6E)-3,7,11-Trimethyldodeca-2,6,10-trienyl 2-acetyl-4-(2,2-dimethyl-4-oxo-4H-1,3-
dioxin-6-yl)-3-oxobutanoate (292) 
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Based on a procedure by Navarro et al.
[82] 
Keto-farnesylester-dioxinone 293 (2.0 g, 4.6 mmol, 
1.0 equiv.) in CH2Cl2 (10 mL) was added to a solution of MgCl2 (1.10 g, 11.5 mmol, 2.5 
equiv.) and pyridine (1.0 mL, 12.5 mmol, 2.7 equiv.) in CH2Cl2 (13 mL) and the resulting 
solution stirred at 0 °C for 20 min. Acetyl chloride (0.5 mL, 7.0 mmol, 1.5 equiv.) was added 
and the mixture stirred for 30 min at 0 °C and 30 min at rt. The reaction mixture was 
quenched with a saturated aqueous solution of NH4Cl (100 mL), extracted with Et2O (2 x 100 
mL), the organics combined, dried (MgSO4) and rotary evaporated to afford diketo-
farnesylester-dioxinone 292 (2.1 g, 98%) as a yellow oil:  
Rf 0.61 (7 : 3 Et2O : pentane);  
IR (neat) vmax 3923 (w, C-H), 1729 (s, C=O), 1709 (s, C=O), 1638 (m, C=C), 1390 (m), 
1374 (s), 1270 (sh.), 1203 (sh.), 1069 (m), 1014 (sh.) cm
-1
;  
HRMS (ESI) calc. for C27H38O7Na [M+Na]
+: requires 497.2515, found 497.2516 (Δ +0.2 
ppm);  
1
H NMR (CDCl3, 400 MHz) δ 17.61 (s, 1H, 28), 5.42 (t, 1H, J = 7.0 Hz, 12), 5.36 (s, 1H, 2), 
5.11 (br. s, 2H, 17 & 22), 4.77 (d, J = 7.0 Hz, 2H, 11), 3.75 (s, 2H, 7), 2.43 (s, 3H, 27), 2.16-
1.97 (m, 8H, 15, 16, 20 & 21), 1.77 (s, 3H, 25), 1.72 (s, 6H, 14 & 19), 1.70 (s, 3H, 24), 1.62 
(s, 6H, 5 & 6);  
13
C NMR (CDCl3, 100 MHz) δ 195.8 (26), 193.5 (8), 165.2 (1), 160.8 (10), 143.6 (13), 135.7 
(3), 132.5 (18), 124.2 (23), 123.4 (17), 117.6 (22), 108.5 (12), 107.2 (4), 96.5 (2C, 2 & 9), 
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61.9 (11), 43.1 (7), 39.5 (2C, 15 & 20), 26.7 (27), 26.2 (16), 25.7 (21), 25.5 (25), 25.0 (2C, 5 
& 6), 17.7 (24), 16.6 (14 / 19), 16.0 (14 / 19).  
 
7-Hydroxy-2,2,5-trimethyl-8-((2E,6E)-3,7,11-trimethyldodeca-2,6,10-trienyl)-4H-
benzo[d][1,3]dioxin-4-one (286) 
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Diketo-farnesylester-dioxinone 292 (900 mg, 2.11 mmol, 1.0 equiv.) was stirred in THF (20 
mL), Pd(PPh3)4 (244 mg, 0.21 mmol, 0.1 equiv.) and Cs2CO3 (2.1 g, 6.3 mmol, 3.0 equiv.) 
were added and the resulting solution stirred at 0 °C. The reaction mixture was allowed to 
warm to rt and stirred for 2h. The reaction mixture was quenched with a saturated aqueous 
solution of NH4Cl (100 mL), extracted with Et2O (2 x 50 mL), the organics combined, dried 
(MgSO4), rotary evaporated and chromatographed (3 : 7 Et2O : pentane) to afford farnesyl-
resorcylate 286 (574 mg, 66%) as a pale yellow solid. 
m.p. 180-184 °C (pentane);  
Rf 0.40 (1 : 1 Et2O : pentane);  
IR (neat) vmax 3282 (br., O-H), 2924 (m, C-H), 2854 (m, C-H), 1728 (sh., C=O), 1696 (sh., 
C=O), 1607 (sh., C=C), 1514 (sh., C-C), 1451 (m), 1410 (m), 1376 (m), 1275 (s), 1209 (s), 
1166 sh.), 1107 (sh.), 1044 (w) cm
-1
;  
HRMS (ESI) calc. for C26H35O4 [M+H]
+: requires 411.2542, found 411.2535 (Δ +1.7 ppm);  
1
H NMR (CDCl3, 400 MHz)  6.39 (s, 1H, 12), 5.86 (s, 1H, 5), 5.21-5.19 (m, 1H, 14), 5.09-
5.05 (m, 2H, 19 & 24), 3.33 (d, J = 8.0 Hz, 2H, 13), 2.59 (s, 3H, 7), 2.13-1.94 (m, 8H, 17, 18, 
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22, & 23), 1.80 (s, 3H, 16), 1.68 (s, 6H, 21 & 27), 1.67 (s, 3H, 26), 1.59 (s, 3H, 10 / 11), 1.58 
(s, 3H, 10 / 11);   
13
C NMR (CDCl3, 125 MHz)  160.9 (8), 160.0 (4), 156.0 (2), 142.9 (6), 139.0 (15), 135.7 
(20), 131.3 (25), 124.3 (19), 123.5 (24), 120.7 (14), 113.6 (3), 112.5 (5), 105.5 (1), 104.8 (9), 
39.7 (2C, 17 & 22), 26.7 (2C, 18 & 23), 26.3 (27), 25.7 (2C, 10 & 11), 21.9 (2C, 7 & 13), 
17.7 (26), 16.2 (2C, 16 & 21). 
 
Methyl 2,4-dihydroxy-6-methyl-3-((2E,6E)-3,7,11-trimethyldodeca-2,6,10-
trienyl)benzoate (300) 
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Diketo-farnesyl-resorcylate 286 (70 mg, 0.17 mmol, 1.0 equiv.) and Cs2CO3 (110 mg, 0.34 
mmol, 2.0 equiv.) in MeOH (2 mL) were heated at 60 
o
C in a sealed tube for 72 h. The 
reaction mixture was quenched with a saturated aqueous solution of NH4Cl (10 mL), 
extracted with Et2O (2 x 10 mL), the organics combined, dried (MgSO4), rotary evaporated 
and chromatographed (1 : 1 Et2O : pentane) to afford farnesyl-resorcylate 300 (68 mg, 94%) 
as a yellow oil:  
Rf 0.66 (7 : 3 Et2O : pentane);  
IR (neat) vmax 3408 (br., O-H), 2916 (m, C-H), 2854 (m, C-H), 1649 (sh., C=C), 1618 (sh., 
C=C), 1438 (m), 1318 (m), 1270 (s), 1196 (m), 1155 (sh.) cm
-1
;  
HRMS (ESI) calc. for C24H33O4 [M+H]
+: requires 385.2379, found 385.2377 (Δ –0.5 ppm);  
1
H NMR (CDCl3, 500 MHz) δ 12.08 (s, 1H, 25), 6.22 (s, 1H, 26), 5.78 (s, 1H, 5), 5.29-5.26 
(m, 1H, 11), 5.10-5.05 (m, 2H, 16 & 21), 3.43 (d, J = 7.0 Hz, 2H, 10), 3.02 (s, 3H, 9), 2.46 (s, 
3H, 7), 2.14-1.95 (m, 8H, 14, 15, 19 & 20), 1.81 (s, 3H, 24), 1.67 (23), 1.59 (2C, 13 & 18);   
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13
C NMR (CDCl3, 125 MHz) δ 172.7 (8), 162.6 (4), 159.5 (2), 140.8 (6), 139.2 (12), 135.6 
(17), 131.3 (22), 124.4 (16), 123.6 (21), 121.4 (11), 111.4 (3), 111.3 (1), 105.1 (5), 51.8 (9), 
39.7 (2C, 14 & 19), 26.7 (15), 26.3 (20), 25.7 (24), 24.1 (7), 22.0 (10), 17.7 (23), 16.3, 16.0 
(2C, 13 & 18).  
 
7-(t-Butyldiphenylsilyloxy)-2,2,5-trimethyl-8-((2E,6E)-3,7,11-trimethyldodeca-2,6,10-
trienyl)-4H-benzo[d][1,3]dioxin-4-one (301) 
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Resorcylate 286 (260 mg, 0.63 mmol, 1.0 equiv.) and imidazole (65 mg, 0.94 mmol, 1.5 
equiv.) were stirred in CH2Cl2 (4 mL), TBDPSCl (0.2 mL, 0.76 mmol, 1.2 equiv.) was added 
dropwise and the resulting solution stirred for 12 h. The reaction was quenched with a 
saturated aqueous solution of NH4Cl (50 mL), extracted with Et2O (2 x 50 mL), the organics 
combined, dried (MgSO4), rotary evaporated and chromatographed (1 : 9 Et2O : pentane) to 
afford silylether 301 (360 mg, 88%) as a colourless oil:  
Rf 0.70 (1 : 9 Et2O : pentane);  
IR (neat) vmax 2930 (w, C-H), 2857 (w, C-H), 1733 (w, C=O), 1606 (sh., C=C), 1569 (sh., 
C-C), 1428 (w), 1319 (w), 1113 (s), 1169 (w) cm
-1
;  
HRMS (ESI) calc. for C42H55O4Si [M+H]
+
: requires 651.3870, found 651.3878 ( +1.2 
ppm);  
1
H NMR (CDCl3, 400 MHz) δ 7.74-7.71 (m, 4H, 32), 7.43-7.39 (m, 6H, 31 & 33), 5.99 (s, 
1H, 5), 5.27 (t, J = 7.0 Hz, 1H, 14), 5.14-5.07 (m, 2H, 19 & 24), 3.47 (d, J = 7.0 Hz, 2H, 13), 
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2.23 (s, 3H, 7), 2.13-1.96 (m, 8H, 17, 18, 22 & 23), 1.81 (s, 3H, 27), 1.69 (br. s, 9H, 10, 11 & 
26), 1.60 (br. s, 16 & 21), 1.13 (s, 9H, 29);  
13
C NMR (CDCl3, 100 MHz) δ 160.9 (8), 158.7 (4), 156.2 (2), 141.5 (6), 132.0 (15), 131.3 
(20), 130.2 (25), 129.7 (2C, 30), 128.0 (4C, 32), 127.7 (6C, 31 & 33), 124.3 (19), 124.1 (24), 
121.9 (14), 118.0 (3), 106.0 (5), 104.7 (2C, 9 & 1), 39.7 (2C, 17 & 22), 26.5 (3C, 29), 25.8 
(18), 25.7 (23), 22.4 (27), 21.8 (2C, 10 & 11), 19.6 (2C, 7 & 13), 19.0 (28), 17.7 (26), 16.4 
(16 / 21), 16.0 (16 / 21). 
 
2-(Trimethylsilyl)ethyl 2,4-dihydroxy-6-methyl-3-((2E,6E)-3,7,11-trimethyldodeca-
2,6,10-trienyl)benzoate (303) 
3
4
5
6
1
2
OH
28
8 O
O
9
10
Si
11
7HO27
12
13
14
16
15
17
18
19
21
20
22
23
24
26
25
303  
Isopropylidene protected resorcylate 286 (16 mg, 40 μmol, 1.0 equiv.) and Cs2CO3 (25 mg, 
76 μmol, 2.0 equiv.) were heated in a sealed tube with HOCH2CH2OTMS 280 (0.5 mL) and 
THF (0.25 mL) for 18 h. The reaction mixture was quenched with a saturated aqueous 
solution of NH4Cl (20 mL), extracted with Et2O (2 x 20 mL), the organics combined, dried 
(MgSO4), rotary evaporated and chromatographed (2 : 8 Et2O : hexanes to Et2O) to afford 
resorcylate 303 (19 mg, 75%) as a colourless oil: 
Rf 0.85 (2 : 8 Et2O : hexanes);  
IR (neat) vmax 3460 (w, O-H), 2970 (m, C-H), 2947 (m, C-H), 1738 (s, C=O), 1436 (w), 
1366 (s), 1217 (s), 1206 (m) cm
-1
;  
HRMS (ESI) calc. for C28H45O4Si [M+H]
+
: requires 473.3087, found 473.3081 ( –1.3 
ppm);  
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1
H NMR (CDCl3, 500 MHz) δ 12.02 (s, 1H, 27), 6.21 (s, 1H, 28), 5.76 (s, 1H, 5), 5.28-5.26 
(m, 1H, 13), 5.09-5.05 (m, 2H, 18 & 23), 4.43-4.40 (m, 2H, 9), 3.44 (d, J = 7.0 Hz, 2H, 12), 
2.48 (s, 3H, 7), 2.12-1.95 (m, 8H, 16, 17, 21 & 22), 1.81 (s, 3H, 26), 1.67 (s, 3H, 25), 1.59 (s, 
3H, 15 / 20), 1.58 (s, 3H, 15 / 20), 1.18-1.14 (m, 2H, 10), 0.08 (s, 9H, 11);  
13
C NMR (CDCl3, 125 MHz) δ 172.4 (8), 162.6 (4), 159.3 (2), 140.9 (6), 138.9 (14), 135.6 
(19), 131.3 (24), 124.4 (18), 123.6 (23), 121.5 (13), 111.3 (3C, 1, 3 & 5), 63.6 (9), 39.7 (2C, 
16 & 21), 26.7 (17), 26.3 (22), 25.7 (26), 24.3 (7), 22.0 (12), 17.7 (25), 16.3 (10), 16.1 (2C, 
15 & 20), -1.5 (3C, 11). 
 
Methyl 2,4-dihydroxy-6-methyl-3-(3-methylbut-2-enyl)benzoate (308) 
3
4
5
6
1
2
OH
15
8
O
7HO16
10
11
12
14
13
OMe 9
308  
Isopropylidene protected resorcylate 142 (50 mg, 0.17 mmol, 1.0 equiv.) and Cs2CO3 (110 
mg, 0.34 mmol, 2.0 equiv.) were heated in a sealed tube with MeOH (1 mL) for 18 h. The 
reaction mixture was quenched with a saturated aqueous solution of NH4Cl (20 mL), 
extracted with Et2O (2 x 20 mL), the organics combined, dried (MgSO4), rotary evaporated 
and chromatographed (3 : 7 Et2O : hexanes) to afford methylester 308
[69]
 (38 mg, 90%) as a 
white solid:  
m.p. 75 - 77 
o
C (pentane);  
Rf 0.55 (1 : 1 Et2O : hexanes);  
IR (neat) vmax 2988 (w, C-H), 1746 (m, C=O), 1372 (m), 1216 (sh.) cm
-1
;  
HRMS (CI) calc. for C14H19O4 [M+H]
+
: requires 251.1283, found 251.1287 ( +1.6 ppm); 
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1
H NMR (CDCl3, 400 MHz) δ 12.11 (s, 1H, 16), 6.24 (s, 1H, 15), 5.75 (s, 1H, 5), 5.28 (t, J = 
7.0 Hz, 1H, 11), 3.94 (s, 3H, 9), 3.44 (d, J = 7.0 Hz, 2H, 10), 2.48 (s, 3H, 7), 1.84 (s, 3H, 14), 
1.77 (s, 3H, 13). 
13
C NMR (CDCl3, 100 MHz) δ 172.6 (8), 162.6 (4), 159.2 (2), 140.8 (6), 135.1 (12), 121.6 
(11), 111.4, 111.3 (3C, 1, 3 & 5) 51.8 (9), 25.8 (14), 24.1 (7), 22.1 (10), 17.9 (13). 
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6.3 Additional Experimental Procedures
XI
 
(R)-5-Hydroxy-2,2,8-trimethyl-3,4,8,9-tetrahydropyrano[3,4-g]chromen-6(2H)-one 
(122)
XII
 
O
O
OH
122
O
 
H2SiF6 in H2O (20% w/w; 50 μL, 80 μmol, 4.0 equiv.) was added with stirring to a solution 
of resorcylate 109 (10 mg, 20 μmol, 1.0 equiv.) in MeCN (4 mL) at 0 °C. After 15 min, the 
reaction mixture was heated at reflux for 45 min after which 1 micro spatula tip head of p-
TsOH (cat.) was added and the mixture heated at reflux for 2 h. The reaction was cooled to rt 
and quenched with a saturated aqueous solution of NaHCO3 (20 mL). The mixture was 
extracted with Et2O (3 x 25 mL), dried (MgSO4), concentrated by rotary evaporation and 
chromatographed (3 : 1 hexanes : Et2O) to afford tricyclic resorcylate 122 (3 mg, 51%) as a 
colourless solid:  
Rf 0.49 (3 : 1 hexanes : Et2O);  
25
D][ = +33.00 (c 0.2, CHCl3);  
IR (neat) vmax 3432 (O-H), 2925 (C-H), 1659 (C=C), 1634 (C=C), 1584 (C-C), 1434, 1370, 
1311, 1253, 1235, 1157, 1118, 1041 cm
-1
;  
HRMS (ESI) calc. for C15H19O4 [M + H]
+
: requires 263.1283; found 263.1294; 
                                                          
XI
The additional experimental procedures were carried out by colleagues within the Barrett 
group. They have been added into this thesis for clarity and to aid the reader. Each 
experiment is clearly labelled with the name of the person that conducted it. These colleagues 
are duly thanked for their contribution to this research.  
XII
 This experiment was carried out by Toni Pfaffeneder under the supervision of Dr 
Frederick Calo. They are duly thanked for their contribution to this research.  
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1
H NMR (400 MHz,CDCl3) δ 11.47 (s, 1H), 6.14 (s, 1H), 4.67 – 4.61 (m, 1H), 2.82–2.80 (m, 
2H), 2.68-2.65 (m, 2H), 1.82-1.80 (m, 2H), 1.49 (d, J = 6.4 Hz, 3H), 1.34 (s, 3H), 1.33 (s, 
3H);  
13
C NMR (100 MHz, CDCl3) δ 161.8 (2C), 137.8 (2C), 107.5, 100.1 (2C), 75.6 (2C), 34.6, 
31.8, 26.8, 26.6, 20.8, 16.3. 
 
7-Hydroxy-2,2-dimethyl-8-(2-methylbut-3-en-2-yl)-5-phenethyl-4Hbenzo[ 
d][1,3]dioxin-4-one (149)
XIII
 
HO
OO
O
149  
Diketo-dioxinone 148 (50 mg, 0.13 mmol, 1.0 equiv.) and Cs2CO3 (85 mg, 0.26 mmol, 2.0 
equiv.) in THF (5 mL) were heated to reflux for 5 h. The reaction was quenched with H2O 
(10 mL), and the mixture acidified to pH 3 with 1 M HCl and extracted with EtOAc (3 x 15 
mL). The combined organic extracts were dried (MgSO4), filtered, rotary evaporated and 
chromatographed (1 : 9 EtOAc : hexanes) to afford phenol 149 (32 mg, 68%) as a white 
solid: 
m.p. = 103-105 °C (hexanes);  
Rf 0.64 (1 : 4 EtOAc : hexanes);  
IR (neat) νmax 3213 (O-H), 2986 (C-H), 1693 (C=O), 1684 (C=C), 1593 (C-C), 1497, 1400, 
1298, 1209, 1070, 884 cm
-1
;  
HRMS (ESI) calc. for C23H27O4 [M+H]
+
: requires 367.1904; found [M+H]+ 367.1896; 
                                                          
XIII
 This experiment was carried out by Dr Sylvain Laclef. He is duly thanked for his 
contribution to this research. 
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1
H NMR (CDCl3, 500 MHz) δ 7.29 - 7.27 (m, 4H), 7.18 (m, 1H), 7.11 (s, 1H), 6.41 (dd, J = 
10.6, 17.8 Hz, 1H), 6.41 (s, 1H), 5.44 (d, J = 17.8 Hz, 1H), 5.37 (d, J = 10.6 Hz, 1H), 3.26 
(m, 2H), 2.87 (m, 2H), 1.70 (s, 6H), 1.53 (s, 6H);  
13
C NMR (CDCl3, 125 MHz) δ 160.5, 160.4, 157.1, 148.9, 146.7, 142.0, 128.6, 128.3 (2C), 
125.8 (2C), 117.6, 115.3, 113.6, 106.1, 104.0, 40.9, 37.1, 36.6, 27.5 (2C), 25.5 (2C). 
 
Amorfrutin A: 2-Hydroxy-4-methoxy-3-(3-methyl-2-buten-1-yl)-6-phenethylbenzoic 
acid (8)
XIV
 
OOH
OMe
MeO
(8)  
KOH (48%, 0.62 mL, 5.3 mmol, 10.0 equiv.) was added to lactone 299 (200 mg, 0.52 mmol, 
1.0 equiv.) in DMSO (1 mL) and the mixture was heated at 80 °C for 12 h. After cooling, the 
mixture was acidified to pH 1 using 1 M HCl and extracted with EtOAc (2 x 15 mL). The 
combined organic layers were dried (MgSO4), filtered, rotary evaporated and 
chromatographed (1 : 1 hexanes : EtOAc) to afford amorfrutin A (8)
[10a] 
(149 mg, 83%) as a 
white solid:  
m.p. = 139-141 °C (cyclohexane); 
Rf 0.43 (EtOAc : hexanes 1 : 1);  
IR (neat) vmax 2867 (C-H), 1630 (C=C), 1611 (C=C), 1571 (C-C), 1496, 1454 1436, 1226, 
1112 cm
-1
;  
HRMS (ESI) calc. for C21H24O4 [M + H]
+
: requires 341.1753, found 341.1753;  
                                                          
XIV
 This experiment was carried out by Dr Sylvain Laclef. He is duly thanked for his 
contribution to this research. 
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1
H NMR (CDCl3, 500 MHz) δ 11.6 (s, 1H), 7.34 - 7.20 (m, 5H), 6.22 (s, 1H), 5.20 (m, 1H), 
3.80 (s, 3H), 3.35 (d, J = 7.1 Hz, 2H), 3.26 (d, 2H), 2.92 (m, 2H), 1.79 (s, 3H), 1.68 (s, 3H);  
13
C NMR (CDCl3, 125 MHz) δ 175.4, 162.9, 162.1, 145.7, 141.9, 131.8, 128.5 (2C), 128.3 
(2C), 125.9, 122.2, 115.3, 106.4, 103.6, 55.5, 39.2, 38.1, 25.8, 22.0, 17.8;  
Anal. Calc. for C21H24O4: C, 74.09; H, 7.11. Found C, 73.94; H, 7.02.  
 
7-Hydroxy-2,2-dimethyl-8-(3-methylbut-2-enyl)-5-phenethyl-4H-benzo[d][1,3]dioxin-4-
one (171) and 7-hydroxy-2,2-dimethyl-8-(]1-
2
H2]-3-methylbut-2-enyl)-5-phenethyl-4H-
benzo[d][1,3]dioxin-4-one (170) and 7-hydroxy-5-(4-methoxyphenethyl)-2,2-dimethyl-8-
([1-
2
H2]-3-methylbut-2-enyl)-4H-benzo[d][1,3]dioxin-4-one (172) and 7-hydroxy-5-(4-
methoxyphenethyl)-2,2-dimethyl-8-(3-methylbut-2-enyl)-4H-benzo[d][1,3]dioxin-4-one 
(173)
XV
  
OO
O
HO
OMe
OO
O
HO
OMe
D DOO
O
HO
OO
O
HO
D D
172 173171170
 
Diketo-ester-dioxinone 168
 
(186 mg, 0.43 mmol, 1.0 equiv.) and deuterated-diketo-ester-
dioxinone 169 (200 mg, 0.43 mmol, 1.0 equiv.) were added to a stirring solution of Pd(PPh3)4 
(25 mg, 20 μmol, 5 mol%) and Cs2CO3 (42 mg, 0.13 mmol, 3.0 equiv.) in THF (2 mL) at 0 
°C. The resulting mixture was allowed to warm to rt and stirred for 12 h. The reaction was 
quenched with a saturated aqueous solution of NH4Cl (10 mL) and extracted with Et2O (2 x 
10 mL). The organics were combined, dried (MgSO4) and rotary evaporated. The crude 
                                                          
XV
 This experiment was carried out by Dr Sylvain Laclef. He is duly thanked for his 
contribution to this research. 
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residue was chromatographed (1 : 9 EtOAc : hexanes) to afford prenyl-phenyl-resorcylate 
170 and deuterated-prenyl-phenyl-resorcylate 171 (110 mg, 70%) in a 1:1 ratio as a white 
solid and deuterated-prenyl-methoxy-resorcylate 172 and prenyl-methoxy-resorcylate 173 
(119 mg, 70%) as a 1:1 ratio as a white solid. 
Prenyl-phenyl-resorcylate 170 and deuterated-prenyl-phenyl-resorcylate 171: 
m.p. 119-120 
o
C (hexanes);  
Rf  0.81 (3 : 1 EtOAc : hexanes);  
IR (neat) vmax  2997 (C-H), 2930 (C-H), 1689 (C=O), 1593 (C=C), 1512 (C-C), 1419, 1300, 
1213, 909 cm
-1
; 
171: HRMS (ESI) cal. for C23H24D2O4, requires 369.1957, found 369.1957 (Δ = 0.0 ppm);  
170: HRMS (ESI) cal. for C23H26O4, requires 367.1909, found 367.1914 (Δ = 1.4 ppm); 
1
H NMR (CDCl3, 400 MHz) δ 7.29-7.28 (m, 8H), 7.22-7.17 (m, 2H), 6.43 (s, 2H), 6.30 (s, 
2H), 5.22 (s, 2H), 3.35 (d, J = 8.0 Hz, 2H), 3.31-3.29 (m, 4H), 2.91-2.87 (m, 4H), 1.83 (s, 
6H), 1.77 (s, 6H), 1.71 (s, 6H);  
13
C NMR (CDCl3, 100 MHz)  166.9, 160.9, 144.5, 140.2, 128.6, 126.4, 124.6, 120.4, 112.8, 
110.2, 106.7, 101.7, 96.6, 62.5, 40.5, 39.5, 31.7, 27.6, 25.9 (2C), 25.8, 25.6, 24.7.  
 
Deuterated-prenyl-methoxy-resorcylate 172 and prenyl-methoxy-resorcylate 173:  
m.p. 84-86 
o
C (pentane);  
Rf 0.43 (2 : 8 EtOAc : hexanes);  
IR (neat) vmax 2924 (C-H), 2256 (C-H), 1718 (C=O), 1625 (C=C), 1592 (C=C), 1512 (C-C), 
1416, 1393, 1351, 1291, 1244, 1038 cm
-1
; 
172: HRMS (ESI) cal. for C24H26D2O5, 399.2135, found 399.2131 (Δ = 1.0 ppm);  
173: HRMS (ESI) cal. for C24H28O5, 397.2015, found 397.1992 (Δ = 5.8 ppm); 
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1
H NMR (CDCl3, 400 MHz): δ 7.19 (d, J = 8.5 Hz, 4H), 6.82 (d, J = 8.5 Hz, 4H), 6.42 (s, 
2H), 6.37 (s, 2H), 5.21 (br. s, 2H), 3.80 (s, 6H), 3.34 (d, J = 8.0 Hz, 2H), 3.24 (m, 4H), 2.82 
(m, 4H), 1.80 (s, 6H), 1.74 (s, 6H), 1.68 (s, 12H);  
13
C NMR (CDCl3, 100 MHz):  160.6, 160.0, 157.8, 156.2, 146.5, 134.9, 134.1, 129.6 (2C), 
120.9, 113.7 (2C), 113.1, 105.0, 104.7, 55.3, 37.0, 36.5, 25.8, 25.7, 22.0, 17.9. 
 
(E)-3-Methyl-6-(5-(2-methylprop-1-enyl)furan-3-yl)hex-2-enyl 4-(2,2-dimethyl-4-oxo-
4H-1,3-dioxin-6-yl)-3-oxobutanoate (195)
XVI
 
O O
O
O
O
O O
195  
To a solution of CDI (413 mg, 2.55 mmol, 3.0 equiv.) in THF (11 mL) was added alcohol 
275 (200 mg, 0.85 mmol, 1.0 equiv.) in THF (6 mL) at –78 °C. The reaction was allowed to 
warm to rt and stirred for 18 h. The reaction was quenched with H2O (50 mL), extracted with 
Et2O (3 x 50 mL), the organics combined, dried (MgSO4) and concentrated by rotary 
evaporation to afford imidazole carboxylate 287 which was used without further purification. 
i-Pr2NH (0.51 mL, 3.88 mmol, 4.5 equiv.) was stirred in THF (5 mL), n-BuLi in hexanes (1.6 
mL, 2.5 M, 3.88 mmol, 4.5 equiv.) was added dropwise at –78 °C and the resultant solution 
stirred for 30 min. A solution of diketo-dioxinone 178 (344 mg, 1.87 mmol, 2.2 equiv.) in 
THF (2 mL) was added and after 10 min, the reaction (which solidified) was allowed to warm 
to –40 °C and stirred for 1 h. A solution of ZnEt2 in hexanes (3.9 mL, 1.0 M, 3.9 mmol, 4.6 
equiv.) was added and after 20 min, the reaction was cooled to –78 °C and a solution of 
imidazole carboxylate 287 (280 mg, 0.85 mmol, 1.0 equiv.) in THF (3 mL) was added 
                                                          
XVI
 This experiment was carried out by Dr Nicolas George. He is duly thanked for his 
contribution to this research. 
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dropwise. The reaction was stirred at –78°C for 45 min and the reaction was quenched with a 
saturated aqueous solution of NH4Cl (5 mL). The solution was allowed to warm to rt, H2O 
(40 mL) added and the pH adjusted to 3 using 1 M HCl. The two layers were separated and 
the aqueous phase was extracted with Et2O (3 × 50 mL). The combined organic layers were 
dried (MgSO4), concentrated by rotary evaporation and chromatographed (7 : 3 hexanes : 
EtOAc) to afford ketoester-dioxinone 195 (228 mg, 60% over 2 steps) as a light yellow oil: 
Rf 0.44 (6 : 4 hexanes : EtOAc);  
IR (neat) vmax 2987 (C-H), 1722 (C=O), 1639 (C=C), 1390, 1375, 1272, 1253, 1203, 1016 
cm
-1
; 
HRMS (ES) calc. for C25H33O7 [M + H]
+
: requires 445.2226; found 445.2229; 
1
H NMR (CDCl3, 400 MHz) δ 7.11 (s, 1H), 6.98 (s, 1H), 6.05 (s, 1H), 5.38 (s, 1H), 5.36 (m, 
1H), 4.68 (d, J = 7.2 Hz, 2H), 3.53 (s, 2H), 3.51 (s, 2H), 2.38 (t, J = 7.5 Hz, 2H), 2.09 (t, J = 
7.4 Hz, 2H), 1.98 (s, 3H), 1.90 (s, 3H), 1.72–1.67 (m, 11H);  
13
C NMR (CDCl3, 100 MHz) δ 195.7, 166.4, 163.6, 160.5, 153.7, 143.4, 136.8, 135.0, 126.1, 
117.6, 114.5, 108.6, 107.4, 97.1, 62.6, 49.1, 47.0, 38.9, 27.8, 27.0, 25.0 (2C), 24.4, 20.1, 16.4.  
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(E)-7-Hydroxy-2,2,5-trimethyl-8-(3-methyl-6-(5-(2-methylprop-1-enyl)furan-3-yl)hex-2-
enyl)-4H-benzo[d][1,3]dioxin-4-one (193)
XVII
  
HO
O
193
OO
O
 
To a solution of the ketoester-dioxinone 195 (192 mg, 0.43 mmol, 1.0 equiv.) in CH2Cl2 (5 
mL) was added MgCl2 (82 mg, 0.86 mmol, 2.0 equiv.) at –10 °C. After 5 min, pyridine (0.93 
mL, 1.16 mmol, 2.6 equiv.) was added dropwise and the resultant solution stirred for 30 min. 
Acetyl chloride (0.37 mL, 0.52 mmol, 1.15 equiv.) was added dropwise and the resultant 
solution stirred for 30 min. The reaction was quenched with a saturated aqueous solution of 
NH4Cl (25 mL), extracted with CH2Cl2 (3 × 25 mL), the organics combined, washed with 
brine (30 mL), dried (MgSO4) and concentrated by rotary evaporation to afford diketo-ester-
dioxinone 194 which was used without further purification. 
Diketo-ester-dioxinone 194 (159 mg, 0.43 mmol, 1.0 equiv.) was stirred in THF, Pd(PPh3)4 
(24 mg, 22 μmol, 5 mol%) was added and the resultant solution was stirred at rt for 70 h. 
Cs2CO3 (420 mg, 1.29 mmol, 3.0 equiv.) was added and the reaction stirred for 15 h. The 
reaction was quenched with H2O (5 mL) and EtOAc (25 mL) and the pH adjusted to 5 using 
0.1 M HCl. The two layers were separated and the aqueous phase was extracted with EtOAc 
(3 × 25 mL). The combined organic layers were washed with brine (30 mL), dried (MgSO4), 
concentrated by rotary evaporation and chromatographed (8 : 2 hexanes : EtOAc) affording 
isopropylidene protected resorcylate 193 (77 mg, 42% over 2 steps) as a yellow oil: 
Rf 0.52 (7 : 3 hexanes : EtOAc); 
                                                          
XVII
 This experiment was carried out by Dr Nicolas George. He is duly thanked for his 
contribution to this research. 
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IR (neat) vmax 2768 (C-H), 1692 (C=O), 1607 (C=C), 1592 (C-C), 1294, 1276, 1208, 1166, 
1107, 1042, 908, 730 cm
-1
; 
HRMS (ES) calc. for C26H33O5 [M+H]
+
: requires 425.2328, found: 425.2322; 
1
H NMR (CDCl3, 400 MHz) δ 7.08 (s, 1H), 6.97 (br. s, 1H), 6.49 (s, 1H), 6.04 (s, 1H), 6.01 
(s, 1H), 5.21 (t, J = 7.2 Hz, 1H), 3.33 (t, J = 7.5 Hz, 2H), 2.60 (s, 3H), 2.36 (t, J = 7.5 Hz, 
2H), 2.05 (t, J = 7.4 Hz, 2H), 1.97 (s, 3H), 1.89 (s, 3H), 1.80 (s, 3H), 1.72–1.67 (m, 8H); 
3
C NMR (CDCl3, 100 MHz) δ 161.7, 160.4, 156.2, 153.7, 142.6, 137.0, 136.8, 134.8, 126.3, 
121.4, 114.5, 113.6, 113.3, 108.7, 104.9 (2C), 39.2, 28.1, 27.0, 25.7 (2C), 24.4, 22.0, 21.8, 
20.1, 16.1. 
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Cristatic Acid Methyl Ester: (E)-Methyl 2,4-dihydroxy-6-methyl-3-(3-methyl-6-(5-(2-
methylprop-1-enyl)furan-3-yl)hex-2-enyl)benzoate (183)
XVIII
 
O
HO
O OH
OMe
183  
Resorcylate 193 (11 mg, 26 μmol, 1.0 equiv.) was added a solution of NaOMe (6 mg, 0.26 
mmol, 10.0 equiv.) with in methanol (1 mL). The reaction was heated at 65 °C in a sealed 
tube for 20 h. The reaction was quenched with 0.1 M HCl (15 mL) and EtOAc (20 mL). The 
two layers were separated and the aqueous layer was extracted with EtOAc (3 × 20 mL). The 
combined organic layers were washed with brine (10 mL), dried (MgSO4), concentrated by 
rotary evaporation and chromatographed (6 : 1 hexanes : EtOAc) affording Cristatic cid 
methyl ester 183
[6]
 (7 mg, 64%) as a colourless oil: 
Rf 0.42 (4 : 1 hexanes : EtOAc); 
IR (neat) vmax 2865 (C-H), 1651 (C=C), 1620 (C=C), 1455, 1419, 1378, 1272, 1195, 808 cm
-
1
; 
HRMS (ES) calc. for C24H31O5M+H]
+
: requires 399.2171; found: 399.2186 ; 
1
H NMR (CDCl3, 400 MHz) δ 12.13 (s, 1H), 7.10 (s, 1H) 6.25 (s, 1H), 6.06 (s, 1H), 6.03 (m, 
1H), 5.75 (s, 1H), 5.31 (t, J = 7.2 Hz, 1H), 3.95 (s, 3H), 3.45 (d, J = 7.3 Hz, 2H), 2.49 (s, 3H), 
2.37 (t, J = 7.5 Hz, 2H), 2.09 (t, J = 7.5 Hz, 2H), 1.98 (s, 3H) 1.91 (s, 3H) 1.83 (s, 3H), 1.69 
(m, J = 7.6 Hz, 2H);  
13
C NMR (CDCl3, 100 MHz) δ 173.1, 163.0, 159.4, 154.0,141.3, 138.3, 137.1, 135.2, 127.0, 
122.1, 114.8, 112.1, 111.4, 109.1, 105.6, 52.1, 39.5, 28.6, 27.0, 24.7, 24.2, 22.2, 20.2, 16.3.  
                                                          
XVIII
 This experiment was carried out by Dr Nicolas George. He is duly thanked for his 
contribution to this research. 
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6.4 X-Ray Date 
6.4.1 Triclyle 130 
(S)-6-Hydroxy-3,3,9-trimethyl-9,10-dihydro-[1,3]dioxino[5,4-f]isochromene-1,7-dione (130) 
Cambridge CCDC code: SANSIL 
Published: Anderson, K.; Calo, F.; Pfaffeneder, T.; White, A. J. P.; Barrett, A. G. B. Org. 
Lett. 2011, 13, 5748-5750. 
 
Table 22. Crystal data and structure refinement for 130 
Identification code 130  
Formula C14H14O6  
Formula weight 278.25  
Temperature 173(2) K  
Diffractometer, wavelength OD Xcalibur PX Ultra, 1.54184 Å  
Crystal system, space group Monoclinic, P2(1)  
Unit cell dimensions a = 7.72443(17) Å α = 90° 
 b = 8.2531(3) Å β = 96.121(3)° 
 c = 19.2848(7) Å γ = 90° 
Volume, Z 1222.41(7) Å3, 4  
Density (calculated) 1.512 Mg/m3  
Absorption coefficient 1.012 mm-1  
F(000) 584  
Crystal colour / morphology Colourless plates  
Crystal size 0.13 x 0.04 x 0.01 mm3  
θ range for data collection 2.30 to 72.24°  
Index ranges -9<=h<=6, -10<=k<=10, -
23<=l<=23 
 
Reflns collected / unique 8496 / 4644 [R(int) = 0.0608]  
 2902  
Absorption correction Analytical  
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Max. and min. transmission 0.990 and 0.935  
Refinement method Full-matrix least-squares on F2  
Data / restraints / parameters 4644 / 3 / 370  
Goodness-of-fit on F2 0.947  
Final R indices [F>4σ(F)] R1 = 0.0531, wR2 = 0.0933  
 R1+ = 0.0531, wR2+ = 0.0933  
 R1- = 0.0532, wR2- = 0.0935  
R indices (all data) R1 = 0.1073, wR2 = 0.1089  
Absolute structure parameter x+ = 0.1(2), x- = 0.9(2)  
Extinction coefficient 0.00056(12)  
Largest diff. peak, hole 0.252, -0.242 eÅ-3  
Mean and maximum shift/error 0.000 and 0.000  
 
Table 23. Bond lengths [Å] and angles [°] for 130 
C(1A)-O(1A) 1.202(4) 
C(1A)-O(2A) 1.371(4) 
C(1A)-C(14A) 1.477(5) 
O(2A)-C(3A) 1.435(5) 
C(3A)-O(4A) 1.438(5) 
C(3A)-C(16A) 1.507(5) 
C(3A)-C(15A) 1.509(4) 
O(4A)-C(5A) 1.372(4) 
C(5A)-C(6A) 1.370(5) 
C(5A)-C(14A) 1.414(5) 
C(6A)-C(7A) 1.389(5) 
C(7A)-O(17A) 1.346(5) 
C(7A)-C(8A) 1.415(5) 
C(8A)-C(13A) 1.407(6) 
C(8A)-C(9A) 1.468(5) 
C(9A)-O(9A) 1.234(4) 
C(9A)-O(10A) 1.337(5) 
O(10A)-C(11A) 1.471(4) 
C(11A)-C(12A) 1.504(4) 
C(11A)-C(18A) 1.519(5) 
C(12A)-C(13A) 1.501(5) 
C(13A)-C(14A) 1.401(5) 
C(1B)-O(1B) 1.214(4) 
C(1B)-O(2B) 1.361(4) 
C(1B)-C(14B) 1.464(5) 
O(2B)-C(3B) 1.447(4) 
C(3B)-O(4B) 1.436(4) 
C(3B)-C(16B) 1.508(5) 
C(3B)-C(15B) 1.513(4) 
O(4B)-C(5B) 1.363(4) 
C(5B)-C(6B) 1.388(6) 
C(5B)-C(14B) 1.409(5) 
C(6B)-C(7B) 1.376(5) 
C(7B)-O(17B) 1.351(5) 
C(7B)-C(8B) 1.416(5) 
C(8B)-C(13B) 1.395(5) 
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C(8B)-C(9B) 1.467(5) 
C(9B)-O(9B) 1.232(5) 
C(9B)-O(10B) 1.332(5) 
O(10B)-C(11B) 1.471(4) 
C(11B)-C(12B) 1.498(5) 
C(11B)-C(18B) 1.515(5) 
C(12B)-C(13B) 1.504(5) 
C(13B)-C(14B) 1.404(5) 
 
O(1A)-C(1A)-O(2A) 117.4(4) 
O(1A)-C(1A)-C(14A) 127.4(4) 
O(2A)-C(1A)-C(14A) 115.2(4) 
C(1A)-O(2A)-C(3A) 119.8(3) 
O(2A)-C(3A)-O(4A) 109.6(3) 
O(2A)-C(3A)-C(16A) 105.9(3) 
O(4A)-C(3A)-C(16A) 106.1(3) 
O(2A)-C(3A)-C(15A) 111.0(3) 
O(4A)-C(3A)-C(15A) 110.0(3) 
C(16A)-C(3A)-C(15A) 114.0(3) 
C(5A)-O(4A)-C(3A) 114.9(3) 
C(6A)-C(5A)-O(4A) 117.1(4) 
C(6A)-C(5A)-C(14A) 123.0(3) 
O(4A)-C(5A)-C(14A) 119.9(4) 
C(5A)-C(6A)-C(7A) 118.4(4) 
O(17A)-C(7A)-C(6A) 118.2(4) 
O(17A)-C(7A)-C(8A) 121.2(4) 
C(6A)-C(7A)-C(8A) 120.6(4) 
C(13A)-C(8A)-C(7A) 120.3(3) 
C(13A)-C(8A)-C(9A) 120.9(4) 
C(7A)-C(8A)-C(9A) 118.6(4) 
O(9A)-C(9A)-O(10A) 117.3(4) 
O(9A)-C(9A)-C(8A) 122.7(4) 
O(10A)-C(9A)-C(8A) 120.0(4) 
C(9A)-O(10A)-C(11A) 117.7(3) 
O(10A)-C(11A)-C(12A) 111.1(3) 
O(10A)-C(11A)-C(18A) 105.6(3) 
C(12A)-C(11A)-C(18A) 112.8(3) 
C(13A)-C(12A)-C(11A) 111.9(3) 
C(14A)-C(13A)-C(8A) 118.9(4) 
C(14A)-C(13A)-C(12A) 123.9(4) 
C(8A)-C(13A)-C(12A) 117.0(3) 
C(13A)-C(14A)-C(5A) 118.7(4) 
C(13A)-C(14A)-C(1A) 122.4(4) 
C(5A)-C(14A)-C(1A) 118.8(3) 
O(1B)-C(1B)-O(2B) 116.7(4) 
O(1B)-C(1B)-C(14B) 126.9(3) 
O(2B)-C(1B)-C(14B) 116.3(4) 
C(1B)-O(2B)-C(3B) 118.7(3) 
O(4B)-C(3B)-O(2B) 109.3(3) 
O(4B)-C(3B)-C(16B) 107.2(3) 
O(2B)-C(3B)-C(16B) 105.8(3) 
O(4B)-C(3B)-C(15B) 110.9(3) 
O(2B)-C(3B)-C(15B) 110.4(3) 
C(16B)-C(3B)-C(15B) 113.0(3) 
C(5B)-O(4B)-C(3B) 115.4(3) 
O(4B)-C(5B)-C(6B) 116.2(4) 
O(4B)-C(5B)-C(14B) 121.3(4) 
C(6B)-C(5B)-C(14B) 122.4(3) 
C(7B)-C(6B)-C(5B) 118.7(4) 
O(17B)-C(7B)-C(6B) 117.9(4) 
O(17B)-C(7B)-C(8B) 121.5(4) 
C(6B)-C(7B)-C(8B) 120.6(4) 
C(13B)-C(8B)-C(7B) 120.2(4) 
C(13B)-C(8B)-C(9B) 121.5(4) 
C(7B)-C(8B)-C(9B) 118.3(4) 
O(9B)-C(9B)-O(10B) 117.3(4) 
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O(9B)-C(9B)-C(8B) 123.0(4) 
O(10B)-C(9B)-C(8B) 119.7(4) 
C(9B)-O(10B)-C(11B) 117.9(3) 
O(10B)-C(11B)-C(12B) 111.3(3) 
O(10B)-C(11B)-C(18B) 106.0(3) 
C(12B)-C(11B)-C(18B) 113.5(3) 
C(11B)-C(12B)-C(13B) 110.9(3) 
C(8B)-C(13B)-C(14B) 119.8(4) 
C(8B)-C(13B)-C(12B) 116.4(3) 
C(14B)-C(13B)-C(12B) 123.8(3) 
C(13B)-C(14B)-C(5B) 118.3(4) 
C(13B)-C(14B)-C(1B) 123.7(4) 
C(5B)-C(14B)-C(1B) 117.8(3) 
 
Figure 21: X-ray Crystal Structure One of Tricycle 130  
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Figure 22: X-ray Crystal Structure Two of Tricycle 130 
 
6.4.2 Angelicoin A (6) 
((R)-6,8-Dihydroxy-3-methyl-7-(3-methylbut-2-enyl)isochroman-1-one) (6) 
Cambridge CCDC code: SANSEH 
Published: Anderson, K.; Calo, F.; Pfaffeneder, T.; White, A. J. P.; Barrett, A. G. B. Org. 
Lett. 2011, 13, 5748-5750. 
 
Table 24. Crystal Data and Structure Refinement for 6 
Identification code 6  
Formula C15H18O4  
Formula weight 262.29  
Temperature 173 K  
Diffractometer, wavelength OD Xcalibur PX Ultra, 1.54184 Å  
Crystal system, space group Monoclinic, C2  
Unit cell dimensions a = 10.00787(16) Å  α = 90° 
 b = 26.3372(5) Å  β = 99.8553(16)° 
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 c = 10.8051(2) Å γ = 90° 
Volume, Z 2805.97(9) Å3, 8  
Density (calculated) 1.242 Mg/m3  
Absorption coefficient 0.735 mm-1  
F(000) 1120  
Crystal colour / morphology Colourless tablets  
Crystal size 0.18 x 0.09 x 0.04 mm3  
θ range for data collection 3.36 to 72.55°  
Index ranges -12<=h<=9, -31<=k<=32, -
12<=l<=13 
 
Reflns collected / unique 11153 / 5262 [R(int) = 0.0211]  
Reflns observed [F>4σ(F)] 4840  
Absorption correction Analytical  
Max. and min. transmission 0.970 and 0.909  
Refinement method Full-matrix least-squares on F2  
Data / restraints / parameters 5262 / 5 / 364  
Goodness-of-fit on F2 1.049  
Final R indices [F>4σ(F)] R1 = 0.0356, wR2 = 0.0958  
 R1+ = 0.0356, wR2+ = 0.0958  
 R1- = 0.0358, wR2- = 0.0966  
R indices (all data) R1 = 0.0391, wR2 = 0.0993  
Absolute structure parameter x+ = -0.00(15), x- = 1.33(15)  
Extinction coefficient 0.00037(6)  
Largest diff. peak, hole 0.158, -0.127 eÅ-3  
Mean and maximum shift/error 0.000 and 0.001  
 
Table 25. Bond Lengths [Å] and Angles [°] for 6 
O(1A)-C(1A) 1.241(2) 
C(1A)-O(2A) 1.337(2) 
C(1A)-C(10A) 1.441(3) 
O(2A)-C(3A) 1.465(2) 
C(3A)-C(11A) 1.504(3) 
C(3A)-C(4A) 1.511(2) 
C(4A)-C(5A) 1.504(3) 
C(5A)-C(6A) 1.372(3) 
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C(5A)-C(10A) 1.415(2) 
C(6A)-C(7A) 1.405(3) 
C(7A)-O(12A) 1.348(2) 
C(7A)-C(8A) 1.397(2) 
C(8A)-C(9A) 1.392(3) 
C(8A)-C(13A) 1.506(3) 
C(9A)-O(18A) 1.356(2) 
C(9A)-C(10A) 1.403(3) 
C(13A)-C(14A) 1.501(3) 
C(14A)-C(15A) 1.331(3) 
C(15A)-C(16A) 1.499(3) 
C(15A)-C(17A) 1.507(3) 
O(1B)-C(1B) 1.241(2) 
C(1B)-O(2B) 1.328(2) 
C(1B)-C(10B) 1.447(2) 
O(2B)-C(3B) 1.469(2) 
C(3B)-C(4B) 1.508(3) 
C(3B)-C(11B) 1.512(3) 
C(4B)-C(5B) 1.504(3) 
C(5B)-C(6B) 1.376(3) 
C(5B)-C(10B) 1.404(2) 
C(6B)-C(7B) 1.403(3) 
C(7B)-O(12B) 1.347(2) 
C(7B)-C(8B) 1.398(3) 
C(8B)-C(9B) 1.393(3) 
C(8B)-C(13B) 1.508(3) 
C(9B)-O(18B) 1.359(2) 
C(9B)-C(10B) 1.416(3) 
C(13B)-C(14B) 1.500(3) 
C(14B)-C(15B) 1.329(3) 
C(15B)-C(16B) 1.497(3) 
C(15B)-C(17B) 1.500(3) 
O(1A)-C(1A)-O(2A) 115.93(18) 
O(1A)-C(1A)-C(10A) 123.27(19) 
O(2A)-C(1A)-C(10A) 120.79(17) 
C(1A)-O(2A)-C(3A) 119.00(15) 
O(2A)-C(3A)-C(11A) 105.02(16) 
O(2A)-C(3A)-C(4A) 110.78(14) 
C(11A)-C(3A)-C(4A) 114.19(17) 
C(5A)-C(4A)-C(3A) 111.38(15) 
C(6A)-C(5A)-C(10A) 119.54(18) 
C(6A)-C(5A)-C(4A) 122.85(17) 
C(10A)-C(5A)-C(4A) 117.55(17) 
C(5A)-C(6A)-C(7A) 120.30(17) 
O(12A)-C(7A)-C(8A) 116.57(18) 
O(12A)-C(7A)-C(6A) 122.12(16) 
C(8A)-C(7A)-C(6A) 121.31(17) 
C(9A)-C(8A)-C(7A) 118.00(18) 
C(9A)-C(8A)-C(13A) 120.74(17) 
C(7A)-C(8A)-C(13A) 121.26(17) 
O(18A)-C(9A)-C(8A) 117.09(17) 
O(18A)-C(9A)-C(10A) 121.52(17) 
C(8A)-C(9A)-C(10A) 121.38(16) 
C(9A)-C(10A)-C(5A) 119.41(17) 
C(9A)-C(10A)-C(1A) 120.45(16) 
C(5A)-C(10A)-C(1A) 120.09(18) 
C(14A)-C(13A)-C(8A) 111.58(17) 
C(15A)-C(14A)-C(13A) 127.3(2) 
C(14A)-C(15A)-C(16A) 123.8(2) 
C(14A)-C(15A)-C(17A) 121.1(2) 
C(16A)-C(15A)-C(17A) 115.1(2) 
O(1B)-C(1B)-O(2B) 116.93(17) 
O(1B)-C(1B)-C(10B) 122.69(18) 
O(2B)-C(1B)-C(10B) 120.38(16) 
C(1B)-O(2B)-C(3B) 119.65(14) 
O(2B)-C(3B)-C(4B) 110.92(14) 
6 Experimental 
309 
 
O(2B)-C(3B)-C(11B) 104.93(15) 
C(4B)-C(3B)-C(11B) 113.63(17) 
C(5B)-C(4B)-C(3B) 111.41(15) 
C(6B)-C(5B)-C(10B) 119.81(18) 
C(6B)-C(5B)-C(4B) 122.42(16) 
C(10B)-C(5B)-C(4B) 117.71(16) 
C(5B)-C(6B)-C(7B) 120.10(17) 
O(12B)-C(7B)-C(8B) 116.69(17) 
O(12B)-C(7B)-C(6B) 121.51(16) 
C(8B)-C(7B)-C(6B) 121.80(16) 
C(9B)-C(8B)-C(7B) 117.47(18) 
C(9B)-C(8B)-C(13B) 121.12(17) 
C(7B)-C(8B)-C(13B) 121.41(17) 
O(18B)-C(9B)-C(8B) 117.26(17) 
O(18B)-C(9B)-C(10B) 121.22(16) 
C(8B)-C(9B)-C(10B) 121.51(16) 
C(5B)-C(10B)-C(9B) 119.19(16) 
C(5B)-C(10B)-C(1B) 120.45(17) 
C(9B)-C(10B)-C(1B) 120.31(16) 
C(14B)-C(13B)-C(8B) 112.22(15) 
C(15B)-C(14B)-C(13B) 126.96(18) 
C(14B)-C(15B)-C(16B) 124.20(18) 
C(14B)-C(15B)-C(17B) 120.67(19) 
C(16B)-C(15B)-C(17B) 115.12(19) 
 
Figure 23: X-ray Crystal Structure of Angelicoin A (6) 
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6.4.3 Resorcylate 155 
7-Hydroxy-2,2,5-trimethyl-4H-benzo[d][1,3]dioxin-4-one (155) 
 
Table 26. Crystal Data and Structure Refinement for 155 
Identification code 155  
Formula C11H12O4  
Formula weight 208.21  
Temperature 173 K  
Diffractometer, wavelength OD Xcalibur PX Ultra, 
1.54184 Å 
 
Crystal system, space group Monoclinic, P2(1)/c  
Unit cell dimensions a = 8.1052(2) Å α = 90° 
 b = 10.0123(2) Å β = 90.567(2)° 
 c = 11.9529(3) Å γ = 90° 
Volume, Z 969.95(4) Å3, 4  
Density (calculated) 1.426 Mg/m3  
Absorption coefficient 0.913 mm-1  
F(000) 440  
Crystal colour / morphology Colourless platy 
needles 
 
Crystal size 0.11 x 0.03 x 0.01 mm3  
θ range for data collection 5.46 to 72.19°  
Index ranges -9<=h<=9, -9<=k<=12, 
-11<=l<=14 
 
Reflns collected / unique 6427 / 1869 [R(int) = 
0.0302] 
 
Reflns observed [F>4σ(F)] 1599  
Absorption correction Analytical  
Max. and min. transmission 0.997 and 0.943  
Refinement method Full-matrix least-
squares on F2 
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Data / restraints / parameters 1869 / 1 / 141  
Goodness-of-fit on F2 1.198  
Final R indices [F>4 σ (F)] R1 = 0.0463, wR2 = 
0.1269 
 
R indices (all data) R1 = 0.0540, wR2 = 
0.1297 
 
Largest diff. peak, hole 0.296, -0.225 eÅ-3  
Mean and maximum shift/error 0.000 and 0.000  
 
Table 27. Bond Lengths [Å] and Angles [°] for 155 
O(1)-C(10) 1.371(3) 
O(1)-C(2) 1.427(3) 
C(2)-O(3) 1.446(3) 
C(2)-C(12) 1.509(3) 
C(2)-C(11) 1.519(3) 
O(3)-C(4) 1.359(3) 
O(4)-C(4) 1.217(3) 
C(4)-C(5) 1.455(3) 
C(5)-C(10) 1.398(3) 
C(5)-C(6) 1.422(3) 
C(6)-C(7) 1.378(3) 
C(6)-C(13) 1.501(3) 
C(7)-C(8) 1.399(3) 
C(8)-O(14) 1.354(3) 
C(8)-C(9) 1.388(3) 
C(9)-C(10) 1.381(3) 
C(10)-O(1)-C(2) 115.08(17) 
O(1)-C(2)-O(3) 109.41(17) 
O(1)-C(2)-C(12) 106.47(18) 
O(3)-C(2)-C(12) 106.24(19) 
O(1)-C(2)-C(11) 111.44(19) 
O(3)-C(2)-C(11) 109.73(19) 
C(12)-C(2)-C(11) 113.3(2) 
C(4)-O(3)-C(2) 118.98(17) 
O(4)-C(4)-O(3) 116.0(2) 
O(4)-C(4)-C(5) 127.0(2) 
O(3)-C(4)-C(5) 116.83(19) 
C(10)-C(5)-C(6) 118.4(2) 
C(10)-C(5)-C(4) 118.0(2) 
C(6)-C(5)-C(4) 123.5(2) 
C(7)-C(6)-C(5) 118.5(2) 
C(7)-C(6)-C(13) 118.9(2) 
C(5)-C(6)-C(13) 122.6(2) 
C(6)-C(7)-C(8) 121.8(2) 
O(14)-C(8)-C(9) 122.3(2) 
O(14)-C(8)-C(7) 117.5(2) 
C(9)-C(8)-C(7) 120.3(2) 
C(10)-C(9)-C(8) 118.1(2) 
O(1)-C(10)-C(9) 116.8(2) 
O(1)-C(10)-C(5) 120.4(2) 
C(9)-C(10)-C(5) 122.8(2) 
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Figure 24: Crystal Structure of Resorcylate 155 
 
 
6.4.4 Branched Isomer Crystal Structure (149) 
7-Hydroxy-2,2-dimethyl-8-(2-methylbut-3-en-2-yl)-5-phenethyl-4Hbenzo[ 
d][1,3]dioxin-4-one (149)  
Cambridge CCDC code: NAQBOY 
Published: Laclef, S.; Anderson, K.; White, A. J. P.; Barrett, A. G. M. Tetrahedron Letters 
2012, 53, 225–227. 
 
Table 28. Crystal data and structure refinement for 149 
Identification code 149  
Formula C23H26O4  
Formula weight 366.44  
Temperature 173 K  
Diffractometer, wavelength OD Xcalibur PX Ultra, 1.54184 Å  
Crystal system, space group Monoclinic, P2(1)/c  
Unit cell dimensions a = 15.26657(8) Å α = 90° 
 b = 11.06990(8) Å β = 94.2348(5)° 
6 Experimental 
313 
 
 c = 23.94085(15) Å γ = 90° 
Volume, Z 4034.94(4) Å3, 8  
Density (calculated) 1.206 Mg/m3  
Absorption coefficient 0.654 mm-1  
F(000) 1568  
Crystal colour / morphology Colourless needles  
Crystal size 0.26 x 0.09 x 0.04 mm3  
θ range for data collection 2.90 to 72.47°  
Index ranges -18<=h<=18, -13<=k<=13, -29<=l<=19  
Reflns collected / unique 32362 / 7923 [R(int) = 0.0206]  
Reflns observed [F>4 σ (F)] 6771  
Absorption correction Analytical  
Max. and min. transmission 0.977 and 0.896  
Refinement method Full-matrix least-squares on F2  
Data / restraints / parameters 7923 / 121 / 535  
Goodness-of-fit on F2 1.074  
Final R indices [F>4 σ (F)] R1 = 0.0483, wR2 = 0.1340  
R indices (all data) R1 = 0.0559, wR2 = 0.1404  
Extinction coefficient 0.00069(12)  
Largest diff. peak, hole 0.592, -0.324 eÅ-3  
Mean and maximum 
shift/error 
0.000 and 0.001  
 
Table 29. Bond Lengths [Å] and Angles [°] for 149 
O(1A)-C(1A) 1.221(2) 
C(1A)-O(2A) 1.350(2) 
C(1A)-C(10A) 1.462(2) 
O(2A)-C(3A) 1.450(2) 
C(3A)-O(4A) 1.4118(19) 
C(3A)-C(12A) 1.506(2) 
C(3A)-C(11A) 1.508(2) 
O(4A)-C(5A) 1.3678(19) 
C(5A)-C(6A) 1.397(2) 
C(5A)-C(10A) 1.410(2) 
C(6A)-C(7A) 1.408(2) 
C(6A)-C(13') 1.540(10) 
C(6A)-C(13A) 1.566(5) 
C(7A)-O(18A) 1.3506(19) 
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C(7A)-C(8A) 1.399(2) 
C(8A)-C(9A) 1.378(2) 
C(9A)-C(10A) 1.414(2) 
C(9A)-C(19A) 1.514(2) 
C(13A)-C(14A) 1.520(6) 
C(13A)-C(16A) 1.530(6) 
C(13A)-C(17A) 1.541(7) 
C(14A)-C(15A) 1.290(9) 
C(13')-C(14') 1.493(9) 
C(13')-C(16') 1.519(10) 
C(13')-C(17') 1.549(9) 
C(14')-C(15') 1.309(12) 
C(19A)-C(20A) 1.536(2) 
C(20A)-C(21A) 1.505(3) 
C(21A)-C(22A) 1.385(3) 
C(21A)-C(26A) 1.386(2) 
C(22A)-C(23A) 1.388(3) 
C(23A)-C(24A) 1.378(4) 
C(24A)-C(25A) 1.367(3) 
C(25A)-C(26A) 1.383(3) 
O(1B)-C(1B) 1.217(2) 
C(1B)-O(2B) 1.348(2) 
C(1B)-C(10B) 1.462(2) 
O(2B)-C(3B) 1.451(2) 
C(3B)-O(4B) 1.417(2) 
C(3B)-C(11B) 1.505(3) 
C(3B)-C(12B) 1.510(3) 
O(4B)-C(5B) 1.370(2) 
C(5B)-C(6B) 1.399(2) 
C(5B)-C(10B) 1.407(2) 
C(6B)-C(7B) 1.408(2) 
C(6B)-C(13*) 1.529(7) 
C(6B)-C(13") 1.555(12) 
C(6B)-C(13B) 1.570(6) 
C(7B)-O(18B) 1.348(2) 
C(7B)-C(8B) 1.396(2) 
C(8B)-C(9B) 1.379(2) 
C(9B)-C(10B) 1.405(2) 
C(9B)-C(19B) 1.511(2) 
C(13B)-C(17B) 1.505(9) 
C(13B)-C(16B) 1.509(7) 
C(13B)-C(14B) 1.571(9) 
C(14B)-C(15B) 1.279(8) 
C(13")-C(14") 1.529(15) 
C(13")-C(16") 1.532(15) 
C(13")-C(17") 1.546(12) 
C(14")-C(15") 1.246(10) 
C(13*)-C(14*) 1.480(11) 
C(13*)-C(17*) 1.504(10) 
C(13*)-C(16*) 1.610(10) 
C(14*)-C(15*) 1.294(11) 
C(19B)-C(20B) 1.538(2) 
C(20B)-C(21B) 1.509(2) 
C(21B)-C(22B) 1.381(3) 
C(21B)-C(26B) 1.391(2) 
C(22B)-C(23B) 1.381(3) 
C(23B)-C(24B) 1.376(3) 
C(24B)-C(25B) 1.377(3) 
C(25B)-C(26B) 1.386(3) 
O(1A)-C(1A)-O(2A) 116.90(15) 
O(1A)-C(1A)-C(10A) 125.16(16) 
O(2A)-C(1A)-C(10A) 117.91(15) 
C(1A)-O(2A)-C(3A) 118.15(13) 
O(4A)-C(3A)-O(2A) 109.08(13) 
O(4A)-C(3A)-C(12A) 106.14(14) 
O(2A)-C(3A)-C(12A) 106.66(14) 
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O(4A)-C(3A)-C(11A) 111.75(14) 
O(2A)-C(3A)-C(11A) 109.53(14) 
C(12A)-C(3A)-C(11A) 113.45(15) 
C(5A)-O(4A)-C(3A) 115.67(13) 
O(4A)-C(5A)-C(6A) 117.36(15) 
O(4A)-C(5A)-C(10A) 117.73(14) 
C(6A)-C(5A)-C(10A) 124.85(15) 
C(5A)-C(6A)-C(7A) 114.06(15) 
C(5A)-C(6A)-C(13') 122.1(4) 
C(7A)-C(6A)-C(13') 123.3(4) 
C(5A)-C(6A)-C(13A) 124.9(2) 
C(7A)-C(6A)-C(13A) 120.9(2) 
O(18A)-C(7A)-C(8A) 119.27(14) 
O(18A)-C(7A)-C(6A) 118.55(15) 
C(8A)-C(7A)-C(6A) 122.18(15) 
C(9A)-C(8A)-C(7A) 122.56(15) 
C(8A)-C(9A)-C(10A) 117.30(15) 
C(8A)-C(9A)-C(19A) 118.27(14) 
C(10A)-C(9A)-C(19A) 124.38(15) 
C(5A)-C(10A)-C(9A) 118.82(15) 
C(5A)-C(10A)-C(1A) 118.12(15) 
C(9A)-C(10A)-C(1A) 123.00(15) 
C(14A)-C(13A)-C(16A) 111.4(4) 
C(14A)-C(13A)-C(17A) 102.0(4) 
C(16A)-C(13A)-C(17A) 110.5(4) 
C(14A)-C(13A)-C(6A) 113.5(3) 
C(16A)-C(13A)-C(6A) 104.9(4) 
C(17A)-C(13A)-C(6A) 114.6(4) 
C(15A)-C(14A)-C(13A) 128.6(6) 
C(14')-C(13')-C(16') 106.4(6) 
C(14')-C(13')-C(6A) 117.5(7) 
C(16')-C(13')-C(6A) 113.5(6) 
C(14')-C(13')-C(17') 109.3(6) 
C(16')-C(13')-C(17') 109.4(7) 
C(6A)-C(13')-C(17') 100.5(6) 
C(15')-C(14')-C(13') 128.9(10) 
C(9A)-C(19A)-C(20A) 111.19(14) 
C(21A)-C(20A)-C(19A) 112.69(14) 
C(22A)-C(21A)-C(26A) 117.87(18) 
C(22A)-C(21A)-C(20A) 120.96(17) 
C(26A)-C(21A)-C(20A) 121.16(16) 
C(21A)-C(22A)-C(23A) 120.9(2) 
C(24A)-C(23A)-C(22A) 120.2(2) 
C(25A)-C(24A)-C(23A) 119.4(2) 
C(24A)-C(25A)-C(26A) 120.5(2) 
C(25A)-C(26A)-C(21A) 121.07(18) 
O(1B)-C(1B)-O(2B) 116.90(15) 
O(1B)-C(1B)-C(10B) 125.40(17) 
O(2B)-C(1B)-C(10B) 117.69(15) 
C(1B)-O(2B)-C(3B) 118.29(13) 
O(4B)-C(3B)-O(2B) 109.06(15) 
O(4B)-C(3B)-C(11B) 106.16(18) 
O(2B)-C(3B)-C(11B) 106.19(16) 
O(4B)-C(3B)-C(12B) 112.02(16) 
O(2B)-C(3B)-C(12B) 109.38(18) 
C(11B)-C(3B)-C(12B) 113.78(19) 
C(5B)-O(4B)-C(3B) 115.04(14) 
O(4B)-C(5B)-C(6B) 117.32(15) 
O(4B)-C(5B)-C(10B) 117.79(15) 
C(6B)-C(5B)-C(10B) 124.86(16) 
C(5B)-C(6B)-C(7B) 114.09(15) 
C(5B)-C(6B)-C(13*) 117.5(3) 
C(7B)-C(6B)-C(13*) 127.6(3) 
C(5B)-C(6B)-C(13") 121.7(5) 
C(7B)-C(6B)-C(13") 124.3(5) 
C(5B)-C(6B)-C(13B) 122.1(3) 
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C(7B)-C(6B)-C(13B) 123.7(3) 
O(18B)-C(7B)-C(8B) 119.13(15) 
O(18B)-C(7B)-C(6B) 119.11(15) 
C(8B)-C(7B)-C(6B) 121.76(15) 
C(9B)-C(8B)-C(7B) 122.89(15) 
C(8B)-C(9B)-C(10B) 117.31(15) 
C(8B)-C(9B)-C(19B) 118.01(15) 
C(10B)-C(9B)-C(19B) 124.66(14) 
C(9B)-C(10B)-C(5B) 118.85(15) 
C(9B)-C(10B)-C(1B) 123.01(15) 
C(5B)-C(10B)-C(1B) 118.06(15) 
C(17B)-C(13B)-C(16B) 111.5(6) 
C(17B)-C(13B)-C(6B) 110.3(5) 
C(16B)-C(13B)-C(6B) 116.9(4) 
C(17B)-C(13B)-C(14B) 111.9(5) 
C(16B)-C(13B)-C(14B) 100.5(5) 
C(6B)-C(13B)-C(14B) 105.2(5) 
C(15B)-C(14B)-C(13B) 125.5(6) 
C(14")-C(13")-C(16") 110.3(8) 
C(14")-C(13")-C(17") 105.6(9) 
C(16")-C(13")-C(17") 110.3(10) 
C(14")-C(13")-C(6B) 109.8(9) 
C(16")-C(13")-C(6B) 105.3(9) 
C(17")-C(13")-C(6B) 115.6(7) 
C(15")-C(14")-C(13") 128.1(8) 
C(14*)-C(13*)-C(17*) 109.0(7) 
C(14*)-C(13*)-C(6B) 111.6(6) 
C(17*)-C(13*)-C(6B) 121.8(6) 
C(14*)-C(13*)-C(16*) 107.3(6) 
C(17*)-C(13*)-C(16*) 102.8(7) 
C(6B)-C(13*)-C(16*) 102.8(6) 
C(15*)-C(14*)-C(13*) 118.2(8) 
C(9B)-C(19B)-C(20B) 109.47(14) 
C(21B)-C(20B)-C(19B) 113.90(15) 
C(22B)-C(21B)-C(26B) 118.12(16) 
C(22B)-C(21B)-C(20B) 120.97(16) 
C(26B)-C(21B)-C(20B) 120.90(17) 
C(23B)-C(22B)-C(21B) 121.21(17) 
C(24B)-C(23B)-C(22B) 120.06(18) 
C(23B)-C(24B)-C(25B) 119.82(17) 
C(24B)-C(25B)-C(26B) 119.97(17) 
C(25B)-C(26B)-C(21B) 120.77(18) 
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Figure 25: X-ray Crystal Structure One of Branched Isomer 149 
 
Figure 26: X-ray Crystal Structure Two of Branched Isomer 149 
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